{"parse":{"title":"Thalidomide","pageid":51078,"revid":860300017,"text":{"*":"<div class=\"mw-parser-output\"><table class=\"infobox\" style=\"width:22em;border-spacing:2px;\"><caption><span title=\"International nonproprietary name (INN): Thalidomide\">Thalidomide</span></caption><tbody><tr><td colspan=\"2\" style=\"text-align:center\">\n<a href=\"/wiki/File:Thalidomide_enantiomers.svg\" class=\"image\"><img alt=\"Thalidomide enantiomers.svg\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/0/08/Thalidomide_enantiomers.svg/200px-Thalidomide_enantiomers.svg.png\" width=\"200\" height=\"242\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/0/08/Thalidomide_enantiomers.svg/300px-Thalidomide_enantiomers.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/0/08/Thalidomide_enantiomers.svg/400px-Thalidomide_enantiomers.svg.png 2x\" data-file-width=\"545\" data-file-height=\"660\" /></a></td></tr><tr><th colspan=\"2\" style=\"text-align:center;background:#ddd\">Clinical data</th></tr><tr><th scope=\"row\" style=\"padding:0.2em 0; line-height:1.2em;\">Pronunciation</th><td>\n<span class=\"nowrap\"><span class=\"IPA nopopups noexcerpt\"><a href=\"/wiki/Help:IPA/English\" title=\"Help:IPA/English\">/<span style=\"border-bottom:1px dotted\"><span title=\"/\u03b8/: &#39;th&#39; in &#39;thigh&#39;\">\u03b8</span><span title=\"/\u0259/: &#39;a&#39; in &#39;about&#39;\">\u0259</span><span title=\"/\u02c8/: primary stress follows\">\u02c8</span><span title=\"&#39;l&#39; in &#39;lie&#39;\">l</span><span title=\"/\u026a/: &#39;i&#39; in &#39;kit&#39;\">\u026a</span><span title=\"&#39;d&#39; in &#39;dye&#39;\">d</span><span title=\"/\u0259/: &#39;a&#39; in &#39;about&#39;\">\u0259</span><span title=\"&#39;m&#39; in &#39;my&#39;\">m</span><span title=\"/a\u026a/: &#39;i&#39; in &#39;tide&#39;\">a\u026a</span><span title=\"&#39;d&#39; in &#39;dye&#39;\">d</span></span>/</a></span></span><sup id=\"cite_ref-1\" class=\"reference\"><a href=\"#cite_note-1\">&#91;1&#93;</a></sup>&#x20;</td></tr><tr><th scope=\"row\" style=\"padding:0.2em 0; line-height:1.2em;\"><a href=\"/wiki/Drug_nomenclature#Trade_names\" title=\"Drug nomenclature\">Trade names</a></th><td>\nContergan, Thalomid, Immunoprin, Talidex, Talizer, Neurosedyn, Distaval and many others</td></tr><tr><th scope=\"row\" style=\"padding:0.2em 0; line-height:1.2em;\">Synonyms</th><td>\n\u03b1-(N-Phthalimido)glutarimide</td></tr><tr><th scope=\"row\" style=\"padding:0.2em 0; line-height:1.2em;\"><a href=\"/wiki/American_Society_of_Health-System_Pharmacists\" title=\"American Society of Health-System Pharmacists\">AHFS</a>/<a href=\"/wiki/Drugs.com\" title=\"Drugs.com\">Drugs.com</a></th><td>\n<span title=\"www.drugs.com\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.drugs.com/monograph/thalidomide.html\">Monograph</a></span></td></tr><tr><th scope=\"row\" style=\"padding:0.2em 0; line-height:1.2em;\"><a href=\"/wiki/MedlinePlus\" title=\"MedlinePlus\">MedlinePlus</a></th><td>\n<span title=\"medlineplus.gov\"><a rel=\"nofollow\" class=\"external text\" href=\"https://medlineplus.gov/druginfo/meds/a699032.html\">a699032</a></span></td></tr><tr><th scope=\"row\" style=\"padding:0.2em 0; line-height:1.2em;\"><a href=\"/wiki/Regulation_of_therapeutic_goods\" title=\"Regulation of therapeutic goods\">License data</a></th><td>\n<div class=\"plainlist\">\n<ul><li><small><abbr class=\"country-name\" title=\"European Union\">EU</abbr></small>&#160;<a href=\"/wiki/European_Medicines_Agency\" title=\"European Medicines Agency\">EMA</a>:&#160;<span title=\"www.ema.europa.eu: &#39;Thalidomide&#39;\"><a rel=\"nofollow\" class=\"external text\" href=\"http://www.ema.europa.eu/ema/index.jsp?curl=%2Fpages%2Fmedicines%2Flanding%2Fepar_search.jsp&amp;mid=&amp;searchTab=searchByKey&amp;alreadyLoaded=true&amp;isNewQuery=true&amp;status=Authorised&amp;status=Withdrawn&amp;status=Suspended&amp;status=Refused&amp;keywordSearch=Submit&amp;searchType=inn&amp;taxonomyPath=&amp;treeNumber=&amp;searchGenericType=generics&amp;keyword=Thalidomide\">by INN</a></span></li>\n<li><small><abbr class=\"country-name\" title=\"United States\">US</abbr></small>&#160;<span title=\"www.accessdata.fda.gov\"><a href=\"/wiki/U.S._Food_and_Drug_Administration\" class=\"mw-redirect\" title=\"U.S. Food and Drug Administration\">FDA</a>:&#160;<a rel=\"nofollow\" class=\"external text\" href=\"https://www.accessdata.fda.gov/scripts/cder/drugsatfda/index.cfm?fuseaction=Search.SearchAction&amp;SearchTerm=Thalidomide&amp;SearchType=BasicSearch\">Thalidomide</a></span></li></ul></div>\n</td></tr><tr><th scope=\"row\" style=\"padding:0.2em 0; line-height:1.2em;\"><a href=\"/wiki/Pregnancy_category\" title=\"Pregnancy category\">Pregnancy<br />category</a></th><td>\n<div class=\"plainlist\">\n<ul><li><small><abbr class=\"country-name\" title=\"\">AU</abbr>:</small>&#x20;<a href=\"/wiki/Pregnancy_category#Australia\" title=\"Pregnancy category\">X</a> (High risk)&#x20;</li>\n<li><small><abbr class=\"country-name\" title=\"United States\">US</abbr>:</small>&#x20;<a href=\"/wiki/Pregnancy_category#United_States\" title=\"Pregnancy category\">X</a> (Contraindicated)&#x20;</li></ul>\n<ul><li class=\"mw-empty-elt\"></li></ul>\n</div></td></tr><tr><th scope=\"row\" style=\"padding:0.2em 0; line-height:1.2em;\"><a href=\"/wiki/Route_of_administration\" title=\"Route of administration\">Routes of<br />administration</a></th><td>\nBy mouth (<a href=\"/wiki/Capsule_(pharmacy)\" title=\"Capsule (pharmacy)\">capsules</a>)</td></tr><tr><th scope=\"row\" style=\"padding:0.2em 0; line-height:1.2em;\"><a href=\"/wiki/Anatomical_Therapeutic_Chemical_Classification_System\" title=\"Anatomical Therapeutic Chemical Classification System\">ATC code</a></th><td>\n<div class=\"plainlist\"><ul><li><a href=\"/wiki/ATC_code_L04\" title=\"ATC code L04\">L04AX02</a>&#x20;(<span title=\"www.whocc.no\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.whocc.no/atc_ddd_index/?code=L04AX02\">WHO</a></span>)&#x20;</li></ul></div></td></tr><tr><th colspan=\"2\" style=\"text-align:center;background:#ddd\">Legal status</th></tr><tr><th scope=\"row\" style=\"padding:0.2em 0; line-height:1.2em;\"><a href=\"/wiki/Regulation_of_therapeutic_goods\" title=\"Regulation of therapeutic goods\">Legal status</a></th><td>\n<div class=\"plainlist\">\n<ul><li><small><abbr class=\"country-name\" title=\"Australia\">AU</abbr>:</small>&#x20;<a href=\"/wiki/Standard_for_the_Uniform_Scheduling_of_Drugs_and_Poisons#Schedule_4_Prescription_Only_Medicine\" class=\"mw-redirect\" title=\"Standard for the Uniform Scheduling of Drugs and Poisons\">S4</a> (Prescription only)&#x20;</li>\n<li><small><abbr class=\"country-name\" title=\"Canada\">CA</abbr></small>:&#x20;<a href=\"/wiki/Prescription_drug\" title=\"Prescription drug\"> \u211e-only</a>&#x20;</li>\n<li><small><abbr class=\"country-name\" title=\"United Kingdom\">UK</abbr>:</small>&#x20;<a href=\"/wiki/Prescription_drug\" title=\"Prescription drug\">POM</a> (Prescription only)&#x20;</li>\n<li><small><abbr class=\"country-name\" title=\"United States\">US</abbr>:</small>&#x20;<a href=\"/wiki/Prescription_drug\" title=\"Prescription drug\">\u211e-only</a>&#x20;</li></ul></div>\n</td></tr><tr><th colspan=\"2\" style=\"text-align:center;background:#ddd\"><a href=\"/wiki/Pharmacokinetics\" title=\"Pharmacokinetics\">Pharmacokinetic</a> data</th></tr><tr><th scope=\"row\" style=\"padding:0.2em 0; line-height:1.2em;\"><a href=\"/wiki/Bioavailability\" title=\"Bioavailability\">Bioavailability</a></th><td>\n90%</td></tr><tr><th scope=\"row\" style=\"padding:0.2em 0; line-height:1.2em;\"><a href=\"/wiki/Plasma_protein_binding\" title=\"Plasma protein binding\">Protein binding</a></th><td>\n55% and 66% for the (<i>R</i>)-(+)- and (<i>S</i>)-(\u2212)-enantiomers, respectively<sup id=\"cite_ref-clinp_2-1\" class=\"reference\"><a href=\"#cite_note-clinp-2\">&#91;2&#93;</a></sup></td></tr><tr><th scope=\"row\" style=\"padding:0.2em 0; line-height:1.2em;\"><a href=\"/wiki/Drug_metabolism\" title=\"Drug metabolism\">Metabolism</a></th><td>\n<a href=\"/wiki/Liver\" title=\"Liver\">Liver</a> (minimally via <a href=\"/wiki/CYP2C19\" title=\"CYP2C19\">CYP2C19</a>-mediated 5-hydroxylation; mostly via non-enzymatic hydrolysis at the four amide sites)<sup id=\"cite_ref-clinp_2-0\" class=\"reference\"><a href=\"#cite_note-clinp-2\">&#91;2&#93;</a></sup></td></tr><tr><th scope=\"row\" style=\"padding:0.2em 0; line-height:1.2em;\"><a href=\"/wiki/Biological_half-life\" title=\"Biological half-life\">Elimination <span class=\"nowrap\">half-life</span></a></th><td>\n5\u20137.5 hours (dose-dependent)<sup id=\"cite_ref-clinp_2-2\" class=\"reference\"><a href=\"#cite_note-clinp-2\">&#91;2&#93;</a></sup></td></tr><tr><th scope=\"row\" style=\"padding:0.2em 0; line-height:1.2em;\"><a href=\"/wiki/Excretion\" title=\"Excretion\">Excretion</a></th><td>\nUrine, faeces<sup id=\"cite_ref-clinp_2-3\" class=\"reference\"><a href=\"#cite_note-clinp-2\">&#91;2&#93;</a></sup></td></tr><tr><th colspan=\"2\" style=\"text-align:center;background:#ddd\">Identifiers</th></tr><tr><td colspan=\"2\" style=\"text-align:center\">\n<div class=\"NavFrame collapsed\" style=\"border: none; padding: 0;\">\n<div class=\"NavHead\" style=\"font-size: 105%; background: transparent; text-align: left;\"><a href=\"/wiki/IUPAC_nomenclature_of_chemistry\" title=\"IUPAC nomenclature of chemistry\">IUPAC name</a></div>\n<ul class=\"NavContent\" style=\"list-style: none none; margin-left: 0; word-break:break-all; text-align:left; padding-left:1.5em; text-indent:-1.5em; font-size: 105%; margin-top: 0; margin-bottom: 0; line-height: inherit;\"><li style=\"line-height: inherit; margin: 0\"><span style=\"font-size: 11px;\">2-(2,6-dioxopiperidin-3-yl)-2,3-dihydro-1<i>H</i>-isoindole-1,3-dione</span></li></ul>\n</div></td></tr><tr><th scope=\"row\" style=\"padding:0.2em 0; line-height:1.2em;\"><a href=\"/wiki/CAS_Registry_Number\" title=\"CAS Registry Number\">CAS Number</a></th><td>\n<div class=\"plainlist\"><ul><li><span title=\"www.commonchemistry.org\"><a rel=\"nofollow\" class=\"external text\" href=\"http://www.commonchemistry.org/ChemicalDetail.aspx?ref=50-35-1\">50-35-1</a></span><sup>&#160;<img alt=\"\u2611\" src=\"//upload.wikimedia.org/wikipedia/en/thumb/f/fb/Yes_check.svg/7px-Yes_check.svg.png\" width=\"7\" height=\"7\" srcset=\"//upload.wikimedia.org/wikipedia/en/thumb/f/fb/Yes_check.svg/11px-Yes_check.svg.png 1.5x, //upload.wikimedia.org/wikipedia/en/thumb/f/fb/Yes_check.svg/14px-Yes_check.svg.png 2x\" data-file-width=\"600\" data-file-height=\"600\" /><span style=\"display:none\">Y</span></sup></li></ul></div></td></tr><tr><th scope=\"row\" style=\"padding:0.2em 0; line-height:1.2em;\"><a href=\"/wiki/PubChem#CID\" title=\"PubChem\">PubChem</a> <span style=\"font-weight:normal\"><abbr title=\"Compound ID\">CID</abbr></span></th><td>\n<div class=\"plainlist\"><ul><li><span title=\"pubchem.ncbi.nlm.nih.gov\"><a rel=\"nofollow\" class=\"external text\" href=\"https://pubchem.ncbi.nlm.nih.gov/compound/5426\">5426</a></span></li></ul></div></td></tr><tr><th scope=\"row\" style=\"padding:0.2em 0; line-height:1.2em;\"><a href=\"/wiki/Guide_to_Pharmacology\" title=\"Guide to Pharmacology\">IUPHAR/BPS</a></th><td>\n<div class=\"plainlist\"><ul><li><span title=\"www.guidetopharmacology.org\"><a rel=\"nofollow\" class=\"external text\" href=\"http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7327\">7327</a></span></li></ul></div></td></tr><tr><th scope=\"row\" style=\"padding:0.2em 0; line-height:1.2em;\"><a href=\"/wiki/DrugBank\" title=\"DrugBank\">DrugBank</a></th><td>\n<div class=\"plainlist\"><ul><li><span title=\"www.drugbank.ca\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.drugbank.ca/drugs/DB01041\">DB01041</a></span><sup>&#160;<img alt=\"\u2611\" src=\"//upload.wikimedia.org/wikipedia/en/thumb/f/fb/Yes_check.svg/7px-Yes_check.svg.png\" width=\"7\" height=\"7\" srcset=\"//upload.wikimedia.org/wikipedia/en/thumb/f/fb/Yes_check.svg/11px-Yes_check.svg.png 1.5x, //upload.wikimedia.org/wikipedia/en/thumb/f/fb/Yes_check.svg/14px-Yes_check.svg.png 2x\" data-file-width=\"600\" data-file-height=\"600\" /><span style=\"display:none\">Y</span></sup></li></ul></div></td></tr><tr><th scope=\"row\" style=\"padding:0.2em 0; line-height:1.2em;\"><a href=\"/wiki/ChemSpider\" title=\"ChemSpider\">ChemSpider</a></th><td>\n<div class=\"plainlist\"><ul><li><span title=\"www.chemspider.com\"><a rel=\"nofollow\" class=\"external text\" href=\"http://www.chemspider.com/Chemical-Structure.5233.html\">5233</a></span><sup>&#160;<img alt=\"\u2611\" src=\"//upload.wikimedia.org/wikipedia/en/thumb/f/fb/Yes_check.svg/7px-Yes_check.svg.png\" width=\"7\" height=\"7\" srcset=\"//upload.wikimedia.org/wikipedia/en/thumb/f/fb/Yes_check.svg/11px-Yes_check.svg.png 1.5x, //upload.wikimedia.org/wikipedia/en/thumb/f/fb/Yes_check.svg/14px-Yes_check.svg.png 2x\" data-file-width=\"600\" data-file-height=\"600\" /><span style=\"display:none\">Y</span></sup></li></ul></div></td></tr><tr><th scope=\"row\" style=\"padding:0.2em 0; line-height:1.2em;\"><a href=\"/wiki/Unique_Ingredient_Identifier\" title=\"Unique Ingredient Identifier\">UNII</a></th><td>\n<div class=\"plainlist\"><ul><li><span title=\"fdasis.nlm.nih.gov\"><a rel=\"nofollow\" class=\"external text\" href=\"https://fdasis.nlm.nih.gov/srs/srsdirect.jsp?regno=4Z8R6ORS6L\">4Z8R6ORS6L</a></span></li></ul></div></td></tr><tr><th scope=\"row\" style=\"padding:0.2em 0; line-height:1.2em;\"><a href=\"/wiki/KEGG\" title=\"KEGG\">KEGG</a></th><td>\n<div class=\"plainlist\"><ul><li><span title=\"www.kegg.jp\"><a rel=\"nofollow\" class=\"external text\" href=\"http://www.kegg.jp/entry/D00754\">D00754</a></span><sup>&#160;<img alt=\"\u2611\" src=\"//upload.wikimedia.org/wikipedia/en/thumb/f/fb/Yes_check.svg/7px-Yes_check.svg.png\" width=\"7\" height=\"7\" srcset=\"//upload.wikimedia.org/wikipedia/en/thumb/f/fb/Yes_check.svg/11px-Yes_check.svg.png 1.5x, //upload.wikimedia.org/wikipedia/en/thumb/f/fb/Yes_check.svg/14px-Yes_check.svg.png 2x\" data-file-width=\"600\" data-file-height=\"600\" /><span style=\"display:none\">Y</span></sup></li></ul></div></td></tr><tr><th scope=\"row\" style=\"padding:0.2em 0; line-height:1.2em;\"><a href=\"/wiki/ChEBI\" title=\"ChEBI\">ChEBI</a></th><td>\n<div class=\"plainlist\"><ul><li><span title=\"www.ebi.ac.uk\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI:9513\">CHEBI:9513</a></span><sup>&#160;<img alt=\"\u2612\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/a/a2/X_mark.svg/7px-X_mark.svg.png\" width=\"7\" height=\"8\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/a/a2/X_mark.svg/11px-X_mark.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/a/a2/X_mark.svg/14px-X_mark.svg.png 2x\" data-file-width=\"525\" data-file-height=\"600\" /><span style=\"display:none\">N</span></sup></li></ul></div></td></tr><tr><th scope=\"row\" style=\"padding:0.2em 0; line-height:1.2em;\"><a href=\"/wiki/ChEMBL\" title=\"ChEMBL\">ChEMBL</a></th><td>\n<div class=\"plainlist\"><ul><li><span title=\"www.ebi.ac.uk\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.ebi.ac.uk/chembldb/index.php/compound/inspect/CHEMBL468\">CHEMBL468</a></span><sup>&#160;<img alt=\"\u2611\" src=\"//upload.wikimedia.org/wikipedia/en/thumb/f/fb/Yes_check.svg/7px-Yes_check.svg.png\" width=\"7\" height=\"7\" srcset=\"//upload.wikimedia.org/wikipedia/en/thumb/f/fb/Yes_check.svg/11px-Yes_check.svg.png 1.5x, //upload.wikimedia.org/wikipedia/en/thumb/f/fb/Yes_check.svg/14px-Yes_check.svg.png 2x\" data-file-width=\"600\" data-file-height=\"600\" /><span style=\"display:none\">Y</span></sup></li></ul></div></td></tr><tr><th scope=\"row\" style=\"padding:0.2em 0; line-height:1.2em;\"><a href=\"/wiki/ECHA_InfoCard\" class=\"mw-redirect\" title=\"ECHA InfoCard\"><span title=\"echa.europa.eu\">ECHA InfoCard</span></a></th><td>\n<a rel=\"nofollow\" class=\"external text\" href=\"https://echa.europa.eu/substance-information/-/substanceinfo/100.000.029\">100.000.029</a> <a href=\"https://www.wikidata.org/wiki/Q203174#P2566\" title=\"Edit this at Wikidata\"><img alt=\"Edit this at Wikidata\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/7/73/Blue_pencil.svg/10px-Blue_pencil.svg.png\" width=\"10\" height=\"10\" style=\"vertical-align: text-top\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/7/73/Blue_pencil.svg/15px-Blue_pencil.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/7/73/Blue_pencil.svg/20px-Blue_pencil.svg.png 2x\" data-file-width=\"600\" data-file-height=\"600\" /></a></td></tr><tr><th colspan=\"2\" style=\"text-align:center;background:#ddd\">Chemical and physical data</th></tr><tr><th scope=\"row\" style=\"padding:0.2em 0; line-height:1.2em;\"><a href=\"/wiki/Chemical_formula\" title=\"Chemical formula\">Formula</a></th><td>\n<span title=\"Carbon\">C</span><sub>13</sub><span title=\"Hydrogen\">H</span><sub>10</sub><span title=\"Nitrogen\">N</span><sub>2</sub><span title=\"Oxygen\">O</span><sub>4</sub></td></tr><tr><th scope=\"row\" style=\"padding:0.2em 0; line-height:1.2em;\"><a href=\"/wiki/Molar_mass\" title=\"Molar mass\">Molar mass</a></th><td>\n258.23&#160;g\u00b7mol<sup>\u22121</sup></td></tr><tr><th scope=\"row\" style=\"padding:0.2em 0; line-height:1.2em;\">3D model (<a href=\"/wiki/JSmol\" class=\"mw-redirect\" title=\"JSmol\">JSmol</a>)</th><td>\n<div class=\"plainlist\"><ul><li><span title=\"chemapps.stolaf.edu (3D interactive model)\"><a rel=\"nofollow\" class=\"external text\" href=\"https://chemapps.stolaf.edu/jmol/jmol.php?model=O%3DC%28N1C2CCC%28NC2%3DO%29%3DO%29C3%3DCC%3DCC%3DC3C1%3DO\">Interactive image</a></span></li></ul></div></td></tr><tr><th scope=\"row\" style=\"padding:0.2em 0; line-height:1.2em;\"><a href=\"/wiki/Chirality_(chemistry)\" title=\"Chirality (chemistry)\">Chirality</a></th><td>\nRacemic mixture</td></tr><tr><td colspan=\"2\" style=\"text-align:center\">\n<div class=\"NavFrame collapsed\" style=\"border: none; padding: 0;\">\n<div class=\"NavHead\" style=\"font-size: 105%; background: transparent; text-align: left;\"><a href=\"/wiki/Simplified_molecular-input_line-entry_system\" title=\"Simplified molecular-input line-entry system\">SMILES</a></div>\n<ul class=\"NavContent\" style=\"list-style: none none; margin-left: 0; word-break:break-all; font-size: 105%; margin-top: 0; margin-bottom: 0; line-height: inherit;\"><li style=\"line-height: inherit; margin: 0\"><div style=\"word-wrap:break-word; text-indent:-1.5em; text-align:left; padding-left:1.5em; font-size:11px; line-height:120%;\">O=C(N1C2CCC(NC2=O)=O)C3=CC=CC=C3C1=O</div></li></ul>\n</div></td></tr><tr><td colspan=\"2\" style=\"text-align:center\">\n<div class=\"NavFrame collapsed\" style=\"border: none; padding: 0;\">\n<div class=\"NavHead\" style=\"font-size: 105%; background: transparent; text-align: left;\"><a href=\"/wiki/International_Chemical_Identifier\" title=\"International Chemical Identifier\">InChI</a></div>\n<ul class=\"NavContent\" style=\"list-style: none none; margin-left: 0; word-break:break-all; font-size: 105%; margin-top: 0; margin-bottom: 0; line-height: inherit;\"><li style=\"line-height: inherit; margin: 0\"><div style=\"word-wrap:break-word; text-indent:-1.5em; text-align:left; padding-left:1.5em; font-size:11px; line-height:120%;\">InChI=1S/C13H10N2O4/c16-10-6-5-9(11(17)14-10)15-12(18)7-3-1-2-4-8(7)13(15)19/h1-4,9H,5-6H2,(H,14,16,17)<sup>&#160;<img alt=\"\u2611\" src=\"//upload.wikimedia.org/wikipedia/en/thumb/f/fb/Yes_check.svg/7px-Yes_check.svg.png\" width=\"7\" height=\"7\" srcset=\"//upload.wikimedia.org/wikipedia/en/thumb/f/fb/Yes_check.svg/11px-Yes_check.svg.png 1.5x, //upload.wikimedia.org/wikipedia/en/thumb/f/fb/Yes_check.svg/14px-Yes_check.svg.png 2x\" data-file-width=\"600\" data-file-height=\"600\" /><span style=\"display:none\">Y</span></sup></div></li><li style=\"line-height: inherit; margin: 0\"><div style=\"word-wrap:break-word; text-indent:-1.5em; text-align:left; padding-left:1.5em; font-size:11px; line-height:120%;\">Key:UEJJHQNACJXSKW-UHFFFAOYSA-N<sup>&#160;<img alt=\"\u2611\" src=\"//upload.wikimedia.org/wikipedia/en/thumb/f/fb/Yes_check.svg/7px-Yes_check.svg.png\" width=\"7\" height=\"7\" srcset=\"//upload.wikimedia.org/wikipedia/en/thumb/f/fb/Yes_check.svg/11px-Yes_check.svg.png 1.5x, //upload.wikimedia.org/wikipedia/en/thumb/f/fb/Yes_check.svg/14px-Yes_check.svg.png 2x\" data-file-width=\"600\" data-file-height=\"600\" /><span style=\"display:none\">Y</span></sup></div></li></ul>\n</div></td></tr><tr><th colspan=\"2\" style=\"text-align:center;background:#ddd\"><span style=\"font-weight:normal;\">&#160;<sup><img alt=\"\u2612\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/a/a2/X_mark.svg/7px-X_mark.svg.png\" width=\"7\" height=\"8\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/a/a2/X_mark.svg/11px-X_mark.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/a/a2/X_mark.svg/14px-X_mark.svg.png 2x\" data-file-width=\"525\" data-file-height=\"600\" /><span style=\"display:none\">N</span><img alt=\"\u2611\" src=\"//upload.wikimedia.org/wikipedia/en/thumb/f/fb/Yes_check.svg/7px-Yes_check.svg.png\" width=\"7\" height=\"7\" srcset=\"//upload.wikimedia.org/wikipedia/en/thumb/f/fb/Yes_check.svg/11px-Yes_check.svg.png 1.5x, //upload.wikimedia.org/wikipedia/en/thumb/f/fb/Yes_check.svg/14px-Yes_check.svg.png 2x\" data-file-width=\"600\" data-file-height=\"600\" /><span style=\"display:none\">Y</span></sup>&#160;<a href=\"/wiki/Wikipedia:WikiProject_Chemicals/Chembox_validation\" title=\"Wikipedia:WikiProject Chemicals/Chembox validation\">(what is this?)</a></span><span style=\"font-weight:normal;\">&#160;&#160;<span class=\"reflink plainlinks nourlexpansion\"><a class=\"external text\" href=\"//en.wikipedia.org/w/index.php?title=Special:ComparePages&amp;rev1=420478187&amp;page2=Thalidomide\">(verify)</a></span></span></th></tr></tbody></table>\n<p><b>Thalidomide</b>, sold under the brand name <b>Immunoprin</b>, among others, is an <a href=\"/wiki/Immunotherapy\" title=\"Immunotherapy\">immunomodulatory drug</a> and the prototype of the <a href=\"/wiki/Discovery_and_development_of_thalidomide_and_its_analogs\" class=\"mw-redirect\" title=\"Discovery and development of thalidomide and its analogs\">thalidomide class of drugs</a>. Today, thalidomide is used mainly as a treatment of certain cancers (<a href=\"/wiki/Multiple_myeloma\" title=\"Multiple myeloma\">multiple myeloma</a>) and of a complication of <a href=\"/wiki/Leprosy\" title=\"Leprosy\">leprosy</a>.\n</p><p>Thalidomide was first marketed in 1957 in <a href=\"/wiki/West_Germany\" title=\"West Germany\">West Germany</a> under the trade name <b>Contergan</b>. The German drug company <a href=\"/wiki/Gr%C3%BCnenthal\" title=\"Gr\u00fcnenthal\">Chemie Gr\u00fcnenthal</a> developed and sold the drug. Primarily prescribed as a <a href=\"/wiki/Sedative\" title=\"Sedative\">sedative</a> or <a href=\"/wiki/Hypnotic\" title=\"Hypnotic\">hypnotic</a>, thalidomide also claimed to cure \"<a href=\"/wiki/Anxiety\" title=\"Anxiety\">anxiety</a>, <a href=\"/wiki/Insomnia\" title=\"Insomnia\">insomnia</a>, <a href=\"/wiki/Gastritis\" title=\"Gastritis\">gastritis</a>, and tension\".<sup id=\"cite_ref-miller_3-0\" class=\"reference\"><a href=\"#cite_note-miller-3\">&#91;3&#93;</a></sup> Afterwards, it was used against <a href=\"/wiki/Nausea\" title=\"Nausea\">nausea</a> and to alleviate <a href=\"/wiki/Morning_sickness\" title=\"Morning sickness\">morning sickness</a> in pregnant women. Thalidomide became an <a href=\"/wiki/Over_the_counter\" class=\"mw-redirect\" title=\"Over the counter\">over-the-counter</a> drug in West Germany on October 1, 1957. Shortly after the drug was sold in West Germany, between 5,000 and 7,000 infants were born with <a href=\"/wiki/Phocomelia\" title=\"Phocomelia\">phocomelia</a> (malformation of the limbs). Only 40% of these children survived.<sup id=\"cite_ref-oncozine.com_4-0\" class=\"reference\"><a href=\"#cite_note-oncozine.com-4\">&#91;4&#93;</a></sup> Throughout the world, about 10,000 cases were reported of infants with phocomelia due to thalidomide; only 50% of the 10,000 survived. Those subjected to thalidomide while in the womb experienced limb deficiencies in a way that the long limbs either were not developed or presented themselves as stumps. Other effects included deformed eyes and hearts, deformed alimentary and urinary tracts, blindness and deafness.<sup id=\"cite_ref-5\" class=\"reference\"><a href=\"#cite_note-5\">&#91;5&#93;</a></sup> The negative effects of thalidomide led to the development of more structured drug regulations and control over drug use and development.<sup id=\"cite_ref-The_chemical_industry_6-0\" class=\"reference\"><a href=\"#cite_note-The_chemical_industry-6\">&#91;6&#93;</a></sup>\n</p>\n<div class=\"toclimit-3\"><div id=\"toc\" class=\"toc\"><input type=\"checkbox\" role=\"button\" id=\"toctogglecheckbox\" class=\"toctogglecheckbox\" style=\"display:none\" /><div class=\"toctitle\" lang=\"en\" dir=\"ltr\"><h2>Contents</h2><span class=\"toctogglespan\"><label class=\"toctogglelabel\" for=\"toctogglecheckbox\"></label></span></div>\n<ul>\n<li class=\"toclevel-1 tocsection-1\"><a href=\"#Medical_uses\"><span class=\"tocnumber\">1</span> <span class=\"toctext\">Medical uses</span></a></li>\n<li class=\"toclevel-1 tocsection-2\"><a href=\"#Contraindications\"><span class=\"tocnumber\">2</span> <span class=\"toctext\">Contraindications</span></a></li>\n<li class=\"toclevel-1 tocsection-3\"><a href=\"#Adverse_effects\"><span class=\"tocnumber\">3</span> <span class=\"toctext\">Adverse effects</span></a>\n<ul>\n<li class=\"toclevel-2 tocsection-4\"><a href=\"#Interactions\"><span class=\"tocnumber\">3.1</span> <span class=\"toctext\">Interactions</span></a></li>\n<li class=\"toclevel-2 tocsection-5\"><a href=\"#Overdose\"><span class=\"tocnumber\">3.2</span> <span class=\"toctext\">Overdose</span></a></li>\n</ul>\n</li>\n<li class=\"toclevel-1 tocsection-6\"><a href=\"#Pharmacology\"><span class=\"tocnumber\">4</span> <span class=\"toctext\">Pharmacology</span></a></li>\n<li class=\"toclevel-1 tocsection-7\"><a href=\"#Chemistry\"><span class=\"tocnumber\">5</span> <span class=\"toctext\">Chemistry</span></a></li>\n<li class=\"toclevel-1 tocsection-8\"><a href=\"#History\"><span class=\"tocnumber\">6</span> <span class=\"toctext\">History</span></a>\n<ul>\n<li class=\"toclevel-2 tocsection-9\"><a href=\"#Leprosy_treatment\"><span class=\"tocnumber\">6.1</span> <span class=\"toctext\">Leprosy treatment</span></a></li>\n<li class=\"toclevel-2 tocsection-10\"><a href=\"#Cancer_treatment\"><span class=\"tocnumber\">6.2</span> <span class=\"toctext\">Cancer treatment</span></a></li>\n</ul>\n</li>\n<li class=\"toclevel-1 tocsection-11\"><a href=\"#Society_and_culture\"><span class=\"tocnumber\">7</span> <span class=\"toctext\">Society and culture</span></a>\n<ul>\n<li class=\"toclevel-2 tocsection-12\"><a href=\"#Birth_defects_crisis\"><span class=\"tocnumber\">7.1</span> <span class=\"toctext\">Birth defects crisis</span></a></li>\n<li class=\"toclevel-2 tocsection-13\"><a href=\"#Aftermath_of_scandal\"><span class=\"tocnumber\">7.2</span> <span class=\"toctext\">Aftermath of scandal</span></a>\n<ul>\n<li class=\"toclevel-3 tocsection-14\"><a href=\"#Germany\"><span class=\"tocnumber\">7.2.1</span> <span class=\"toctext\">Germany</span></a></li>\n<li class=\"toclevel-3 tocsection-15\"><a href=\"#United_Kingdom\"><span class=\"tocnumber\">7.2.2</span> <span class=\"toctext\">United Kingdom</span></a></li>\n<li class=\"toclevel-3 tocsection-16\"><a href=\"#Australia\"><span class=\"tocnumber\">7.2.3</span> <span class=\"toctext\">Australia</span></a></li>\n<li class=\"toclevel-3 tocsection-17\"><a href=\"#Canada\"><span class=\"tocnumber\">7.2.4</span> <span class=\"toctext\">Canada</span></a></li>\n<li class=\"toclevel-3 tocsection-18\"><a href=\"#United_States\"><span class=\"tocnumber\">7.2.5</span> <span class=\"toctext\">United States</span></a></li>\n</ul>\n</li>\n<li class=\"toclevel-2 tocsection-19\"><a href=\"#Notable_cases\"><span class=\"tocnumber\">7.3</span> <span class=\"toctext\">Notable cases</span></a></li>\n<li class=\"toclevel-2 tocsection-20\"><a href=\"#Change_in_drug_regulations\"><span class=\"tocnumber\">7.4</span> <span class=\"toctext\">Change in drug regulations</span></a></li>\n</ul>\n</li>\n<li class=\"toclevel-1 tocsection-21\"><a href=\"#Research\"><span class=\"tocnumber\">8</span> <span class=\"toctext\">Research</span></a>\n<ul>\n<li class=\"toclevel-2 tocsection-22\"><a href=\"#Thalidomide_analogs\"><span class=\"tocnumber\">8.1</span> <span class=\"toctext\">Thalidomide analogs</span></a></li>\n<li class=\"toclevel-2 tocsection-23\"><a href=\"#Clinical_research\"><span class=\"tocnumber\">8.2</span> <span class=\"toctext\">Clinical research</span></a></li>\n</ul>\n</li>\n<li class=\"toclevel-1 tocsection-24\"><a href=\"#See_also\"><span class=\"tocnumber\">9</span> <span class=\"toctext\">See also</span></a></li>\n<li class=\"toclevel-1 tocsection-25\"><a href=\"#References\"><span class=\"tocnumber\">10</span> <span class=\"toctext\">References</span></a></li>\n<li class=\"toclevel-1 tocsection-26\"><a href=\"#Further_reading\"><span class=\"tocnumber\">11</span> <span class=\"toctext\">Further reading</span></a></li>\n<li class=\"toclevel-1 tocsection-27\"><a href=\"#External_links\"><span class=\"tocnumber\">12</span> <span class=\"toctext\">External links</span></a></li>\n</ul>\n</div>\n</div>\n<h2><span class=\"mw-headline\" id=\"Medical_uses\">Medical uses</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Thalidomide&amp;action=edit&amp;section=1\" title=\"Edit section: Medical uses\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<div class=\"thumb tright\"><div class=\"thumbinner\" style=\"width:222px;\"><a href=\"/wiki/File:Pack_of_Thalidomide_tablets.jpg\" class=\"image\"><img alt=\"\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/9/9e/Pack_of_Thalidomide_tablets.jpg/220px-Pack_of_Thalidomide_tablets.jpg\" width=\"220\" height=\"146\" class=\"thumbimage\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/9/9e/Pack_of_Thalidomide_tablets.jpg/330px-Pack_of_Thalidomide_tablets.jpg 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/9/9e/Pack_of_Thalidomide_tablets.jpg/440px-Pack_of_Thalidomide_tablets.jpg 2x\" data-file-width=\"3088\" data-file-height=\"2056\" /></a>  <div class=\"thumbcaption\"><div class=\"magnify\"><a href=\"/wiki/File:Pack_of_Thalidomide_tablets.jpg\" class=\"internal\" title=\"Enlarge\"></a></div>Pack of thalidomide capsules</div></div></div>\n<p>Thalidomide is used as a first-line treatment in <a href=\"/wiki/Multiple_myeloma\" title=\"Multiple myeloma\">multiple myeloma</a> in combination with <a href=\"/wiki/Dexamethasone\" title=\"Dexamethasone\">dexamethasone</a> or with <a href=\"/wiki/Melphalan\" title=\"Melphalan\">melphalan</a> and <a href=\"/wiki/Prednisone\" title=\"Prednisone\">prednisone</a>, to treat acute episodes of <a href=\"/wiki/Erythema_nodosum_leprosum\" class=\"mw-redirect\" title=\"Erythema nodosum leprosum\">erythema nodosum leprosum</a>, and for maintenance therapy.<sup id=\"cite_ref-UKlabel2017_7-0\" class=\"reference\"><a href=\"#cite_note-UKlabel2017-7\">&#91;7&#93;</a></sup><sup id=\"cite_ref-USlabel2017_8-0\" class=\"reference\"><a href=\"#cite_note-USlabel2017-8\">&#91;8&#93;</a></sup>\n</p><p>Thalidomide is used <a href=\"/wiki/Off-label_use\" title=\"Off-label use\">off-label</a> in several ways.\n</p><p>The bacterium that causes <a href=\"/wiki/Tuberculosis\" title=\"Tuberculosis\">tuberculosis</a> is related to leprosy. Thalidomide may be helpful in some cases where <a href=\"/wiki/Tuberculosis_management\" title=\"Tuberculosis management\">standard TB drugs</a> and <a href=\"/wiki/Corticosteroid\" title=\"Corticosteroid\">corticosteroids</a> are not sufficient to resolve severe inflammation in the brain.<sup id=\"cite_ref-9\" class=\"reference\"><a href=\"#cite_note-9\">&#91;9&#93;</a></sup><sup id=\"cite_ref-10\" class=\"reference\"><a href=\"#cite_note-10\">&#91;10&#93;</a></sup>\n</p><p>It is used as a second-line treatment to manage <a href=\"/wiki/Graft_versus_host\" class=\"mw-redirect\" title=\"Graft versus host\">graft versus host</a> disease and <a href=\"/wiki/Aphthous_stomatitis\" title=\"Aphthous stomatitis\">aphthous stomatitis</a> in children and has been prescribed for other conditions in children including <a href=\"/wiki/Actinic_prurigo\" title=\"Actinic prurigo\">actinic prurigo</a> and <a href=\"/wiki/Epidermolysis_bullosa\" title=\"Epidermolysis bullosa\">epidermolysis bullosa</a>; the evidence for these uses is weak.<sup id=\"cite_ref-11\" class=\"reference\"><a href=\"#cite_note-11\">&#91;11&#93;</a></sup>  It is recommended only as a third line treatment in <a href=\"/wiki/Graft_versus_host\" class=\"mw-redirect\" title=\"Graft versus host\">graft versus host</a> disease in adults, based on lack of efficacy and side effects observed in clinical trials.<sup id=\"cite_ref-12\" class=\"reference\"><a href=\"#cite_note-12\">&#91;12&#93;</a></sup><sup id=\"cite_ref-13\" class=\"reference\"><a href=\"#cite_note-13\">&#91;13&#93;</a></sup>\n</p>\n<h2><span class=\"mw-headline\" id=\"Contraindications\">Contraindications</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Thalidomide&amp;action=edit&amp;section=2\" title=\"Edit section: Contraindications\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<p>Thalidomide should not be used by people who are breast feeding or pregnant, trying to conceive a child, or cannot or will not follow the risk management program to prevent pregnancies. The prescribing doctor is required to ensure that contraception is being used, and regular pregnancy tests must be administered.   Some people are allergic to thalidomide and should not take it.  It should be used with caution in people with chronic infections like HIV or hepatitis B.<sup id=\"cite_ref-USlabel2017_8-1\" class=\"reference\"><a href=\"#cite_note-USlabel2017-8\">&#91;8&#93;</a></sup><sup id=\"cite_ref-UKlabel2017_7-1\" class=\"reference\"><a href=\"#cite_note-UKlabel2017-7\">&#91;7&#93;</a></sup>\n</p>\n<h2><span class=\"mw-headline\" id=\"Adverse_effects\">Adverse effects</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Thalidomide&amp;action=edit&amp;section=3\" title=\"Edit section: Adverse effects\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<div role=\"note\" class=\"hatnote navigation-not-searchable\">See also: <a href=\"/wiki/List_of_thalidomide_side_effects\" title=\"List of thalidomide side effects\">List of thalidomide side effects</a></div>\n<p>Thalidomide <a href=\"/wiki/Teratogen\" class=\"mw-redirect\" title=\"Teratogen\">causes birth defects</a>.<sup id=\"cite_ref-USlabel2017_8-2\" class=\"reference\"><a href=\"#cite_note-USlabel2017-8\">&#91;8&#93;</a></sup><sup id=\"cite_ref-UKlabel2017_7-2\" class=\"reference\"><a href=\"#cite_note-UKlabel2017-7\">&#91;7&#93;</a></sup><sup id=\"cite_ref-toxmech2009_14-0\" class=\"reference\"><a href=\"#cite_note-toxmech2009-14\">&#91;14&#93;</a></sup>  The FDA and other regulatory agencies have approved marketing of the drug only with an auditable  <a href=\"/wiki/Risk_evaluation_and_mitigation_strategy\" class=\"mw-redirect\" title=\"Risk evaluation and mitigation strategy\">risk evaluation and mitigation strategy</a> that ensures that people using the drug are aware of the risks and avoid pregnancy; this applies to men and women both, as the drug can be transmitted in sperm.<sup id=\"cite_ref-toxmech2009_14-1\" class=\"reference\"><a href=\"#cite_note-toxmech2009-14\">&#91;14&#93;</a></sup>\n</p><p>There is a high risk that thalidomide can cause excessive <a href=\"/wiki/Thrombosis\" title=\"Thrombosis\">blood clots</a>. There is also a high risk that thalidomide can interfere with formation of various kinds of new blood cells, creating a risk of infection via <a href=\"/wiki/Neutropenia\" title=\"Neutropenia\">neutropenia</a>, <a href=\"/wiki/Leukopenia\" title=\"Leukopenia\">leukopenia</a>, and <a href=\"/wiki/Lymphopenia\" class=\"mw-redirect\" title=\"Lymphopenia\">lymphopenia</a>, and risks that blood will not clot via <a href=\"/wiki/Thrombocytopenia\" title=\"Thrombocytopenia\">thrombocytopenia</a>.  There is also a risk of <a href=\"/wiki/Anemia\" title=\"Anemia\">anemia</a> via lack of red blood cells.  The drug can also damage nerves, causing <a href=\"/wiki/Peripheral_neuropathy\" title=\"Peripheral neuropathy\">peripheral neuropathy</a> that may be irreversible.<sup id=\"cite_ref-USlabel2017_8-3\" class=\"reference\"><a href=\"#cite_note-USlabel2017-8\">&#91;8&#93;</a></sup><sup id=\"cite_ref-UKlabel2017_7-3\" class=\"reference\"><a href=\"#cite_note-UKlabel2017-7\">&#91;7&#93;</a></sup>\n</p><p>Thalidomide has several cardiovascular adverse effects, including risk of <a href=\"/wiki/Heart_attack\" class=\"mw-redirect\" title=\"Heart attack\">heart attacks</a>, <a href=\"/wiki/Pulmonary_hypertension\" title=\"Pulmonary hypertension\">pulmonary hypertension</a>, and changes in heart rhythm including <a href=\"/wiki/Syncope_(medicine)\" title=\"Syncope (medicine)\">syncope</a>, <a href=\"/wiki/Bradycardia\" title=\"Bradycardia\">bradycardia</a> and <a href=\"/wiki/Atrioventricular_block\" title=\"Atrioventricular block\">atrioventricular block</a>.<sup id=\"cite_ref-USlabel2017_8-4\" class=\"reference\"><a href=\"#cite_note-USlabel2017-8\">&#91;8&#93;</a></sup><sup id=\"cite_ref-UKlabel2017_7-4\" class=\"reference\"><a href=\"#cite_note-UKlabel2017-7\">&#91;7&#93;</a></sup>\n</p><p>It can cause <a href=\"/wiki/Liver_damage\" class=\"mw-redirect\" title=\"Liver damage\">liver damage</a> and severe skin reactions like <a href=\"/wiki/Stevens-Johnson_Syndrome\" class=\"mw-redirect\" title=\"Stevens-Johnson Syndrome\">Stevens-Johnson Syndrome</a>.  It tends to make people sleepy, which creates risk for driving and operating other machinery.   As it kills cancer cells, it can cause <a href=\"/wiki/Tumor_lysis_syndrome\" title=\"Tumor lysis syndrome\">tumor lysis syndrome</a>. Thalidomide can <a href=\"/wiki/Amenorrhea\" title=\"Amenorrhea\">prevent menstruation</a>.<sup id=\"cite_ref-USlabel2017_8-5\" class=\"reference\"><a href=\"#cite_note-USlabel2017-8\">&#91;8&#93;</a></sup><sup id=\"cite_ref-UKlabel2017_7-5\" class=\"reference\"><a href=\"#cite_note-UKlabel2017-7\">&#91;7&#93;</a></sup>\n</p><p>Other than the above, very common (reported in more than 10% of people) adverse effects include tremor, dizziness, tingling, numbness, constipation, and peripheral edema.<sup id=\"cite_ref-USlabel2017_8-6\" class=\"reference\"><a href=\"#cite_note-USlabel2017-8\">&#91;8&#93;</a></sup><sup id=\"cite_ref-UKlabel2017_7-6\" class=\"reference\"><a href=\"#cite_note-UKlabel2017-7\">&#91;7&#93;</a></sup>\n</p><p>Common (reported by 1-10% of people) adverse effects include confusion, depressed mood, reduced coordination, heart failure, difficulty breathing, interstitial lung disease, lung inflammation, vomiting, dry mouth, rashes, dry skin, fever, weakness, and a sense of unwellness.<sup id=\"cite_ref-USlabel2017_8-7\" class=\"reference\"><a href=\"#cite_note-USlabel2017-8\">&#91;8&#93;</a></sup><sup id=\"cite_ref-UKlabel2017_7-7\" class=\"reference\"><a href=\"#cite_note-UKlabel2017-7\">&#91;7&#93;</a></sup>\n</p>\n<h3><span class=\"mw-headline\" id=\"Interactions\">Interactions</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Thalidomide&amp;action=edit&amp;section=4\" title=\"Edit section: Interactions\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<p>There are no expected <a href=\"/wiki/Pharmacokinetics\" title=\"Pharmacokinetics\">pharmacokinetic</a> interactions between thalidomide and other medicines due to its neutral effects on p-glycoprotein and P450 cytochromes.  It may interact with sedatives due to its sedative action. It may also interact with bradycardic agents due to its bradycardia-inducing effects. The risk of peripheral neuropathy may be increased by concomitant treatment with other agents known to cause peripheral neuropathy.<sup id=\"cite_ref-TGA_15-0\" class=\"reference\"><a href=\"#cite_note-TGA-15\">&#91;15&#93;</a></sup> The risk of venous thromboembolisms with thalidomide seems to be increased when patients are treated with oral contraceptives or other cytotoxic agents (including doxorubicin and melphalan) concurrently. Thalidomide may interfere with the contraceptive effects of various contraceptives and hence it is advised that women of reproductive age use at least two different means of contraception to ensure that no child will be conceived while they are receiving thalidomide.<sup id=\"cite_ref-TGA_15-1\" class=\"reference\"><a href=\"#cite_note-TGA-15\">&#91;15&#93;</a></sup><sup id=\"cite_ref-USlabel2017_8-8\" class=\"reference\"><a href=\"#cite_note-USlabel2017-8\">&#91;8&#93;</a></sup><sup id=\"cite_ref-UKlabel2017_7-8\" class=\"reference\"><a href=\"#cite_note-UKlabel2017-7\">&#91;7&#93;</a></sup>\n</p>\n<h3><span class=\"mw-headline\" id=\"Overdose\">Overdose</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Thalidomide&amp;action=edit&amp;section=5\" title=\"Edit section: Overdose\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<p>As of 2013 eighteen cases of overdoses had been reported with doses of up to 14.4&#160;g, none of them fatal.<sup id=\"cite_ref-TGA_15-2\" class=\"reference\"><a href=\"#cite_note-TGA-15\">&#91;15&#93;</a></sup> No specific antidote for overdoses exists and treatment is purely supportive.<sup id=\"cite_ref-TGA_15-3\" class=\"reference\"><a href=\"#cite_note-TGA-15\">&#91;15&#93;</a></sup>\n</p>\n<h2><span class=\"mw-headline\" id=\"Pharmacology\">Pharmacology</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Thalidomide&amp;action=edit&amp;section=6\" title=\"Edit section: Pharmacology\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<p>The precise mechanism of action for thalidomide is unknown although efforts to identify thalidomide's <a href=\"/wiki/Teratology\" title=\"Teratology\">teratogenic</a> action generated 2000 research papers and the proposal of 15 or 16 plausible mechanisms by 2000.<sup id=\"cite_ref-Stephens2000_16-0\" class=\"reference\"><a href=\"#cite_note-Stephens2000-16\">&#91;16&#93;</a></sup> As of 2015 the main theories were inhibition of the process of <a href=\"/wiki/Angiogenesis\" title=\"Angiogenesis\">angiogenesis</a>, its inhibition of <a href=\"/wiki/Cereblon\" title=\"Cereblon\">cereblon</a>, a <a href=\"/wiki/Ubiquitin_ligase\" title=\"Ubiquitin ligase\">ubiquitin ligase</a>, and its ability to generate <a href=\"/wiki/Reactive_oxygen_species\" title=\"Reactive oxygen species\">reactive oxygen species</a> which in turn kill cells.<sup id=\"cite_ref-Vargesson2015_17-0\" class=\"reference\"><a href=\"#cite_note-Vargesson2015-17\">&#91;17&#93;</a></sup><sup id=\"cite_ref-Kim2011_18-0\" class=\"reference\"><a href=\"#cite_note-Kim2011-18\">&#91;18&#93;</a></sup> In 2018, results were first published which suggested that thalidomide's teratogenic effects are mediated through degradation of the transcription factor, <a href=\"/wiki/SALL4\" title=\"SALL4\">SALL4</a>, an as yet unverified finding.<sup id=\"cite_ref-19\" class=\"reference\"><a href=\"#cite_note-19\">&#91;19&#93;</a></sup>\n</p><p>Thalidomide also binds to and acts as an <a href=\"/wiki/Receptor_antagonist\" title=\"Receptor antagonist\">antagonist</a> of the <a href=\"/wiki/Androgen_receptor\" title=\"Androgen receptor\">androgen receptor</a> (AR) and hence is a <a href=\"/wiki/Nonsteroidal_antiandrogen\" title=\"Nonsteroidal antiandrogen\">nonsteroidal antiandrogen</a> (NSAA) of some capacity.<sup id=\"cite_ref-LiuSu2010_20-0\" class=\"reference\"><a href=\"#cite_note-LiuSu2010-20\">&#91;20&#93;</a></sup> In accordance, it can produce <a href=\"/wiki/Gynecomastia\" title=\"Gynecomastia\">gynecomastia</a> and <a href=\"/wiki/Sexual_dysfunction\" title=\"Sexual dysfunction\">sexual dysfunction</a> as side effects in men.<sup id=\"cite_ref-NuttallWarrier2015_21-0\" class=\"reference\"><a href=\"#cite_note-NuttallWarrier2015-21\">&#91;21&#93;</a></sup>\n</p><p>Thalidomide is provided as a racemic mixture of two <a href=\"/wiki/Enantiomer\" title=\"Enantiomer\">enantiomers</a>; while there are reports that only one of the enantiomers may cause birth defects, the body converts each enantiomer into the other through mechanisms that are not well understood.<sup id=\"cite_ref-toxmech2009_14-2\" class=\"reference\"><a href=\"#cite_note-toxmech2009-14\">&#91;14&#93;</a></sup>\n</p>\n<h2><span class=\"mw-headline\" id=\"Chemistry\">Chemistry</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Thalidomide&amp;action=edit&amp;section=7\" title=\"Edit section: Chemistry\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<div class=\"thumb tright\"><div class=\"thumbinner\" style=\"width:302px;\"><a href=\"/wiki/File:Thalidomide-structures.png\" class=\"image\"><img alt=\"\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/b/bb/Thalidomide-structures.png/300px-Thalidomide-structures.png\" width=\"300\" height=\"162\" class=\"thumbimage\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/b/bb/Thalidomide-structures.png/450px-Thalidomide-structures.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/b/bb/Thalidomide-structures.png/600px-Thalidomide-structures.png 2x\" data-file-width=\"1100\" data-file-height=\"594\" /></a>  <div class=\"thumbcaption\"><div class=\"magnify\"><a href=\"/wiki/File:Thalidomide-structures.png\" class=\"internal\" title=\"Enlarge\"></a></div>The two enantiomers of thalidomide:<br />Left: (<i>S</i>)-(\u2212)-thalidomide<br />Right: (<i>R</i>)-(+)-thalidomide</div></div></div>\n<p>Thalidomide is <a href=\"/wiki/Racemic_mixture\" title=\"Racemic mixture\">racemic</a>; while the S-thalidomide is the bioactive form of the molecule, the individual enantiomers can <a href=\"/wiki/Racemization\" title=\"Racemization\">racemize</a> to each other due to the acidic hydrogen at the <a href=\"/wiki/Chiral_centre\" class=\"mw-redirect\" title=\"Chiral centre\">chiral centre</a>, which is the carbon of the glutarimide ring bonded to the phthalimide substituent. The racemization process can occur <i><a href=\"/wiki/In_vivo\" title=\"In vivo\">in vivo</a></i>.<sup id=\"cite_ref-clinp_2-4\" class=\"reference\"><a href=\"#cite_note-clinp-2\">&#91;2&#93;</a></sup><sup id=\"cite_ref-stereospecific44_22-0\" class=\"reference\"><a href=\"#cite_note-stereospecific44-22\">&#91;22&#93;</a></sup><sup id=\"cite_ref-pmid14505639_23-0\" class=\"reference\"><a href=\"#cite_note-pmid14505639-23\">&#91;23&#93;</a></sup><sup id=\"cite_ref-Bartlett2004_24-0\" class=\"reference\"><a href=\"#cite_note-Bartlett2004-24\">&#91;24&#93;</a></sup>\n</p><p><a href=\"/wiki/Celgene_Corporation\" class=\"mw-redirect\" title=\"Celgene Corporation\">Celgene Corporation</a> originally synthesized thalidomide using a three-step sequence starting with <a href=\"/wiki/Glutamate\" class=\"mw-redirect\" title=\"Glutamate\">L-glutamic acid</a> treatment, but this has since been reformed by the use of <a href=\"/wiki/Glutamine\" title=\"Glutamine\">L-glutamine</a>.<sup id=\"cite_ref-synth_25-0\" class=\"reference\"><a href=\"#cite_note-synth-25\">&#91;25&#93;</a></sup> As shown in the image below, N-carbethoxyphtalimide (1) can react with L-glutamine to yield N-Phthaloyl-L-glutamine (2). Cyclization of N-Phthaloyl-L-glutamine occurs using <a href=\"/wiki/Carbonyldiimidazole\" title=\"Carbonyldiimidazole\">carbonyldiimidazole</a>, which then yields thalidomide (3).<sup id=\"cite_ref-synth_25-1\" class=\"reference\"><a href=\"#cite_note-synth-25\">&#91;25&#93;</a></sup> Celgene Corporation's original method resulted in a 31% yield of S-thalidomide, whereas the two-step synthesis yields 85-93% product that is 99% pure.\n</p>\n<div class=\"center\"><div class=\"thumb tnone\"><div class=\"thumbinner\" style=\"width:569px;\"><a href=\"/wiki/File:Thalidomide_syntehsis.png\" class=\"image\"><img alt=\"\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/6f/Thalidomide_syntehsis.png/567px-Thalidomide_syntehsis.png\" width=\"567\" height=\"124\" class=\"thumbimage\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/6f/Thalidomide_syntehsis.png/851px-Thalidomide_syntehsis.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/6f/Thalidomide_syntehsis.png/1134px-Thalidomide_syntehsis.png 2x\" data-file-width=\"1843\" data-file-height=\"402\" /></a>  <div class=\"thumbcaption\"><div class=\"magnify\"><a href=\"/wiki/File:Thalidomide_syntehsis.png\" class=\"internal\" title=\"Enlarge\"></a></div>Muller et al.'s two-step thalidomide synthesis</div></div></div></div>\n<h2><span class=\"mw-headline\" id=\"History\">History</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Thalidomide&amp;action=edit&amp;section=8\" title=\"Edit section: History\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<p>Thalidomide was <a href=\"/wiki/Drug_discovery\" title=\"Drug discovery\">discovered</a> by scientists at the German pharmaceutical company Chemie Gr\u00fcnenthal (now <a href=\"/wiki/Gr%C3%BCnenthal_GmbH\" class=\"mw-redirect\" title=\"Gr\u00fcnenthal GmbH\">Gr\u00fcnenthal GmbH</a>) around 1953.   The company had been set up as a soap maker just after WWII ended, to address the urgent market need for antibiotics. Heinrich Mueckter was appointed to head the discovery program based on his experience working with the German army's antiviral research program. In the course of preparing <a href=\"/wiki/Reagents\" class=\"mw-redirect\" title=\"Reagents\">reagents</a> for the work, Mueckter's assistant Wilhelm Kunz isolated a by-product, that was in turn recognized by pharmacologist Herbert Keller as an analog of <a href=\"/wiki/Glutethimide\" title=\"Glutethimide\">glutethimide</a>, a <a href=\"/wiki/Sedative\" title=\"Sedative\">sedative</a>, and the medicinal chemistry work turned to improving the lead compound into a suitable drug; the result was thalidomide.  The toxicity was examined in several animals, and the drug was introduced in 1956 as a sedative.<sup id=\"cite_ref-26\" class=\"reference\"><a href=\"#cite_note-26\">&#91;26&#93;</a></sup>\n</p><p>Researchers at Chemie Gr\u00fcnenthal also found that thalidomide was a particularly effective <a href=\"/wiki/Antiemetic\" title=\"Antiemetic\">antiemetic</a> that had an inhibitory effect on <a href=\"/wiki/Morning_sickness\" title=\"Morning sickness\">morning sickness</a>.<sup id=\"cite_ref-pmid15172781_27-0\" class=\"reference\"><a href=\"#cite_note-pmid15172781-27\">&#91;27&#93;</a></sup> Hence, on October 1, 1957, the company launched thalidomide and began marketing it under the trade name Contergan.<sup id=\"cite_ref-28\" class=\"reference\"><a href=\"#cite_note-28\">&#91;28&#93;</a></sup><sup id=\"cite_ref-Bombay_29-0\" class=\"reference\"><a href=\"#cite_note-Bombay-29\">&#91;29&#93;</a></sup> It was proclaimed a \"wonder drug\" for <a href=\"/wiki/Insomnia\" title=\"Insomnia\">insomnia</a>, coughs, colds and headaches.<sup class=\"noprint Inline-Template Template-Fact\" style=\"white-space:nowrap;\">&#91;<i><a href=\"/wiki/Wikipedia:Citation_needed\" title=\"Wikipedia:Citation needed\"><span title=\"This claim needs references to reliable sources. (April 2017)\">citation needed</span></a></i>&#93;</sup>\n</p><p>During this time period, the use of medications during pregnancy was not strictly controlled, and drugs were not thoroughly tested for potential harm to the <a href=\"/wiki/Fetus\" title=\"Fetus\">fetus</a>.<sup id=\"cite_ref-pmid15172781_27-1\" class=\"reference\"><a href=\"#cite_note-pmid15172781-27\">&#91;27&#93;</a></sup> Thousands of pregnant women took the drug to relieve their symptoms. At the time of the drug's development, scientists did not believe any drug taken by a pregnant woman could pass across the <a href=\"/wiki/Placental_barrier\" class=\"mw-redirect\" title=\"Placental barrier\">placental barrier</a> and harm the developing fetus,<sup id=\"cite_ref-The_chemical_industry_6-1\" class=\"reference\"><a href=\"#cite_note-The_chemical_industry-6\">&#91;6&#93;</a></sup> even though the effect of alcohol on fetal development had been documented by case studies on alcoholic mothers since at least 1957.<sup id=\"cite_ref-30\" class=\"reference\"><a href=\"#cite_note-30\">&#91;30&#93;</a></sup> There soon appeared reports of findings of abnormalities in children being born, traced back to the use of the drug thalidomide. In late 1959, it was noticed that <a href=\"/wiki/Peripheral_neuritis\" class=\"mw-redirect\" title=\"Peripheral neuritis\">peripheral neuritis</a> developed in patients who took the drug over a period of time, and it was only after this point that thalidomide ceased to be provided over the counter.<sup id=\"cite_ref-31\" class=\"reference\"><a href=\"#cite_note-31\">&#91;31&#93;</a></sup>\n</p><p>Hence, while initially considered safe, the drug was responsible for <a href=\"/wiki/Teratology\" title=\"Teratology\">teratogenic</a> deformities in children born after their mothers used it during pregnancies, prior to the third trimester. In November 1961, thalidomide was taken off the market due to massive pressure from the press and public.<sup id=\"cite_ref-50year_32-0\" class=\"reference\"><a href=\"#cite_note-50year-32\">&#91;32&#93;</a></sup> Experts estimate that the drug thalidomide led to the death of approximately 2,000 children and serious birth defects in more than 10,000 children, about 5,000 of them in <a href=\"/wiki/West_Germany\" title=\"West Germany\">West Germany</a>.<sup class=\"noprint Inline-Template Template-Fact\" style=\"white-space:nowrap;\">&#91;<i><a href=\"/wiki/Wikipedia:Citation_needed\" title=\"Wikipedia:Citation needed\"><span title=\"This claim needs references to reliable sources. (March 2017)\">citation needed</span></a></i>&#93;</sup> The regulatory authorities in <a href=\"/wiki/East_Germany\" title=\"East Germany\">East Germany</a> did not approve thalidomide.<sup id=\"cite_ref-oncozine.com_4-1\" class=\"reference\"><a href=\"#cite_note-oncozine.com-4\">&#91;4&#93;</a></sup><sup class=\"noprint Inline-Template\"><span style=\"white-space: nowrap;\">&#91;<i><a href=\"/wiki/Wikipedia:Link_rot\" title=\"Wikipedia:Link rot\"><span title=\"&#160;Dead link since October 2015\">dead link</span></a></i>&#93;</span></sup> One reason for the initially unobserved side effects of the drug and the subsequent approval in West Germany was that at that time drugs did not have to be tested for <a href=\"/wiki/Teratogenic\" class=\"mw-redirect\" title=\"Teratogenic\">teratogenic</a> effects. They had been tested on rodents only, as was usual at the time.<sup id=\"cite_ref-VFA_33-0\" class=\"reference\"><a href=\"#cite_note-VFA-33\">&#91;33&#93;</a></sup>\n</p><p>In the UK, the British pharmaceutical company The Distillers Company (Biochemicals) Ltd, a subsidiary of Distillers Co. Ltd (now part of <a href=\"/wiki/Diageo_plc\" class=\"mw-redirect\" title=\"Diageo plc\">Diageo plc</a>), marketed thalidomide under the brand name Distaval as a remedy for <a href=\"/wiki/Morning_sickness\" title=\"Morning sickness\">morning sickness</a> throughout the United Kingdom, Australia and New Zealand. Their advertisement claimed that \"Distaval can be given with complete safety to pregnant women and nursing mothers without adverse effect on mother or child...Outstandingly safe Distaval has been prescribed for nearly three years in this country.\"<sup id=\"cite_ref-oncozine.com_4-2\" class=\"reference\"><a href=\"#cite_note-oncozine.com-4\">&#91;4&#93;</a></sup><sup class=\"noprint Inline-Template\"><span style=\"white-space: nowrap;\">&#91;<i><a href=\"/wiki/Wikipedia:Link_rot\" title=\"Wikipedia:Link rot\"><span title=\"&#160;Dead link since June 2014\">dead link</span></a></i>&#93;</span></sup> Around the world, more and more pharmaceutical companies started to produce and market the drug under license from Chemie Gr\u00fcnenthal. By the mid-1950s, 14 pharmaceutical companies were marketing thalidomide in 46 countries under at least 37 different trade names.\n</p><p>In the U.S., representatives from <i>Chemie Gr\u00fcnenthal</i> approached <i><a href=\"/wiki/Smith,_Kline_%26_French\" title=\"Smith, Kline &amp; French\">Smith, Kline &amp; French</a></i> (SKF), now <a href=\"/wiki/GlaxoSmithKline\" title=\"GlaxoSmithKline\">GlaxoSmithKline</a> (GSK) with a request to market and distribute the drug in North America. A memorandum rediscovered in 2010 in the archives of the U.S. <a href=\"/wiki/Food_and_Drug_Administration\" title=\"Food and Drug Administration\">Food and Drug Administration</a> (FDA) shows that, as part of its in-licensing approach, <i>Smith, Kline and French</i> conducted animal tests and ran a clinical trial of the drug in the United States involving 875 people, including pregnant women, in 1956\u201357.<sup class=\"noprint Inline-Template Template-Fact\" style=\"white-space:nowrap;\">&#91;<i><a href=\"/wiki/Wikipedia:Citation_needed\" title=\"Wikipedia:Citation needed\"><span title=\"This claim needs references to reliable sources. (October 2015)\">citation needed</span></a></i>&#93;</sup> In 1956, researchers at SKF involved in clinical trials noted that even when used in very high doses, thalidomide could not induce sleep in mice.<sup class=\"noprint Inline-Template Template-Fact\" style=\"white-space:nowrap;\">&#91;<i><a href=\"/wiki/Wikipedia:Citation_needed\" title=\"Wikipedia:Citation needed\"><span title=\"This claim needs references to reliable sources. (October 2015)\">citation needed</span></a></i>&#93;</sup> And when administered at doses 50 to 650 times larger than that claimed by <i>Chemie Gr\u00fcnenthal</i> to be \"sleep inducing\", the researchers could still not achieve the hypnotic effect in animals that it had on humans.<sup class=\"noprint Inline-Template Template-Fact\" style=\"white-space:nowrap;\">&#91;<i><a href=\"/wiki/Wikipedia:Citation_needed\" title=\"Wikipedia:Citation needed\"><span title=\"This claim needs references to reliable sources. (October 2015)\">citation needed</span></a></i>&#93;</sup> After completion of the trial, and based on reasons kept hidden for decades, SKF declined to commercialize the drug. Later, <i>Chemie Gr\u00fcnenthal</i>, in 1958, reached an agreement with <i>William S Merrell Company</i> in Cincinnati, Ohio, (<a href=\"/wiki/Marion_Merrell_Dow#Richardson-Merrell\" title=\"Marion Merrell Dow\">later Richardson-Merrell</a>, now part of <a href=\"/wiki/Sanofi\" title=\"Sanofi\">Sanofi</a>), to market and distribute thalidomide throughout the United States.<sup id=\"cite_ref-oncozine.com_4-3\" class=\"reference\"><a href=\"#cite_note-oncozine.com-4\">&#91;4&#93;</a></sup><sup class=\"noprint Inline-Template\"><span style=\"white-space: nowrap;\">&#91;<i><a href=\"/wiki/Wikipedia:Link_rot\" title=\"Wikipedia:Link rot\"><span title=\"&#160;Dead link since June 2014\">dead link</span></a></i>&#93;</span></sup>\n</p><p>The U.S. FDA refused to approve thalidomide for marketing and distribution. However, the drug was distributed in large quantities for testing purposes, after the American distributor and manufacturer <a href=\"/wiki/Marion_Merrell_Dow#Richardson-Merrell\" title=\"Marion Merrell Dow\">Richardson-Merrell</a> had applied for its approval in September 1960.<sup class=\"noprint Inline-Template Template-Fact\" style=\"white-space:nowrap;\">&#91;<i><a href=\"/wiki/Wikipedia:Citation_needed\" title=\"Wikipedia:Citation needed\"><span title=\"This claim needs references to reliable sources. (October 2015)\">citation needed</span></a></i>&#93;</sup> The official in charge of the FDA review, <a href=\"/wiki/Frances_Oldham_Kelsey\" title=\"Frances Oldham Kelsey\">Frances Oldham Kelsey</a>, did not rely on information from the company, which did not include any test results. Richardson-Merrell was called on to perform tests and report the results. The company demanded approval six times, and was refused each time. Nevertheless, a total of 17 children with thalidomide-induced malformations were born in the U.S.<sup id=\"cite_ref-34\" class=\"reference\"><a href=\"#cite_note-34\">&#91;34&#93;</a></sup>\n</p><p>In Canada, the history of the drug thalidomide dates back to April 1, 1961. There were many different forms sold, with the most common variant being Talimol.<sup id=\"cite_ref-pmid14076167_35-0\" class=\"reference\"><a href=\"#cite_note-pmid14076167-35\">&#91;35&#93;</a></sup> Two months after Talimol went on sale, pharmaceutical companies sent physicians letters warning about the risk of birth defects.<sup id=\"cite_ref-pmid14076167_35-1\" class=\"reference\"><a href=\"#cite_note-pmid14076167-35\">&#91;35&#93;</a></sup> It was not until March 2, 1962, that both drugs were banned from the Canadian market by the FDD, and soon afterward physicians were warned to destroy their supplies.<sup id=\"cite_ref-pmid14076167_35-2\" class=\"reference\"><a href=\"#cite_note-pmid14076167-35\">&#91;35&#93;</a></sup>\n</p>\n<h3><span class=\"mw-headline\" id=\"Leprosy_treatment\">Leprosy treatment</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Thalidomide&amp;action=edit&amp;section=9\" title=\"Edit section: Leprosy treatment\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<p>In 1964, Israeli physician <a href=\"/wiki/Jacob_Sheskin\" title=\"Jacob Sheskin\">Jacob Sheskin</a> administered thalidomide to a patient critically ill with leprosy. The patient exhibited <a href=\"/wiki/Erythema_nodosum\" title=\"Erythema nodosum\">erythema nodosum leprosum&#160;(ENL)</a>, a painful skin condition, one of the complications of <a href=\"/wiki/Leprosy\" title=\"Leprosy\">leprosy</a>. This was attempted despite the ban on thalidomide's use, but results were favourable: the patient slept for hours and was able to get out of bed without aid upon awakening. A clinical trial studying the use of thalidomide in leprosy soon followed.<sup id=\"cite_ref-Silverman_36-0\" class=\"reference\"><a href=\"#cite_note-Silverman-36\">&#91;36&#93;</a></sup>\n</p><p>Thalidomide has been used by Brazilian physicians as the drug of choice for the treatment of severe ENL since 1965, and by 1996, at least 33 cases of thalidomide embryopathy were recorded in people born in Brazil after 1965.<sup id=\"cite_ref-37\" class=\"reference\"><a href=\"#cite_note-37\">&#91;37&#93;</a></sup> Since 1994, the production, dispensing, and prescription of thalidomide have been strictly controlled, requiring women to use two forms of birth control and submit to regular pregnancy tests. Despite this, cases of thalidomide embryopathy continue,<sup id=\"cite_ref-38\" class=\"reference\"><a href=\"#cite_note-38\">&#91;38&#93;</a></sup><sup id=\"cite_ref-39\" class=\"reference\"><a href=\"#cite_note-39\">&#91;39&#93;</a></sup> with at least 100 cases identified in Brazil between 2005 and 2010.<sup id=\"cite_ref-40\" class=\"reference\"><a href=\"#cite_note-40\">&#91;40&#93;</a></sup> 5.8 million thalidomide pills were distributed throughout Brazil in this time period, largely to poor Brazilians in areas with poor access to healthcare, and these cases have occurred despite the controls.\n</p><p>In 1998 the FDA approved the drug's use in the treatment of ENL.<sup id=\"cite_ref-nyt-fda_41-0\" class=\"reference\"><a href=\"#cite_note-nyt-fda-41\">&#91;41&#93;</a></sup> Because of thalidomide's potential for causing birth defects, the drug may be distributed only under tightly controlled conditions. The FDA required that <a href=\"/wiki/Celgene_Corporation\" class=\"mw-redirect\" title=\"Celgene Corporation\">Celgene Corporation</a>, which planned to market thalidomide under the brand name <i>Thalomid</i>, establish a system for thalidomide education and prescribing safety (STEPS) oversight program. The conditions required under the program include limiting prescription and dispensing rights to authorized prescribers and pharmacies only, keeping a registry of all patients prescribed thalidomide, providing extensive patient education about the risks associated with the drug, and providing periodic pregnancy tests for women who take the drug.<sup id=\"cite_ref-nyt-fda_41-1\" class=\"reference\"><a href=\"#cite_note-nyt-fda-41\">&#91;41&#93;</a></sup>\n</p><p>In 2010, the <a href=\"/wiki/World_Health_Organisation\" class=\"mw-redirect\" title=\"World Health Organisation\">World Health Organisation (WHO)</a> stated that it did not recommend thalidomide due the difficulty of adequately controlling its use, and due to the availability of <a href=\"/wiki/Clofazimine\" title=\"Clofazimine\">clofazimine</a>.<sup id=\"cite_ref-42\" class=\"reference\"><a href=\"#cite_note-42\">&#91;42&#93;</a></sup>\n</p>\n<h3><span class=\"mw-headline\" id=\"Cancer_treatment\">Cancer treatment</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Thalidomide&amp;action=edit&amp;section=10\" title=\"Edit section: Cancer treatment\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<p>Shortly after the teratogenic properties of thalidomide were recognized in the mid-1960s, its anti-cancer potential was explored and two clinical trials were conducted in people with advanced cancer, including some people with multiple myeloma; the trials were inconclusive.<sup id=\"cite_ref-Kyle_43-0\" class=\"reference\"><a href=\"#cite_note-Kyle-43\">&#91;43&#93;</a></sup>\n</p><p>Little further work was done with thalidomide in cancer until the 1990s.<sup id=\"cite_ref-Kyle_43-1\" class=\"reference\"><a href=\"#cite_note-Kyle-43\">&#91;43&#93;</a></sup>\n</p><p><a href=\"/wiki/Judah_Folkman\" title=\"Judah Folkman\">Judah Folkman</a> pioneered studies into the role of <a href=\"/wiki/Angiogenesis\" title=\"Angiogenesis\">angiogenesis</a> (the proliferation and growth of blood vessels) in the development of cancer, and in the early 1970s had shown that <a href=\"/wiki/Solid_tumors\" class=\"mw-redirect\" title=\"Solid tumors\">solid tumors</a> could not expand without it.<sup id=\"cite_ref-NASbio_44-0\" class=\"reference\"><a href=\"#cite_note-NASbio-44\">&#91;44&#93;</a></sup><sup id=\"cite_ref-Beilenberg_45-0\" class=\"reference\"><a href=\"#cite_note-Beilenberg-45\">&#91;45&#93;</a></sup> In 1993 he surprised the scientific world by hypothesizing the same was true of <a href=\"/wiki/Blood_cancers\" class=\"mw-redirect\" title=\"Blood cancers\">blood cancers</a>,<sup id=\"cite_ref-Folkman_46-0\" class=\"reference\"><a href=\"#cite_note-Folkman-46\">&#91;46&#93;</a></sup> and the next year he published work showing that a <a href=\"/wiki/Biomarker\" title=\"Biomarker\">biomarker</a> of angiogenesis was higher in all people with cancer, but especially high in people with blood cancers, and other evidence emerged as well.<sup id=\"cite_ref-Folkman_46-1\" class=\"reference\"><a href=\"#cite_note-Folkman-46\">&#91;46&#93;</a></sup>  Meanwhile, a member of his lab, Robert D'Amato,  was looking for <a href=\"/wiki/Angiogenesis_inhibitors\" class=\"mw-redirect\" title=\"Angiogenesis inhibitors\">angiogenesis inhibitors</a>, and discovered in 1994 that thalidomide inhibited angiogenesis.<sup id=\"cite_ref-47\" class=\"reference\"><a href=\"#cite_note-47\">&#91;47&#93;</a></sup> Around that time, the wife of a man who was dying of multiple myeloma and whom standard treatments had failed, called Folkman asking him about his anti-angiogenesis ideas.<sup id=\"cite_ref-Beilenberg_45-1\" class=\"reference\"><a href=\"#cite_note-Beilenberg-45\">&#91;45&#93;</a></sup>  Folkman persuaded the patient's doctor to try thalidomide, and that doctor conducted a clinical trial of thalidomide for people with multiple myeloma in which about a third of the subjects responded to the treatment.<sup id=\"cite_ref-Beilenberg_45-2\" class=\"reference\"><a href=\"#cite_note-Beilenberg-45\">&#91;45&#93;</a></sup>  The results of that trial were published in the New England Journal of Medicine in 1999.<sup id=\"cite_ref-Beilenberg_45-3\" class=\"reference\"><a href=\"#cite_note-Beilenberg-45\">&#91;45&#93;</a></sup><sup id=\"cite_ref-nejm-myeloma_48-0\" class=\"reference\"><a href=\"#cite_note-nejm-myeloma-48\">&#91;48&#93;</a></sup>\n</p><p>After further work was done by Celgene and others, in 2006 the U.S.&#160;Food and Drug Administration granted accelerated approval for thalidomide in combination with dexamethasone for the treatment of newly diagnosed <a href=\"/wiki/Multiple_myeloma\" title=\"Multiple myeloma\">multiple myeloma</a> patients.<sup id=\"cite_ref-Beilenberg_45-4\" class=\"reference\"><a href=\"#cite_note-Beilenberg-45\">&#91;45&#93;</a></sup><sup id=\"cite_ref-49\" class=\"reference\"><a href=\"#cite_note-49\">&#91;49&#93;</a></sup>\n</p>\n<h2><span class=\"mw-headline\" id=\"Society_and_culture\">Society and culture</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Thalidomide&amp;action=edit&amp;section=11\" title=\"Edit section: Society and culture\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<h3><span class=\"mw-headline\" id=\"Birth_defects_crisis\">Birth defects crisis</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Thalidomide&amp;action=edit&amp;section=12\" title=\"Edit section: Birth defects crisis\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<div class=\"thumb tright\"><div class=\"thumbinner\" style=\"width:222px;\"><a href=\"/wiki/File:NCP14053.jpg\" class=\"image\"><img alt=\"\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/a/a5/NCP14053.jpg/220px-NCP14053.jpg\" width=\"220\" height=\"142\" class=\"thumbimage\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/a/a5/NCP14053.jpg/330px-NCP14053.jpg 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/a/a5/NCP14053.jpg/440px-NCP14053.jpg 2x\" data-file-width=\"2840\" data-file-height=\"1838\" /></a>  <div class=\"thumbcaption\"><div class=\"magnify\"><a href=\"/wiki/File:NCP14053.jpg\" class=\"internal\" title=\"Enlarge\"></a></div>Baby born to a mother who had taken thalidomide while pregnant</div></div></div>\n<p>In the late 1950s and early 1960s, more than 10,000 children in 46 countries were born with <a href=\"/wiki/Deformities\" class=\"mw-redirect\" title=\"Deformities\">deformities</a> such as <a href=\"/wiki/Phocomelia\" title=\"Phocomelia\">phocomelia</a> as a consequence of thalidomide use.<sup id=\"cite_ref-Bren_50-0\" class=\"reference\"><a href=\"#cite_note-Bren-50\">&#91;50&#93;</a></sup>  The severity and location of the deformities depended on how many days into the pregnancy the mother was before beginning treatment; thalidomide taken on the 20th day of pregnancy caused central brain damage, day 21 would damage the eyes, day 22 the ears and face, day 24 the arms, and leg damage would occur if taken up to day 28. Thalidomide did not damage the fetus if taken after 42 days gestation.<sup id=\"cite_ref-50year_32-1\" class=\"reference\"><a href=\"#cite_note-50year-32\">&#91;32&#93;</a></sup>\n</p><p>It is not known exactly how many worldwide victims of the drug there have been, although estimates range from 10,000 to 20,000<sup id=\"cite_ref-nyt-answers_51-0\" class=\"reference\"><a href=\"#cite_note-nyt-answers-51\">&#91;51&#93;</a></sup>  to 100,000.<sup id=\"cite_ref-50year_32-2\" class=\"reference\"><a href=\"#cite_note-50year-32\">&#91;32&#93;</a></sup> Despite the side effects, thalidomide was sold in pharmacies in Canada until 1962.<sup id=\"cite_ref-pmid14076167_35-3\" class=\"reference\"><a href=\"#cite_note-pmid14076167-35\">&#91;35&#93;</a></sup><sup id=\"cite_ref-52\" class=\"reference\"><a href=\"#cite_note-52\">&#91;52&#93;</a></sup>\n</p>\n<div class=\"thumb tright\"><div class=\"thumbinner\" style=\"width:222px;\"><a href=\"/wiki/File:Artificial_limbs_for_a_thalidomide_child,_1961-1965._(9660575567).jpg\" class=\"image\"><img alt=\"\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/b/bd/Artificial_limbs_for_a_thalidomide_child%2C_1961-1965._%289660575567%29.jpg/220px-Artificial_limbs_for_a_thalidomide_child%2C_1961-1965._%289660575567%29.jpg\" width=\"220\" height=\"303\" class=\"thumbimage\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/b/bd/Artificial_limbs_for_a_thalidomide_child%2C_1961-1965._%289660575567%29.jpg/330px-Artificial_limbs_for_a_thalidomide_child%2C_1961-1965._%289660575567%29.jpg 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/b/bd/Artificial_limbs_for_a_thalidomide_child%2C_1961-1965._%289660575567%29.jpg/440px-Artificial_limbs_for_a_thalidomide_child%2C_1961-1965._%289660575567%29.jpg 2x\" data-file-width=\"908\" data-file-height=\"1250\" /></a>  <div class=\"thumbcaption\"><div class=\"magnify\"><a href=\"/wiki/File:Artificial_limbs_for_a_thalidomide_child,_1961-1965._(9660575567).jpg\" class=\"internal\" title=\"Enlarge\"></a></div>These artificial limbs were made for an affected child in the 1960s by the <a href=\"/wiki/Department_of_Health_and_Social_Security\" title=\"Department of Health and Social Security\">Department of Health and Social Security</a>'s Limb Fitting Centre in <a href=\"/wiki/Roehampton\" title=\"Roehampton\">Roehampton</a>, London</div></div></div>\n<p>In the United Kingdom, the drug was licensed in 1958 and withdrawn in 1961. Of the approximately 2,000 babies born with defects, around half died within a few months and 466 survived to at least 2010.<sup id=\"cite_ref-53\" class=\"reference\"><a href=\"#cite_note-53\">&#91;53&#93;</a></sup>\n</p><p>In Spain, thalidomide was widely available throughout the 1970s, perhaps even into the 1980s. There were two reasons for this. First, state controls and safeguarding were poor; indeed, it was not until 2008 that the government even admitted the country had ever imported thalidomide. Second, Gr\u00fcnenthal failed to insist that its sister company in Madrid warn Spanish doctors, and permitted it to not warn them. The Spanish advocacy group for victims of thalidomide estimates that in 2015, there were 250\u2013300 living victims of thalidomide in Spain.<sup id=\"cite_ref-SundayTimesMag_Spain_54-0\" class=\"reference\"><a href=\"#cite_note-SundayTimesMag_Spain-54\">&#91;54&#93;</a></sup>\n</p><p>Although the Australian obstetrician <a href=\"/wiki/William_McBride_(doctor)\" title=\"William McBride (doctor)\">William McBride</a> took credit for raising the alarm about Thalidomide it was a <a href=\"/wiki/Midwife\" title=\"Midwife\">midwife</a> who first suspected the drug was causing birth defects in the babies of patients under his care at <a href=\"/wiki/Crown_Street_Women%27s_Hospital\" title=\"Crown Street Women&#39;s Hospital\">Crown Street Women's Hospital</a> in Sydney.<sup id=\"cite_ref-55\" class=\"reference\"><a href=\"#cite_note-55\">&#91;55&#93;</a></sup> German <a href=\"/wiki/Paediatrician\" class=\"mw-redirect\" title=\"Paediatrician\">paediatrician</a> <a href=\"/wiki/Widukind_Lenz\" title=\"Widukind Lenz\">Widukind Lenz</a> who also suspected the link is credited with conducting the scientific research that proved Thalidomide was causing birth defects in 1961.<sup id=\"cite_ref-56\" class=\"reference\"><a href=\"#cite_note-56\">&#91;56&#93;</a></sup><sup id=\"cite_ref-40_years_on_57-0\" class=\"reference\"><a href=\"#cite_note-40_years_on-57\">&#91;57&#93;</a></sup> McBride was later awarded a number of honors, including a medal and prize money by L'Institut de la Vie in Paris,<sup id=\"cite_ref-58\" class=\"reference\"><a href=\"#cite_note-58\">&#91;58&#93;</a></sup> but he was eventually struck off the Australian medical register in 1993 for scientific fraud.<sup id=\"cite_ref-59\" class=\"reference\"><a href=\"#cite_note-59\">&#91;59&#93;</a></sup><sup id=\"cite_ref-60\" class=\"reference\"><a href=\"#cite_note-60\">&#91;60&#93;</a></sup> Further animal tests were conducted by Dr George Somers, Chief Pharmacologist of <a href=\"/wiki/Distillers_Company\" class=\"mw-redirect\" title=\"Distillers Company\">Distillers Company</a> in Britain, which showed foetal abnormalities in rabbits.<sup id=\"cite_ref-61\" class=\"reference\"><a href=\"#cite_note-61\">&#91;61&#93;</a></sup> Similar results were also published showing these effects in rats<sup id=\"cite_ref-62\" class=\"reference\"><a href=\"#cite_note-62\">&#91;62&#93;</a></sup><sup id=\"cite_ref-pmid14288814_63-0\" class=\"reference\"><a href=\"#cite_note-pmid14288814-63\">&#91;63&#93;</a></sup> and other species.<sup id=\"cite_ref-64\" class=\"reference\"><a href=\"#cite_note-64\">&#91;64&#93;</a></sup>\n</p><p>In <a href=\"/wiki/East_Germany\" title=\"East Germany\">East Germany</a>, the head of the central pharmacy control commission, Friedrich Jung, suspected an antivitaminic effect of thalidomide as derivative of <a href=\"/wiki/Glutamic_acid\" title=\"Glutamic acid\">glutamic acid</a>.<sup id=\"cite_ref-65\" class=\"reference\"><a href=\"#cite_note-65\">&#91;65&#93;</a></sup> Meanwhile, in <a href=\"/wiki/West_Germany\" title=\"West Germany\">West Germany</a>, it took some time before the increase in <a href=\"/wiki/Dysmelia\" title=\"Dysmelia\">dysmelia</a> at the end of the 1950s was connected with thalidomide. In 1958, Karl Beck, a former pediatric doctor in <a href=\"/wiki/Bayreuth\" title=\"Bayreuth\">Bayreuth</a>, wrote an article in a local newspaper claiming a relationship between nuclear weapons testing and cases of dysmelia in children.<sup id=\"cite_ref-daeb_66-0\" class=\"reference\"><a href=\"#cite_note-daeb-66\">&#91;66&#93;</a></sup> Based on this, <a href=\"/wiki/Free_Democratic_Party_(Germany)\" title=\"Free Democratic Party (Germany)\">FDP</a> <a href=\"/wiki/Whip_(politics)\" title=\"Whip (politics)\">whip</a> <a href=\"/wiki/Erich_Mende\" title=\"Erich Mende\">Erich Mende</a> requested an official statement from the federal government.<sup id=\"cite_ref-daeb_66-1\" class=\"reference\"><a href=\"#cite_note-daeb-66\">&#91;66&#93;</a></sup> For statistical reasons, the main data series used to research dysmelia cases started by chance at the same time as the approval date for thalidomide.<sup id=\"cite_ref-daeb_66-2\" class=\"reference\"><a href=\"#cite_note-daeb-66\">&#91;66&#93;</a></sup> After the Nazi regime with its <a href=\"/wiki/Law_for_the_Prevention_of_Hereditarily_Diseased_Offspring\" title=\"Law for the Prevention of Hereditarily Diseased Offspring\">Law for the Prevention of Hereditarily Diseased Offspring</a> used mandatory statistical monitoring to commit various <a href=\"/wiki/Action_T4\" class=\"mw-redirect\" title=\"Action T4\">crimes</a>, western Germany had been very reluctant to monitor <a href=\"/wiki/Congenital_disorder\" class=\"mw-redirect\" title=\"Congenital disorder\">congenital disorders</a> in a similarly strict way.<sup id=\"cite_ref-th_67-0\" class=\"reference\"><a href=\"#cite_note-th-67\">&#91;67&#93;</a></sup> The parliamentary report rejected any relation with radioactivity and the abnormal increase of dysmelia.<sup id=\"cite_ref-daeb_66-3\" class=\"reference\"><a href=\"#cite_note-daeb-66\">&#91;66&#93;</a></sup> Also the DFG research project installed after the Mende request was not helpful. The project was led by pathologist <a href=\"/wiki/Franz_B%C3%BCchner_(pathologist)\" title=\"Franz B\u00fcchner (pathologist)\">Franz B\u00fcchner</a>, who ran the project to propagate his <a href=\"/wiki/Teratology\" title=\"Teratology\">teratological</a> theory. B\u00fcchner saw lack of healthy nutrition and behavior of the mothers as being more important than genetic reasons.<sup id=\"cite_ref-th_67-1\" class=\"reference\"><a href=\"#cite_note-th-67\">&#91;67&#93;</a></sup> Furthermore, it took a while to install a Surgeon General in Germany; the <a href=\"/wiki/Federal_Ministry_of_Health_(Germany)\" title=\"Federal Ministry of Health (Germany)\">Federal Ministry of Health</a> was not founded until 1962, some months after thalidomide was banned from the market.<sup id=\"cite_ref-daeb_66-4\" class=\"reference\"><a href=\"#cite_note-daeb-66\">&#91;66&#93;</a></sup> In Germany approximately 2,500 thalidomide babies were born.<sup id=\"cite_ref-40_years_on_57-1\" class=\"reference\"><a href=\"#cite_note-40_years_on-57\">&#91;57&#93;</a></sup>\n</p><p>Several countries either restricted the drug's use or never approved it. Ingeborg Eichler, a member of the <a href=\"/wiki/Austria\" title=\"Austria\">Austrian</a> pharmaceutical admission conference, enforced thalidomide (tradename Softenon) being sold under the rules of <a href=\"/wiki/Prescription_medication\" class=\"mw-redirect\" title=\"Prescription medication\">prescription medication</a> and as a result relatively few affected children were born in Austria and Switzerland.<sup id=\"cite_ref-68\" class=\"reference\"><a href=\"#cite_note-68\">&#91;68&#93;</a></sup> In the United States, <a href=\"/wiki/Pharmacologist\" class=\"mw-redirect\" title=\"Pharmacologist\">pharmacologist</a> <a href=\"/wiki/Frances_Oldham_Kelsey\" title=\"Frances Oldham Kelsey\">Frances Oldham Kelsey</a> <a href=\"/wiki/M.D.\" class=\"mw-redirect\" title=\"M.D.\">M.D.</a> withstood pressure from the <a href=\"/wiki/Marion_Merrell_Dow\" title=\"Marion Merrell Dow\">Richardson-Merrell</a> company and refused <a href=\"/wiki/Food_and_Drug_Administration\" title=\"Food and Drug Administration\">Food and Drug Administration</a> (FDA) approval to market thalidomide, saying further studies were needed.<sup id=\"cite_ref-Bren_50-1\" class=\"reference\"><a href=\"#cite_note-Bren-50\">&#91;50&#93;</a></sup> This reduced the impact of thalidomide in United States patients. Although thalidomide was never approved for sale in the United States at the time, over 2.5 million tablets had been distributed to over 1,000 physicians during a clinical testing program. It is estimated that nearly 20,000 patients, several hundred of whom were pregnant women, were given the drug to help alleviate morning sickness or as a sedative, and at least 17 children were consequently born in America with thalidomide-associated deformities.<sup id=\"cite_ref-Braun_69-0\" class=\"reference\"><a href=\"#cite_note-Braun-69\">&#91;69&#93;</a></sup><sup id=\"cite_ref-70\" class=\"reference\"><a href=\"#cite_note-70\">&#91;70&#93;</a></sup>\n</p><p>A woman named <a href=\"/wiki/Sherri_Finkbine\" title=\"Sherri Finkbine\">Sherri Finkbine</a> publicized the serious problems of thalidomide.<sup id=\"cite_ref-71\" class=\"reference\"><a href=\"#cite_note-71\">&#91;71&#93;</a></sup> Finkbine had been taking <a href=\"/wiki/Hypnotic\" title=\"Hypnotic\">sleeping pills</a> that contained this drug while she was pregnant, as it was popular at the time. She had later learned that thalidomide was causing fetal deformities. She wanted to abort her pregnancy, but the laws of Arizona allowed abortion only if the mother's life was in danger. Finkbine traveled to <a href=\"/wiki/Sweden\" title=\"Sweden\">Sweden</a> to have the abortion, which was expensive for her. Thalidomide was found to have deformed the fetus.<sup id=\"cite_ref-Braun_69-1\" class=\"reference\"><a href=\"#cite_note-Braun-69\">&#91;69&#93;</a></sup>\n</p>\n<h3><span class=\"mw-headline\" id=\"Aftermath_of_scandal\">Aftermath of scandal</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Thalidomide&amp;action=edit&amp;section=13\" title=\"Edit section: Aftermath of scandal\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<p>The numerous reports of malformations in babies brought about the awareness of the side effects of the drug on pregnant women. The birth defects caused by the drug thalidomide can range from moderate malformation to more severe forms. Possible birth defects include phocomelia, dysmelia, amelia, bone hypoplasticity, and other congenital defects affecting the ear, heart, or internal organs.<sup id=\"cite_ref-pmid15172781_27-2\" class=\"reference\"><a href=\"#cite_note-pmid15172781-27\">&#91;27&#93;</a></sup> Franks et al. looked at how the drug affected newborn babies, the severity of their deformities, and reviewed the drug in its early years. Webb in 1963 also reviewed the history of the drug and the different forms of birth defects it had caused. \"The most common form of birth defects from thalidomide is shortened limbs, with the arms being more frequently affected. This syndrome is the presence of deformities of the long bones of the limbs resulting in shortening and other abnormalities.\"<sup id=\"cite_ref-pmid14076167_35-4\" class=\"reference\"><a href=\"#cite_note-pmid14076167-35\">&#91;35&#93;</a></sup>\n</p>\n<h4><span class=\"mw-headline\" id=\"Germany\">Germany</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Thalidomide&amp;action=edit&amp;section=14\" title=\"Edit section: Germany\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h4>\n<p>In 1968, a large criminal trial began in Germany, charging several Gr\u00fcnenthal officials with negligent homicide and injury. \nAfter Gr\u00fcnenthal settled with the victims in April 1970, the trial ended in December 1970 with no finding of guilt. As part of the settlement, Gr\u00fcnenthal paid 100 million <a href=\"/wiki/Deutsche_Mark\" title=\"Deutsche Mark\">DM</a> into a special foundation; the German government added 320 million DM. The foundation paid victims a one-time sum of 2,500-25,000 DM (depending on severity of disability) and a monthly stipend of 100-450 DM. The monthly stipends have since been raised substantially and are now paid entirely by the government (as the foundation had run out of money). Gr\u00fcnenthal paid another 50 million Euros into the foundation in 2008.\n</p><p>On 31 August 2012, Gr\u00fcnenthal chief executive Harald F. Stock who served as the Chief Executive Officer of Gr\u00fcnenthal <a href=\"/wiki/Gesellschaft_mit_beschr%C3%A4nkter_Haftung\" title=\"Gesellschaft mit beschr\u00e4nkter Haftung\">GmbH</a> from January 2009 to May 28, 2013 and was also a Member of Executive Board until May 28, 2013, apologized for the first time for producing the drug and remaining silent about the birth defects.<sup id=\"cite_ref-72\" class=\"reference\"><a href=\"#cite_note-72\">&#91;72&#93;</a></sup> At a ceremony, Stock unveiled a statue of a disabled child to symbolize those harmed by thalidomide and apologized for not trying to reach out to victims for over 50&#160;years. At the time of the apology, there were 5,000 to 6,000 sufferers still alive. Victim advocates called the apology \"insulting\" and \"too little, too late\", and criticized the company for not compensating victims. They also criticized the company for their claim that no one could have known the harm the drug caused, arguing that there were plenty of red flags at the time.<sup id=\"cite_ref-73\" class=\"reference\"><a href=\"#cite_note-73\">&#91;73&#93;</a></sup>\n</p>\n<h4><span class=\"mw-headline\" id=\"United_Kingdom\">United Kingdom</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Thalidomide&amp;action=edit&amp;section=15\" title=\"Edit section: United Kingdom\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h4>\n<p>In 1968, after a long campaign by <i><a href=\"/wiki/The_Sunday_Times\" title=\"The Sunday Times\">The Sunday Times</a></i>, a compensation settlement for the UK victims was reached with <a href=\"/wiki/Distillers_Company\" class=\"mw-redirect\" title=\"Distillers Company\">Distillers Company</a> (now part of <a href=\"/wiki/Diageo\" title=\"Diageo\">Diageo</a>), which had distributed the drug in the UK.<sup id=\"cite_ref-they_didn&#39;t_know_74-0\" class=\"reference\"><a href=\"#cite_note-they_didn&#39;t_know-74\">&#91;74&#93;</a></sup><sup id=\"cite_ref-75\" class=\"reference\"><a href=\"#cite_note-75\">&#91;75&#93;</a></sup> This compensation, which is distributed by the Thalidomide Trust in the UK, was substantially increased by Diageo in 2005.<sup id=\"cite_ref-76\" class=\"reference\"><a href=\"#cite_note-76\">&#91;76&#93;</a></sup> The UK Government gave survivors a grant of \u00a320 million, to be distributed through the Thalidomide Trust, in December 2009.<sup id=\"cite_ref-UK_Government_grant_77-0\" class=\"reference\"><a href=\"#cite_note-UK_Government_grant-77\">&#91;77&#93;</a></sup>\n</p>\n<h4><span class=\"mw-headline\" id=\"Australia\">Australia</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Thalidomide&amp;action=edit&amp;section=16\" title=\"Edit section: Australia\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h4>\n<p>Melbourne woman Lynette Rowe, who was born without limbs, led an Australian <a href=\"/wiki/Class_action\" title=\"Class action\">class action</a> lawsuit against the drug's manufacturer, Gr\u00fcnenthal, which fought to have the case heard in Germany. The <a href=\"/wiki/Supreme_Court_of_Victoria\" title=\"Supreme Court of Victoria\">Supreme Court of Victoria</a> dismissed Gr\u00fcnenthal's application in 2012, and the case was heard in Australia.<sup id=\"cite_ref-78\" class=\"reference\"><a href=\"#cite_note-78\">&#91;78&#93;</a></sup> On 17 July 2012, Rowe was awarded an out-of-court settlement, believed to be in the millions of dollars and paving the way for class action victims to receive further compensation.<sup id=\"cite_ref-79\" class=\"reference\"><a href=\"#cite_note-79\">&#91;79&#93;</a></sup> In February 2014, the Supreme Court of Victoria endorsed the settlement of $89 million AUD to 107 victims of the drug in Australia and New Zealand.<sup id=\"cite_ref-80\" class=\"reference\"><a href=\"#cite_note-80\">&#91;80&#93;</a></sup><sup id=\"cite_ref-81\" class=\"reference\"><a href=\"#cite_note-81\">&#91;81&#93;</a></sup>\n</p>\n<h4><span class=\"mw-headline\" id=\"Canada\">Canada</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Thalidomide&amp;action=edit&amp;section=17\" title=\"Edit section: Canada\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h4>\n<p>The drug thalidomide's birth defects in children affected many people's lives, and from these events came the formation of the group called <a href=\"/w/index.php?title=The_Thalidomide_Victims_Association_of_Canada&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"The Thalidomide Victims Association of Canada (page does not exist)\">The Thalidomide Victims Association of Canada</a>, a group of 120 Canadian survivors.<sup id=\"cite_ref-82\" class=\"reference\"><a href=\"#cite_note-82\">&#91;82&#93;</a></sup><sup id=\"cite_ref-83\" class=\"reference\"><a href=\"#cite_note-83\">&#91;83&#93;</a></sup> Their goal was to prevent future usage of drugs that could be of potential harm to mothers and babies. The members from the thalidomide victims association were involved in the STEPS program, which aimed to prevent teratogenicity.<sup id=\"cite_ref-pmid15172781_27-3\" class=\"reference\"><a href=\"#cite_note-pmid15172781-27\">&#91;27&#93;</a></sup>\n</p><p>The effects of thalidomide increased fears regarding the safety of pharmaceutical drugs. The Society of Toxicology of Canada was formed after the effects of thalidomide were made public, focusing on toxicology as a discipline separate from pharmacology.<sup id=\"cite_ref-pmid12909394_84-0\" class=\"reference\"><a href=\"#cite_note-pmid12909394-84\">&#91;84&#93;</a></sup> The need for the testing and approval of the toxins in certain pharmaceutical drugs became more important after the disaster. The Society of Toxicology of Canada is responsible for the Conservation Environment Protection Act, focusing on researching the impact to human health of chemical substances.<sup id=\"cite_ref-pmid12909394_84-1\" class=\"reference\"><a href=\"#cite_note-pmid12909394-84\">&#91;84&#93;</a></sup> Thalidomide brought on changes in the way drugs are tested, what type of drugs are used during pregnancy, and increased the awareness of potential side effects of drugs.\n</p><p>According to <a href=\"/wiki/W5_(TV_series)\" title=\"W5 (TV series)\">Canadian news magazine program <i>W5</i></a>, most, but not all, victims  of thalidomide receive annual benefits as compensation from the <a href=\"/wiki/Government_of_Canada\" title=\"Government of Canada\">Government of Canada</a>. Excluded are those who cannot provide the documentation the government requires.<sup id=\"cite_ref-85\" class=\"reference\"><a href=\"#cite_note-85\">&#91;85&#93;</a></sup>\n</p>\n<h4><span class=\"mw-headline\" id=\"United_States\">United States</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Thalidomide&amp;action=edit&amp;section=18\" title=\"Edit section: United States\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h4>\n<div class=\"thumb tright\"><div class=\"thumbinner\" style=\"width:172px;\"><a href=\"/wiki/File:Frances_Oldham_Kelsey_and_John_F._Kennedy.jpg\" class=\"image\"><img alt=\"\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/1/18/Frances_Oldham_Kelsey_and_John_F._Kennedy.jpg/170px-Frances_Oldham_Kelsey_and_John_F._Kennedy.jpg\" width=\"170\" height=\"221\" class=\"thumbimage\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/1/18/Frances_Oldham_Kelsey_and_John_F._Kennedy.jpg/255px-Frances_Oldham_Kelsey_and_John_F._Kennedy.jpg 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/1/18/Frances_Oldham_Kelsey_and_John_F._Kennedy.jpg/340px-Frances_Oldham_Kelsey_and_John_F._Kennedy.jpg 2x\" data-file-width=\"1182\" data-file-height=\"1536\" /></a>  <div class=\"thumbcaption\"><div class=\"magnify\"><a href=\"/wiki/File:Frances_Oldham_Kelsey_and_John_F._Kennedy.jpg\" class=\"internal\" title=\"Enlarge\"></a></div>1962: FDA pharmacologist <a href=\"/wiki/Frances_Oldham_Kelsey\" title=\"Frances Oldham Kelsey\">Frances Oldham Kelsey</a> receives the <a href=\"/wiki/President%27s_Award_for_Distinguished_Federal_Civilian_Service\" title=\"President&#39;s Award for Distinguished Federal Civilian Service\">President's Award for Distinguished Federal Civilian Service</a> from President <a href=\"/wiki/John_F._Kennedy\" title=\"John F. Kennedy\">John F. Kennedy</a> for blocking sale of thalidomide in the United States.</div></div></div>\n<p>For correctly denying the application despite the pressure from Richardson-Merrell, Kelsey eventually received the President's Award for Distinguished Federal Civilian Service at a 1962 ceremony with President <a href=\"/wiki/John_F._Kennedy\" title=\"John F. Kennedy\">John F. Kennedy</a>. In September 2010, the FDA honored Kelsey with the first Kelsey award, given annually to an FDA staff member. This came 50 years after Kelsey, then a new medical officer at the agency, first reviewed the application from the William S. Merrell Company of Cincinnati.<sup id=\"cite_ref-86\" class=\"reference\"><a href=\"#cite_note-86\">&#91;86&#93;</a></sup> \n</p><p>Cardiologist <a href=\"/wiki/Helen_B._Taussig\" title=\"Helen B. Taussig\">Helen B. Taussig</a> learned of the damaging effects of the drug thalidomide on newborns and in 1967, testified before Congress on this matter after a trip to Germany where she worked with infants with <a href=\"/wiki/Phocomelia\" title=\"Phocomelia\">phocomelia</a> (severe limb deformities). As a result of her efforts, thalidomide was banned in the United States and Europe.<sup class=\"noprint Inline-Template Template-Fact\" style=\"white-space:nowrap;\">&#91;<i><a href=\"/wiki/Wikipedia:Citation_needed\" title=\"Wikipedia:Citation needed\"><span title=\"This claim needs references to reliable sources. (April 2016)\">citation needed</span></a></i>&#93;</sup>\n</p>\n<h3><span class=\"mw-headline\" id=\"Notable_cases\">Notable cases</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Thalidomide&amp;action=edit&amp;section=19\" title=\"Edit section: Notable cases\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<div class=\"thumb tright\"><div class=\"thumbinner\" style=\"width:222px;\"><a href=\"/wiki/File:Niko_von_Glasow.jpg\" class=\"image\"><img alt=\"\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/1/16/Niko_von_Glasow.jpg/220px-Niko_von_Glasow.jpg\" width=\"220\" height=\"293\" class=\"thumbimage\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/1/16/Niko_von_Glasow.jpg/330px-Niko_von_Glasow.jpg 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/1/16/Niko_von_Glasow.jpg/440px-Niko_von_Glasow.jpg 2x\" data-file-width=\"480\" data-file-height=\"640\" /></a>  <div class=\"thumbcaption\"><div class=\"magnify\"><a href=\"/wiki/File:Niko_von_Glasow.jpg\" class=\"internal\" title=\"Enlarge\"></a></div>Niko von Glasow, German filmmaker</div></div></div>\n<ul><li><a href=\"/wiki/Lorraine_Mercer\" title=\"Lorraine Mercer\">Lorraine Mercer</a>  <a href=\"/wiki/Order_of_the_British_Empire\" title=\"Order of the British Empire\">MBE</a>  of the United Kingdom, born with <a href=\"/wiki/Phocomelia\" title=\"Phocomelia\">phocomelia</a> of both arms and legs, is the only thalidomide survivor to carry the Olympic Torch.<sup id=\"cite_ref-Tamplin_87-0\" class=\"reference\"><a href=\"#cite_note-Tamplin-87\">&#91;87&#93;</a></sup></li>\n<li><a href=\"/wiki/Thomas_Quasthoff\" title=\"Thomas Quasthoff\">Thomas Quasthoff</a>, an internationally acclaimed bass-baritone, who describes himself: \"1.34 meters tall, short arms, seven fingers&#160;\u2014 four right, three left&#160;\u2014 large, relatively well-formed head, brown eyes, distinctive lips; profession: singer\".<sup id=\"cite_ref-88\" class=\"reference\"><a href=\"#cite_note-88\">&#91;88&#93;</a></sup></li>\n<li><a href=\"/wiki/Niko_von_Glasow\" title=\"Niko von Glasow\">Niko von Glasow</a> produced a documentary called <i><a href=\"/wiki/NoBody%27s_Perfect\" title=\"NoBody&#39;s Perfect\">NoBody's Perfect</a></i>, based on the lives of 12 people affected by the drug, which was released in 2008.<sup id=\"cite_ref-89\" class=\"reference\"><a href=\"#cite_note-89\">&#91;89&#93;</a></sup><sup id=\"cite_ref-90\" class=\"reference\"><a href=\"#cite_note-90\">&#91;90&#93;</a></sup></li>\n<li><a href=\"/wiki/Merc%C3%A9des_Benegbi\" title=\"Merc\u00e9des Benegbi\">Merc\u00e9des Benegbi</a>, born with phocomelia of both arms, drove the successful campaign for compensation from her government for Canadians who were affected by thalidomide.<sup id=\"cite_ref-91\" class=\"reference\"><a href=\"#cite_note-91\">&#91;91&#93;</a></sup></li></ul>\n<h3><span class=\"mw-headline\" id=\"Change_in_drug_regulations\">Change in drug regulations</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Thalidomide&amp;action=edit&amp;section=20\" title=\"Edit section: Change in drug regulations\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<p>The disaster prompted many countries to introduce tougher rules for the testing and licensing of drugs, such as the <a href=\"/wiki/Kefauver_Harris_Amendment\" title=\"Kefauver Harris Amendment\">Kefauver Harris Amendment</a><sup id=\"cite_ref-92\" class=\"reference\"><a href=\"#cite_note-92\">&#91;92&#93;</a></sup>  (U.S.), <a href=\"/wiki/Directive_65/65/EEC1\" class=\"mw-redirect\" title=\"Directive 65/65/EEC1\">Directive 65/65/EEC1</a> (E.U.),<sup id=\"cite_ref-93\" class=\"reference\"><a href=\"#cite_note-93\">&#91;93&#93;</a></sup> and the <a href=\"/wiki/Medicines_Act_1968\" title=\"Medicines Act 1968\">Medicines Act 1968</a>.<sup id=\"cite_ref-94\" class=\"reference\"><a href=\"#cite_note-94\">&#91;94&#93;</a></sup><sup id=\"cite_ref-95\" class=\"reference\"><a href=\"#cite_note-95\">&#91;95&#93;</a></sup> In the United States, the new regulations strengthened the FDA, among other ways, by requiring applicants to prove efficacy and to disclose all side effects encountered in testing.<sup id=\"cite_ref-Bren_50-2\" class=\"reference\"><a href=\"#cite_note-Bren-50\">&#91;50&#93;</a></sup> The FDA subsequently initiated the <a href=\"/wiki/Drug_Efficacy_Study_Implementation\" title=\"Drug Efficacy Study Implementation\">Drug Efficacy Study Implementation</a> to reclassify drugs already on the market.\n</p>\n<h2><span class=\"mw-headline\" id=\"Research\">Research</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Thalidomide&amp;action=edit&amp;section=21\" title=\"Edit section: Research\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<p>Research efforts have been focused on determining how thalidomide causes birth defects and its other activities in the human body, efforts to develop safer analogs, and efforts to find further uses for thalidomide.\n</p>\n<h3><span class=\"mw-headline\" id=\"Thalidomide_analogs\">Thalidomide analogs</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Thalidomide&amp;action=edit&amp;section=22\" title=\"Edit section: Thalidomide analogs\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<div role=\"note\" class=\"hatnote navigation-not-searchable\">Main article: <a href=\"/wiki/Development_of_analogs_of_thalidomide\" title=\"Development of analogs of thalidomide\">Development of analogs of thalidomide</a></div>\n<p>The exploration of the <a href=\"/wiki/Antiangiogenic\" class=\"mw-redirect\" title=\"Antiangiogenic\">antiangiogenic</a> and immunomodulatory activities of thalidomide has led to the study and creation of thalidomide <a href=\"/wiki/Analog_(chemistry)\" class=\"mw-redirect\" title=\"Analog (chemistry)\">analogs</a>.<sup id=\"cite_ref-pmid10447943_96-0\" class=\"reference\"><a href=\"#cite_note-pmid10447943-96\">&#91;96&#93;</a></sup><sup id=\"cite_ref-pmid11740816_97-0\" class=\"reference\"><a href=\"#cite_note-pmid11740816-97\">&#91;97&#93;</a></sup> Celgene has sponsored numerous clinical trials with analogues to thalidomide, such as <a href=\"/wiki/Lenalidomide\" title=\"Lenalidomide\">lenalidomide</a>, that are substantially more powerful and have fewer side effects&#160;\u2014 except for greater <a href=\"/wiki/Myelosuppression\" class=\"mw-redirect\" title=\"Myelosuppression\">myelosuppression</a>.<sup id=\"cite_ref-98\" class=\"reference\"><a href=\"#cite_note-98\">&#91;98&#93;</a></sup> In 2005, Celgene received FDA approval for <a href=\"/wiki/Lenalidomide\" title=\"Lenalidomide\">lenalidomide</a> (Revlimid) as the first commercially useful derivative. Revlimid is available only in a restricted distribution setting to avoid its use during pregnancy. Further studies are being conducted to find safer compounds with useful qualities. Another more potent analog, <a href=\"/wiki/Pomalidomide\" title=\"Pomalidomide\">pomalidomide</a>, is now FDA approved.<sup id=\"cite_ref-99\" class=\"reference\"><a href=\"#cite_note-99\">&#91;99&#93;</a></sup> Additionally, <a href=\"/wiki/Apremilast\" title=\"Apremilast\">apremilast</a> was approved by the FDA in March 2014. These <a href=\"/wiki/Discovery_and_development_of_thalidomide_and_its_analogs\" class=\"mw-redirect\" title=\"Discovery and development of thalidomide and its analogs\">thalidomide analogs</a> can be used to treat different diseases, or used in a regimen to fight two conditions.<sup id=\"cite_ref-100\" class=\"reference\"><a href=\"#cite_note-100\">&#91;100&#93;</a></sup>\n</p><p>Interest turned to <a href=\"/wiki/Pomalidomide\" title=\"Pomalidomide\">pomalidomide</a>, a <a href=\"/wiki/Derivative_(chemistry)\" title=\"Derivative (chemistry)\">derivative</a> of thalidomide marketed by <a href=\"/wiki/Celgene_Corporation\" class=\"mw-redirect\" title=\"Celgene Corporation\">Celgene</a>. It is a very active anti-angiogenic agent <sup id=\"cite_ref-pmid11740816_97-1\" class=\"reference\"><a href=\"#cite_note-pmid11740816-97\">&#91;97&#93;</a></sup>  and also acts as an <a href=\"/wiki/Immunomodulator\" class=\"mw-redirect\" title=\"Immunomodulator\">immunomodulator</a>. Pomalidomide was approved in February 2013 by the U.S. <a href=\"/wiki/Food_and_Drug_Administration\" title=\"Food and Drug Administration\">Food and Drug Administration</a> (FDA) as a treatment for relapsed and refractory <a href=\"/wiki/Multiple_myeloma\" title=\"Multiple myeloma\">multiple myeloma</a>.<sup id=\"cite_ref-P1_101-0\" class=\"reference\"><a href=\"#cite_note-P1-101\">&#91;101&#93;</a></sup> It received a similar approval from the <a href=\"/wiki/European_Commission\" title=\"European Commission\">European Commission</a> in August 2013, and is expected to be marketed in Europe under the brand name <b>Imnovid</b>.<sup id=\"cite_ref-P2_102-0\" class=\"reference\"><a href=\"#cite_note-P2-102\">&#91;102&#93;</a></sup>\n</p>\n<h3><span class=\"mw-headline\" id=\"Clinical_research\">Clinical research</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Thalidomide&amp;action=edit&amp;section=23\" title=\"Edit section: Clinical research\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<p>There is no conclusive evidence that thalidomide or <a href=\"/wiki/Lenalidomide\" title=\"Lenalidomide\">lenalidomide</a> is useful to bring about or maintain remission in Crohn's disease.<sup id=\"cite_ref-103\" class=\"reference\"><a href=\"#cite_note-103\">&#91;103&#93;</a></sup><sup id=\"cite_ref-104\" class=\"reference\"><a href=\"#cite_note-104\">&#91;104&#93;</a></sup>\n</p><p>Thalidomide was studied in a Phase II trial for <a href=\"/wiki/Kaposi%27s_sarcoma\" title=\"Kaposi&#39;s sarcoma\">Kaposi's sarcoma</a>, a rare soft-tissue cancer most commonly seen in the immunocompromised, that is caused by the <a href=\"/wiki/Kaposi%27s_sarcoma-associated_herpesvirus\" title=\"Kaposi&#39;s sarcoma-associated herpesvirus\">Kaposi's sarcoma-associated herpesvirus</a> (KSHV).<sup id=\"cite_ref-105\" class=\"reference\"><a href=\"#cite_note-105\">&#91;105&#93;</a></sup><sup id=\"cite_ref-pmid15172781_27-4\" class=\"reference\"><a href=\"#cite_note-pmid15172781-27\">&#91;27&#93;</a></sup>\n</p>\n<div class=\"div-col columns column-width\" style=\"-moz-column-width: 30em; -webkit-column-width: 30em; column-width: 30em;\">\n<ul><li>AIDS wasting syndrome,<sup id=\"cite_ref-106\" class=\"reference\"><a href=\"#cite_note-106\">&#91;106&#93;</a></sup> associated diarrhoea<sup id=\"cite_ref-107\" class=\"reference\"><a href=\"#cite_note-107\">&#91;107&#93;</a></sup></li>\n<li><a href=\"/wiki/Renal_cell_carcinoma\" title=\"Renal cell carcinoma\">Renal cell carcinoma</a> (RCC)<sup id=\"cite_ref-pmid15172781_27-5\" class=\"reference\"><a href=\"#cite_note-pmid15172781-27\">&#91;27&#93;</a></sup><sup id=\"cite_ref-108\" class=\"reference\"><a href=\"#cite_note-108\">&#91;108&#93;</a></sup></li>\n<li><a href=\"/wiki/Glioblastoma_multiforme\" class=\"mw-redirect\" title=\"Glioblastoma multiforme\">Glioblastoma multiforme</a><sup id=\"cite_ref-pmid15172781_27-6\" class=\"reference\"><a href=\"#cite_note-pmid15172781-27\">&#91;27&#93;</a></sup></li>\n<li><a href=\"/wiki/Prostate_cancer\" title=\"Prostate cancer\">Prostate cancer</a><sup id=\"cite_ref-pmid15172781_27-7\" class=\"reference\"><a href=\"#cite_note-pmid15172781-27\">&#91;27&#93;</a></sup></li>\n<li><a href=\"/wiki/Melanoma\" title=\"Melanoma\">Melanoma</a><sup id=\"cite_ref-pmid15172781_27-8\" class=\"reference\"><a href=\"#cite_note-pmid15172781-27\">&#91;27&#93;</a></sup></li>\n<li><a href=\"/wiki/Colorectal_cancer\" title=\"Colorectal cancer\">Colorectal cancer</a><sup id=\"cite_ref-pmid15172781_27-9\" class=\"reference\"><a href=\"#cite_note-pmid15172781-27\">&#91;27&#93;</a></sup></li>\n<li><a href=\"/wiki/Crohn%27s_disease\" title=\"Crohn&#39;s disease\">Crohn's disease</a><sup id=\"cite_ref-pmid15172781_27-10\" class=\"reference\"><a href=\"#cite_note-pmid15172781-27\">&#91;27&#93;</a></sup></li>\n<li><a href=\"/wiki/Rheumatoid_arthritis\" title=\"Rheumatoid arthritis\">Rheumatoid arthritis</a><sup id=\"cite_ref-pmid15172781_27-11\" class=\"reference\"><a href=\"#cite_note-pmid15172781-27\">&#91;27&#93;</a></sup></li>\n<li><a href=\"/wiki/Behcet%27s_syndrome\" class=\"mw-redirect\" title=\"Behcet&#39;s syndrome\">Behcet's syndrome</a><sup id=\"cite_ref-109\" class=\"reference\"><a href=\"#cite_note-109\">&#91;109&#93;</a></sup></li>\n<li><a href=\"/wiki/Breast_cancer\" title=\"Breast cancer\">Breast cancer</a><sup id=\"cite_ref-pmid15172781_27-12\" class=\"reference\"><a href=\"#cite_note-pmid15172781-27\">&#91;27&#93;</a></sup></li>\n<li><a href=\"/wiki/Head_and_neck_cancer\" title=\"Head and neck cancer\">Head and neck cancer</a><sup id=\"cite_ref-pmid15172781_27-13\" class=\"reference\"><a href=\"#cite_note-pmid15172781-27\">&#91;27&#93;</a></sup></li>\n<li><a href=\"/wiki/Ovarian_cancer\" title=\"Ovarian cancer\">Ovarian cancer</a><sup id=\"cite_ref-pmid15172781_27-14\" class=\"reference\"><a href=\"#cite_note-pmid15172781-27\">&#91;27&#93;</a></sup></li>\n<li>Chronic heart failure<sup id=\"cite_ref-pmid15172781_27-15\" class=\"reference\"><a href=\"#cite_note-pmid15172781-27\">&#91;27&#93;</a></sup></li>\n<li>Graft-versus-host disease<sup id=\"cite_ref-pmid15172781_27-16\" class=\"reference\"><a href=\"#cite_note-pmid15172781-27\">&#91;27&#93;</a></sup></li>\n<li><a href=\"/wiki/Tuberculous_meningitis\" title=\"Tuberculous meningitis\">Tuberculous meningitis</a><sup id=\"cite_ref-110\" class=\"reference\"><a href=\"#cite_note-110\">&#91;110&#93;</a></sup></li></ul>\n</div>\n<h2><span class=\"mw-headline\" id=\"See_also\">See also</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Thalidomide&amp;action=edit&amp;section=24\" title=\"Edit section: See also\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<div class=\"div-col columns column-width\" style=\"-moz-column-width: 22em; -webkit-column-width: 22em; column-width: 22em;\">\n<ul><li><a href=\"/wiki/Pharmacovigilance\" title=\"Pharmacovigilance\">Pharmacovigilance</a></li>\n<li><a href=\"/wiki/Immunomodulatory_drug\" class=\"mw-redirect\" title=\"Immunomodulatory drug\">Immunomodulatory drug</a></li>\n<li><a href=\"/wiki/Discovery_and_development_of_thalidomide_and_its_analogs\" class=\"mw-redirect\" title=\"Discovery and development of thalidomide and its analogs\">Discovery and development of thalidomide and its analogs</a></li>\n<li><a href=\"/wiki/Drug_of_last_resort\" title=\"Drug of last resort\">Drug of last resort</a></li>\n<li><a href=\"/wiki/Health_crisis\" title=\"Health crisis\">Health crisis</a></li>\n<li><a href=\"/wiki/Holt-Oram_syndrome\" class=\"mw-redirect\" title=\"Holt-Oram syndrome\">Holt-Oram syndrome</a></li>\n<li><a href=\"/wiki/Category:People_with_phocomelia\" title=\"Category:People with phocomelia\">Category:People with phocomelia</a></li>\n<li><a href=\"/wiki/Diethylstilbestrol\" title=\"Diethylstilbestrol\">Diethylstilbestrol</a></li></ul>\n</div>\n<h2><span class=\"mw-headline\" id=\"References\">References</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Thalidomide&amp;action=edit&amp;section=25\" title=\"Edit section: References\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<div class=\"reflist columns references-column-width\" style=\"-moz-column-width: 30em; -webkit-column-width: 30em; column-width: 30em; list-style-type: decimal;\">\n<ol class=\"references\">\n<li id=\"cite_note-1\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-1\">^</a></b></span> <span class=\"reference-text\"><cite id=\"CITEREFReference-OED-Thalidomide\" class=\"citation\"><a rel=\"nofollow\" class=\"external text\" href=\"http://oed.com/search?searchType=dictionary&amp;q=Thalidomide\">\"Thalidomide\"</a>. <i><a href=\"/wiki/Oxford_English_Dictionary\" title=\"Oxford English Dictionary\">Oxford English Dictionary</a></i> (3rd ed.). Oxford University Press. September 2005.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=bookitem&amp;rft.atitle=Thalidomide&amp;rft.btitle=Oxford+English+Dictionary&amp;rft.edition=3rd&amp;rft.pub=Oxford+University+Press&amp;rft.date=2005-09&amp;rft_id=http%3A%2F%2Foed.com%2Fsearch%3FsearchType%3Ddictionary%26q%3DThalidomide&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AThalidomide\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span>&#160;<span style=\"font-size:0.95em; font-size:90%; color:#555\">(Subscription or <a rel=\"nofollow\" class=\"external text\" href=\"http://www.oxforddnb.com/help/subscribe#public\">UK public library membership</a> required.)</span></span>\n</li>\n<li id=\"cite_note-clinp-2\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-clinp_2-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-clinp_2-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-clinp_2-2\"><sup><i><b>c</b></i></sup></a> <a href=\"#cite_ref-clinp_2-3\"><sup><i><b>d</b></i></sup></a> <a href=\"#cite_ref-clinp_2-4\"><sup><i><b>e</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation journal\">Teo SK, Colburn WA, Tracewell WG, Kook KA, Stirling DI, Jaworsky MS, Scheffler MA, Thomas SD, Laskin OL (2004). \"Clinical pharmacokinetics of thalidomide\". <i>Clinical Pharmacokinetics</i>. <b>43</b> (5): 311\u201327. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.2165/00003088-200443050-00004\">10.2165/00003088-200443050-00004</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/15080764\">15080764</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Clinical+Pharmacokinetics&amp;rft.atitle=Clinical+pharmacokinetics+of+thalidomide&amp;rft.volume=43&amp;rft.issue=5&amp;rft.pages=311-27&amp;rft.date=2004&amp;rft_id=info%3Adoi%2F10.2165%2F00003088-200443050-00004&amp;rft_id=info%3Apmid%2F15080764&amp;rft.aulast=Teo&amp;rft.aufirst=SK&amp;rft.au=Colburn%2C+WA&amp;rft.au=Tracewell%2C+WG&amp;rft.au=Kook%2C+KA&amp;rft.au=Stirling%2C+DI&amp;rft.au=Jaworsky%2C+MS&amp;rft.au=Scheffler%2C+MA&amp;rft.au=Thomas%2C+SD&amp;rft.au=Laskin%2C+OL&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AThalidomide\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-miller-3\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-miller_3-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Miller, Marylin T. (1991). \"Thalidomide Embryopathy: A Model for the Study of Congenital Incomitant Horizontal Strabismus\". <i>Transactions of the American Ophthalmological Society</i>. <b>81</b>: 623\u2013674.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Transactions+of+the+American+Ophthalmological+Society&amp;rft.atitle=Thalidomide+Embryopathy%3A+A+Model+for+the+Study+of+Congenital+Incomitant+Horizontal+Strabismus&amp;rft.volume=81&amp;rft.pages=623-674&amp;rft.date=1991&amp;rft.aulast=Miller&amp;rft.aufirst=Marylin+T.&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AThalidomide\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-oncozine.com-4\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-oncozine.com_4-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-oncozine.com_4-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-oncozine.com_4-2\"><sup><i><b>c</b></i></sup></a> <a href=\"#cite_ref-oncozine.com_4-3\"><sup><i><b>d</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation web\">Hofland P. <a rel=\"nofollow\" class=\"external text\" href=\"https://oncozine.com/reversal-of-fortune-how-a-vilified-drug-became-a-life-saving-agent-in-the-war-against-cancer/\">\"Reversal of Fortune: How a Vilified Drug Became a Life-saving Agent in the \"War\" Against Cancer\"</a>. <i>Onco'Zine</i>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=Onco%27Zine&amp;rft.atitle=Reversal+of+Fortune%3A+How+a+Vilified+Drug+Became+a+Life-saving+Agent+in+the+%22War%22+Against+Cancer&amp;rft.aulast=Hofland&amp;rft.aufirst=Peter&amp;rft_id=https%3A%2F%2Foncozine.com%2Freversal-of-fortune-how-a-vilified-drug-became-a-life-saving-agent-in-the-war-against-cancer%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AThalidomide\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-5\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-5\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation book\">Cuthbert, Alan (2003). <a rel=\"nofollow\" class=\"external text\" href=\"http://www.oxfordreference.com/view/10.1093/acref/9780198524038.001.0001/acref-9780198524038\"><i>The Oxford Companion to the Body</i></a>. Oxford University Press. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1093/acref/9780198524038.001.0001\">10.1093/acref/9780198524038.001.0001</a>. <a href=\"/wiki/International_Standard_Book_Number\" title=\"International Standard Book Number\">ISBN</a>&#160;<a href=\"/wiki/Special:BookSources/9780198524038\" title=\"Special:BookSources/9780198524038\">9780198524038</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=book&amp;rft.btitle=The+Oxford+Companion+to+the+Body&amp;rft.pub=Oxford+University+Press&amp;rft.date=2003&amp;rft_id=info%3Adoi%2F10.1093%2Facref%2F9780198524038.001.0001&amp;rft.isbn=9780198524038&amp;rft.aulast=Cuthbert&amp;rft.aufirst=Alan&amp;rft_id=http%3A%2F%2Fwww.oxfordreference.com%2Fview%2F10.1093%2Facref%2F9780198524038.001.0001%2Facref-9780198524038&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AThalidomide\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-The_chemical_industry-6\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-The_chemical_industry_6-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-The_chemical_industry_6-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation book\">Heaton, C. A. (1994). <i>The Chemical Industry</i>. Springer. <a href=\"/wiki/International_Standard_Book_Number\" title=\"International Standard Book Number\">ISBN</a>&#160;<a href=\"/wiki/Special:BookSources/0-7514-0018-1\" title=\"Special:BookSources/0-7514-0018-1\">0-7514-0018-1</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=book&amp;rft.btitle=The+Chemical+Industry&amp;rft.pub=Springer&amp;rft.date=1994&amp;rft.isbn=0-7514-0018-1&amp;rft.aulast=Heaton&amp;rft.aufirst=C.+A.&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AThalidomide\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-UKlabel2017-7\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-UKlabel2017_7-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-UKlabel2017_7-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-UKlabel2017_7-2\"><sup><i><b>c</b></i></sup></a> <a href=\"#cite_ref-UKlabel2017_7-3\"><sup><i><b>d</b></i></sup></a> <a href=\"#cite_ref-UKlabel2017_7-4\"><sup><i><b>e</b></i></sup></a> <a href=\"#cite_ref-UKlabel2017_7-5\"><sup><i><b>f</b></i></sup></a> <a href=\"#cite_ref-UKlabel2017_7-6\"><sup><i><b>g</b></i></sup></a> <a href=\"#cite_ref-UKlabel2017_7-7\"><sup><i><b>h</b></i></sup></a> <a href=\"#cite_ref-UKlabel2017_7-8\"><sup><i><b>i</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation web\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.medicines.org.uk/emc/medicine/21005\">\"Thalidomide Celgene 50 mg Hard Capsules - Summary of Product Characteristics\"</a>. UK Electronic Medicines Compendium. January 2017<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">26 June</span> 2017</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Thalidomide+Celgene+50+mg+Hard+Capsules+-+Summary+of+Product+Characteristics&amp;rft.pub=UK+Electronic+Medicines+Compendium&amp;rft.date=2017-01&amp;rft_id=https%3A%2F%2Fwww.medicines.org.uk%2Femc%2Fmedicine%2F21005&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AThalidomide\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-USlabel2017-8\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-USlabel2017_8-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-USlabel2017_8-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-USlabel2017_8-2\"><sup><i><b>c</b></i></sup></a> <a href=\"#cite_ref-USlabel2017_8-3\"><sup><i><b>d</b></i></sup></a> <a href=\"#cite_ref-USlabel2017_8-4\"><sup><i><b>e</b></i></sup></a> <a href=\"#cite_ref-USlabel2017_8-5\"><sup><i><b>f</b></i></sup></a> <a href=\"#cite_ref-USlabel2017_8-6\"><sup><i><b>g</b></i></sup></a> <a href=\"#cite_ref-USlabel2017_8-7\"><sup><i><b>h</b></i></sup></a> <a href=\"#cite_ref-USlabel2017_8-8\"><sup><i><b>i</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation web\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/020785s061lbl.pdf\">\"US Thalomid label\"</a> <span style=\"font-size:85%;\">(PDF)</span>. FDA. January 2017<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">26 June</span> 2017</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=US+Thalomid+label&amp;rft.pub=FDA&amp;rft.date=2017-01&amp;rft_id=https%3A%2F%2Fwww.accessdata.fda.gov%2Fdrugsatfda_docs%2Flabel%2F2017%2F020785s061lbl.pdf&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AThalidomide\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span> For label updates see <a rel=\"nofollow\" class=\"external text\" href=\"https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&amp;ApplNo=020785\">FDA index page for NDA 020785</a></span>\n</li>\n<li id=\"cite_note-9\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-9\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Buonsenso D, Serranti D, Valentini P (October 2010). <a rel=\"nofollow\" class=\"external text\" href=\"https://web.archive.org/web/20160818223324/http://www.europeanreview.org/wp/wp-content/uploads/827.pdf\">\"Management of central nervous system tuberculosis in children: light and shade\"</a> <span style=\"font-size:85%;\">(PDF)</span>. <i>European Review for Medical and Pharmacological Sciences</i>. <b>14</b> (10): 845\u201353. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/21222370\">21222370</a>. Archived from <a rel=\"nofollow\" class=\"external text\" href=\"http://www.europeanreview.org/wp/wp-content/uploads/827.pdf\">the original</a> <span style=\"font-size:85%;\">(PDF)</span> on 2016-08-18.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=European+Review+for+Medical+and+Pharmacological+Sciences&amp;rft.atitle=Management+of+central+nervous+system+tuberculosis+in+children%3A+light+and+shade&amp;rft.volume=14&amp;rft.issue=10&amp;rft.pages=845-53&amp;rft.date=2010-10&amp;rft_id=info%3Apmid%2F21222370&amp;rft.aulast=Buonsenso&amp;rft.aufirst=D&amp;rft.au=Serranti%2C+D&amp;rft.au=Valentini%2C+P&amp;rft_id=http%3A%2F%2Fwww.europeanreview.org%2Fwp%2Fwp-content%2Fuploads%2F827.pdf&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AThalidomide\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-10\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-10\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">van Toorn R, Solomons R (March 2014). \"Update on the diagnosis and management of tuberculous meningitis in children\". <i>Seminars in Pediatric Neurology</i>. <b>21</b> (1): 12\u20138. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1016/j.spen.2014.01.006\">10.1016/j.spen.2014.01.006</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/24655399\">24655399</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Seminars+in+Pediatric+Neurology&amp;rft.atitle=Update+on+the+diagnosis+and+management+of+tuberculous+meningitis+in+children&amp;rft.volume=21&amp;rft.issue=1&amp;rft.pages=12-8&amp;rft.date=2014-03&amp;rft_id=info%3Adoi%2F10.1016%2Fj.spen.2014.01.006&amp;rft_id=info%3Apmid%2F24655399&amp;rft.aulast=van+Toorn&amp;rft.aufirst=R&amp;rft.au=Solomons%2C+R&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AThalidomide\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-11\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-11\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Yang CS, Kim C, Antaya RJ (April 2015). \"Review of thalidomide use in the pediatric population\". <i>Journal of the American Academy of Dermatology</i>. <b>72</b> (4): 703\u201311. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1016/j.jaad.2015.01.002\">10.1016/j.jaad.2015.01.002</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/25617013\">25617013</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Journal+of+the+American+Academy+of+Dermatology&amp;rft.atitle=Review+of+thalidomide+use+in+the+pediatric+population&amp;rft.volume=72&amp;rft.issue=4&amp;rft.pages=703-11&amp;rft.date=2015-04&amp;rft_id=info%3Adoi%2F10.1016%2Fj.jaad.2015.01.002&amp;rft_id=info%3Apmid%2F25617013&amp;rft.aulast=Yang&amp;rft.aufirst=CS&amp;rft.au=Kim%2C+C&amp;rft.au=Antaya%2C+RJ&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AThalidomide\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-12\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-12\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Wolff D, Gerbitz A, Ayuk F, Kiani A, Hildebrandt GC, Vogelsang GB, Elad S, Lawitschka A, Socie G, Pavletic SZ, Holler E, Greinix H (December 2010). <a rel=\"nofollow\" class=\"external text\" href=\"http://www.bbmt.org/article/S1083-8791(10)00275-2/fulltext\">\"Consensus conference on clinical practice in chronic graft-versus-host disease (GVHD): first-line and topical treatment of chronic GVHD\"</a>. <i>Biology of Blood and Marrow Transplantation</i>. <b>16</b> (12): 1611\u201328. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1016/j.bbmt.2010.06.015\">10.1016/j.bbmt.2010.06.015</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/20601036\">20601036</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Biology+of+Blood+and+Marrow+Transplantation&amp;rft.atitle=Consensus+conference+on+clinical+practice+in+chronic+graft-versus-host+disease+%28GVHD%29%3A+first-line+and+topical+treatment+of+chronic+GVHD&amp;rft.volume=16&amp;rft.issue=12&amp;rft.pages=1611-28&amp;rft.date=2010-12&amp;rft_id=info%3Adoi%2F10.1016%2Fj.bbmt.2010.06.015&amp;rft_id=info%3Apmid%2F20601036&amp;rft.aulast=Wolff&amp;rft.aufirst=D&amp;rft.au=Gerbitz%2C+A&amp;rft.au=Ayuk%2C+F&amp;rft.au=Kiani%2C+A&amp;rft.au=Hildebrandt%2C+GC&amp;rft.au=Vogelsang%2C+GB&amp;rft.au=Elad%2C+S&amp;rft.au=Lawitschka%2C+A&amp;rft.au=Socie%2C+G&amp;rft.au=Pavletic%2C+SZ&amp;rft.au=Holler%2C+E&amp;rft.au=Greinix%2C+H&amp;rft_id=http%3A%2F%2Fwww.bbmt.org%2Farticle%2FS1083-8791%2810%2900275-2%2Ffulltext&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AThalidomide\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-13\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-13\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Wolff D, Schleuning M, von Harsdorf S, Bacher U, Gerbitz A, Stadler M, Ayuk F, Kiani A, Schwerdtfeger R, Vogelsang GB, Kobbe G, Gramatzki M, Lawitschka A, Mohty M, Pavletic SZ, Greinix H, Holler E (January 2011). <a rel=\"nofollow\" class=\"external text\" href=\"http://www.bbmt.org/article/S1083-8791(10)00223-5/fulltext\">\"Consensus Conference on Clinical Practice in Chronic GVHD: Second-Line Treatment of Chronic Graft-versus-Host Disease\"</a>. <i>Biology of Blood and Marrow Transplantation</i>. <b>17</b> (1): 1\u201317. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1016/j.bbmt.2010.05.011\">10.1016/j.bbmt.2010.05.011</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/20685255\">20685255</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Biology+of+Blood+and+Marrow+Transplantation&amp;rft.atitle=Consensus+Conference+on+Clinical+Practice+in+Chronic+GVHD%3A+Second-Line+Treatment+of+Chronic+Graft-versus-Host+Disease&amp;rft.volume=17&amp;rft.issue=1&amp;rft.pages=1-17&amp;rft.date=2011-01&amp;rft_id=info%3Adoi%2F10.1016%2Fj.bbmt.2010.05.011&amp;rft_id=info%3Apmid%2F20685255&amp;rft.aulast=Wolff&amp;rft.aufirst=D&amp;rft.au=Schleuning%2C+M&amp;rft.au=von+Harsdorf%2C+S&amp;rft.au=Bacher%2C+U&amp;rft.au=Gerbitz%2C+A&amp;rft.au=Stadler%2C+M&amp;rft.au=Ayuk%2C+F&amp;rft.au=Kiani%2C+A&amp;rft.au=Schwerdtfeger%2C+R&amp;rft.au=Vogelsang%2C+GB&amp;rft.au=Kobbe%2C+G&amp;rft.au=Gramatzki%2C+M&amp;rft.au=Lawitschka%2C+A&amp;rft.au=Mohty%2C+M&amp;rft.au=Pavletic%2C+SZ&amp;rft.au=Greinix%2C+H&amp;rft.au=Holler%2C+E&amp;rft_id=http%3A%2F%2Fwww.bbmt.org%2Farticle%2FS1083-8791%2810%2900223-5%2Ffulltext&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AThalidomide\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-toxmech2009-14\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-toxmech2009_14-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-toxmech2009_14-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-toxmech2009_14-2\"><sup><i><b>c</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation journal\">Smith SW (July 2009). \"Chiral toxicology: it's the same thing...only different\". <i>Toxicological Sciences</i>. <b>110</b> (1): 4\u201330. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1093/toxsci/kfp097\">10.1093/toxsci/kfp097</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/19414517\">19414517</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Toxicological+Sciences&amp;rft.atitle=Chiral+toxicology%3A+it%27s+the+same+thing...only+different&amp;rft.volume=110&amp;rft.issue=1&amp;rft.pages=4-30&amp;rft.date=2009-07&amp;rft_id=info%3Adoi%2F10.1093%2Ftoxsci%2Fkfp097&amp;rft_id=info%3Apmid%2F19414517&amp;rft.aulast=Smith&amp;rft.aufirst=SW&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AThalidomide\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-TGA-15\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-TGA_15-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-TGA_15-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-TGA_15-2\"><sup><i><b>c</b></i></sup></a> <a href=\"#cite_ref-TGA_15-3\"><sup><i><b>d</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation web\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent&amp;id=CP-2010-PI-03581-3\">\"THALOMID\u00ae CAPSULES\"</a> <span style=\"font-size:85%;\">(PDF)</span>. <i>TGA eBusiness Services</i>. Celgene Pty Limited. 21 June 2013<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">17 January</span> 2014</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=TGA+eBusiness+Services&amp;rft.atitle=THALOMID%C2%AE+CAPSULES&amp;rft.date=2013-06-21&amp;rft_id=https%3A%2F%2Fwww.ebs.tga.gov.au%2Febs%2Fpicmi%2Fpicmirepository.nsf%2Fpdf%3FOpenAgent%26id%3DCP-2010-PI-03581-3&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AThalidomide\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-Stephens2000-16\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-Stephens2000_16-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Stephens TD, Bunde CJ, Fillmore BJ (June 2000). \"Mechanism of action in thalidomide teratogenesis\". <i>Biochemical Pharmacology</i>. <b>59</b> (12): 1489\u201399. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1016/S0006-2952%2899%2900388-3\">10.1016/S0006-2952(99)00388-3</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/10799645\">10799645</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Biochemical+Pharmacology&amp;rft.atitle=Mechanism+of+action+in+thalidomide+teratogenesis&amp;rft.volume=59&amp;rft.issue=12&amp;rft.pages=1489-99&amp;rft.date=2000-06&amp;rft_id=info%3Adoi%2F10.1016%2FS0006-2952%2899%2900388-3&amp;rft_id=info%3Apmid%2F10799645&amp;rft.aulast=Stephens&amp;rft.aufirst=TD&amp;rft.au=Bunde%2C+CJ&amp;rft.au=Fillmore%2C+BJ&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AThalidomide\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-Vargesson2015-17\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-Vargesson2015_17-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Vargesson N (June 2015). <a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC4737249\">\"Thalidomide-induced teratogenesis: history and mechanisms\"</a>. <i>Birth Defects Research. Part C, Embryo Today</i>. <b>105</b> (2): 140\u201356. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1002/bdrc.21096\">10.1002/bdrc.21096</a>. <a href=\"/wiki/PubMed_Central\" title=\"PubMed Central\">PMC</a>&#160;<span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC4737249\">4737249</a>&#8239;<img alt=\"Freely accessible\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png\" title=\"Freely accessible\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/26043938\">26043938</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Birth+Defects+Research.+Part+C%2C+Embryo+Today&amp;rft.atitle=Thalidomide-induced+teratogenesis%3A+history+and+mechanisms&amp;rft.volume=105&amp;rft.issue=2&amp;rft.pages=140-56&amp;rft.date=2015-06&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4737249&amp;rft_id=info%3Apmid%2F26043938&amp;rft_id=info%3Adoi%2F10.1002%2Fbdrc.21096&amp;rft.aulast=Vargesson&amp;rft.aufirst=N&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4737249&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AThalidomide\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-Kim2011-18\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-Kim2011_18-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Kim JH, Scialli AR (July 2011). \"Thalidomide: the tragedy of birth defects and the effective treatment of disease\". <i>Toxicological Sciences</i>. <b>122</b> (1): 1\u20136. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1093/toxsci/kfr088\">10.1093/toxsci/kfr088</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/21507989\">21507989</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Toxicological+Sciences&amp;rft.atitle=Thalidomide%3A+the+tragedy+of+birth+defects+and+the+effective+treatment+of+disease&amp;rft.volume=122&amp;rft.issue=1&amp;rft.pages=1-6&amp;rft.date=2011-07&amp;rft_id=info%3Adoi%2F10.1093%2Ftoxsci%2Fkfr088&amp;rft_id=info%3Apmid%2F21507989&amp;rft.aulast=Kim&amp;rft.aufirst=JH&amp;rft.au=Scialli%2C+AR&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AThalidomide\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-19\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-19\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Donovan KA, An J, Nowak RP, Yuan JC, Fink EC, Berry BC, Ebert BL, Fischer ES (1 August 2018). <a rel=\"nofollow\" class=\"external text\" href=\"https://elifesciences.org/articles/38430\">\"Thalidomide promotes degradation of SALL4, a transcription factor implicated in Duane Radial Ray Syndrome\"</a>. <i>eLIFE</i>. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.7554/eLife.38430\">10.7554/eLife.38430</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=eLIFE&amp;rft.atitle=Thalidomide+promotes+degradation+of+SALL4%2C+a+transcription+factor+implicated+in+Duane+Radial+Ray+Syndrome&amp;rft.date=2018-08-01&amp;rft_id=info%3Adoi%2F10.7554%2FeLife.38430&amp;rft.aulast=Donovan&amp;rft.aufirst=KA&amp;rft.au=An%2C+J&amp;rft.au=Nowak%2C+RP&amp;rft.au=Yuan%2C+JC&amp;rft.au=Fink%2C+EC&amp;rft.au=Berry%2C+BC&amp;rft.au=Ebert%2C+BL&amp;rft.au=Fischer%2C+ES&amp;rft_id=https%3A%2F%2Felifesciences.org%2Farticles%2F38430&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AThalidomide\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span><span style=\"position:relative; top: -2px;\"><a href=\"/wiki/Open_access\" title=\"open access publication \u2013 free to read\"><img alt=\"open access publication \u2013 free to read\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/7/77/Open_Access_logo_PLoS_transparent.svg/9px-Open_Access_logo_PLoS_transparent.svg.png\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/7/77/Open_Access_logo_PLoS_transparent.svg/14px-Open_Access_logo_PLoS_transparent.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/7/77/Open_Access_logo_PLoS_transparent.svg/18px-Open_Access_logo_PLoS_transparent.svg.png 2x\" data-file-width=\"640\" data-file-height=\"1000\" /></a></span>Note: the manuscript has been accepted, but not yet fully published, only available in PDF form and not yet assigned to a volume/issue.</span>\n</li>\n<li id=\"cite_note-LiuSu2010-20\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-LiuSu2010_20-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Liu B, Su L, Geng J, Liu J, Zhao G (October 2010). \"Developments in nonsteroidal antiandrogens targeting the androgen receptor\". <i>ChemMedChem</i>. <b>5</b> (10): 1651\u201361. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1002/cmdc.201000259\">10.1002/cmdc.201000259</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/20853390\">20853390</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=ChemMedChem&amp;rft.atitle=Developments+in+nonsteroidal+antiandrogens+targeting+the+androgen+receptor&amp;rft.volume=5&amp;rft.issue=10&amp;rft.pages=1651-61&amp;rft.date=2010-10&amp;rft_id=info%3Adoi%2F10.1002%2Fcmdc.201000259&amp;rft_id=info%3Apmid%2F20853390&amp;rft.aulast=Liu&amp;rft.aufirst=B&amp;rft.au=Su%2C+L&amp;rft.au=Geng%2C+J&amp;rft.au=Liu%2C+J&amp;rft.au=Zhao%2C+G&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AThalidomide\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-NuttallWarrier2015-21\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-NuttallWarrier2015_21-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Nuttall FQ, Warrier RS, Gannon MC (May 2015). <a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC4412434\">\"Gynecomastia and drugs: a critical evaluation of the literature\"</a>. <i>European Journal of Clinical Pharmacology</i>. <b>71</b> (5): 569\u201378. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1007/s00228-015-1835-x\">10.1007/s00228-015-1835-x</a>. <a href=\"/wiki/PubMed_Central\" title=\"PubMed Central\">PMC</a>&#160;<span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC4412434\">4412434</a>&#8239;<img alt=\"Freely accessible\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png\" title=\"Freely accessible\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/25827472\">25827472</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=European+Journal+of+Clinical+Pharmacology&amp;rft.atitle=Gynecomastia+and+drugs%3A+a+critical+evaluation+of+the+literature&amp;rft.volume=71&amp;rft.issue=5&amp;rft.pages=569-78&amp;rft.date=2015-05&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4412434&amp;rft_id=info%3Apmid%2F25827472&amp;rft_id=info%3Adoi%2F10.1007%2Fs00228-015-1835-x&amp;rft.aulast=Nuttall&amp;rft.aufirst=FQ&amp;rft.au=Warrier%2C+RS&amp;rft.au=Gannon%2C+MC&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4412434&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AThalidomide\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-stereospecific44-22\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-stereospecific44_22-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Eriksson T, Bj\u00f6rkman S, Roth B, Fyge A, H\u00f6glund P (1995). \"Stereospecific determination, chiral inversion in vitro and pharmacokinetics in humans of the enantiomers of thalidomide\". <i>Chirality</i>. <b>7</b> (1): 44\u201352. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1002/chir.530070109\">10.1002/chir.530070109</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/7702998\">7702998</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Chirality&amp;rft.atitle=Stereospecific+determination%2C+chiral+inversion+in+vitro+and+pharmacokinetics+in+humans+of+the+enantiomers+of+thalidomide&amp;rft.volume=7&amp;rft.issue=1&amp;rft.pages=44-52&amp;rft.date=1995&amp;rft_id=info%3Adoi%2F10.1002%2Fchir.530070109&amp;rft_id=info%3Apmid%2F7702998&amp;rft.aulast=Eriksson&amp;rft.aufirst=T&amp;rft.au=Bj%C3%B6rkman%2C+S&amp;rft.au=Roth%2C+B&amp;rft.au=Fyge%2C+A&amp;rft.au=H%C3%B6glund%2C+P&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AThalidomide\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-pmid14505639-23\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-pmid14505639_23-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Man HW, Corral LG, Stirling DI, Muller GW (October 2003). \"Alpha-fluoro-substituted thalidomide analogues\". <i>Bioorganic &amp; Medicinal Chemistry Letters</i>. <b>13</b> (20): 3415\u20137. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1016/S0960-894X%2803%2900778-9\">10.1016/S0960-894X(03)00778-9</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/14505639\">14505639</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Bioorganic+%26+Medicinal+Chemistry+Letters&amp;rft.atitle=Alpha-fluoro-substituted+thalidomide+analogues&amp;rft.volume=13&amp;rft.issue=20&amp;rft.pages=3415-7&amp;rft.date=2003-10&amp;rft_id=info%3Adoi%2F10.1016%2FS0960-894X%2803%2900778-9&amp;rft_id=info%3Apmid%2F14505639&amp;rft.aulast=Man&amp;rft.aufirst=HW&amp;rft.au=Corral%2C+LG&amp;rft.au=Stirling%2C+DI&amp;rft.au=Muller%2C+GW&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AThalidomide\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-Bartlett2004-24\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-Bartlett2004_24-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Bartlett JB, Dredge K, Dalgleish AG (April 2004). \"The evolution of thalidomide and its IMiD derivatives as anticancer agents\". <i>Nature Reviews. Cancer</i>. <b>4</b> (4): 314\u201322. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1038/nrc1323\">10.1038/nrc1323</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/15057291\">15057291</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Nature+Reviews.+Cancer&amp;rft.atitle=The+evolution+of+thalidomide+and+its+IMiD+derivatives+as+anticancer+agents&amp;rft.volume=4&amp;rft.issue=4&amp;rft.pages=314-22&amp;rft.date=2004-04&amp;rft_id=info%3Adoi%2F10.1038%2Fnrc1323&amp;rft_id=info%3Apmid%2F15057291&amp;rft.aulast=Bartlett&amp;rft.aufirst=JB&amp;rft.au=Dredge%2C+K&amp;rft.au=Dalgleish%2C+AG&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AThalidomide\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-synth-25\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-synth_25-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-synth_25-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation journal\">Muller G, Konnecke W, Smith A, Khetani V (19 March 1999). \"A Concise Two-Step Synthesis of Thalidomide\". <i>Organic Process Research &amp; Development</i>. <b>3</b> (2): 139\u2013140. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1021/op980201b\">10.1021/op980201b</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Organic+Process+Research+%26+Development&amp;rft.atitle=A+Concise+Two-Step+Synthesis+of+Thalidomide&amp;rft.volume=3&amp;rft.issue=2&amp;rft.pages=139-140&amp;rft.date=1999-03-19&amp;rft_id=info%3Adoi%2F10.1021%2Fop980201b&amp;rft.aulast=Muller&amp;rft.aufirst=George&amp;rft.au=Konnecke%2C+William&amp;rft.au=Smith%2C+Alison&amp;rft.au=Khetani%2C+Vikram&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AThalidomide\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-26\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-26\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation book\">Sneader, Walter (2005). <i>Drug discovery&#160;: a history</i> (Rev. and updated ed.). Chichester: Wiley. p.&#160;367. <a href=\"/wiki/International_Standard_Book_Number\" title=\"International Standard Book Number\">ISBN</a>&#160;<a href=\"/wiki/Special:BookSources/978-0-471-89979-2\" title=\"Special:BookSources/978-0-471-89979-2\">978-0-471-89979-2</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=book&amp;rft.btitle=Drug+discovery+%3A+a+history&amp;rft.place=Chichester&amp;rft.pages=367&amp;rft.edition=Rev.+and+updated&amp;rft.pub=Wiley&amp;rft.date=2005&amp;rft.isbn=978-0-471-89979-2&amp;rft.aulast=Sneader&amp;rft.aufirst=Walter&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AThalidomide\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-pmid15172781-27\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-pmid15172781_27-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-pmid15172781_27-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-pmid15172781_27-2\"><sup><i><b>c</b></i></sup></a> <a href=\"#cite_ref-pmid15172781_27-3\"><sup><i><b>d</b></i></sup></a> <a href=\"#cite_ref-pmid15172781_27-4\"><sup><i><b>e</b></i></sup></a> <a href=\"#cite_ref-pmid15172781_27-5\"><sup><i><b>f</b></i></sup></a> <a href=\"#cite_ref-pmid15172781_27-6\"><sup><i><b>g</b></i></sup></a> <a href=\"#cite_ref-pmid15172781_27-7\"><sup><i><b>h</b></i></sup></a> <a href=\"#cite_ref-pmid15172781_27-8\"><sup><i><b>i</b></i></sup></a> <a href=\"#cite_ref-pmid15172781_27-9\"><sup><i><b>j</b></i></sup></a> <a href=\"#cite_ref-pmid15172781_27-10\"><sup><i><b>k</b></i></sup></a> <a href=\"#cite_ref-pmid15172781_27-11\"><sup><i><b>l</b></i></sup></a> <a href=\"#cite_ref-pmid15172781_27-12\"><sup><i><b>m</b></i></sup></a> <a href=\"#cite_ref-pmid15172781_27-13\"><sup><i><b>n</b></i></sup></a> <a href=\"#cite_ref-pmid15172781_27-14\"><sup><i><b>o</b></i></sup></a> <a href=\"#cite_ref-pmid15172781_27-15\"><sup><i><b>p</b></i></sup></a> <a href=\"#cite_ref-pmid15172781_27-16\"><sup><i><b>q</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation journal\">Franks ME, Macpherson GR, Figg WD (May 2004). \"Thalidomide\". <i>Lancet</i>. <b>363</b> (9423): 1802\u201311. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1016/S0140-6736%2804%2916308-3\">10.1016/S0140-6736(04)16308-3</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/15172781\">15172781</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Lancet&amp;rft.atitle=Thalidomide&amp;rft.volume=363&amp;rft.issue=9423&amp;rft.pages=1802-11&amp;rft.date=2004-05&amp;rft_id=info%3Adoi%2F10.1016%2FS0140-6736%2804%2916308-3&amp;rft_id=info%3Apmid%2F15172781&amp;rft.aulast=Franks&amp;rft.aufirst=ME&amp;rft.au=Macpherson%2C+GR&amp;rft.au=Figg%2C+WD&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AThalidomide\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-28\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-28\">^</a></b></span> <span class=\"reference-text\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.grunenthal.com/about-us/history\">Gr\u00fcnenthal: Where we come from</a>. Official website, undated. Retrieved 2 July 2018. See also <a rel=\"nofollow\" class=\"external text\" href=\"http://www.contergan.grunenthal.info/thalidomid/Home_/351300028.jsp;jsessionid=D8966B9045A2EDE78D5AC41F85C93424.drp1?naviLocale=en_EN\">Developments regarding thalidomide</a></span>\n</li>\n<li id=\"cite_note-Bombay-29\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-Bombay_29-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Moghe VV, Kulkarni U, Parmar UI (2008). <a rel=\"nofollow\" class=\"external text\" href=\"http://www.bhj.org.in/journal/2008_5003_july/download/page-472-476.pdf\">\"Thalidomide\"</a> <span style=\"font-size:85%;\">(PDF)</span>. <i>Bombay Hospital Journal</i>. Bombay: Bombay Hospital. <b>50</b> (3): 472\u20136.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Bombay+Hospital+Journal&amp;rft.atitle=Thalidomide&amp;rft.volume=50&amp;rft.issue=3&amp;rft.pages=472-6&amp;rft.date=2008&amp;rft.aulast=Moghe&amp;rft.aufirst=Vijay+V&amp;rft.au=Kulkarni%2C+Ujjwala&amp;rft.au=Parmar%2C+Urvashi+I&amp;rft_id=http%3A%2F%2Fwww.bhj.org.in%2Fjournal%2F2008_5003_july%2Fdownload%2Fpage-472-476.pdf&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AThalidomide\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-30\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-30\">^</a></b></span> <span class=\"reference-text\">See Rouquette (1957) cited by <cite class=\"citation journal\">Landesman-Dwyer S (1982). \"Maternal drinking and pregnancy outcome\". <i>Applied Research in Mental Retardation</i>. <b>3</b> (3): 241\u201363. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1016/0270-3092%2882%2990018-2\">10.1016/0270-3092(82)90018-2</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/7149705\">7149705</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Applied+Research+in+Mental+Retardation&amp;rft.atitle=Maternal+drinking+and+pregnancy+outcome&amp;rft.volume=3&amp;rft.issue=3&amp;rft.pages=241-63&amp;rft.date=1982&amp;rft_id=info%3Adoi%2F10.1016%2F0270-3092%2882%2990018-2&amp;rft_id=info%3Apmid%2F7149705&amp;rft.aulast=Landesman-Dwyer&amp;rft.aufirst=S&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AThalidomide\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-31\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-31\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Kelsey FO (1967). \"Events after thalidomide\". <i>Journal of Dental Research</i>. <b>46</b> (6): 1201\u20135. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1177/00220345670460061201\">10.1177/00220345670460061201</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/5235007\">5235007</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Journal+of+Dental+Research&amp;rft.atitle=Events+after+thalidomide&amp;rft.volume=46&amp;rft.issue=6&amp;rft.pages=1201-5&amp;rft.date=1967&amp;rft_id=info%3Adoi%2F10.1177%2F00220345670460061201&amp;rft_id=info%3Apmid%2F5235007&amp;rft.aulast=Kelsey&amp;rft.aufirst=FO&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AThalidomide\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-50year-32\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-50year_32-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-50year_32-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-50year_32-2\"><sup><i><b>c</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation news\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.youtube.com/watch?v=_NLbhOyLLMY\">\"Thalidomide: The Fifty Year Fight (no longer available)\"</a>. <a href=\"/wiki/BBC\" title=\"BBC\">BBC</a>. 15 May 2014<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">13 September</span> 2015</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Thalidomide%3A+The+Fifty+Year+Fight+%28no+longer+available%29&amp;rft.date=2014-05-15&amp;rft_id=https%3A%2F%2Fwww.youtube.com%2Fwatch%3Fv%3D_NLbhOyLLMY&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AThalidomide\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-VFA-33\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-VFA_33-0\">^</a></b></span> <span class=\"reference-text\"><a rel=\"nofollow\" class=\"external text\" href=\"http://www.vfa.de/de/arzneimittel-forschung/artikel-arzneimittel-forschung/teratogenitaet.html\">VFA: teratogenic effects</a> 6. July 2011.</span>\n</li>\n<li id=\"cite_note-34\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-34\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web\"><a rel=\"nofollow\" class=\"external text\" href=\"https://web.archive.org/web/20090512235601/http://www.fda.gov/fdac/features/2001/201_kelsey.html\">\"Report\"</a>. U.S. Food and Drug Administration. May 12, 2009. Archived from <a rel=\"nofollow\" class=\"external text\" href=\"http://www.fda.gov/fdac/features/2001/201_kelsey.html\">the original</a> on 12 May 2009.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Report&amp;rft.pub=U.S.+Food+and+Drug+Administration&amp;rft.date=2009-05-12&amp;rft_id=http%3A%2F%2Fwww.fda.gov%2Ffdac%2Ffeatures%2F2001%2F201_kelsey.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AThalidomide\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-pmid14076167-35\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-pmid14076167_35-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-pmid14076167_35-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-pmid14076167_35-2\"><sup><i><b>c</b></i></sup></a> <a href=\"#cite_ref-pmid14076167_35-3\"><sup><i><b>d</b></i></sup></a> <a href=\"#cite_ref-pmid14076167_35-4\"><sup><i><b>e</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation journal\">Webb JF (November 1963). <a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC1921912\">\"Canadian Thalidomide Experience\"</a>. <i>Canadian Medical Association Journal</i>. <b>89</b>: 987\u201392. <a href=\"/wiki/PubMed_Central\" title=\"PubMed Central\">PMC</a>&#160;<span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC1921912\">1921912</a>&#8239;<img alt=\"Freely accessible\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png\" title=\"Freely accessible\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/14076167\">14076167</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Canadian+Medical+Association+Journal&amp;rft.atitle=Canadian+Thalidomide+Experience&amp;rft.volume=89&amp;rft.pages=987-92&amp;rft.date=1963-11&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC1921912&amp;rft_id=info%3Apmid%2F14076167&amp;rft.aulast=Webb&amp;rft.aufirst=JF&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC1921912&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AThalidomide\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-Silverman-36\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-Silverman_36-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Silverman WA (August 2002). \"The schizophrenic career of a \"monster drug<span style=\"padding-right:0.2em;\">\"</span>\". <i>Pediatrics</i>. <b>110</b> (2 Pt 1): 404\u20136. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1542/peds.110.2.404\">10.1542/peds.110.2.404</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/12165600\">12165600</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Pediatrics&amp;rft.atitle=The+schizophrenic+career+of+a+%22monster+drug%22&amp;rft.volume=110&amp;rft.issue=2+Pt+1&amp;rft.pages=404-6&amp;rft.date=2002-08&amp;rft_id=info%3Adoi%2F10.1542%2Fpeds.110.2.404&amp;rft_id=info%3Apmid%2F12165600&amp;rft.aulast=Silverman&amp;rft.aufirst=WA&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AThalidomide\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-37\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-37\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Castilla EE, Ashton-Prolla P, Barreda-Mejia E, Brunoni D, Cavalcanti DP, Correa-Neto J, Delgadillo JL, Dutra MG, Felix T, Giraldo A, Juarez N, Lopez-Camelo JS, Nazer J, Orioli IM, Paz JE, Pessoto MA, Pina-Neto JM, Quadrelli R, Rittler M, Rueda S, Saltos M, S\u00e1nchez O, Sch\u00fcler L (December 1996). \"Thalidomide, a current teratogen in South America\". <i>Teratology</i>. <b>54</b> (6): 273\u20137. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1002/%28SICI%291096-9926%28199702%2955%3A2%3C156%3A%3AAID-TERA6%3E3.0.CO%3B2-1\">10.1002/(SICI)1096-9926(199702)55:2&#60;156::AID-TERA6&#62;3.0.CO;2-1</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/9098920\">9098920</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Teratology&amp;rft.atitle=Thalidomide%2C+a+current+teratogen+in+South+America&amp;rft.volume=54&amp;rft.issue=6&amp;rft.pages=273-7&amp;rft.date=1996-12&amp;rft_id=info%3Adoi%2F10.1002%2F%28SICI%291096-9926%28199702%2955%3A2%3C156%3A%3AAID-TERA6%3E3.0.CO%3B2-1&amp;rft_id=info%3Apmid%2F9098920&amp;rft.aulast=Castilla&amp;rft.aufirst=EE&amp;rft.au=Ashton-Prolla%2C+P&amp;rft.au=Barreda-Mejia%2C+E&amp;rft.au=Brunoni%2C+D&amp;rft.au=Cavalcanti%2C+DP&amp;rft.au=Correa-Neto%2C+J&amp;rft.au=Delgadillo%2C+JL&amp;rft.au=Dutra%2C+MG&amp;rft.au=Felix%2C+T&amp;rft.au=Giraldo%2C+A&amp;rft.au=Juarez%2C+N&amp;rft.au=Lopez-Camelo%2C+JS&amp;rft.au=Nazer%2C+J&amp;rft.au=Orioli%2C+IM&amp;rft.au=Paz%2C+JE&amp;rft.au=Pessoto%2C+MA&amp;rft.au=Pina-Neto%2C+JM&amp;rft.au=Quadrelli%2C+R&amp;rft.au=Rittler%2C+M&amp;rft.au=Rueda%2C+S&amp;rft.au=Saltos%2C+M&amp;rft.au=S%C3%A1nchez%2C+O&amp;rft.au=Sch%C3%BCler%2C+L&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AThalidomide\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-38\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-38\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Paumgartten FJ, Chahoud I (July 2006). \"Thalidomide embryopathy cases in Brazil after 1965\". <i>Reproductive Toxicology</i>. <b>22</b> (1): 1\u20132. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1016/j.reprotox.2005.11.007\">10.1016/j.reprotox.2005.11.007</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/16427249\">16427249</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Reproductive+Toxicology&amp;rft.atitle=Thalidomide+embryopathy+cases+in+Brazil+after+1965&amp;rft.volume=22&amp;rft.issue=1&amp;rft.pages=1-2&amp;rft.date=2006-07&amp;rft_id=info%3Adoi%2F10.1016%2Fj.reprotox.2005.11.007&amp;rft_id=info%3Apmid%2F16427249&amp;rft.aulast=Paumgartten&amp;rft.aufirst=FJ&amp;rft.au=Chahoud%2C+I&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AThalidomide\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-39\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-39\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Braziliense C (January 2006). <a rel=\"nofollow\" class=\"external text\" href=\"https://web.archive.org/web/20120313095445/http://www.saude.df.gov.br/003/00301009.asp?ttCD_CHAVE=31041\">\"Talidomida volta a assustar\"</a> &#91;Thalidomide again scare&#93; (in Portuguese). Archived from <a rel=\"nofollow\" class=\"external text\" href=\"http://www.saude.df.gov.br/003/00301009.asp?ttCD_CHAVE=31041\">the original</a> on March 13, 2012.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Talidomida+volta+a+assustar&amp;rft.date=2006-01&amp;rft.aulast=Braziliense&amp;rft.aufirst=Correio&amp;rft_id=http%3A%2F%2Fwww.saude.df.gov.br%2F003%2F00301009.asp%3FttCD_CHAVE%3D31041&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AThalidomide\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-40\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-40\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation news\">Crawford A (23 July 2013). <a rel=\"nofollow\" class=\"external text\" href=\"https://www.bbc.com/news/magazine-23418102\">\"Brazil's new generation of Thalidomide babies\"</a>. <i>BBC News</i>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=BBC+News&amp;rft.atitle=Brazil%27s+new+generation+of+Thalidomide+babies&amp;rft.date=2013-07-23&amp;rft.aulast=Crawford&amp;rft.aufirst=Angus&amp;rft_id=https%3A%2F%2Fwww.bbc.com%2Fnews%2Fmagazine-23418102&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AThalidomide\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-nyt-fda-41\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-nyt-fda_41-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-nyt-fda_41-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation news\">Stolberg SG (17 July 1998). <a rel=\"nofollow\" class=\"external text\" href=\"https://www.nytimes.com/1998/07/17/us/thalidomide-approved-to-treat-leprosy-with-other-uses-seen.html\">\"Thalidomide Approved to Treat Leprosy, With Other Uses Seen\"</a>. <i>New York Times</i><span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">8 January</span> 2012</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=New+York+Times&amp;rft.atitle=Thalidomide+Approved+to+Treat+Leprosy%2C+With+Other+Uses+Seen&amp;rft.date=1998-07-17&amp;rft.aulast=Stolberg&amp;rft.aufirst=Sheryl+Gay&amp;rft_id=https%3A%2F%2Fwww.nytimes.com%2F1998%2F07%2F17%2Fus%2Fthalidomide-approved-to-treat-leprosy-with-other-uses-seen.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AThalidomide\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-42\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-42\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web\">Anon. <a rel=\"nofollow\" class=\"external text\" href=\"http://www.who.int/lep/research/thalidomide/en/index.html\">\"Use of thalidomide in leprosy\"</a>. <i>WHO:leprosy elimination</i>. WHO<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">22 April</span> 2010</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=WHO%3Aleprosy+elimination&amp;rft.atitle=Use+of+thalidomide+in+leprosy&amp;rft.au=Anon&amp;rft_id=http%3A%2F%2Fwww.who.int%2Flep%2Fresearch%2Fthalidomide%2Fen%2Findex.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AThalidomide\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-Kyle-43\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-Kyle_43-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-Kyle_43-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation journal\">Kyle RA, Rajkumar SV (March 2008). <a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC2265446\">\"Multiple myeloma\"</a>. <i>Blood</i>. <b>111</b> (6): 2962\u201372. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1182/blood-2007-10-078022\">10.1182/blood-2007-10-078022</a>. <a href=\"/wiki/PubMed_Central\" title=\"PubMed Central\">PMC</a>&#160;<span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC2265446\">2265446</a>&#8239;<img alt=\"Freely accessible\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png\" title=\"Freely accessible\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/18332230\">18332230</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Blood&amp;rft.atitle=Multiple+myeloma&amp;rft.volume=111&amp;rft.issue=6&amp;rft.pages=2962-72&amp;rft.date=2008-03&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2265446&amp;rft_id=info%3Apmid%2F18332230&amp;rft_id=info%3Adoi%2F10.1182%2Fblood-2007-10-078022&amp;rft.aulast=Kyle&amp;rft.aufirst=RA&amp;rft.au=Rajkumar%2C+SV&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2265446&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AThalidomide\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-NASbio-44\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-NASbio_44-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web\">Donahoe PK (2014). <a rel=\"nofollow\" class=\"external text\" href=\"http://www.nasonline.org/publications/biographical-memoirs/memoir-pdfs/folkman-judah.pdf\">\"Judah Folkman: 1933\u20132008. A Biographical Memoir\"</a> <span style=\"font-size:85%;\">(PDF)</span>. National Academy of Sciences.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Judah+Folkman%3A+1933%E2%80%932008.+A+Biographical+Memoir&amp;rft.pub=National+Academy+of+Sciences&amp;rft.date=2014&amp;rft.aulast=Donahoe&amp;rft.aufirst=Patricia+K&amp;rft_id=http%3A%2F%2Fwww.nasonline.org%2Fpublications%2Fbiographical-memoirs%2Fmemoir-pdfs%2Ffolkman-judah.pdf&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AThalidomide\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-Beilenberg-45\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-Beilenberg_45-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-Beilenberg_45-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-Beilenberg_45-2\"><sup><i><b>c</b></i></sup></a> <a href=\"#cite_ref-Beilenberg_45-3\"><sup><i><b>d</b></i></sup></a> <a href=\"#cite_ref-Beilenberg_45-4\"><sup><i><b>e</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation journal\">Bielenberg DR, D'Amore PA (2008). \"Judah Folkman's contribution to the inhibition of angiogenesis\". <i>Lymphatic Research and Biology</i>. <b>6</b> (3\u20134): 203\u20137. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1089/lrb.2008.1016\">10.1089/lrb.2008.1016</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/19093793\">19093793</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Lymphatic+Research+and+Biology&amp;rft.atitle=Judah+Folkman%27s+contribution+to+the+inhibition+of+angiogenesis&amp;rft.volume=6&amp;rft.issue=3%E2%80%934&amp;rft.pages=203-7&amp;rft.date=2008&amp;rft_id=info%3Adoi%2F10.1089%2Flrb.2008.1016&amp;rft_id=info%3Apmid%2F19093793&amp;rft.aulast=Bielenberg&amp;rft.aufirst=DR&amp;rft.au=D%27Amore%2C+PA&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AThalidomide\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-Folkman-46\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-Folkman_46-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-Folkman_46-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation journal\">Folkman J (December 2001). \"Angiogenesis-dependent diseases\". <i>Seminars in Oncology</i>. <b>28</b> (6): 536\u201342. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1016/s0093-7754%2801%2990021-1\">10.1016/s0093-7754(01)90021-1</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/11740806\">11740806</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Seminars+in+Oncology&amp;rft.atitle=Angiogenesis-dependent+diseases&amp;rft.volume=28&amp;rft.issue=6&amp;rft.pages=536-42&amp;rft.date=2001-12&amp;rft_id=info%3Adoi%2F10.1016%2Fs0093-7754%2801%2990021-1&amp;rft_id=info%3Apmid%2F11740806&amp;rft.aulast=Folkman&amp;rft.aufirst=J&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AThalidomide\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-47\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-47\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Ribatti D (2008). <a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC2268723\">\"Judah Folkman, a pioneer in the study of angiogenesis\"</a>. <i>Angiogenesis</i>. <b>11</b> (1): 3\u201310. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1007/s10456-008-9092-6\">10.1007/s10456-008-9092-6</a>. <a href=\"/wiki/PubMed_Central\" title=\"PubMed Central\">PMC</a>&#160;<span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC2268723\">2268723</a>&#8239;<img alt=\"Freely accessible\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png\" title=\"Freely accessible\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/18247146\">18247146</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Angiogenesis&amp;rft.atitle=Judah+Folkman%2C+a+pioneer+in+the+study+of+angiogenesis&amp;rft.volume=11&amp;rft.issue=1&amp;rft.pages=3-10&amp;rft.date=2008&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2268723&amp;rft_id=info%3Apmid%2F18247146&amp;rft_id=info%3Adoi%2F10.1007%2Fs10456-008-9092-6&amp;rft.aulast=Ribatti&amp;rft.aufirst=D&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2268723&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AThalidomide\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-nejm-myeloma-48\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-nejm-myeloma_48-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Singhal S, Mehta J, Desikan R, Ayers D, Roberson P, Eddlemon P, Munshi N, Anaissie E, Wilson C, Dhodapkar M, Zeddis J, Barlogie B (November 1999). \"Antitumor activity of thalidomide in refractory multiple myeloma\". <i>The New England Journal of Medicine</i>. <b>341</b> (21): 1565\u201371. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1056/NEJM199911183412102\">10.1056/NEJM199911183412102</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/10564685\">10564685</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+New+England+Journal+of+Medicine&amp;rft.atitle=Antitumor+activity+of+thalidomide+in+refractory+multiple+myeloma&amp;rft.volume=341&amp;rft.issue=21&amp;rft.pages=1565-71&amp;rft.date=1999-11&amp;rft_id=info%3Adoi%2F10.1056%2FNEJM199911183412102&amp;rft_id=info%3Apmid%2F10564685&amp;rft.aulast=Singhal&amp;rft.aufirst=S&amp;rft.au=Mehta%2C+J&amp;rft.au=Desikan%2C+R&amp;rft.au=Ayers%2C+D&amp;rft.au=Roberson%2C+P&amp;rft.au=Eddlemon%2C+P&amp;rft.au=Munshi%2C+N&amp;rft.au=Anaissie%2C+E&amp;rft.au=Wilson%2C+C&amp;rft.au=Dhodapkar%2C+M&amp;rft.au=Zeddis%2C+J&amp;rft.au=Barlogie%2C+B&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AThalidomide\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-49\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-49\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web\"><a rel=\"nofollow\" class=\"external text\" href=\"http://www.cancer.gov/cancertopics/druginfo/fda-thalidomide\">\"FDA Approval for Thalidomide\"</a>. National Cancer Institute<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">8 January</span> 2012</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=FDA+Approval+for+Thalidomide&amp;rft.pub=National+Cancer+Institute&amp;rft_id=http%3A%2F%2Fwww.cancer.gov%2Fcancertopics%2Fdruginfo%2Ffda-thalidomide&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AThalidomide\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-Bren-50\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-Bren_50-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-Bren_50-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-Bren_50-2\"><sup><i><b>c</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation news\">Bren L (2001-02-28). <a rel=\"nofollow\" class=\"external text\" href=\"http://permanent.access.gpo.gov/lps1609/www.fda.gov/fdac/features/2001/201_kelsey.html\">\"Frances Oldham Kelsey: FDA Medical Reviewer Leaves Her Mark on History\"</a>. <i>FDA Consumer</i>. U.S. <a href=\"/wiki/Food_and_Drug_Administration\" title=\"Food and Drug Administration\">Food and Drug Administration</a><span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">2009-12-23</span></span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=FDA+Consumer&amp;rft.atitle=Frances+Oldham+Kelsey%3A+FDA+Medical+Reviewer+Leaves+Her+Mark+on+History&amp;rft.date=2001-02-28&amp;rft.au=Bren+L&amp;rft_id=http%3A%2F%2Fpermanent.access.gpo.gov%2Flps1609%2Fwww.fda.gov%2Ffdac%2Ffeatures%2F2001%2F201_kelsey.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AThalidomide\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-nyt-answers-51\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-nyt-answers_51-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation news\"><a href=\"/wiki/Carl_Zimmer\" title=\"Carl Zimmer\">Zimmer C</a> (March 15, 2010). <a rel=\"nofollow\" class=\"external text\" href=\"https://www.nytimes.com/2010/03/16/science/16limb.html?ref=science&amp;pagewanted=all\">\"Answers Begin to Emerge on How Thalidomide Caused Defects\"</a>. <a href=\"/wiki/New_York_Times\" class=\"mw-redirect\" title=\"New York Times\">New York Times</a><span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">2010-03-21</span></span>. <q>As they report in the current issue of Science, a protein known as cereblon latched on tightly to the thalidomide</q></cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Answers+Begin+to+Emerge+on+How+Thalidomide+Caused+Defects&amp;rft.date=2010-03-15&amp;rft.au=Zimmer+C&amp;rft_id=https%3A%2F%2Fwww.nytimes.com%2F2010%2F03%2F16%2Fscience%2F16limb.html%3Fref%3Dscience%26pagewanted%3Dall&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AThalidomide\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-52\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-52\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web\"><a rel=\"nofollow\" class=\"external text\" href=\"https://web.archive.org/web/20110929135332/http://www.history.ca/ontv/titledetails.aspx?titleid=21267\">\"Turning Points of History\u2013Prescription for Disaster\"</a>. History Television. Archived from <a rel=\"nofollow\" class=\"external text\" href=\"http://www.history.ca/ontv/titledetails.aspx?titleid=21267\">the original</a> on September 29, 2011<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">24 February</span> 2010</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Turning+Points+of+History%E2%80%93Prescription+for+Disaster&amp;rft.pub=History+Television&amp;rft_id=http%3A%2F%2Fwww.history.ca%2Fontv%2Ftitledetails.aspx%3Ftitleid%3D21267&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AThalidomide\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-53\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-53\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation news\"><a rel=\"nofollow\" class=\"external text\" href=\"http://news.bbc.co.uk/1/hi/health/8458855.stm\">\"Apology for thalidomide survivors\"</a>. BBC News. 14 January 2010<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">2010-01-14</span></span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Apology+for+thalidomide+survivors&amp;rft.date=2010-01-14&amp;rft_id=http%3A%2F%2Fnews.bbc.co.uk%2F1%2Fhi%2Fhealth%2F8458855.stm&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AThalidomide\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-SundayTimesMag_Spain-54\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-SundayTimesMag_Spain_54-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation news\">Scott C, Haupt O (3 May 2015). <a rel=\"nofollow\" class=\"external text\" href=\"http://www.thesundaytimes.co.uk/sto/Magazine/article1551306.ece\">\"The forgotten victims\"</a>. <i><a href=\"/wiki/The_Sunday_Times_Magazine\" title=\"The Sunday Times Magazine\">The Sunday Times Magazine</a></i>. pp.&#160;12\u201319<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">8 May</span> 2015</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Sunday+Times+Magazine&amp;rft.atitle=The+forgotten+victims&amp;rft.pages=12-19&amp;rft.date=2015-05-03&amp;rft.aulast=Scott&amp;rft.aufirst=Caroline&amp;rft.au=Haupt%2C+Oliver&amp;rft_id=http%3A%2F%2Fwww.thesundaytimes.co.uk%2Fsto%2FMagazine%2Farticle1551306.ece&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AThalidomide\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-55\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-55\">^</a></b></span> <span class=\"reference-text\"><a rel=\"nofollow\" class=\"external free\" href=\"http://www.abc.net.au/news/health/2018-06-29/thalidomide-william-mcbride-flawed-character-norman-swan/9920608\">http://www.abc.net.au/news/health/2018-06-29/thalidomide-william-mcbride-flawed-character-norman-swan/9920608</a></span>\n</li>\n<li id=\"cite_note-56\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-56\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web\">Anon. <a rel=\"nofollow\" class=\"external text\" href=\"http://www.whonamedit.com/doctor.cfm/1002.html\">\"Widukind Lenz\"</a>. <i>who name it?</i>. Ole Daniel Enersen<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">2009-05-01</span></span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=who+name+it%3F&amp;rft.atitle=Widukind+Lenz&amp;rft.au=Anon&amp;rft_id=http%3A%2F%2Fwww.whonamedit.com%2Fdoctor.cfm%2F1002.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AThalidomide\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-40_years_on-57\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-40_years_on_57-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-40_years_on_57-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation news\">Anon (2002-06-07). <a rel=\"nofollow\" class=\"external text\" href=\"http://news.bbc.co.uk/1/hi/uk/2031459.stm\">\"Thalidomide:40 years on\"</a>. <i>BBC news</i>. BBC<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">2009-05-01</span></span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=BBC+news&amp;rft.atitle=Thalidomide%3A40+years+on&amp;rft.date=2002-06-07&amp;rft.au=Anon&amp;rft_id=http%3A%2F%2Fnews.bbc.co.uk%2F1%2Fhi%2Fuk%2F2031459.stm&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AThalidomide\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-58\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-58\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web\"><a rel=\"nofollow\" class=\"external text\" href=\"https://web.archive.org/web/20121028204857/http://embryology.med.unsw.edu.au/Defect/page5i.htm\">\"Report of Thalidomide at University of New South Wales\"</a>. Embryology.med.unsw.edu.au. Archived from <a rel=\"nofollow\" class=\"external text\" href=\"http://embryology.med.unsw.edu.au/Defect/page5i.htm\">the original</a> on 2012-10-28<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">2012-12-30</span></span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Report+of+Thalidomide+at+University+of+New+South+Wales&amp;rft.pub=Embryology.med.unsw.edu.au&amp;rft_id=http%3A%2F%2Fembryology.med.unsw.edu.au%2FDefect%2Fpage5i.htm&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AThalidomide\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-59\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-59\">^</a></b></span> <span class=\"reference-text\"><a rel=\"nofollow\" class=\"external free\" href=\"http://www.abc.net.au/news/health/2018-06-29/thalidomide-william-mcbride-flawed-character-norman-swan/9920608\">http://www.abc.net.au/news/health/2018-06-29/thalidomide-william-mcbride-flawed-character-norman-swan/9920608</a></span>\n</li>\n<li id=\"cite_note-60\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-60\">^</a></b></span> <span class=\"reference-text\"> <a rel=\"nofollow\" class=\"external free\" href=\"https://www.independent.co.uk/news/world/thalidomide-doctor-guilty-of-medical-fraud-william-mcbride-who-exposed-the-danger-of-one-anti-nausea-1474190.html\">https://www.independent.co.uk/news/world/thalidomide-doctor-guilty-of-medical-fraud-william-mcbride-who-exposed-the-danger-of-one-anti-nausea-1474190.html</a></span>\n</li>\n<li id=\"cite_note-61\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-61\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Somers GF (1963). \"The foetal toxicity of thalidomide\". <i>Proc. European Soc. Study Drug Toxicity</i>. <b>1</b>: 49.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Proc.+European+Soc.+Study+Drug+Toxicity&amp;rft.atitle=The+foetal+toxicity+of+thalidomide&amp;rft.volume=1&amp;rft.pages=49&amp;rft.date=1963&amp;rft.aulast=Somers&amp;rft.aufirst=GF&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AThalidomide\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-62\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-62\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">King C, Kendrick F (1962). \"Teratogenic effects of thalidomide in the Sprague Dawley rat\". <i>The Lancet</i>. <b>280</b> (7265): 1116. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1016/S0140-6736%2862%2990822-X\">10.1016/S0140-6736(62)90822-X</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/14288814\">14288814</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Lancet&amp;rft.atitle=Teratogenic+effects+of+thalidomide+in+the+Sprague+Dawley+rat&amp;rft.volume=280&amp;rft.issue=7265&amp;rft.pages=1116&amp;rft.date=1962&amp;rft_id=info%3Adoi%2F10.1016%2FS0140-6736%2862%2990822-X&amp;rft_id=info%3Apmid%2F14288814&amp;rft.aulast=King&amp;rft.aufirst=C.T.G.&amp;rft.au=Kendrick%2C+F.J.&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AThalidomide\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-pmid14288814-63\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-pmid14288814_63-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">McColl JD, Globus M, Robinson S (1965). \"Effect of some therapeutic agents on the developing rat fetus\". <i>Toxicology and Applied Pharmacology</i>. <b>7</b>: 409\u201317. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1016/S0140-6736%2862%2990822-X\">10.1016/S0140-6736(62)90822-X</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/14288814\">14288814</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Toxicology+and+Applied+Pharmacology&amp;rft.atitle=Effect+of+some+therapeutic+agents+on+the+developing+rat+fetus&amp;rft.volume=7&amp;rft.pages=409-17&amp;rft.date=1965&amp;rft_id=info%3Adoi%2F10.1016%2FS0140-6736%2862%2990822-X&amp;rft_id=info%3Apmid%2F14288814&amp;rft.aulast=McColl&amp;rft.aufirst=JD&amp;rft.au=Globus%2C+M&amp;rft.au=Robinson%2C+S&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AThalidomide\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-64\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-64\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation book\">Botting J (April 2015). \"Chapter 18\". <a rel=\"nofollow\" class=\"external text\" href=\"http://www.openbookpublishers.com/htmlreader/978-1-78374-117-5/Ch-18.xhtml#_idTextAnchor074\"><i>Animals and Medicine: The Contribution of Animal Experiments to the Control of Disease</i></a>. OpenBook Publishers. <a href=\"/wiki/International_Standard_Book_Number\" title=\"International Standard Book Number\">ISBN</a>&#160;<a href=\"/wiki/Special:BookSources/9781783741175\" title=\"Special:BookSources/9781783741175\">9781783741175</a><span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">12 August</span> 2015</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=bookitem&amp;rft.atitle=Chapter+18&amp;rft.btitle=Animals+and+Medicine%3A+The+Contribution+of+Animal+Experiments+to+the+Control+of+Disease&amp;rft.pub=OpenBook+Publishers&amp;rft.date=2015-04&amp;rft.isbn=9781783741175&amp;rft.aulast=Botting&amp;rft.aufirst=Jack&amp;rft_id=http%3A%2F%2Fwww.openbookpublishers.com%2Fhtmlreader%2F978-1-78374-117-5%2FCh-18.xhtml%23_idTextAnchor074&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AThalidomide\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-65\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-65\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.neues-deutschland.de/artikel/120351.html\">\"DDR-B\u00fcrger schliefen ohne Contergan\"</a> &#91;East German citizens slept without thalidomide&#93;. <i><a href=\"/wiki/Neues_Deutschland\" title=\"Neues Deutschland\">Neues Deutschland</a></i> (in German). 4 November 2007<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">June 6,</span> 2013</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=Neues+Deutschland&amp;rft.atitle=DDR-B%C3%BCrger+schliefen+ohne+Contergan&amp;rft.date=2007-11-04&amp;rft_id=https%3A%2F%2Fwww.neues-deutschland.de%2Fartikel%2F120351.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AThalidomide\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-daeb-66\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-daeb_66-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-daeb_66-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-daeb_66-2\"><sup><i><b>c</b></i></sup></a> <a href=\"#cite_ref-daeb_66-3\"><sup><i><b>d</b></i></sup></a> <a href=\"#cite_ref-daeb_66-4\"><sup><i><b>e</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation journal\">Thomann K (2007). <a rel=\"nofollow\" class=\"external text\" href=\"http://www.aerzteblatt.de/archiv/57224/\">\"Die Contergan-Katastrophe: Die tr\u00fcgerische Sicherheit der \"harten\" Daten\"</a> &#91;The thalidomide disaster: The false security of 'hard' data&#93;. <i>Deutsches \u00c4rzteblatt</i> (in German). <b>104</b> (41): A\u20132778 / B\u20132454 / C\u20132382. <a rel=\"nofollow\" class=\"external text\" href=\"http://www.contergan-ag50.de/Seiten/presse/20111125-27_artikel/2007_Die_Contergan-Katastrophe_Die_truegerische_Sicherheit_der_harten_Daten-Deutsches_Aerzteblatt.pdf\">Archived</a> <span style=\"font-size:85%;\">(PDF)</span> from the original on December 6, 2011<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">June 6,</span> 2013</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Deutsches+%C3%84rzteblatt&amp;rft.atitle=Die+Contergan-Katastrophe%3A+Die+tr%C3%BCgerische+Sicherheit+der+%22harten%22+Daten&amp;rft.volume=104&amp;rft.issue=41&amp;rft.pages=A-2778+%2F+B-2454+%2F+C-2382&amp;rft.date=2007&amp;rft.aulast=Thomann&amp;rft.aufirst=Klaus-Dieter&amp;rft_id=http%3A%2F%2Fwww.aerzteblatt.de%2Farchiv%2F57224%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AThalidomide\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-th-67\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-th_67-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-th_67-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation book\">Zichner L, Rauschmann MA, Thomann KD (2005). <i>Die Contergankatastrophe eine Bilanz nach 40 Jahren</i> &#91;<i>The Thalidomide catastrophe takes stock after 40 years</i>&#93; (in German). Darmstadt: Steinkopff. <a href=\"/wiki/International_Standard_Book_Number\" title=\"International Standard Book Number\">ISBN</a>&#160;<a href=\"/wiki/Special:BookSources/978-3-7985-1479-9\" title=\"Special:BookSources/978-3-7985-1479-9\">978-3-7985-1479-9</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=book&amp;rft.btitle=Die+Contergankatastrophe+eine+Bilanz+nach+40+Jahren&amp;rft.place=Darmstadt&amp;rft.pub=Steinkopff&amp;rft.date=2005&amp;rft.isbn=978-3-7985-1479-9&amp;rft.aulast=Zichner&amp;rft.aufirst=L&amp;rft.au=Rauschmann%2C+MA&amp;rft.au=Thomann%2C+KD&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AThalidomide\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-68\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-68\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web\"><a rel=\"nofollow\" class=\"external text\" href=\"https://web.archive.org/web/20090814144428/http://orf.at/070930-17124/index.html\">\"10.000 F\u00e4lle von Missbildungen\"</a> &#91;10,000 cases of malformations&#93; (in German). <a href=\"/wiki/ORF_(broadcaster)\" title=\"ORF (broadcaster)\">ORF</a>. Archived from <a rel=\"nofollow\" class=\"external text\" href=\"http://orf.at/070930-17124/index.html\">the original</a> on 2009-08-14<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">June 6,</span> 2013</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=10.000+F%C3%A4lle+von+Missbildungen&amp;rft.pub=ORF&amp;rft_id=http%3A%2F%2Forf.at%2F070930-17124%2Findex.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AThalidomide\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-Braun-69\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-Braun_69-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-Braun_69-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation web\">Braun W (2015-12-29). <a rel=\"nofollow\" class=\"external text\" href=\"https://www.huffingtonpost.com/whitny-braun/thalidomide-the-connectio_b_8881702.html\">\"Thalidomide: The Connection Between a Statue in Trafalgar Square, a 1960s Children's Show Host and the Abortion Debate\"</a>. <i>Huffington Post</i><span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">2017-12-02</span></span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=Huffington+Post&amp;rft.atitle=Thalidomide%3A+The+Connection+Between+a+Statue+in+Trafalgar+Square%2C+a+1960s+Children%27s+Show+Host+and+the+Abortion+Debate&amp;rft.date=2015-12-29&amp;rft.aulast=Braun&amp;rft.aufirst=Whitny&amp;rft_id=https%3A%2F%2Fwww.huffingtonpost.com%2Fwhitny-braun%2Fthalidomide-the-connectio_b_8881702.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AThalidomide\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-70\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-70\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web\">Mekdeci B. <a rel=\"nofollow\" class=\"external text\" href=\"https://web.archive.org/web/20131218004638/http://www.birthdefects.org/research/bendectin_1.php\">\"Bendectin Part 1: How a Commonly Used Drug Caused Birth Defects\"</a>. Archived from <a rel=\"nofollow\" class=\"external text\" href=\"http://www.birthdefects.org/research/bendectin_1.php\">the original</a> on 2013-12-18.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Bendectin+Part+1%3A+How+a+Commonly+Used+Drug+Caused+Birth+Defects&amp;rft.aulast=Mekdeci&amp;rft.aufirst=Betty&amp;rft_id=http%3A%2F%2Fwww.birthdefects.org%2Fresearch%2Fbendectin_1.php&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AThalidomide\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-71\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-71\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.cliohistory.org/click/body-health/reproduction/\">\"Click - Debating Reproductive Rights - Reproductive Rights and Feminism, History of Abortion Battle, History of Abortion Debate, Roe v. Wade and Feminists\"</a>. <i>www.cliohistory.org</i><span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">2017-12-02</span></span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=www.cliohistory.org&amp;rft.atitle=Click+-+Debating+Reproductive+Rights+-+Reproductive+Rights+and+Feminism%2C+History+of+Abortion+Battle%2C+History+of+Abortion+Debate%2C+Roe+v.+Wade+and+Feminists&amp;rft_id=https%3A%2F%2Fwww.cliohistory.org%2Fclick%2Fbody-health%2Freproduction%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AThalidomide\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-72\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-72\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web\"><a rel=\"nofollow\" class=\"external text\" href=\"https://web.archive.org/web/20120901184544/http://www.contergan.grunenthal.info/grt-ctg/GRT-CTG/Stellungnahme/Rede_anlaesslich_Einweihung_des_Contergan-Denkmals/224600963.jsp\">\"Speech on the occasion of the inauguration of Thalidomide-Memorial\"</a>. <i>Gr\u00fcnenthal GmbH Website</i>. Archived from <a rel=\"nofollow\" class=\"external text\" href=\"http://www.contergan.grunenthal.info/grt-ctg/GRT-CTG/Stellungnahme/Rede_anlaesslich_Einweihung_des_Contergan-Denkmals/224600963.jsp\">the original</a> on 2012-09-01.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=Gr%C3%BCnenthal+GmbH+Website&amp;rft.atitle=Speech+on+the+occasion+of+the+inauguration+of+Thalidomide-Memorial&amp;rft_id=http%3A%2F%2Fwww.contergan.grunenthal.info%2Fgrt-ctg%2FGRT-CTG%2FStellungnahme%2FRede_anlaesslich_Einweihung_des_Contergan-Denkmals%2F224600963.jsp&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AThalidomide\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-73\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-73\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation news\"><a rel=\"nofollow\" class=\"external text\" href=\"https://web.archive.org/web/20160316085150/http://www.bbc.com/news/health-19448046\">\"Thalidomide apology insulting, campaigners say\"</a>. <i>BBC News</i>. September 1, 2012. Archived from <a rel=\"nofollow\" class=\"external text\" href=\"https://www.bbc.com/news/health-19448046\">the original</a> on 2016-03-16.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=BBC+News&amp;rft.atitle=Thalidomide+apology+insulting%2C+campaigners+say&amp;rft.date=2012-09-01&amp;rft_id=https%3A%2F%2Fwww.bbc.com%2Fnews%2Fhealth-19448046&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AThalidomide\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-they_didn&#39;t_know-74\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-they_didn&#39;t_know_74-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation news\">Ryan C (1 April 2004). <a rel=\"nofollow\" class=\"external text\" href=\"http://news.bbc.co.uk/1/hi/health/3589173.stm\">\"They just didn't know what it would do\"</a>. <i>BBC <a rel=\"nofollow\" class=\"external free\" href=\"News:Health\">News:Health</a></i>. BBC news. <a rel=\"nofollow\" class=\"external text\" href=\"https://web.archive.org/web/20040707121708/http://news.bbc.co.uk/1/hi/health/3589173.stm\">Archived</a> from the original on 2004-07-07<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">2009-05-01</span></span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=BBC+News%3AHealth&amp;rft.atitle=They+just+didn%27t+know+what+it+would+do&amp;rft.date=2004-04-01&amp;rft.aulast=Ryan&amp;rft.aufirst=Caroline&amp;rft_id=http%3A%2F%2Fnews.bbc.co.uk%2F1%2Fhi%2Fhealth%2F3589173.stm&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AThalidomide\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-75\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-75\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation news\">Flintoff J (March 23, 2008). <a rel=\"nofollow\" class=\"external text\" href=\"https://web.archive.org/web/20080513095824/http://www.timesonline.co.uk/tol/life_and_style/health/article3602694.ece\">\"Thalidomide: the battle for compensation goes on\"</a>. <i>The Sunday Times</i>. London: Times Newspapers Ltd. Archived from <a rel=\"nofollow\" class=\"external text\" href=\"http://www.timesonline.co.uk/tol/life_and_style/health/article3602694.ece\">the original</a> on 2008-05-13<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">2009-05-01</span></span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Sunday+Times&amp;rft.atitle=Thalidomide%3A+the+battle+for+compensation+goes+on&amp;rft.date=2008-03-23&amp;rft.aulast=Flintoff&amp;rft.aufirst=John-Paul&amp;rft_id=http%3A%2F%2Fwww.timesonline.co.uk%2Ftol%2Flife_and_style%2Fhealth%2Farticle3602694.ece&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AThalidomide\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-76\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-76\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation news\"><a rel=\"nofollow\" class=\"external text\" href=\"http://news.bbc.co.uk/1/hi/health/4658919.stm\">\"Compensation offer on Thalidomide\"</a>. BBC News. 7 July 2005. <a rel=\"nofollow\" class=\"external text\" href=\"https://web.archive.org/web/20090120103416/http://news.bbc.co.uk/1/hi/health/4658919.stm\">Archived</a> from the original on 2009-01-20<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">26 July</span> 2011</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Compensation+offer+on+Thalidomide&amp;rft.date=2005-07-07&amp;rft_id=http%3A%2F%2Fnews.bbc.co.uk%2F1%2Fhi%2Fhealth%2F4658919.stm&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AThalidomide\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-UK_Government_grant-77\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-UK_Government_grant_77-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation news\"><a rel=\"nofollow\" class=\"external text\" href=\"http://news.bbc.co.uk/1/hi/8428838.stm\">\"Thalidomide survivors to get \u00a320m\"</a>. BBC News. 23 December 2009. <a rel=\"nofollow\" class=\"external text\" href=\"https://archive.is/20130114042718/http://news.bbc.co.uk/2/hi/8428838.stm\">Archived</a> from the original on 14 January 2013<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">26 July</span> 2011</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Thalidomide+survivors+to+get+%C2%A320m&amp;rft.date=2009-12-23&amp;rft_id=http%3A%2F%2Fnews.bbc.co.uk%2F1%2Fhi%2F8428838.stm&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AThalidomide\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-78\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-78\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation news\"><a rel=\"nofollow\" class=\"external text\" href=\"http://www.abc.net.au/news/2011-12-19/australian-thalidomide-victims-win-hearing-bid/3738116\">\"Australian thalidomide victims win right for hearing\"</a>. <i>ABC News</i>. 19 December 2011.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=ABC+News&amp;rft.atitle=Australian+thalidomide+victims+win+right+for+hearing&amp;rft.date=2011-12-19&amp;rft_id=http%3A%2F%2Fwww.abc.net.au%2Fnews%2F2011-12-19%2Faustralian-thalidomide-victims-win-hearing-bid%2F3738116&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AThalidomide\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-79\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-79\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation news\">Petrie A (19 July 2012). <a rel=\"nofollow\" class=\"external text\" href=\"http://www.smh.com.au/national/landmark-thalidomide-payout-offers-hope-for-thousands-20120718-22apa.html\">\"Landmark thalidomide payout offers hope for thousands\"</a>. <i><a href=\"/wiki/The_Sydney_Morning_Herald\" title=\"The Sydney Morning Herald\">The Sydney Morning Herald</a></i><span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">14 February</span> 2017</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Sydney+Morning+Herald&amp;rft.atitle=Landmark+thalidomide+payout+offers+hope+for+thousands&amp;rft.date=2012-07-19&amp;rft.aulast=Petrie&amp;rft.aufirst=Andrea&amp;rft_id=http%3A%2F%2Fwww.smh.com.au%2Fnational%2Flandmark-thalidomide-payout-offers-hope-for-thousands-20120718-22apa.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AThalidomide\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-80\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-80\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation news\">Farnsworth S (7 February 2014). <a rel=\"nofollow\" class=\"external text\" href=\"http://www.abc.net.au/news/2014-02-07/supreme-court-formally-approves-2489m-class-action-for-thalido/5245034\">\"Supreme Court formally approves $89m compensation payout for Thalidomide victims\"</a>. <a href=\"/wiki/Australian_Broadcasting_Corporation\" title=\"Australian Broadcasting Corporation\">Australian Broadcasting Corporation</a><span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">14 February</span> 2017</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Supreme+Court+formally+approves+%2489m+compensation+payout+for+Thalidomide+victims&amp;rft.date=2014-02-07&amp;rft.aulast=Farnsworth&amp;rft.aufirst=Sarah&amp;rft_id=http%3A%2F%2Fwww.abc.net.au%2Fnews%2F2014-02-07%2Fsupreme-court-formally-approves-2489m-class-action-for-thalido%2F5245034&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AThalidomide\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-81\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-81\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation news\"><a href=\"/wiki/Australian_Associated_Press\" title=\"Australian Associated Press\">Australian Associated Press</a> (7 February 2014). <a rel=\"nofollow\" class=\"external text\" href=\"http://www.stuff.co.nz/national/health/9698482/Thalidomide-survivors-compensation-approved\">\"Thalidomide survivors' compensation approved\"</a>. <i><a href=\"/wiki/The_Sunday_Star-Times\" class=\"mw-redirect\" title=\"The Sunday Star-Times\">The Sunday Star-Times</a></i><span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">14 February</span> 2017</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Sunday+Star-Times&amp;rft.atitle=Thalidomide+survivors%27+compensation+approved&amp;rft.date=2014-02-07&amp;rft.au=Australian+Associated+Press&amp;rft_id=http%3A%2F%2Fwww.stuff.co.nz%2Fnational%2Fhealth%2F9698482%2FThalidomide-survivors-compensation-approved&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AThalidomide\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-82\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-82\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Warren R (2001). <a rel=\"nofollow\" class=\"external text\" href=\"http://permanent.access.gpo.gov/lps1609/www.fda.gov/fdac/departs/2001/201_word.html\">\"Living in a world with thalidomide: a dose of reality\"</a>. <i>FDA Consumer</i>. <b>35</b> (2): 40. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/11444250\">11444250</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=FDA+Consumer&amp;rft.atitle=Living+in+a+world+with+thalidomide%3A+a+dose+of+reality&amp;rft.volume=35&amp;rft.issue=2&amp;rft.pages=40&amp;rft.date=2001&amp;rft_id=info%3Apmid%2F11444250&amp;rft.aulast=Warren&amp;rft.aufirst=R&amp;rft_id=http%3A%2F%2Fpermanent.access.gpo.gov%2Flps1609%2Fwww.fda.gov%2Ffdac%2Fdeparts%2F2001%2F201_word.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AThalidomide\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-83\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-83\">^</a></b></span> <span class=\"reference-text\"><a rel=\"nofollow\" class=\"external text\" href=\"https://web.archive.org/web/20090624192258/http://www.thalidomide.ca/tvac-mission/\">The Thalidomide Victims Association of Canada</a></span>\n</li>\n<li id=\"cite_note-pmid12909394-84\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-pmid12909394_84-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-pmid12909394_84-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation journal\">Racz WJ, Ecobichon DJ, Baril M (August 2003). \"On-line sources of toxicological information in Canada\". <i>Toxicology</i>. <b>190</b> (1\u20132): 3\u201314. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1016/S0300-483X%2803%2900192-6\">10.1016/S0300-483X(03)00192-6</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/12909394\">12909394</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Toxicology&amp;rft.atitle=On-line+sources+of+toxicological+information+in+Canada&amp;rft.volume=190&amp;rft.issue=1%E2%80%932&amp;rft.pages=3-14&amp;rft.date=2003-08&amp;rft_id=info%3Adoi%2F10.1016%2FS0300-483X%2803%2900192-6&amp;rft_id=info%3Apmid%2F12909394&amp;rft.aulast=Racz&amp;rft.aufirst=WJ&amp;rft.au=Ecobichon%2C+DJ&amp;rft.au=Baril%2C+M&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AThalidomide\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-85\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-85\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation news\"><a rel=\"nofollow\" class=\"external text\" href=\"http://www.ctvnews.ca/w5/the-plight-of-the-thalidomide-sample-babies-who-don-t-qualify-for-gov-t-compensation-1.3176590\">\"The plight of the thalidomide 'sample babies' who don't qualify for gov't compensation\"</a>. <i>W5</i><span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">28 November</span> 2016</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=W5&amp;rft.atitle=The+plight+of+the+thalidomide+%27sample+babies%27+who+don%27t+qualify+for+gov%27t+compensation&amp;rft_id=http%3A%2F%2Fwww.ctvnews.ca%2Fw5%2Fthe-plight-of-the-thalidomide-sample-babies-who-don-t-qualify-for-gov-t-compensation-1.3176590&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AThalidomide\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-86\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-86\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation news\">Harris G (13 September 2010). <a rel=\"nofollow\" class=\"external text\" href=\"https://www.nytimes.com/2010/09/14/health/14kelsey.html?_r=1&amp;8dpc\">\"The Public's Quiet Savior From Harmful Medicines\"</a>. <i>The New York Times</i>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+New+York+Times&amp;rft.atitle=The+Public%27s+Quiet+Savior+From+Harmful+Medicines&amp;rft.date=2010-09-13&amp;rft.aulast=Harris&amp;rft.aufirst=Gardiner&amp;rft_id=https%3A%2F%2Fwww.nytimes.com%2F2010%2F09%2F14%2Fhealth%2F14kelsey.html%3F_r%3D1%268dpc&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AThalidomide\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-Tamplin-87\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-Tamplin_87-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation news\">Tamplin H (12 June 2015). <a rel=\"nofollow\" class=\"external text\" href=\"http://www.midsussextimes.co.uk/news/local/mid-sussex-residents-honoured-by-queen-1-6795898\">\"Mid Sussex residents honoured by Queen\"</a>. <i>Mid Sussex Times</i><span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">27 December</span> 2015</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Mid+Sussex+Times&amp;rft.atitle=Mid+Sussex+residents+honoured+by+Queen&amp;rft.date=2015-06-12&amp;rft.aulast=Tamplin&amp;rft.aufirst=Harley&amp;rft_id=http%3A%2F%2Fwww.midsussextimes.co.uk%2Fnews%2Flocal%2Fmid-sussex-residents-honoured-by-queen-1-6795898&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AThalidomide\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-88\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-88\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web\"><a rel=\"nofollow\" class=\"external text\" href=\"https://web.archive.org/web/20120306201745/https://www.portlandphoenix.com/archive/music/02/04/19/classical_Orpheus.html\">\"Orpheus lives: A small good thing in Quastoff\"</a>. <i>The Portland Phoenix</i>. April 19, 2002. Archived from <a rel=\"nofollow\" class=\"external text\" href=\"http://www.portlandphoenix.com/archive/music/02/04/19/classical_Orpheus.html\">the original</a> on March 6, 2012<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">June 6,</span> 2013</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=The+Portland+Phoenix&amp;rft.atitle=Orpheus+lives%3A+A+small+good+thing+in+Quastoff&amp;rft.date=2002-04-19&amp;rft_id=http%3A%2F%2Fwww.portlandphoenix.com%2Farchive%2Fmusic%2F02%2F04%2F19%2Fclassical_Orpheus.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AThalidomide\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-89\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-89\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.imdb.com/title/tt1266093/releaseinfo\">\"NoBody's Perfect (2008): Release Info\"</a>. IMDB<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">June 6,</span> 2013</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=NoBody%27s+Perfect+%282008%29%3A+Release+Info&amp;rft.pub=IMDB&amp;rft_id=https%3A%2F%2Fwww.imdb.com%2Ftitle%2Ftt1266093%2Freleaseinfo&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AThalidomide\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-90\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-90\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web\">Brussat F, Brussat MA. <a rel=\"nofollow\" class=\"external text\" href=\"http://www.spiritualityandpractice.com/films/films.php?id=19559\">\"Film Review: NoBody's Perfect\"</a>. Spirituality &amp; Practice<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">June 6,</span> 2013</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Film+Review%3A+NoBody%27s+Perfect&amp;rft.pub=Spirituality+%26+Practice&amp;rft.aulast=Brussat&amp;rft.aufirst=Frederic&amp;rft.au=Brussat%2C+Mary+Ann&amp;rft_id=http%3A%2F%2Fwww.spiritualityandpractice.com%2Ffilms%2Ffilms.php%3Fid%3D19559&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AThalidomide\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-91\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-91\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web\"><a rel=\"nofollow\" class=\"external text\" href=\"http://www.uwindsor.ca/dailynews/2016-06-07/outstanding-eight-receive-honorary-doctorates-convocation\">\"Outstanding eight to receive honorary doctorates at Convocation\"</a>. <i>Daily News</i>. Windsor, Ontario, Canada: University of Windsor. 9 June 2016<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">6 March</span> 2017</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=Daily+News&amp;rft.atitle=Outstanding+eight+to+receive+honorary+doctorates+at+Convocation&amp;rft.date=2016-06-09&amp;rft_id=http%3A%2F%2Fwww.uwindsor.ca%2Fdailynews%2F2016-06-07%2Foutstanding-eight-receive-honorary-doctorates-convocation&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AThalidomide\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-92\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-92\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web\"><a rel=\"nofollow\" class=\"external text\" href=\"http://www.fda.gov/Drugs/NewsEvents/ucm320924.htm\">\"50 Years: The Kefauver-Harris Amendments\"</a>. <a href=\"/wiki/Food_and_Drug_Administration_(United_States)\" class=\"mw-redirect\" title=\"Food and Drug Administration (United States)\">Food and Drug Administration (United States)</a><span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">6 June</span> 2013</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=50+Years%3A+The+Kefauver-Harris+Amendments&amp;rft.pub=Food+and+Drug+Administration+%28United+States%29&amp;rft_id=http%3A%2F%2Fwww.fda.gov%2FDrugs%2FNewsEvents%2Fucm320924.htm&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AThalidomide\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-93\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-93\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web\"><a rel=\"nofollow\" class=\"external text\" href=\"https://web.archive.org/web/20131203020225/http://www.crncc.nihr.ac.uk/workforce_development/learning_and_development/gcp/gcp_resource/research_standards/history/thalidomide\">\"Thalidomide\"</a>. <a href=\"/wiki/National_Health_Service_(England)\" title=\"National Health Service (England)\">National Health Service (England)</a>. Archived from <a rel=\"nofollow\" class=\"external text\" href=\"http://www.crncc.nihr.ac.uk/workforce_development/learning_and_development/gcp/gcp_resource/research_standards/history/thalidomide\">the original</a> on 3 December 2013<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">6 June</span> 2013</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Thalidomide&amp;rft.pub=National+Health+Service+%28England%29&amp;rft_id=http%3A%2F%2Fwww.crncc.nihr.ac.uk%2Fworkforce_development%2Flearning_and_development%2Fgcp%2Fgcp_resource%2Fresearch_standards%2Fhistory%2Fthalidomide&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AThalidomide\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-94\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-94\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Conroy S, McIntyre J, Choonara I (March 1999). <a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC1720896\">\"Unlicensed and off label drug use in neonates\"</a>. <i>Archives of Disease in Childhood: Fetal and Neonatal Edition</i>. <b>80</b> (2): F142\u20134; discussion F144\u20135. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1136/fn.80.2.F142\">10.1136/fn.80.2.F142</a>. <a href=\"/wiki/PubMed_Central\" title=\"PubMed Central\">PMC</a>&#160;<span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC1720896\">1720896</a>&#8239;<img alt=\"Freely accessible\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png\" title=\"Freely accessible\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/10325794\">10325794</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Archives+of+Disease+in+Childhood%3A+Fetal+and+Neonatal+Edition&amp;rft.atitle=Unlicensed+and+off+label+drug+use+in+neonates&amp;rft.volume=80&amp;rft.issue=2&amp;rft.pages=F142-4%3B+discussion+F144-5&amp;rft.date=1999-03&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC1720896&amp;rft_id=info%3Apmid%2F10325794&amp;rft_id=info%3Adoi%2F10.1136%2Ffn.80.2.F142&amp;rft.aulast=Conroy&amp;rft.aufirst=S&amp;rft.au=McIntyre%2C+J&amp;rft.au=Choonara%2C+I&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC1720896&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AThalidomide\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-95\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-95\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web\"><a rel=\"nofollow\" class=\"external text\" href=\"https://web.archive.org/web/20111014114005/https://www.rpharms.com/museum-pdfs/e3a-thalidomide-and-its-aftermath-2011.pdf\">\"The  evolution of pharmacy, Theme E, Level 3 Thalidomide and its aftermath\"</a> <span style=\"font-size:85%;\">(PDF)</span>. Royal Pharmaceutical Society. 2011. Archived from <a rel=\"nofollow\" class=\"external text\" href=\"https://www.rpharms.com/museum-pdfs/e3a-thalidomide-and-its-aftermath-2011.pdf\">the original</a> <span style=\"font-size:85%;\">(PDF)</span> on 14 October 2011.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=The++evolution+of+pharmacy%2C+Theme+E%2C+Level+3+Thalidomide+and+its+aftermath&amp;rft.pub=Royal+Pharmaceutical+Society&amp;rft.date=2011&amp;rft_id=https%3A%2F%2Fwww.rpharms.com%2Fmuseum-pdfs%2Fe3a-thalidomide-and-its-aftermath-2011.pdf&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AThalidomide\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-pmid10447943-96\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-pmid10447943_96-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Shah JH, Swartz GM, Papathanassiu AE, Treston AM, Fogler WE, Madsen JW, Green SJ (August 1999). \"Synthesis and enantiomeric separation of 2-phthalimidino-glutaric acid analogues: potent inhibitors of tumor metastasis\". <i>Journal of Medicinal Chemistry</i>. <b>42</b> (16): 3014\u20137. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1021/jm990083y\">10.1021/jm990083y</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/10447943\">10447943</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Journal+of+Medicinal+Chemistry&amp;rft.atitle=Synthesis+and+enantiomeric+separation+of+2-phthalimidino-glutaric+acid+analogues%3A+potent+inhibitors+of+tumor+metastasis&amp;rft.volume=42&amp;rft.issue=16&amp;rft.pages=3014-7&amp;rft.date=1999-08&amp;rft_id=info%3Adoi%2F10.1021%2Fjm990083y&amp;rft_id=info%3Apmid%2F10447943&amp;rft.aulast=Shah&amp;rft.aufirst=JH&amp;rft.au=Swartz%2C+GM&amp;rft.au=Papathanassiu%2C+AE&amp;rft.au=Treston%2C+AM&amp;rft.au=Fogler%2C+WE&amp;rft.au=Madsen%2C+JW&amp;rft.au=Green%2C+SJ&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AThalidomide\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-pmid11740816-97\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-pmid11740816_97-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-pmid11740816_97-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation journal\">D'Amato RJ, Lentzsch S, Anderson KC, Rogers MS (December 2001). \"Mechanism of action of thalidomide and 3-aminothalidomide in multiple myeloma\". <i>Seminars in Oncology</i>. <b>28</b> (6): 597\u2013601. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1016/S0093-7754%2801%2990031-4\">10.1016/S0093-7754(01)90031-4</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/11740816\">11740816</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Seminars+in+Oncology&amp;rft.atitle=Mechanism+of+action+of+thalidomide+and+3-aminothalidomide+in+multiple+myeloma&amp;rft.volume=28&amp;rft.issue=6&amp;rft.pages=597-601&amp;rft.date=2001-12&amp;rft_id=info%3Adoi%2F10.1016%2FS0093-7754%2801%2990031-4&amp;rft_id=info%3Apmid%2F11740816&amp;rft.aulast=D%27Amato&amp;rft.aufirst=RJ&amp;rft.au=Lentzsch%2C+S&amp;rft.au=Anderson%2C+KC&amp;rft.au=Rogers%2C+MS&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AThalidomide\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-98\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-98\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Rao KV (September 2007). \"Lenalidomide in the treatment of multiple myeloma\". <i>American Journal of Health-System Pharmacy</i>. <b>64</b> (17): 1799\u2013807. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.2146/ajhp070029\">10.2146/ajhp070029</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/17724360\">17724360</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=American+Journal+of+Health-System+Pharmacy&amp;rft.atitle=Lenalidomide+in+the+treatment+of+multiple+myeloma&amp;rft.volume=64&amp;rft.issue=17&amp;rft.pages=1799-807&amp;rft.date=2007-09&amp;rft_id=info%3Adoi%2F10.2146%2Fajhp070029&amp;rft_id=info%3Apmid%2F17724360&amp;rft.aulast=Rao&amp;rft.aufirst=KV&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AThalidomide\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-99\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-99\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web\"><a rel=\"nofollow\" class=\"external text\" href=\"http://clinicaltrials.gov/ct/search?term=pomalidomide&amp;submit=Search\">\"Search of: pomalidomide\"</a>. Clinicaltrials.gov<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">2012-09-01</span></span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Search+of%3A+pomalidomide&amp;rft.pub=Clinicaltrials.gov&amp;rft_id=http%3A%2F%2Fclinicaltrials.gov%2Fct%2Fsearch%3Fterm%3Dpomalidomide%26submit%3DSearch&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AThalidomide\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-100\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-100\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Raghupathy R, Billett HH (March 2009). \"Promising therapies in sickle cell disease\". <i>Cardiovascular &amp; Hematological Disorders Drug Targets</i>. <b>9</b> (1): 1\u20138. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.2174/187152909787581354\">10.2174/187152909787581354</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/19275572\">19275572</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Cardiovascular+%26+Hematological+Disorders+Drug+Targets&amp;rft.atitle=Promising+therapies+in+sickle+cell+disease&amp;rft.volume=9&amp;rft.issue=1&amp;rft.pages=1-8&amp;rft.date=2009-03&amp;rft_id=info%3Adoi%2F10.2174%2F187152909787581354&amp;rft_id=info%3Apmid%2F19275572&amp;rft.aulast=Raghupathy&amp;rft.aufirst=R&amp;rft.au=Billett%2C+HH&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AThalidomide\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-P1-101\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-P1_101-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web\"><a rel=\"nofollow\" class=\"external text\" href=\"http://www.myelomabeacon.com/news/2013/02/08/pomalyst-pomalidomide-fda-approval-multiple-myeloma/\">\"Pomalyst (Pomalidomide) Approved By FDA For Relapsed And Refractory Multiple Myeloma\"</a>. The Myeloma Beacon<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">2013-08-10</span></span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Pomalyst+%28Pomalidomide%29+Approved+By+FDA+For+Relapsed+And+Refractory+Multiple+Myeloma&amp;rft.pub=The+Myeloma+Beacon&amp;rft_id=http%3A%2F%2Fwww.myelomabeacon.com%2Fnews%2F2013%2F02%2F08%2Fpomalyst-pomalidomide-fda-approval-multiple-myeloma%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AThalidomide\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-P2-102\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-P2_102-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web\"><a rel=\"nofollow\" class=\"external text\" href=\"http://www.myelomabeacon.com/news/2013/08/09/pomalidomide-imnovid-pomalyst-europe-ema-approval-multiple-myeloma/\">\"Pomalidomide Approved In Europe For Relapsed And Refractory Multiple Myeloma\"</a>. The Myeloma Beacon<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">2013-08-10</span></span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Pomalidomide+Approved+In+Europe+For+Relapsed+And+Refractory+Multiple+Myeloma&amp;rft.pub=The+Myeloma+Beacon&amp;rft_id=http%3A%2F%2Fwww.myelomabeacon.com%2Fnews%2F2013%2F08%2F09%2Fpomalidomide-imnovid-pomalyst-europe-ema-approval-multiple-myeloma%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AThalidomide\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-103\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-103\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Srinivasan R, Akobeng AK (April 2009). \"Thalidomide and thalidomide analogues for induction of remission in Crohn's disease\". <i>The Cochrane Database of Systematic Reviews</i> (2): CD007350. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1002/14651858.CD007350.pub2\">10.1002/14651858.CD007350.pub2</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/19370684\">19370684</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Cochrane+Database+of+Systematic+Reviews&amp;rft.atitle=Thalidomide+and+thalidomide+analogues+for+induction+of+remission+in+Crohn%27s+disease&amp;rft.issue=2&amp;rft.pages=CD007350&amp;rft.date=2009-04&amp;rft_id=info%3Adoi%2F10.1002%2F14651858.CD007350.pub2&amp;rft_id=info%3Apmid%2F19370684&amp;rft.aulast=Srinivasan&amp;rft.aufirst=R&amp;rft.au=Akobeng%2C+AK&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AThalidomide\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-104\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-104\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Akobeng AK, Stokkers PC (April 2009). \"Thalidomide and thalidomide analogues for maintenance of remission in Crohn's disease\". <i>The Cochrane Database of Systematic Reviews</i> (2): CD007351. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1002/14651858.CD007351.pub2\">10.1002/14651858.CD007351.pub2</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/19370685\">19370685</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Cochrane+Database+of+Systematic+Reviews&amp;rft.atitle=Thalidomide+and+thalidomide+analogues+for+maintenance+of+remission+in+Crohn%27s+disease&amp;rft.issue=2&amp;rft.pages=CD007351&amp;rft.date=2009-04&amp;rft_id=info%3Adoi%2F10.1002%2F14651858.CD007351.pub2&amp;rft_id=info%3Apmid%2F19370685&amp;rft.aulast=Akobeng&amp;rft.aufirst=AK&amp;rft.au=Stokkers%2C+PC&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AThalidomide\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-105\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-105\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web\">Rose LJ, Fishman AD, Sparano JA (11 March 2013).  Talavera F, McKenna R, Harris JE, eds. <a rel=\"nofollow\" class=\"external text\" href=\"http://emedicine.medscape.com/article/279734-treatment#showall\">\"Kaposi Sarcoma Treatment &amp; Management\"</a>. <i>Medscape Reference</i>. WebMD<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">19 January</span> 2014</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=Medscape+Reference&amp;rft.atitle=Kaposi+Sarcoma+Treatment+%26+Management&amp;rft.date=2013-03-11&amp;rft.aulast=Rose&amp;rft.aufirst=LJ&amp;rft.au=Fishman%2C+AD&amp;rft.au=Sparano%2C+JA&amp;rft_id=http%3A%2F%2Femedicine.medscape.com%2Farticle%2F279734-treatment%23showall&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AThalidomide\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-106\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-106\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Gordon JN, Trebble TM, Ellis RD, Duncan HD, Johns T, Goggin PM (April 2005). <a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC1774430\">\"Thalidomide in the treatment of cancer cachexia: a randomised placebo controlled trial\"</a>. <i>Gut</i>. <b>54</b> (4): 540\u20135. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1136/gut.2004.047563\">10.1136/gut.2004.047563</a>. <a href=\"/wiki/PubMed_Central\" title=\"PubMed Central\">PMC</a>&#160;<span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC1774430\">1774430</a>&#8239;<img alt=\"Freely accessible\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png\" title=\"Freely accessible\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/15753541\">15753541</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Gut&amp;rft.atitle=Thalidomide+in+the+treatment+of+cancer+cachexia%3A+a+randomised+placebo+controlled+trial&amp;rft.volume=54&amp;rft.issue=4&amp;rft.pages=540-5&amp;rft.date=2005-04&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC1774430&amp;rft_id=info%3Apmid%2F15753541&amp;rft_id=info%3Adoi%2F10.1136%2Fgut.2004.047563&amp;rft.aulast=Gordon&amp;rft.aufirst=JN&amp;rft.au=Trebble%2C+TM&amp;rft.au=Ellis%2C+RD&amp;rft.au=Duncan%2C+HD&amp;rft.au=Johns%2C+T&amp;rft.au=Goggin%2C+PM&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC1774430&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AThalidomide\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-107\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-107\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Sharpstone D, Rowbottom A, Francis N, Tovey G, Ellis D, Barrett M, Gazzard B (June 1997). \"Thalidomide: a novel therapy for microsporidiosis\". <i>Gastroenterology</i>. <b>112</b> (6): 1823\u20139. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1053/gast.1997.v112.pm9178672\">10.1053/gast.1997.v112.pm9178672</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/9178672\">9178672</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Gastroenterology&amp;rft.atitle=Thalidomide%3A+a+novel+therapy+for+microsporidiosis&amp;rft.volume=112&amp;rft.issue=6&amp;rft.pages=1823-9&amp;rft.date=1997-06&amp;rft_id=info%3Adoi%2F10.1053%2Fgast.1997.v112.pm9178672&amp;rft_id=info%3Apmid%2F9178672&amp;rft.aulast=Sharpstone&amp;rft.aufirst=D&amp;rft.au=Rowbottom%2C+A&amp;rft.au=Francis%2C+N&amp;rft.au=Tovey%2C+G&amp;rft.au=Ellis%2C+D&amp;rft.au=Barrett%2C+M&amp;rft.au=Gazzard%2C+B&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AThalidomide\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-108\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-108\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Tunio MA, Hashmi A, Qayyum A, Naimatullah N, Masood R (September 2012). \"Low-dose thalidomide in patients with metastatic renal cell carcinoma\". <i>JPMA. The Journal of the Pakistan Medical Association</i>. <b>62</b> (9): 876\u20139. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/23139966\">23139966</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=JPMA.+The+Journal+of+the+Pakistan+Medical+Association&amp;rft.atitle=Low-dose+thalidomide+in+patients+with+metastatic+renal+cell+carcinoma&amp;rft.volume=62&amp;rft.issue=9&amp;rft.pages=876-9&amp;rft.date=2012-09&amp;rft_id=info%3Apmid%2F23139966&amp;rft.aulast=Tunio&amp;rft.aufirst=MA&amp;rft.au=Hashmi%2C+A&amp;rft.au=Qayyum%2C+A&amp;rft.au=Naimatullah%2C+N&amp;rft.au=Masood%2C+R&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AThalidomide\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-109\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-109\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Hamuryudan V, Mat C, Saip S, Ozyazgan Y, Siva A, Yurdakul S, Zwingenberger K, Yazici H (March 1998). \"Thalidomide in the treatment of the mucocutaneous lesions of the Beh\u00e7et syndrome. A randomized, double-blind, placebo-controlled trial\". <i>Annals of Internal Medicine</i>. <b>128</b> (6): 443\u201350. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.7326/0003-4819-128-6-199803150-00004\">10.7326/0003-4819-128-6-199803150-00004</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/9499327\">9499327</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Annals+of+Internal+Medicine&amp;rft.atitle=Thalidomide+in+the+treatment+of+the+mucocutaneous+lesions+of+the+Beh%C3%A7et+syndrome.+A+randomized%2C+double-blind%2C+placebo-controlled+trial&amp;rft.volume=128&amp;rft.issue=6&amp;rft.pages=443-50&amp;rft.date=1998-03&amp;rft_id=info%3Adoi%2F10.7326%2F0003-4819-128-6-199803150-00004&amp;rft_id=info%3Apmid%2F9499327&amp;rft.aulast=Hamuryudan&amp;rft.aufirst=V&amp;rft.au=Mat%2C+C&amp;rft.au=Saip%2C+S&amp;rft.au=Ozyazgan%2C+Y&amp;rft.au=Siva%2C+A&amp;rft.au=Yurdakul%2C+S&amp;rft.au=Zwingenberger%2C+K&amp;rft.au=Yazici%2C+H&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AThalidomide\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-110\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-110\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Wallis RS, Hafner R (April 2015). \"Advancing host-directed therapy for tuberculosis\". <i>Nature Reviews. Immunology</i>. <b>15</b> (4): 255\u201363. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1038/nri3813\">10.1038/nri3813</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/25765201\">25765201</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Nature+Reviews.+Immunology&amp;rft.atitle=Advancing+host-directed+therapy+for+tuberculosis&amp;rft.volume=15&amp;rft.issue=4&amp;rft.pages=255-63&amp;rft.date=2015-04&amp;rft_id=info%3Adoi%2F10.1038%2Fnri3813&amp;rft_id=info%3Apmid%2F25765201&amp;rft.aulast=Wallis&amp;rft.aufirst=RS&amp;rft.au=Hafner%2C+R&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AThalidomide\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n</ol></div>\n<h2><span class=\"mw-headline\" id=\"Further_reading\">Further reading</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Thalidomide&amp;action=edit&amp;section=26\" title=\"Edit section: Further reading\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<ul><li><cite class=\"citation book\">Stephens T, Brynner R (2001-12-24). <i>Dark Remedy: The Impact of Thalidomide and Its Revival as a Vital Medicine</i>. <a href=\"/wiki/Perseus_Books\" class=\"mw-redirect\" title=\"Perseus Books\">Perseus Books</a>. <a href=\"/wiki/International_Standard_Book_Number\" title=\"International Standard Book Number\">ISBN</a>&#160;<a href=\"/wiki/Special:BookSources/0-7382-0590-7\" title=\"Special:BookSources/0-7382-0590-7\">0-7382-0590-7</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=book&amp;rft.btitle=Dark+Remedy%3A+The+Impact+of+Thalidomide+and+Its+Revival+as+a+Vital+Medicine&amp;rft.pub=Perseus+Books&amp;rft.date=2001-12-24&amp;rft.isbn=0-7382-0590-7&amp;rft.aulast=Stephens&amp;rft.aufirst=Trent&amp;rft.au=Brynner%2C+Rock&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AThalidomide\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></li>\n<li><cite class=\"citation book\"><a href=\"/wiki/Phillip_Knightley\" title=\"Phillip Knightley\">Knightley P</a>, <a href=\"/wiki/Harold_Evans\" title=\"Harold Evans\">Evans H</a> (1979). <i>Suffer The Children: The Story of Thalidomide</i>. New York: <a href=\"/wiki/The_Viking_Press\" class=\"mw-redirect\" title=\"The Viking Press\">The Viking Press</a>. <a href=\"/wiki/International_Standard_Book_Number\" title=\"International Standard Book Number\">ISBN</a>&#160;<a href=\"/wiki/Special:BookSources/0-670-68114-8\" title=\"Special:BookSources/0-670-68114-8\">0-670-68114-8</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=book&amp;rft.btitle=Suffer+The+Children%3A+The+Story+of+Thalidomide&amp;rft.place=New+York&amp;rft.pub=The+Viking+Press&amp;rft.date=1979&amp;rft.isbn=0-670-68114-8&amp;rft.aulast=Knightley&amp;rft.aufirst=Phillip&amp;rft.au=Evans%2C+Harold&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AThalidomide\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></li></ul>\n<h2><span class=\"mw-headline\" id=\"External_links\">External links</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Thalidomide&amp;action=edit&amp;section=27\" title=\"Edit section: External links\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<ul><li><a rel=\"nofollow\" class=\"external text\" href=\"http://www.who.int/entity/medicines/publications/newsletter/en/news2003_2.pdf\">WHO Pharmaceuticals Newsletter No. 2, 2003 \u2013 See page 11, Feature Article</a></li>\n<li><a rel=\"nofollow\" class=\"external text\" href=\"http://www.cbc.ca/archives/topic/thalidomide-bitter-pills-broken-promises\">CBC Digital Archives&#160;\u2013 Thalidomide: Bitter Pills, Broken Promises</a></li>\n<li><a rel=\"nofollow\" class=\"external text\" href=\"http://theconversation.com/remind-me-again-what-is-thalidomide-and-how-did-it-cause-so-much-harm-46847\">Remind me again, what is thalidomide and how did it cause so much harm?</a>. The Conversation, 7 December 2015</li></ul>\n<div role=\"navigation\" class=\"navbox\" aria-labelledby=\"Antiangiogenics\" style=\"padding:3px\"><table class=\"nowraplinks collapsible autocollapse navbox-inner\" style=\"border-spacing:0;background:transparent;color:inherit\"><tbody><tr><th scope=\"col\" class=\"navbox-title\" colspan=\"2\"><div class=\"plainlinks hlist navbar mini\"><ul><li class=\"nv-view\"><a href=\"/wiki/Template:Antiangiogenics\" title=\"Template:Antiangiogenics\"><abbr title=\"View this template\" style=\";;background:none transparent;border:none;-moz-box-shadow:none;-webkit-box-shadow:none;box-shadow:none; padding:0;\">v</abbr></a></li><li class=\"nv-talk\"><a href=\"/wiki/Template_talk:Antiangiogenics\" title=\"Template talk:Antiangiogenics\"><abbr title=\"Discuss this template\" style=\";;background:none transparent;border:none;-moz-box-shadow:none;-webkit-box-shadow:none;box-shadow:none; padding:0;\">t</abbr></a></li><li class=\"nv-edit\"><a class=\"external text\" href=\"//en.wikipedia.org/w/index.php?title=Template:Antiangiogenics&amp;action=edit\"><abbr title=\"Edit this template\" style=\";;background:none transparent;border:none;-moz-box-shadow:none;-webkit-box-shadow:none;box-shadow:none; padding:0;\">e</abbr></a></li></ul></div><div id=\"Antiangiogenics\" style=\"font-size:114%;margin:0 4em\"><a href=\"/wiki/Angiogenesis_inhibitor\" title=\"Angiogenesis inhibitor\">Antiangiogenics</a></div></th></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\"><a href=\"/wiki/Endogeny\" class=\"mw-redirect\" title=\"Endogeny\">Endogenous</a></th><td class=\"navbox-list navbox-odd hlist\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\n<ul><li><a href=\"/wiki/ANGPT2\" title=\"ANGPT2\">Angiopoietin 2</a></li>\n<li><a href=\"/wiki/Angiostatin\" title=\"Angiostatin\">angiostatin</a></li>\n<li><a href=\"/w/index.php?title=Canstatin&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"Canstatin (page does not exist)\">canstatin</a></li>\n<li><a href=\"/wiki/Calreticulin\" title=\"Calreticulin\">calreticulin</a></li>\n<li><a href=\"/wiki/Endostatin\" title=\"Endostatin\">endostatin</a></li>\n<li><a href=\"/wiki/Interferon_alpha\" class=\"mw-redirect\" title=\"Interferon alpha\">IFN-\u03b1</a></li>\n<li><a href=\"/wiki/Interferon_beta\" class=\"mw-redirect\" title=\"Interferon beta\">IFN-\u03b2</a></li>\n<li><a href=\"/wiki/Interferon_gamma\" title=\"Interferon gamma\">IFN-\u03b3</a></li>\n<li><a href=\"/wiki/CXCL10\" title=\"CXCL10\">CXCL10</a></li>\n<li><a href=\"/wiki/Interleukin_4\" title=\"Interleukin 4\">IL-4</a></li>\n<li><a href=\"/wiki/Interleukin_12\" title=\"Interleukin 12\">IL-12</a></li>\n<li><a href=\"/wiki/Interleukin_18\" title=\"Interleukin 18\">IL-18</a></li>\n<li><a href=\"/wiki/Maspin\" title=\"Maspin\">maspin</a></li>\n<li><a href=\"/wiki/Meth-1\" class=\"mw-redirect\" title=\"Meth-1\">Meth-1</a></li>\n<li><a href=\"/wiki/Meth-2\" class=\"mw-redirect\" title=\"Meth-2\">Meth-2</a></li>\n<li><a href=\"/wiki/Osteopontin\" title=\"Osteopontin\">osteopontin</a></li>\n<li><a href=\"/wiki/Platelet_factor-4\" class=\"mw-redirect\" title=\"Platelet factor-4\">platelet factor-4</a></li>\n<li><a href=\"/wiki/Prolactin\" title=\"Prolactin\">prolactin</a></li>\n<li><a href=\"/w/index.php?title=Proliferin-related_protein&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"Proliferin-related protein (page does not exist)\">proliferin-related protein</a></li>\n<li><a href=\"/wiki/Prothrombin\" class=\"mw-redirect\" title=\"Prothrombin\">prothrombin</a> (<a href=\"/wiki/Kringle_domain\" title=\"Kringle domain\">kringle domain</a>-2)</li>\n<li><a href=\"/wiki/Antithrombin_III\" class=\"mw-redirect\" title=\"Antithrombin III\">antithrombin III</a> fragment</li>\n<li><a href=\"/wiki/Osteonectin\" title=\"Osteonectin\">SPARC</a></li>\n<li><a href=\"/wiki/Thrombospondin_1\" title=\"Thrombospondin 1\">Thrombospondin 1</a></li>\n<li><a href=\"/wiki/Tissue_inhibitor_of_metalloproteinases\" class=\"mw-redirect\" title=\"Tissue inhibitor of metalloproteinases\">TIMP</a></li>\n<li><a href=\"/wiki/Vasostatin\" class=\"mw-redirect\" title=\"Vasostatin\">vasostatin</a></li>\n<li><a href=\"/wiki/VEGI\" class=\"mw-redirect\" title=\"VEGI\">VEGI</a></li>\n<li><a href=\"/wiki/VEGFR-1\" class=\"mw-redirect\" title=\"VEGFR-1\">soluble VEGFR-1</a></li>\n<li><a href=\"/wiki/NRP-1\" class=\"mw-redirect\" title=\"NRP-1\">NRP-1</a></li>\n<li><a href=\"/wiki/Cartilage-derived_angiogenesis_inhibitor\" title=\"Cartilage-derived angiogenesis inhibitor\">CDAI</a></li></ul>\n</div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\"><a href=\"/wiki/Exogeny\" title=\"Exogeny\">Exogenous</a></th><td class=\"navbox-list navbox-even hlist\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\n<ul><li><a href=\"/wiki/2-Methoxyestradiol\" title=\"2-Methoxyestradiol\">2-Methoxyestradiol</a></li>\n<li><a href=\"/wiki/Alpha-V_beta-3\" class=\"mw-redirect\" title=\"Alpha-V beta-3\">\u03b1<sub>V</sub>\u03b2<sub>3</sub> inhibitors</a></li>\n<li><a href=\"/w/index.php?title=Angiostatic_steroid&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"Angiostatic steroid (page does not exist)\">angiostatic steroids</a></li>\n<li><a href=\"/wiki/Heparin\" title=\"Heparin\">heparin</a></li>\n<li><a href=\"/wiki/Angiostatin\" title=\"Angiostatin\">angiostatin</a></li>\n<li><a href=\"/wiki/Bevacizumab\" title=\"Bevacizumab\">bevacizumab</a></li>\n<li><a href=\"/wiki/Carboxyamidotriazole\" title=\"Carboxyamidotriazole\">carboxyamidotriazole</a></li>\n<li><a href=\"/wiki/Cartilage-Derived_Angiogenesis_Inhibitory_Factor\" class=\"mw-redirect\" title=\"Cartilage-Derived Angiogenesis Inhibitory Factor\">Cartilage-Derived Angiogenesis Inhibitory Factor</a></li>\n<li><a href=\"/w/index.php?title=CM101&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"CM101 (page does not exist)\">CM101</a></li>\n<li><a href=\"/wiki/Endostatin\" title=\"Endostatin\">endostatin</a></li>\n<li><a href=\"/wiki/Interferon_alpha\" class=\"mw-redirect\" title=\"Interferon alpha\">IFN-\u03b1</a></li>\n<li><a href=\"/wiki/Interleukin_12\" title=\"Interleukin 12\">IL-12</a></li>\n<li><a href=\"/wiki/Itraconazole\" title=\"Itraconazole\">itraconazole</a></li>\n<li><a href=\"/w/index.php?title=Linomide&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"Linomide (page does not exist)\">linomide</a></li>\n<li><a href=\"/wiki/Matrix_metalloproteinase_inhibitor\" title=\"Matrix metalloproteinase inhibitor\">matrix metalloproteinase inhibitors</a></li>\n<li><a href=\"/wiki/Platelet_factor-4\" class=\"mw-redirect\" title=\"Platelet factor-4\">platelet factor-4</a></li>\n<li><a href=\"/wiki/Prolactin\" title=\"Prolactin\">prolactin</a></li>\n<li><a href=\"/wiki/SU5416\" class=\"mw-redirect\" title=\"SU5416\">SU5416</a></li>\n<li><a href=\"/wiki/Suramin\" title=\"Suramin\">suramin</a></li>\n<li><a href=\"/wiki/Tasquinimod\" title=\"Tasquinimod\">tasquinimod</a></li>\n<li><a href=\"/w/index.php?title=Tecogalan&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"Tecogalan (page does not exist)\">tecogalan</a></li>\n<li><a href=\"/wiki/Tetrathiomolybdate\" title=\"Tetrathiomolybdate\">tetrathiomolybdate</a></li>\n<li><a class=\"mw-selflink selflink\">thalidomide</a></li>\n<li><a href=\"/wiki/Thrombospondin\" title=\"Thrombospondin\">thrombospondin</a></li>\n<li><a href=\"/wiki/Thrombospondin\" title=\"Thrombospondin\">thrombospondin</a></li>\n<li><a href=\"/w/index.php?title=TNP-470&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"TNP-470 (page does not exist)\">TNP-470</a></li>\n<li><a href=\"/wiki/VEGFR\" class=\"mw-redirect\" title=\"VEGFR\">VEGFR antagonists</a></li></ul>\n</div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\">See also</th><td class=\"navbox-list navbox-odd hlist\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\n<ul><li><a href=\"/wiki/Angiogenesis\" title=\"Angiogenesis\">Angiogenesis</a></li>\n<li><a href=\"/wiki/Category:Angiogenesis_inhibitors\" title=\"Category:Angiogenesis inhibitors\">Angiogenesis inhibitors</a></li></ul>\n</div></td></tr></tbody></table></div>\n<div role=\"navigation\" class=\"navbox\" aria-labelledby=\"Immunosuppressive_drugs_/_Immunosuppressants_(L04)\" style=\"padding:3px\"><table class=\"nowraplinks collapsible autocollapse navbox-inner\" style=\"border-spacing:0;background:transparent;color:inherit\"><tbody><tr><th scope=\"col\" class=\"navbox-title\" colspan=\"2\"><div class=\"plainlinks hlist navbar mini\"><ul><li class=\"nv-view\"><a href=\"/wiki/Template:Immunosuppressants\" title=\"Template:Immunosuppressants\"><abbr title=\"View this template\" style=\";;background:none transparent;border:none;-moz-box-shadow:none;-webkit-box-shadow:none;box-shadow:none; padding:0;\">v</abbr></a></li><li class=\"nv-talk\"><a href=\"/wiki/Template_talk:Immunosuppressants\" title=\"Template talk:Immunosuppressants\"><abbr title=\"Discuss this template\" style=\";;background:none transparent;border:none;-moz-box-shadow:none;-webkit-box-shadow:none;box-shadow:none; padding:0;\">t</abbr></a></li><li class=\"nv-edit\"><a class=\"external text\" href=\"//en.wikipedia.org/w/index.php?title=Template:Immunosuppressants&amp;action=edit\"><abbr title=\"Edit this template\" style=\";;background:none transparent;border:none;-moz-box-shadow:none;-webkit-box-shadow:none;box-shadow:none; padding:0;\">e</abbr></a></li></ul></div><div id=\"Immunosuppressive_drugs_/_Immunosuppressants_(L04)\" style=\"font-size:114%;margin:0 4em\"><a href=\"/wiki/Immunosuppressive_drug\" title=\"Immunosuppressive drug\">Immunosuppressive drugs</a>&#160;/ <a href=\"/wiki/Immunosuppression\" title=\"Immunosuppression\">Immunosuppressants</a> (<a href=\"/wiki/ATC_code_L04\" title=\"ATC code L04\">L04</a>)</div></th></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\">Intracellular<br />(initiation)</th><td class=\"navbox-list navbox-odd hlist\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\"></div><table class=\"nowraplinks navbox-subgroup\" style=\"border-spacing:0\"><tbody><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\"><a href=\"/wiki/Antimetabolite\" title=\"Antimetabolite\">Antimetabolites</a></th><td class=\"navbox-list navbox-odd\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\n<ul><li><i><a href=\"/wiki/Purine_synthesis_inhibitor\" class=\"mw-redirect\" title=\"Purine synthesis inhibitor\">purine synthesis inhibitors</a></i>\n<ul><li><a href=\"/wiki/Azathioprine\" title=\"Azathioprine\">Azathioprine</a></li>\n<li><a href=\"/wiki/Mycophenolic_acid\" title=\"Mycophenolic acid\">Mycophenolic acid</a></li></ul></li></ul>\n<ul><li><i><a href=\"/wiki/Pyrimidine_synthesis_inhibitor\" class=\"mw-redirect\" title=\"Pyrimidine synthesis inhibitor\">pyrimidine synthesis inhibitors</a></i>\n<ul><li><a href=\"/wiki/Leflunomide\" title=\"Leflunomide\">Leflunomide</a></li>\n<li><a href=\"/wiki/Teriflunomide\" title=\"Teriflunomide\">Teriflunomide</a></li></ul></li></ul>\n<ul><li><i><a href=\"/wiki/Antifolate\" title=\"Antifolate\">antifolate</a></i>\n<ul><li><a href=\"/wiki/Methotrexate\" title=\"Methotrexate\">Methotrexate</a></li></ul></li></ul>\n</div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\"><a href=\"/wiki/Macrolide\" title=\"Macrolide\">Macrolides</a>/<br />other <a href=\"/wiki/Interleukin_2\" title=\"Interleukin 2\">IL-2</a> inhibitors</th><td class=\"navbox-list navbox-even\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\n<ul><li><i><a href=\"/wiki/FKBP\" title=\"FKBP\">FKBP</a>/<a href=\"/wiki/Cyclophilin\" title=\"Cyclophilin\">Cyclophilin</a>/<a href=\"/wiki/Calcineurin\" title=\"Calcineurin\">Calcineurin</a></i>\n<ul><li><a href=\"/wiki/Tacrolimus\" title=\"Tacrolimus\">Tacrolimus</a></li>\n<li><a href=\"/wiki/Ciclosporin\" title=\"Ciclosporin\">Ciclosporin</a></li>\n<li><a href=\"/wiki/Pimecrolimus\" title=\"Pimecrolimus\">Pimecrolimus</a></li></ul></li></ul>\n<ul><li><a href=\"/wiki/Abetimus\" title=\"Abetimus\">Abetimus</a></li>\n<li><a href=\"/wiki/Gusperimus\" title=\"Gusperimus\">Gusperimus</a></li></ul>\n</div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\"><a href=\"/wiki/Immunomodulatory_imide_drug\" title=\"Immunomodulatory imide drug\">IMiDs</a></th><td class=\"navbox-list navbox-odd\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\n<ul><li><a href=\"/wiki/Lenalidomide\" title=\"Lenalidomide\">Lenalidomide</a></li>\n<li><a href=\"/wiki/Pomalidomide\" title=\"Pomalidomide\">Pomalidomide</a></li>\n<li><a class=\"mw-selflink selflink\">Thalidomide</a></li>\n<li><i><a href=\"/wiki/PDE4_inhibitor\" class=\"mw-redirect\" title=\"PDE4 inhibitor\">PDE4 inhibitor</a></i>\n<ul><li><a href=\"/wiki/Apremilast\" title=\"Apremilast\">Apremilast</a></li></ul></li></ul>\n</div></td></tr></tbody></table><div></div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\">Intracellular<br />(reception)</th><td class=\"navbox-list navbox-odd hlist\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\"></div><table class=\"nowraplinks navbox-subgroup\" style=\"border-spacing:0\"><tbody><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\"><a href=\"/wiki/Interleukin_1_receptor_antagonist\" title=\"Interleukin 1 receptor antagonist\">IL-1 receptor antagonists</a></th><td class=\"navbox-list navbox-even\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\n<ul><li><a href=\"/wiki/Anakinra\" title=\"Anakinra\">Anakinra</a></li></ul>\n</div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\"><a href=\"/wiki/MTOR\" title=\"MTOR\">mTOR</a></th><td class=\"navbox-list navbox-odd\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\n<ul><li><a href=\"/wiki/Sirolimus\" title=\"Sirolimus\">Sirolimus</a></li>\n<li><a href=\"/wiki/Everolimus\" title=\"Everolimus\">Everolimus</a></li>\n<li><a href=\"/wiki/Ridaforolimus\" title=\"Ridaforolimus\">Ridaforolimus</a></li>\n<li><a href=\"/wiki/Temsirolimus\" title=\"Temsirolimus\">Temsirolimus</a></li>\n<li><a href=\"/wiki/Umirolimus\" title=\"Umirolimus\">Umirolimus</a></li>\n<li><a href=\"/wiki/Zotarolimus\" title=\"Zotarolimus\">Zotarolimus</a></li></ul>\n</div></td></tr></tbody></table><div></div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\">Extracellular</th><td class=\"navbox-list navbox-odd hlist\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\"></div><table class=\"nowraplinks navbox-subgroup\" style=\"border-spacing:0\"><tbody><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\"><a href=\"/wiki/Antibody\" title=\"Antibody\">Antibodies</a></th><td class=\"navbox-list navbox-odd\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\"></div><table class=\"nowraplinks navbox-subgroup\" style=\"border-spacing:0\"><tbody><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\"><a href=\"/wiki/Monoclonal_antibodies\" class=\"mw-redirect\" title=\"Monoclonal antibodies\">Monoclonal</a></th><td class=\"navbox-list navbox-odd\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\"></div><table class=\"nowraplinks navbox-subgroup\" style=\"border-spacing:0\"><tbody><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\">Serum target<br />(noncellular)</th><td class=\"navbox-list navbox-even\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\n<ul><li><i><a href=\"/wiki/Complement_component_5\" title=\"Complement component 5\">Complement component 5</a></i>\n<ul><li><a href=\"/wiki/Eculizumab\" title=\"Eculizumab\">Eculizumab</a></li></ul></li>\n<li><i><a href=\"/wiki/TNF_inhibitor\" title=\"TNF inhibitor\">TNF</a></i>\n<ul><li><a href=\"/wiki/Adalimumab\" title=\"Adalimumab\">Adalimumab</a></li>\n<li><a href=\"/wiki/Afelimomab\" title=\"Afelimomab\">Afelimomab</a></li>\n<li><a href=\"/wiki/Certolizumab_pegol\" title=\"Certolizumab pegol\">Certolizumab pegol</a></li>\n<li><a href=\"/wiki/Golimumab\" title=\"Golimumab\">Golimumab</a></li>\n<li><a href=\"/wiki/Infliximab\" title=\"Infliximab\">Infliximab</a></li>\n<li><a href=\"/wiki/Nerelimomab\" title=\"Nerelimomab\">Nerelimomab</a></li></ul></li>\n<li><i><a href=\"/wiki/Interleukin_5\" title=\"Interleukin 5\">Interleukin 5</a></i>\n<ul><li><a href=\"/wiki/Mepolizumab\" title=\"Mepolizumab\">Mepolizumab</a></li></ul></li>\n<li><i><a href=\"/wiki/Immunoglobulin_E\" title=\"Immunoglobulin E\">Immunoglobulin E</a></i>\n<ul><li><a href=\"/wiki/Omalizumab\" title=\"Omalizumab\">Omalizumab</a></li></ul></li></ul>\n<ul><li><i><a href=\"/wiki/Interferon\" title=\"Interferon\">Interferon</a></i>\n<ul><li><a href=\"/wiki/Faralimomab\" title=\"Faralimomab\">Faralimomab</a></li></ul></li></ul>\n<ul><li><i><a href=\"/wiki/Interleukin_6\" title=\"Interleukin 6\">IL-6</a></i>\n<ul><li><a href=\"/wiki/Elsilimomab\" title=\"Elsilimomab\">Elsilimomab</a></li></ul></li></ul>\n<ul><li><i><a href=\"/wiki/Interleukin_12\" title=\"Interleukin 12\">IL-12</a> and <a href=\"/wiki/Interleukin_23\" title=\"Interleukin 23\">IL-23</a></i>\n<ul><li><a href=\"/wiki/Lebrikizumab\" title=\"Lebrikizumab\">Lebrikizumab</a></li>\n<li><a href=\"/wiki/Ustekinumab\" title=\"Ustekinumab\">Ustekinumab</a></li></ul></li></ul>\n<ul><li><i><a href=\"/wiki/Interleukin_17\" title=\"Interleukin 17\">IL-17A</a></i>\n<ul><li><a href=\"/wiki/Secukinumab\" title=\"Secukinumab\">Secukinumab</a></li></ul></li></ul>\n</div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\">Cellular target</th><td class=\"navbox-list navbox-odd\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\n<ul><li><i><a href=\"/wiki/CD3_(immunology)\" title=\"CD3 (immunology)\">CD3</a></i>\n<ul><li><a href=\"/wiki/Muromonab-CD3\" title=\"Muromonab-CD3\">Muromonab-CD3</a></li>\n<li><a href=\"/wiki/Otelixizumab\" title=\"Otelixizumab\">Otelixizumab</a></li>\n<li><a href=\"/wiki/Teplizumab\" title=\"Teplizumab\">Teplizumab</a></li>\n<li><a href=\"/wiki/Visilizumab\" title=\"Visilizumab\">Visilizumab</a></li></ul></li>\n<li><i><a href=\"/wiki/CD4\" title=\"CD4\">CD4</a></i>\n<ul><li><a href=\"/wiki/Clenoliximab\" title=\"Clenoliximab\">Clenoliximab</a></li>\n<li><a href=\"/wiki/Keliximab\" title=\"Keliximab\">Keliximab</a></li>\n<li><a href=\"/wiki/Zanolimumab\" title=\"Zanolimumab\">Zanolimumab</a></li></ul></li>\n<li><i><a href=\"/wiki/CD11a\" class=\"mw-redirect\" title=\"CD11a\">CD11a</a></i>\n<ul><li><a href=\"/wiki/Efalizumab\" title=\"Efalizumab\">Efalizumab</a></li></ul></li>\n<li><i><a href=\"/wiki/CD18\" class=\"mw-redirect\" title=\"CD18\">CD18</a></i>\n<ul><li><a href=\"/wiki/Erlizumab\" title=\"Erlizumab\">Erlizumab</a></li></ul></li>\n<li><i><a href=\"/wiki/CD20\" title=\"CD20\">CD20</a></i>\n<ul><li><a href=\"/wiki/Obinutuzumab\" title=\"Obinutuzumab\">Obinutuzumab</a></li>\n<li><a href=\"/wiki/Rituximab\" title=\"Rituximab\">Rituximab</a></li>\n<li><a href=\"/wiki/Ocrelizumab\" title=\"Ocrelizumab\">Ocrelizumab</a></li>\n<li><a href=\"/wiki/Pascolizumab\" title=\"Pascolizumab\">Pascolizumab</a></li></ul></li>\n<li><i><a href=\"/wiki/CD23\" title=\"CD23\">CD23</a></i>\n<ul><li><a href=\"/wiki/Gomiliximab\" class=\"mw-redirect\" title=\"Gomiliximab\">Gomiliximab</a></li>\n<li><a href=\"/wiki/Lumiliximab\" title=\"Lumiliximab\">Lumiliximab</a></li></ul></li>\n<li><i><a href=\"/wiki/CD40_(protein)\" title=\"CD40 (protein)\">CD40</a></i>\n<ul><li><a href=\"/wiki/Teneliximab\" title=\"Teneliximab\">Teneliximab</a></li>\n<li><a href=\"/wiki/Toralizumab\" title=\"Toralizumab\">Toralizumab</a></li></ul></li>\n<li><i><a href=\"/wiki/L-selectin\" title=\"L-selectin\">CD62L/L-selectin</a></i>\n<ul><li><a href=\"/wiki/Aselizumab\" title=\"Aselizumab\">Aselizumab</a></li></ul></li>\n<li><i><a href=\"/wiki/CD80\" title=\"CD80\">CD80</a></i>\n<ul><li><a href=\"/wiki/Galiximab\" title=\"Galiximab\">Galiximab</a></li></ul></li>\n<li><i><a href=\"/wiki/Basigin\" title=\"Basigin\">CD147/Basigin</a></i>\n<ul><li><a href=\"/wiki/Gavilimomab\" title=\"Gavilimomab\">Gavilimomab</a></li></ul></li>\n<li><i><a href=\"/wiki/CD154\" title=\"CD154\">CD154</a></i>\n<ul><li><a href=\"/wiki/Ruplizumab\" title=\"Ruplizumab\">Ruplizumab</a></li></ul></li></ul>\n<ul><li><i>BLyS</i>\n<ul><li><a href=\"/wiki/Belimumab\" title=\"Belimumab\">Belimumab</a></li>\n<li><a href=\"/wiki/Blisibimod\" title=\"Blisibimod\">Blisibimod</a></li></ul></li>\n<li><i><a href=\"/wiki/CTLA-4\" title=\"CTLA-4\">CTLA-4</a></i>\n<ul><li><a href=\"/wiki/Ipilimumab\" title=\"Ipilimumab\">Ipilimumab</a></li>\n<li><a href=\"/wiki/Tremelimumab\" title=\"Tremelimumab\">Tremelimumab</a></li></ul></li>\n<li><i><a href=\"/wiki/Chloramphenicol_acetyltransferase\" title=\"Chloramphenicol acetyltransferase\">CAT</a></i>\n<ul><li><a href=\"/wiki/Bertilimumab\" title=\"Bertilimumab\">Bertilimumab</a></li>\n<li><a href=\"/wiki/Lerdelimumab\" title=\"Lerdelimumab\">Lerdelimumab</a></li>\n<li><a href=\"/wiki/Metelimumab\" title=\"Metelimumab\">Metelimumab</a></li></ul></li>\n<li><i><a href=\"/wiki/Integrin\" title=\"Integrin\">Integrin</a></i>\n<ul><li><a href=\"/wiki/Natalizumab\" title=\"Natalizumab\">Natalizumab</a></li></ul></li>\n<li><i><a href=\"/wiki/Interleukin-6_receptor\" title=\"Interleukin-6 receptor\">Interleukin-6 receptor</a></i>\n<ul><li><a href=\"/wiki/Tocilizumab\" title=\"Tocilizumab\">Tocilizumab</a></li></ul></li>\n<li><i><a href=\"/wiki/Lymphocyte_function-associated_antigen_1\" title=\"Lymphocyte function-associated antigen 1\">LFA-1</a></i>\n<ul><li><a href=\"/wiki/Odulimomab\" title=\"Odulimomab\">Odulimomab</a></li></ul></li></ul>\n<ul><li><i><a href=\"/wiki/IL-2_receptor\" title=\"IL-2 receptor\">IL-2 receptor/CD25</a></i>\n<ul><li><a href=\"/wiki/Basiliximab\" title=\"Basiliximab\">Basiliximab</a></li>\n<li><a href=\"/wiki/Daclizumab\" title=\"Daclizumab\">Daclizumab</a></li>\n<li><a href=\"/wiki/Inolimomab\" title=\"Inolimomab\">Inolimomab</a></li></ul></li></ul>\n<ul><li><i><a href=\"/wiki/T_cell\" title=\"T cell\">T-lymphocyte</a></i> (<a href=\"/wiki/Zolimomab_aritox\" title=\"Zolimomab aritox\">Zolimomab aritox</a>)</li></ul>\n</div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\">Unsorted</th><td class=\"navbox-list navbox-even\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\n<ul><li><a href=\"/wiki/Atorolimumab\" title=\"Atorolimumab\">Atorolimumab</a></li>\n<li><a href=\"/wiki/Cedelizumab\" title=\"Cedelizumab\">Cedelizumab</a></li>\n<li><a href=\"/wiki/Fontolizumab\" title=\"Fontolizumab\">Fontolizumab</a></li>\n<li><a href=\"/wiki/Maslimomab\" title=\"Maslimomab\">Maslimomab</a></li>\n<li><a href=\"/wiki/Morolimumab\" title=\"Morolimumab\">Morolimumab</a></li>\n<li><a href=\"/wiki/Pexelizumab\" title=\"Pexelizumab\">Pexelizumab</a></li>\n<li><a href=\"/wiki/Reslizumab\" title=\"Reslizumab\">Reslizumab</a></li>\n<li><a href=\"/wiki/Rovelizumab\" title=\"Rovelizumab\">Rovelizumab</a></li>\n<li><a href=\"/wiki/Siplizumab\" title=\"Siplizumab\">Siplizumab</a></li>\n<li><a href=\"/wiki/Talizumab\" title=\"Talizumab\">Talizumab</a></li>\n<li><a href=\"/wiki/Telimomab_aritox\" title=\"Telimomab aritox\">Telimomab aritox</a></li>\n<li><a href=\"/wiki/Vapaliximab\" title=\"Vapaliximab\">Vapaliximab</a></li>\n<li><a href=\"/wiki/Vepalimomab\" title=\"Vepalimomab\">Vepalimomab</a></li></ul>\n</div></td></tr></tbody></table><div></div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\"><a href=\"/wiki/Polyclonal_antibodies\" title=\"Polyclonal antibodies\">Polyclonal</a></th><td class=\"navbox-list navbox-odd\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\n<ul><li><a href=\"/wiki/Anti-thymocyte_globulin\" title=\"Anti-thymocyte globulin\">Anti-thymocyte globulin</a></li>\n<li><a href=\"/wiki/Anti-lymphocyte_globulin\" title=\"Anti-lymphocyte globulin\">Anti-lymphocyte globulin</a></li></ul>\n</div></td></tr></tbody></table><div></div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\">-cept (<a href=\"/wiki/Fusion_protein\" title=\"Fusion protein\">Fusion</a>)</th><td class=\"navbox-list navbox-even\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\n<ul><li><i><a href=\"/wiki/CTLA-4\" title=\"CTLA-4\">CTLA-4</a></i>\n<ul><li><a href=\"/wiki/Abatacept\" title=\"Abatacept\">Abatacept</a></li>\n<li><a href=\"/wiki/Belatacept\" title=\"Belatacept\">Belatacept</a></li></ul></li>\n<li><i><a href=\"/wiki/TNF_inhibitor\" title=\"TNF inhibitor\">TNF inhibitor</a></i>\n<ul><li><a href=\"/wiki/Etanercept\" title=\"Etanercept\">Etanercept</a></li>\n<li><a href=\"/wiki/Pegsunercept\" title=\"Pegsunercept\">Pegsunercept</a></li></ul></li>\n<li><a href=\"/wiki/Aflibercept\" title=\"Aflibercept\">Aflibercept</a></li>\n<li><a href=\"/wiki/Alefacept\" title=\"Alefacept\">Alefacept</a></li>\n<li><a href=\"/wiki/Rilonacept\" title=\"Rilonacept\">Rilonacept</a></li></ul>\n</div></td></tr></tbody></table><div></div></td></tr></tbody></table></div>\n<div role=\"navigation\" class=\"navbox\" aria-labelledby=\"Androgen_receptor_modulators\" style=\"padding:3px\"><table class=\"nowraplinks hlist collapsible collapsed navbox-inner\" style=\"border-spacing:0;background:transparent;color:inherit\"><tbody><tr><th scope=\"col\" class=\"navbox-title\" colspan=\"2\"><div class=\"plainlinks hlist navbar mini\"><ul><li class=\"nv-view\"><a href=\"/wiki/Template:Androgen_receptor_modulators\" title=\"Template:Androgen receptor modulators\"><abbr title=\"View this template\" style=\";;background:none transparent;border:none;-moz-box-shadow:none;-webkit-box-shadow:none;box-shadow:none; padding:0;\">v</abbr></a></li><li class=\"nv-talk\"><a href=\"/wiki/Template_talk:Androgen_receptor_modulators\" title=\"Template talk:Androgen receptor modulators\"><abbr title=\"Discuss this template\" style=\";;background:none transparent;border:none;-moz-box-shadow:none;-webkit-box-shadow:none;box-shadow:none; padding:0;\">t</abbr></a></li><li class=\"nv-edit\"><a class=\"external text\" href=\"//en.wikipedia.org/w/index.php?title=Template:Androgen_receptor_modulators&amp;action=edit\"><abbr title=\"Edit this template\" style=\";;background:none transparent;border:none;-moz-box-shadow:none;-webkit-box-shadow:none;box-shadow:none; padding:0;\">e</abbr></a></li></ul></div><div id=\"Androgen_receptor_modulators\" style=\"font-size:114%;margin:0 4em\"><a href=\"/wiki/Androgen_receptor\" title=\"Androgen receptor\">Androgen receptor</a> <a href=\"/wiki/Receptor_modulator\" title=\"Receptor modulator\">modulators</a></div></th></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%;text-align:center;\"><a href=\"/wiki/Androgen_receptor\" title=\"Androgen receptor\"><abbr title=\"Androgen receptor\">AR</abbr></a></th><td class=\"navbox-list navbox-odd\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\"></div><table class=\"nowraplinks navbox-subgroup\" style=\"border-spacing:0\"><tbody><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:6em;;text-align:center\">Agonists</th><td class=\"navbox-list navbox-odd\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;padding:0px\"><div style=\"padding:0em 0.25em\">\n<ul><li><i>Testosterone derivatives:</i> <a href=\"/wiki/4-Androstenediol\" title=\"4-Androstenediol\">4-Androstenediol</a></li>\n<li><a href=\"/wiki/4-Dehydroepiandrosterone\" title=\"4-Dehydroepiandrosterone\">4-Dehydroepiandrosterone (4-DHEA)</a></li>\n<li><a href=\"/wiki/4-Hydroxytestosterone\" title=\"4-Hydroxytestosterone\">4-Hydroxytestosterone</a></li>\n<li><a href=\"/w/index.php?title=4,17%CE%B1-Dimethyltestosterone&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"4,17\u03b1-Dimethyltestosterone (page does not exist)\">4,17\u03b1-Dimethyltestosterone</a></li>\n<li><a href=\"/wiki/5-Androstenedione\" title=\"5-Androstenedione\">5-Androstenedione</a></li>\n<li><a href=\"/wiki/11-Ketotestosterone\" title=\"11-Ketotestosterone\">11-Ketotestosterone</a></li>\n<li><a href=\"/wiki/11%CE%B2-Hydroxyandrostenedione\" title=\"11\u03b2-Hydroxyandrostenedione\">11\u03b2-Hydroxyandrostenedione</a></li>\n<li><a href=\"/wiki/Adrenosterone\" title=\"Adrenosterone\">Adrenosterone (11-ketoandrostenedione, 11-oxoandrostenedione)</a></li>\n<li><a href=\"/wiki/5-Androstenediol\" class=\"mw-redirect\" title=\"5-Androstenediol\">Androstenediol (5-androstenediol)</a>\n<ul><li><a href=\"/wiki/Androstenediol_3%CE%B2-acetate\" title=\"Androstenediol 3\u03b2-acetate\">Androstenediol 3\u03b2-acetate</a></li>\n<li><a href=\"/wiki/Androstenediol_17%CE%B2-acetate\" title=\"Androstenediol 17\u03b2-acetate\">Androstenediol 17\u03b2-acetate</a></li>\n<li><a href=\"/wiki/Androstenediol_diacetate\" title=\"Androstenediol diacetate\">Androstenediol diacetate</a></li>\n<li><a href=\"/wiki/Androstenediol_dipropionate\" title=\"Androstenediol dipropionate\">Androstenediol dipropionate</a></li></ul></li>\n<li><a href=\"/wiki/4-Androstenedione\" class=\"mw-redirect\" title=\"4-Androstenedione\">Androstenedione (4-androstenedione)</a></li>\n<li><a href=\"/wiki/Atamestane\" title=\"Atamestane\">Atamestane</a></li>\n<li><a href=\"/wiki/Boldenone\" title=\"Boldenone\">Boldenone</a>\n<ul><li><a href=\"/wiki/Boldenone_undecylenate\" title=\"Boldenone undecylenate\">Boldenone undecylenate</a></li></ul></li>\n<li><a href=\"/wiki/Boldione\" title=\"Boldione\">Boldione (1,4-androstadienedione)</a></li>\n<li><a href=\"/wiki/Clostebol\" title=\"Clostebol\">Clostebol</a>\n<ul><li><a href=\"/wiki/Clostebol_acetate\" title=\"Clostebol acetate\">Clostebol acetate</a></li>\n<li><a href=\"/wiki/Clostebol_caproate\" title=\"Clostebol caproate\">Clostebol caproate</a></li>\n<li><a href=\"/wiki/Clostebol_propionate\" title=\"Clostebol propionate\">Clostebol propionate</a></li></ul></li>\n<li><a href=\"/wiki/Cloxotestosterone\" title=\"Cloxotestosterone\">Cloxotestosterone</a>\n<ul><li><a href=\"/wiki/Cloxotestosterone_acetate\" title=\"Cloxotestosterone acetate\">Cloxotestosterone acetate</a></li></ul></li>\n<li><a href=\"/wiki/Dehydroandrosterone\" title=\"Dehydroandrosterone\">Dehydroandrosterone</a></li>\n<li><a href=\"/wiki/Dehydroepiandrosterone\" title=\"Dehydroepiandrosterone\">DHEA (androstenolone, prasterone; 5-DHEA)</a>\n<ul><li><a href=\"/wiki/Prasterone_enanthate\" title=\"Prasterone enanthate\">DHEA enanthate (prasterone enanthate)</a></li>\n<li><a href=\"/wiki/Dehydroepiandrosterone_sulfate\" title=\"Dehydroepiandrosterone sulfate\">DHEA sulfate</a></li></ul></li>\n<li><a href=\"/wiki/Exemestane\" title=\"Exemestane\">Exemestane</a></li>\n<li><a href=\"/wiki/Formestane\" title=\"Formestane\">Formestane</a></li>\n<li><a href=\"/wiki/Plomestane\" title=\"Plomestane\">Plomestane</a></li>\n<li><a href=\"/wiki/Quinbolone\" title=\"Quinbolone\">Quinbolone</a></li>\n<li><a href=\"/wiki/Silandrone\" title=\"Silandrone\">Silandrone</a></li>\n<li><a href=\"/wiki/Testosterone_(medication)\" title=\"Testosterone (medication)\">Testosterone</a><sup>#</sup> (<a href=\"/wiki/Testosterone/dutasteride\" title=\"Testosterone/dutasteride\">+dutasteride</a>)\n<ul><li><a href=\"/wiki/List_of_androgen_esters#Testosterone_esters\" title=\"List of androgen esters\">Testosterone esters</a></li>\n<li><a href=\"/wiki/Polytestosterone_phloretin_phosphate\" title=\"Polytestosterone phloretin phosphate\">Polytestosterone phloretin phosphate</a></li></ul></li></ul>\n<ul><li><i>Dihydrotestosterone derivatives:</i> <a href=\"/wiki/1-Androstenediol\" title=\"1-Androstenediol\">1-Androstenediol</a></li>\n<li><a href=\"/wiki/1-Androstenedione\" title=\"1-Androstenedione\">1-Androstenedione</a></li>\n<li><a href=\"/wiki/1-Androsterone\" title=\"1-Androsterone\">1-Androsterone (1-andro, 1-DHEA)</a></li>\n<li><a href=\"/wiki/1-Testosterone\" title=\"1-Testosterone\">1-Testosterone</a></li>\n<li><a href=\"/wiki/3%CE%B1-Androstanediol\" title=\"3\u03b1-Androstanediol\">3\u03b1-Androstanediol</a></li>\n<li><a href=\"/wiki/5%CE%B1-Androst-2-en-17-one\" class=\"mw-redirect\" title=\"5\u03b1-Androst-2-en-17-one\">5\u03b1-Androst-2-en-17-one</a></li>\n<li><a href=\"/wiki/7%CE%B2-Hydroxyepiandrosterone\" title=\"7\u03b2-Hydroxyepiandrosterone\">7\u03b2-Hydroxyepiandrosterone</a></li>\n<li><a href=\"/wiki/11-Ketodihydrotestosterone\" title=\"11-Ketodihydrotestosterone\">11-Ketodihydrotestosterone</a></li>\n<li><a href=\"/wiki/Androsterone\" title=\"Androsterone\">Androsterone</a></li>\n<li><a href=\"/wiki/Bolazine\" title=\"Bolazine\">Bolazine</a>\n<ul><li><a href=\"/wiki/Bolazine_capronate\" title=\"Bolazine capronate\">Bolazine capronate</a></li></ul></li>\n<li><a href=\"/wiki/Dihydroethisterone\" class=\"mw-redirect\" title=\"Dihydroethisterone\">Dihydroethisterone</a></li>\n<li><a href=\"/w/index.php?title=Dihydroethyltestosterone&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"Dihydroethyltestosterone (page does not exist)\">Dihydroethyltestosterone</a></li>\n<li><a href=\"/wiki/Dihydrofluoxymesterone\" title=\"Dihydrofluoxymesterone\">Dihydrofluoxymesterone</a></li>\n<li><a href=\"/w/index.php?title=Dihydromethylandrostenediol&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"Dihydromethylandrostenediol (page does not exist)\">Dihydromethylandrostenediol</a></li>\n<li><a href=\"/wiki/Dihydrotestosterone\" title=\"Dihydrotestosterone\">Dihydrotestosterone (DHT)</a> (<a href=\"/wiki/Androstanolone\" title=\"Androstanolone\">androstanolone, stanolone</a>)\n<ul><li><a href=\"/wiki/List_of_androgen_esters#Dihydrotestosterone_esters\" title=\"List of androgen esters\">Dihydrotestosterone esters</a></li></ul></li>\n<li><a href=\"/wiki/Drostanolone\" title=\"Drostanolone\">Drostanolone</a>\n<ul><li><a href=\"/wiki/Drostanolone_propionate\" title=\"Drostanolone propionate\">Drostanolone propionate</a></li></ul></li>\n<li><a href=\"/wiki/Epiandrosterone\" title=\"Epiandrosterone\">Epiandrosterone</a></li>\n<li><a href=\"/wiki/Epitiostanol\" title=\"Epitiostanol\">Epitiostanol</a></li>\n<li><a href=\"/wiki/Mepitiostane\" title=\"Mepitiostane\">Mepitiostane</a></li>\n<li><a href=\"/wiki/Mesabolone\" title=\"Mesabolone\">Mesabolone</a></li>\n<li><a href=\"/wiki/Mesterolone\" title=\"Mesterolone\">Mesterolone</a>\n<ul><li><a href=\"/wiki/Mesterolone_cipionate\" title=\"Mesterolone cipionate\">Mesterolone cipionate</a></li></ul></li>\n<li><a href=\"/wiki/Methyldiazinol\" title=\"Methyldiazinol\">Methyldiazinol</a></li>\n<li><a href=\"/wiki/Nisterime\" title=\"Nisterime\">Nisterime</a>\n<ul><li><a href=\"/wiki/Nisterime_acetate\" title=\"Nisterime acetate\">Nisterime acetate</a></li></ul></li>\n<li><a href=\"/wiki/Prostanozol\" title=\"Prostanozol\">Prostanozol</a></li>\n<li><a href=\"/wiki/Stenbolone\" title=\"Stenbolone\">Stenbolone</a>\n<ul><li><a href=\"/wiki/Stenbolone_acetate\" title=\"Stenbolone acetate\">Stenbolone acetate</a></li></ul></li>\n<li><a href=\"/wiki/Testifenon\" title=\"Testifenon\">Testifenon (testiphenon, testiphenone)</a></li></ul>\n<ul><li><i>19-Nortestosterone derivatives:</i> <a href=\"/wiki/7%CE%B1-Methyl-19-norandrostenedione\" title=\"7\u03b1-Methyl-19-norandrostenedione\">7\u03b1-Methyl-19-norandrostenedione (MENT dione, trestione)</a></li>\n<li><a href=\"/wiki/11%CE%B2-Methyl-19-nortestosterone\" title=\"11\u03b2-Methyl-19-nortestosterone\">11\u03b2-Methyl-19-nortestosterone</a>\n<ul><li><a href=\"/wiki/11%CE%B2-Methyl-19-nortestosterone_dodecylcarbonate\" title=\"11\u03b2-Methyl-19-nortestosterone dodecylcarbonate\">11\u03b2-Methyl-19-nortestosterone dodecylcarbonate</a></li></ul></li>\n<li><a href=\"/wiki/19-Nor-5-androstenediol\" title=\"19-Nor-5-androstenediol\">19-Nor-5-androstenediol</a></li>\n<li><a href=\"/wiki/19-Nor-5-androstenedione\" title=\"19-Nor-5-androstenedione\">19-Nor-5-androstenedione</a></li>\n<li><a href=\"/wiki/19-Nordehydroepiandrosterone\" title=\"19-Nordehydroepiandrosterone\">19-Nordehydroepiandrosterone</a></li>\n<li><a href=\"/wiki/Bolandiol\" title=\"Bolandiol\">Bolandiol</a>\n<ul><li><a href=\"/wiki/Bolandiol_dipropionate\" title=\"Bolandiol dipropionate\">Bolandiol dipropionate</a></li></ul></li>\n<li><a href=\"/wiki/Bolandione\" title=\"Bolandione\">Bolandione (19-nor-4-androstenedione)</a></li>\n<li><a href=\"/wiki/Bolmantalate\" title=\"Bolmantalate\">Bolmantalate (nandrolone adamantoate)</a></li>\n<li><a href=\"/wiki/Dienedione\" title=\"Dienedione\">Dienedione</a></li>\n<li><a href=\"/wiki/Dienolone\" title=\"Dienolone\">Dienolone</a></li>\n<li><a href=\"/wiki/Dimethandrolone\" title=\"Dimethandrolone\">Dimethandrolone</a>\n<ul><li><a href=\"/wiki/Dimethandrolone_buciclate\" title=\"Dimethandrolone buciclate\">Dimethandrolone buciclate</a></li>\n<li><a href=\"/wiki/Dimethandrolone_dodecylcarbonate\" title=\"Dimethandrolone dodecylcarbonate\">Dimethandrolone dodecylcarbonate</a></li>\n<li><a href=\"/wiki/Dimethandrolone_undecanoate\" title=\"Dimethandrolone undecanoate\">Dimethandrolone undecanoate</a></li></ul></li>\n<li><a href=\"/wiki/LS-1727\" title=\"LS-1727\">LS-1727 (nandrolone 17\u03b2-<i>N</i>-(2-chloroethyl)-<i>N</i>-nitrosocarbamate)</a></li>\n<li><a href=\"/wiki/Methoxydienone\" title=\"Methoxydienone\">Methoxydienone (methoxygonadiene)</a></li>\n<li><a href=\"/wiki/Nandrolone\" title=\"Nandrolone\">Nandrolone</a>\n<ul><li><a href=\"/wiki/List_of_androgen_esters#Nandrolone_esters\" title=\"List of androgen esters\">Nandrolone esters</a></li></ul></li>\n<li><a href=\"/wiki/Norclostebol\" title=\"Norclostebol\">Norclostebol</a>\n<ul><li><a href=\"/wiki/Norclostebol_acetate\" title=\"Norclostebol acetate\">Norclostebol acetate</a></li></ul></li>\n<li><a href=\"/wiki/Normethandrone\" title=\"Normethandrone\">Normethandrone (methylestrenolone, normethisterone)</a></li>\n<li><a href=\"/wiki/Oxabolone\" title=\"Oxabolone\">Oxabolone</a>\n<ul><li><a href=\"/wiki/Oxabolone_cipionate\" title=\"Oxabolone cipionate\">Oxabolone cipionate (oxabolone cypionate)</a></li></ul></li>\n<li><a href=\"/wiki/Trenbolone\" title=\"Trenbolone\">Trenbolone</a>\n<ul><li><a href=\"/wiki/Trenbolone_acetate\" title=\"Trenbolone acetate\">Trenbolone acetate</a></li>\n<li><a href=\"/wiki/Trenbolone_enanthate\" title=\"Trenbolone enanthate\">Trenbolone enanthate</a></li>\n<li><a href=\"/wiki/Trenbolone_hexahydrobenzylcarbonate\" title=\"Trenbolone hexahydrobenzylcarbonate\">Trenbolone hexahydrobenzylcarbonate</a></li>\n<li><a href=\"/wiki/Trenbolone_undecanoate\" title=\"Trenbolone undecanoate\">Trenbolone undecanoate</a></li></ul></li>\n<li><a href=\"/wiki/Trendione\" title=\"Trendione\">Trendione</a></li>\n<li><a href=\"/wiki/Trestolone\" title=\"Trestolone\">Trestolone (MENT)</a>\n<ul><li><a href=\"/wiki/Trestolone_acetate\" title=\"Trestolone acetate\">Trestolone acetate</a></li>\n<li><a href=\"/wiki/Trestolone_enanthate\" title=\"Trestolone enanthate\">Trestolone enanthate</a></li></ul></li></ul>\n<ul><li><i>Dihydrotestosterone and 19-nortestosterone derivatives:</i> <a href=\"/wiki/5%CE%B1-Dihydrolevonorgestrel\" title=\"5\u03b1-Dihydrolevonorgestrel\">5\u03b1-Dihydrolevonorgestrel</a></li>\n<li><a href=\"/wiki/5%CE%B1-Dihydronandrolone\" title=\"5\u03b1-Dihydronandrolone\">5\u03b1-Dihydronandrolone</a></li>\n<li><a href=\"/wiki/5%CE%B1-Dihydronorethandrolone\" title=\"5\u03b1-Dihydronorethandrolone\">5\u03b1-Dihydronorethandrolone</a></li>\n<li><a href=\"/wiki/5%CE%B1-Dihydronorethisterone\" title=\"5\u03b1-Dihydronorethisterone\">5\u03b1-Dihydronorethisterone</a></li>\n<li><a href=\"/wiki/5%CE%B1-Dihydronormethandrone\" title=\"5\u03b1-Dihydronormethandrone\">5\u03b1-Dihydronormethandrone</a></li>\n<li><a href=\"/w/index.php?title=5%CE%B1-Dihydrotrestolone&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"5\u03b1-Dihydrotrestolone (page does not exist)\">5\u03b1-Dihydrotrestolone</a></li>\n<li><a href=\"/wiki/19-Norandrosterone\" title=\"19-Norandrosterone\">19-Norandrosterone</a></li></ul>\n<ul><li><i>17\u03b1-Alkylated testosterone derivatives:</i> <a href=\"/wiki/Bolasterone\" title=\"Bolasterone\">Bolasterone</a></li>\n<li><a href=\"/wiki/Calusterone\" title=\"Calusterone\">Calusterone</a></li>\n<li><a href=\"/wiki/Chlorodehydromethylandrostenediol\" title=\"Chlorodehydromethylandrostenediol\">Chlorodehydromethylandrostenediol (CDMA)</a></li>\n<li><a href=\"/wiki/Chlorodehydromethyltestosterone\" title=\"Chlorodehydromethyltestosterone\">Chlorodehydromethyltestosterone (CDMT)</a></li>\n<li><a href=\"/wiki/Chloromethylandrostenediol\" title=\"Chloromethylandrostenediol\">Chloromethylandrostenediol (CMA)</a></li>\n<li><a href=\"/wiki/Enestebol\" title=\"Enestebol\">Enestebol</a></li>\n<li><a href=\"/wiki/Ethyltestosterone\" title=\"Ethyltestosterone\">Ethyltestosterone</a></li>\n<li><a href=\"/wiki/Fluoxymesterone\" title=\"Fluoxymesterone\">Fluoxymesterone</a></li>\n<li><a href=\"/wiki/Formebolone\" title=\"Formebolone\">Formebolone</a></li>\n<li><a href=\"/wiki/Hydroxystenozole\" title=\"Hydroxystenozole\">Hydroxystenozole</a></li>\n<li><a href=\"/wiki/Metandienone\" title=\"Metandienone\">Metandienone (methandrostenolone)</a></li>\n<li><a href=\"/wiki/Methandriol\" title=\"Methandriol\">Methandriol (methylandrostenediol)</a>\n<ul><li><a href=\"/wiki/Methandriol_bisenanthoyl_acetate\" title=\"Methandriol bisenanthoyl acetate\">Methandriol bisenanthoyl acetate</a></li>\n<li><a href=\"/wiki/Methandriol_diacetate\" title=\"Methandriol diacetate\">Methandriol diacetate</a></li>\n<li><a href=\"/wiki/Methandriol_dipropionate\" title=\"Methandriol dipropionate\">Methandriol dipropionate</a></li>\n<li><a href=\"/wiki/Methandriol_propionate\" title=\"Methandriol propionate\">Methandriol propionate</a></li></ul></li>\n<li><a href=\"/wiki/Methylclostebol\" title=\"Methylclostebol\">Methylclostebol (chloromethyltestosterone)</a></li>\n<li><a href=\"/wiki/Methyltestosterone\" title=\"Methyltestosterone\">Methyltestosterone</a> (<a href=\"/wiki/Esterified_estrogens/methyltestosterone\" title=\"Esterified estrogens/methyltestosterone\">+esterified estrogens</a>)\n<ul><li><a href=\"/wiki/Methyltestosterone_3-hexyl_ether\" title=\"Methyltestosterone 3-hexyl ether\">Methyltestosterone 3-hexyl ether</a></li></ul></li>\n<li><a href=\"/wiki/Oxymesterone\" title=\"Oxymesterone\">Oxymesterone</a></li>\n<li><a href=\"/wiki/Penmesterol\" title=\"Penmesterol\">Penmesterol</a></li>\n<li><a href=\"/wiki/Tiomesterone\" title=\"Tiomesterone\">Tiomesterone</a></li></ul>\n<ul><li><i>17\u03b1-Alkylated dihydrotestosterone derivatives:</i> <a href=\"/wiki/Androisoxazole\" title=\"Androisoxazole\">Androisoxazole</a></li>\n<li><a href=\"/wiki/Desoxymethyltestosterone\" title=\"Desoxymethyltestosterone\">Desoxymethyltestosterone</a></li>\n<li><a href=\"/wiki/Furazabol\" title=\"Furazabol\">Furazabol</a></li>\n<li><a href=\"/wiki/Mebolazine\" title=\"Mebolazine\">Mebolazine (dimethazine)</a></li>\n<li><a href=\"/wiki/Mestanolone\" title=\"Mestanolone\">Mestanolone</a></li>\n<li><a href=\"/wiki/Metenolone\" title=\"Metenolone\">Metenolone</a>\n<ul><li><a href=\"/wiki/Metenolone_acetate\" title=\"Metenolone acetate\">Metenolone acetate</a></li>\n<li><a href=\"/wiki/Metenolone_enanthate\" title=\"Metenolone enanthate\">Metenolone enanthate</a></li></ul></li>\n<li><a href=\"/wiki/Methasterone\" title=\"Methasterone\">Methasterone</a></li>\n<li><a href=\"/wiki/Methyl-1-testosterone\" title=\"Methyl-1-testosterone\">Methyl-1-testosterone</a></li>\n<li><a href=\"/wiki/Methylepitiostanol\" title=\"Methylepitiostanol\">Methylepitiostanol</a></li>\n<li><a href=\"/wiki/Methylstenbolone\" title=\"Methylstenbolone\">Methylstenbolone</a></li>\n<li><a href=\"/wiki/Oxandrolone\" title=\"Oxandrolone\">Oxandrolone</a></li>\n<li><a href=\"/wiki/Oxymetholone\" title=\"Oxymetholone\">Oxymetholone</a></li>\n<li><a href=\"/wiki/Stanozolol\" title=\"Stanozolol\">Stanozolol</a></li></ul>\n<ul><li><i>17\u03b1-Alkylated 19-nortestosterone derivatives:</i> <a href=\"/wiki/Bolenol\" title=\"Bolenol\">Bolenol</a></li>\n<li><a href=\"/wiki/Dimethyldienolone\" title=\"Dimethyldienolone\">Dimethyldienolone</a></li>\n<li><a href=\"/wiki/Dimethyltrienolone\" title=\"Dimethyltrienolone\">Dimethyltrienolone</a></li>\n<li><a href=\"/wiki/Ethyldienolone\" title=\"Ethyldienolone\">Ethyldienolone</a></li>\n<li><a href=\"/wiki/Ethylestrenol\" title=\"Ethylestrenol\">Ethylestrenol</a></li>\n<li><a href=\"/wiki/Methyldienolone\" title=\"Methyldienolone\">Methyldienolone</a></li>\n<li><a href=\"/wiki/Methylhydroxynandrolone\" title=\"Methylhydroxynandrolone\">Methylhydroxynandrolone (MOHN, MHN)</a></li>\n<li><a href=\"/wiki/Metribolone\" title=\"Metribolone\">Metribolone</a></li>\n<li><a href=\"/wiki/Mibolerone\" title=\"Mibolerone\">Mibolerone</a></li>\n<li><a href=\"/wiki/Norboletone\" title=\"Norboletone\">Norboletone</a></li>\n<li><a href=\"/wiki/Norethandrolone\" title=\"Norethandrolone\">Norethandrolone</a></li>\n<li><a href=\"/wiki/Propetandrol\" title=\"Propetandrol\">Propetandrol</a></li>\n<li><a href=\"/wiki/RU-2309\" title=\"RU-2309\">RU-2309</a></li>\n<li><a href=\"/wiki/Tetrahydrogestrinone\" title=\"Tetrahydrogestrinone\">Tetrahydrogestrinone</a></li></ul>\n<ul><li><i>17\u03b1-Vinyltestosterone derivatives:</i> <a href=\"/wiki/Norvinisterone\" title=\"Norvinisterone\">Norvinisterone (vinylnortestosterone)</a></li>\n<li><a href=\"/wiki/Vinyltestosterone\" title=\"Vinyltestosterone\">Vinyltestosterone</a></li></ul>\n<ul><li><i>17\u03b1-Ethynyltestosterone derivatives:</i> <a href=\"/wiki/%CE%944-Tibolone\" title=\"\u03944-Tibolone\">\u0394<sup>4</sup>-Tibolone</a></li>\n<li><a href=\"/wiki/Danazol\" title=\"Danazol\">Danazol</a></li>\n<li><a href=\"/wiki/Desogestrel\" title=\"Desogestrel\">Desogestrel</a></li>\n<li><a href=\"/wiki/Ethisterone\" title=\"Ethisterone\">Ethisterone (ethynyltestosterone)</a></li>\n<li><a href=\"/wiki/Etonogestrel\" title=\"Etonogestrel\">Etonogestrel</a></li>\n<li><a href=\"/wiki/Etynodiol\" title=\"Etynodiol\">Etynodiol</a></li>\n<li><a href=\"/wiki/Etynodiol_diacetate\" title=\"Etynodiol diacetate\">Etynodiol diacetate</a></li>\n<li><a href=\"/wiki/Gestodene\" title=\"Gestodene\">Gestodene</a></li>\n<li><a href=\"/wiki/Gestrinone\" title=\"Gestrinone\">Gestrinone</a></li>\n<li><a href=\"/wiki/Levonorgestrel\" title=\"Levonorgestrel\">Levonorgestrel</a></li>\n<li><a href=\"/wiki/Levonorgestrel_ester\" class=\"mw-redirect\" title=\"Levonorgestrel ester\">Levonorgestrel esters</a> (e.g., <a href=\"/wiki/Levonorgestrel_butanoate\" title=\"Levonorgestrel butanoate\">levonorgestrel butanoate</a>)</li>\n<li><a href=\"/wiki/Lynestrenol\" title=\"Lynestrenol\">Lynestrenol</a></li>\n<li><a href=\"/wiki/Lynestrenol_phenylpropionate\" title=\"Lynestrenol phenylpropionate\">Lynestrenol phenylpropionate</a></li>\n<li><a href=\"/wiki/Norethisterone\" title=\"Norethisterone\">Norethisterone</a></li>\n<li><a href=\"/wiki/Norethisterone_ester\" class=\"mw-redirect\" title=\"Norethisterone ester\">Norethisterone esters</a> (e.g., <a href=\"/wiki/Norethisterone_acetate\" title=\"Norethisterone acetate\">norethisterone acetate</a>, <a href=\"/wiki/Norethisterone_enanthate\" title=\"Norethisterone enanthate\">norethisterone enanthate</a>)</li>\n<li><a href=\"/wiki/Norgestrel\" title=\"Norgestrel\">Norgestrel</a></li>\n<li><a href=\"/wiki/Norgestrienone\" title=\"Norgestrienone\">Norgestrienone</a></li>\n<li><a href=\"/wiki/Quingestanol\" title=\"Quingestanol\">Quingestanol</a></li>\n<li><a href=\"/wiki/Quingestanol_acetate\" title=\"Quingestanol acetate\">Quingestanol acetate</a></li>\n<li><a href=\"/wiki/Tibolone\" title=\"Tibolone\">Tibolone</a></li></ul>\n<ul><li><i>Progesterone derivatives:</i> <a href=\"/wiki/Medroxyprogesterone_acetate\" title=\"Medroxyprogesterone acetate\">Medroxyprogesterone acetate</a></li>\n<li><a href=\"/wiki/Megestrol_acetate\" title=\"Megestrol acetate\">Megestrol acetate</a></li></ul>\n<ul><li><i>Others/unsorted:</i> <a href=\"/wiki/3-Keto-5%CE%B1-abiraterone\" title=\"3-Keto-5\u03b1-abiraterone\">3-Keto-5\u03b1-abiraterone</a></li>\n<li><a href=\"/wiki/5%CE%B1-Androstane\" class=\"mw-redirect\" title=\"5\u03b1-Androstane\">5\u03b1-Androstane</a></li>\n<li><a href=\"/wiki/Alternariol\" title=\"Alternariol\">Alternariol</a></li>\n<li><a href=\"/wiki/Cl-4AS-1\" title=\"Cl-4AS-1\">Cl-4AS-1</a></li>\n<li><a href=\"/wiki/Drupanol\" title=\"Drupanol\">Drupanol</a></li>\n<li><a href=\"/wiki/ZM-182345\" title=\"ZM-182345\">ZM-182345</a></li></ul>\n</div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:6em;;text-align:center\">Mixed<br />(<a href=\"/wiki/Selective_androgen_receptor_modulator\" title=\"Selective androgen receptor modulator\"><abbr title=\"Selective androgen receptor modulator\">SARMs</abbr></a>)</th><td class=\"navbox-list navbox-even\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;padding:0px\"><div style=\"padding:0em 0.25em\">\n<ul><li><i>Nonsteroidal:</i> <a href=\"/w/index.php?title=198RL26&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"198RL26 (page does not exist)\">198RL26</a></li>\n<li><a href=\"/w/index.php?title=ACP-105&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"ACP-105 (page does not exist)\">ACP-105</a></li>\n<li><a href=\"/w/index.php?title=AC-262536&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"AC-262536 (page does not exist)\">AC-262536</a></li>\n<li><a href=\"/wiki/Acetothiolutamide\" title=\"Acetothiolutamide\">Acetothiolutamide</a></li>\n<li><a href=\"/wiki/Andarine\" title=\"Andarine\">Andarine (acetamidoxolutamide, androxolutamide, GTx-007, S-4)</a></li>\n<li><a href=\"/w/index.php?title=BMS-564929&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"BMS-564929 (page does not exist)\">BMS-564929</a></li>\n<li><a href=\"/w/index.php?title=DTIB&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"DTIB (page does not exist)\">DTIB</a></li>\n<li><a href=\"/wiki/Enobosarm\" title=\"Enobosarm\">Enobosarm (ostarine, MK-2866, GTx-024, S-22)</a></li>\n<li><a href=\"/w/index.php?title=FTBU-1&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"FTBU-1 (page does not exist)\">FTBU-1</a></li>\n<li><a href=\"/w/index.php?title=GSK-4336A&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"GSK-4336A (page does not exist)\">GSK-4336A</a></li>\n<li><a href=\"/w/index.php?title=GSK-8698&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"GSK-8698 (page does not exist)\">GSK-8698</a></li>\n<li><a href=\"/wiki/LG-121071\" title=\"LG-121071\">LG-121071 (LGD-121071)</a></li>\n<li><a href=\"/wiki/LGD-2226\" title=\"LGD-2226\">LGD-2226</a></li>\n<li><a href=\"/w/index.php?title=LGD-2941&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"LGD-2941 (page does not exist)\">LGD-2941 (LGD-122941)</a></li>\n<li><a href=\"/wiki/LGD-3303\" title=\"LGD-3303\">LGD-3303</a></li>\n<li><a href=\"/wiki/LGD-4033\" title=\"LGD-4033\">LGD-4033</a></li>\n<li><a href=\"/w/index.php?title=JNJ-26146900&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"JNJ-26146900 (page does not exist)\">JNJ-26146900</a></li>\n<li><a href=\"/w/index.php?title=JNJ-28330835&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"JNJ-28330835 (page does not exist)\">JNJ-28330835</a></li>\n<li><a href=\"/w/index.php?title=JNJ-37654032&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"JNJ-37654032 (page does not exist)\">JNJ-37654032</a></li>\n<li><a href=\"/w/index.php?title=ORM-11984&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"ORM-11984 (page does not exist)\">ORM-11984</a></li>\n<li><a href=\"/w/index.php?title=R-1_(drug)&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"R-1 (drug) (page does not exist)\">R-1</a></li>\n<li><a href=\"/wiki/RAD140\" title=\"RAD140\">RAD140</a></li>\n<li><a href=\"/wiki/RU-59063\" title=\"RU-59063\">RU-59063</a></li>\n<li><a href=\"/w/index.php?title=S-1_(drug)&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"S-1 (drug) (page does not exist)\">S-1</a></li>\n<li><a href=\"/wiki/S-23_(drug)\" title=\"S-23 (drug)\">S-23</a></li>\n<li><a href=\"/wiki/S-40503\" title=\"S-40503\">S-40503</a></li>\n<li><a href=\"/w/index.php?title=S-101479&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"S-101479 (page does not exist)\">S-101479</a></li>\n<li><a href=\"/wiki/Triclosan\" title=\"Triclosan\">Triclosan</a></li></ul>\n<ul><li><i>Steroidal:</i> <a href=\"/w/index.php?title=EM-9017&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"EM-9017 (page does not exist)\">EM-9017</a></li>\n<li><a href=\"/wiki/MK-0773\" title=\"MK-0773\">MK-0773</a></li>\n<li><a href=\"/wiki/TFM-4AS-1\" title=\"TFM-4AS-1\">TFM-4AS-1</a></li>\n<li><a href=\"/wiki/YK-11\" title=\"YK-11\">YK-11</a></li></ul>\n</div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:6em;;text-align:center\">Antagonists</th><td class=\"navbox-list navbox-odd\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;padding:0px\"><div style=\"padding:0em 0.25em\">\n<ul><li><i>Steroidal:</i> <a href=\"/wiki/7%CE%B1-Thioprogesterone\" title=\"7\u03b1-Thioprogesterone\">7\u03b1-Thioprogesterone</a></li>\n<li><a href=\"/wiki/7%CE%B1-Thiospironolactone\" title=\"7\u03b1-Thiospironolactone\">7\u03b1-Thiospironolactone</a></li>\n<li><a href=\"/wiki/7%CE%B1-Thiomethylspironolactone\" title=\"7\u03b1-Thiomethylspironolactone\">7\u03b1-Thiomethylspironolactone</a></li>\n<li><a href=\"/wiki/11%CE%B1-Hydroxyprogesterone\" title=\"11\u03b1-Hydroxyprogesterone\">11\u03b1-Hydroxyprogesterone</a></li>\n<li><a href=\"/wiki/15%CE%B2-Hydroxycyproterone_acetate\" title=\"15\u03b2-Hydroxycyproterone acetate\">15\u03b2-Hydroxycyproterone acetate</a></li>\n<li><a href=\"/wiki/Abiraterone\" title=\"Abiraterone\">Abiraterone</a></li>\n<li><a href=\"/wiki/Abiraterone_acetate\" title=\"Abiraterone acetate\">Abiraterone acetate</a></li>\n<li><a href=\"/wiki/Allyltestosterone\" title=\"Allyltestosterone\">Allyltestosterone</a></li>\n<li><a href=\"/wiki/Benorterone\" title=\"Benorterone\">Benorterone</a></li>\n<li><a href=\"/wiki/BOMT\" title=\"BOMT\">BOMT</a></li>\n<li><a href=\"/wiki/Canrenoic_acid\" title=\"Canrenoic acid\">Canrenoic acid</a></li>\n<li><a href=\"/wiki/Canrenone\" title=\"Canrenone\">Canrenone</a></li>\n<li><a href=\"/wiki/Chlormadinone_acetate\" title=\"Chlormadinone acetate\">Chlormadinone acetate</a></li>\n<li><a href=\"/wiki/Clascoterone\" title=\"Clascoterone\">Clascoterone</a></li>\n<li><a href=\"/wiki/Clometerone\" title=\"Clometerone\">Clometerone</a></li>\n<li><a href=\"/wiki/Cyproheptadine\" title=\"Cyproheptadine\">Cyproheptadine</a></li>\n<li><a href=\"/wiki/Cyproterone\" title=\"Cyproterone\">Cyproterone</a></li>\n<li><a href=\"/wiki/Cyproterone_acetate\" title=\"Cyproterone acetate\">Cyproterone acetate</a></li>\n<li><a href=\"/wiki/Delanterone\" title=\"Delanterone\">Delanterone</a></li>\n<li><a href=\"/wiki/Delmadinone_acetate\" title=\"Delmadinone acetate\">Delmadinone acetate</a></li>\n<li><a href=\"/wiki/Dicirenone\" title=\"Dicirenone\">Dicirenone</a></li>\n<li><a href=\"/wiki/Dienogest\" title=\"Dienogest\">Dienogest</a></li>\n<li><a href=\"/wiki/Drospirenone\" title=\"Drospirenone\">Drospirenone</a></li>\n<li><a href=\"/wiki/DU-41165\" title=\"DU-41165\">DU-41165</a></li>\n<li><a href=\"/wiki/Edogestrone\" title=\"Edogestrone\">Edogestrone</a></li>\n<li><a href=\"/w/index.php?title=EM-4350&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"EM-4350 (page does not exist)\">EM-4350</a></li>\n<li><a href=\"/wiki/EM-5854\" title=\"EM-5854\">EM-5854</a></li>\n<li><a href=\"/w/index.php?title=EM-5855&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"EM-5855 (page does not exist)\">EM-5855</a></li>\n<li><a href=\"/w/index.php?title=EM-6537&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"EM-6537 (page does not exist)\">EM-6537</a></li>\n<li><a href=\"/wiki/Epitestosterone\" title=\"Epitestosterone\">Epitestosterone</a></li>\n<li><a href=\"/wiki/Galeterone\" title=\"Galeterone\">Galeterone</a></li>\n<li><a href=\"/wiki/Guggulsterone\" title=\"Guggulsterone\">Guggulsterone</a></li>\n<li><a href=\"/wiki/Medrogestone\" title=\"Medrogestone\">Medrogestone</a></li>\n<li><a href=\"/wiki/Megestrol_acetate\" title=\"Megestrol acetate\">Megestrol acetate</a></li>\n<li><a href=\"/wiki/Mespirenone\" title=\"Mespirenone\">Mespirenone</a></li>\n<li><a href=\"/wiki/Metogest\" title=\"Metogest\">Metogest</a></li>\n<li><a href=\"/wiki/Mexrenone\" title=\"Mexrenone\">Mexrenone</a></li>\n<li><a href=\"/wiki/Mifepristone\" title=\"Mifepristone\">Mifepristone</a></li>\n<li><a href=\"/wiki/Nomegestrol_acetate\" title=\"Nomegestrol acetate\">Nomegestrol acetate</a></li>\n<li><a href=\"/wiki/Nordinone\" title=\"Nordinone\">Nordinone</a></li>\n<li><a href=\"/wiki/Osaterone\" title=\"Osaterone\">Osaterone</a></li>\n<li><a href=\"/wiki/Osaterone_acetate\" title=\"Osaterone acetate\">Osaterone acetate</a></li>\n<li><a href=\"/wiki/Oxendolone\" title=\"Oxendolone\">Oxendolone</a></li>\n<li><a href=\"/wiki/Potassium_canrenoate\" title=\"Potassium canrenoate\">Potassium canrenoate</a></li>\n<li><a href=\"/wiki/Promegestone\" title=\"Promegestone\">Promegestone</a></li>\n<li><a href=\"/wiki/Prorenone\" title=\"Prorenone\">Prorenone</a></li>\n<li><a href=\"/wiki/Rosterolone\" title=\"Rosterolone\">Rosterolone</a></li>\n<li><a href=\"/w/index.php?title=RU-15328&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"RU-15328 (page does not exist)\">RU-15328</a></li>\n<li><a href=\"/wiki/SC-5233\" title=\"SC-5233\">SC-5233 (spirolactone)</a></li>\n<li><a href=\"/wiki/Spironolactone\" title=\"Spironolactone\">Spironolactone</a></li>\n<li><a href=\"/wiki/Spirorenone\" title=\"Spirorenone\">Spirorenone</a></li>\n<li><a href=\"/wiki/Spiroxasone\" title=\"Spiroxasone\">Spiroxasone</a></li>\n<li><a href=\"/wiki/Topterone\" title=\"Topterone\">Topterone</a></li>\n<li><a href=\"/wiki/Trimegestone\" title=\"Trimegestone\">Trimegestone</a></li>\n<li><a href=\"/wiki/Trimethyltrienolone\" title=\"Trimethyltrienolone\">Trimethyltrienolone (R-2956)</a></li>\n<li><a href=\"/wiki/Zanoterone\" title=\"Zanoterone\">Zanoterone</a></li></ul>\n<ul><li><i>Nonsteroidal:</i> <a href=\"/wiki/5N-Bicalutamide\" title=\"5N-Bicalutamide\">5<i>N</i>-Bicalutamide</a></li>\n<li><a href=\"/wiki/AA560\" title=\"AA560\">AA560</a></li>\n<li><a href=\"/w/index.php?title=Antarlide&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"Antarlide (page does not exist)\">Antarlides</a></li>\n<li><a href=\"/w/index.php?title=Arabilin&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"Arabilin (page does not exist)\">Arabilin</a></li>\n<li><a href=\"/wiki/Apalutamide\" title=\"Apalutamide\">Apalutamide</a></li>\n<li><a href=\"/wiki/Atraric_acid\" title=\"Atraric acid\">Atraric acid</a></li>\n<li><a href=\"/w/index.php?title=AZD-3514&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"AZD-3514 (page does not exist)\">AZD-3514</a></li>\n<li><a href=\"/wiki/Bakuchiol\" title=\"Bakuchiol\">Bakuchiol</a></li>\n<li><a href=\"/w/index.php?title=BAY-1024767&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"BAY-1024767 (page does not exist)\">BAY-1024767</a></li>\n<li><a href=\"/wiki/Bicalutamide\" title=\"Bicalutamide\">Bicalutamide</a></li>\n<li><a href=\"/wiki/Bisphenol\" title=\"Bisphenol\">Bisphenols</a> (e.g., <a href=\"/wiki/Bisphenol_A_diglycidyl_ether\" title=\"Bisphenol A diglycidyl ether\">BADGE</a>, <a href=\"/w/index.php?title=Bisphenol_F_diglycidyl_ether&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"Bisphenol F diglycidyl ether (page does not exist)\">BFDGE</a>, <a href=\"/wiki/Bisphenol_A\" title=\"Bisphenol A\">bisphenol A</a>, <a href=\"/wiki/Bisphenol_F\" title=\"Bisphenol F\">bisphenol F</a>, <a href=\"/wiki/Bisphenol_S\" title=\"Bisphenol S\">bisphenol S</a>)</li>\n<li><a href=\"/w/index.php?title=BMS-501949&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"BMS-501949 (page does not exist)\">BMS-501949</a></li>\n<li><a href=\"/w/index.php?title=BMS-570511&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"BMS-570511 (page does not exist)\">BMS-570511</a></li>\n<li><a href=\"/wiki/BMS-641988\" title=\"BMS-641988\">BMS-641988</a></li>\n<li><a href=\"/w/index.php?title=CH5137291&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"CH5137291 (page does not exist)\">CH5137291</a></li>\n<li><a href=\"/wiki/Cimetidine\" title=\"Cimetidine\">Cimetidine</a></li>\n<li><a href=\"/wiki/Cioteronel\" title=\"Cioteronel\">Cioteronel</a></li>\n<li><a href=\"/wiki/Darolutamide\" title=\"Darolutamide\">Darolutamide</a></li>\n<li><a href=\"/wiki/DDT\" title=\"DDT\">DDT</a> (via metabolite <a href=\"/wiki/Dichlorodiphenyldichloroethylene\" title=\"Dichlorodiphenyldichloroethylene\">p,p\u2019-DDE</a>)</li>\n<li><a href=\"/wiki/Dieldrin\" title=\"Dieldrin\">Dieldrin</a></li>\n<li><a href=\"/wiki/DIMP_(antiandrogen)\" title=\"DIMP (antiandrogen)\">DIMP</a></li>\n<li><a href=\"/wiki/Endosulfan\" title=\"Endosulfan\">Endosulfan</a></li>\n<li><a href=\"/wiki/Enzalutamide\" title=\"Enzalutamide\">Enzalutamide</a></li>\n<li><a href=\"/wiki/EPI-001\" title=\"EPI-001\">EPI-001</a></li>\n<li><a href=\"/wiki/Fenarimol\" title=\"Fenarimol\">Fenarimol</a></li>\n<li><a href=\"/wiki/Flutamide\" title=\"Flutamide\">Flutamide</a></li>\n<li><a href=\"/wiki/Hydroxyflutamide\" title=\"Hydroxyflutamide\">Hydroxyflutamide</a></li>\n<li><a href=\"/wiki/Inocoterone\" title=\"Inocoterone\">Inocoterone</a></li>\n<li><a href=\"/wiki/Inocoterone_acetate\" title=\"Inocoterone acetate\">Inocoterone acetate</a></li>\n<li><a href=\"/wiki/Ketoconazole\" title=\"Ketoconazole\">Ketoconazole</a></li>\n<li><a href=\"/wiki/Lavender_oil\" title=\"Lavender oil\">Lavender oil</a></li>\n<li><a href=\"/w/index.php?title=LG-105&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"LG-105 (page does not exist)\">LG-105</a></li>\n<li><a href=\"/wiki/LG-120907\" title=\"LG-120907\">LG-120907</a></li>\n<li><a href=\"/w/index.php?title=LGD-1331&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"LGD-1331 (page does not exist)\">LGD-1331</a></li>\n<li><a href=\"/wiki/Linuron\" title=\"Linuron\">Linuron</a></li>\n<li><a href=\"/wiki/Methiocarb\" title=\"Methiocarb\">Methiocarb</a></li>\n<li><a href=\"/w/index.php?title=N-Butylbenzenesulfonamide&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"N-Butylbenzenesulfonamide (page does not exist)\"><i>N</i>-Butylbenzenesulfonamide</a></li>\n<li><a href=\"/wiki/N-Desmethylapalutamide\" title=\"N-Desmethylapalutamide\"><i>N</i>-Desmethylapalutamide</a></li>\n<li><a href=\"/wiki/N-Desmethylenzalutamide\" title=\"N-Desmethylenzalutamide\"><i>N</i>-Desmethylenzalutamide</a></li>\n<li><a href=\"/wiki/Nilutamide\" title=\"Nilutamide\">Nilutamide</a></li>\n<li><a href=\"/w/index.php?title=ONC1-13B&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"ONC1-13B (page does not exist)\">ONC1-13B</a></li>\n<li><a href=\"/wiki/ORM-15341\" title=\"ORM-15341\">ORM-15341</a></li>\n<li><a href=\"/wiki/Pentomone\" title=\"Pentomone\">Pentomone</a></li>\n<li><a href=\"/w/index.php?title=PF-998425&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"PF-998425 (page does not exist)\">PF-998425</a></li>\n<li><a href=\"/wiki/Phenothrin\" title=\"Phenothrin\">Phenothrin</a></li>\n<li><a href=\"/wiki/Prochloraz\" title=\"Prochloraz\">Prochloraz</a></li>\n<li><a href=\"/wiki/Procymidone\" title=\"Procymidone\">Procymidone</a></li>\n<li><a href=\"/wiki/Proxalutamide\" title=\"Proxalutamide\">Proxalutamide</a></li>\n<li><a href=\"/wiki/Ralaniten\" title=\"Ralaniten\">Ralaniten (EPI-002)</a></li>\n<li><a href=\"/wiki/Ralaniten_acetate\" title=\"Ralaniten acetate\">Ralaniten acetate (EPI-506)</a></li>\n<li><a href=\"/wiki/RD-162\" title=\"RD-162\">RD-162</a></li>\n<li><a href=\"/w/index.php?title=Ro_2-7239&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"Ro 2-7239 (page does not exist)\">Ro 2-7239</a></li>\n<li><a href=\"/w/index.php?title=Ro_5-2537&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"Ro 5-2537 (page does not exist)\">Ro 5-2537</a></li>\n<li><a href=\"/wiki/RU-22930\" title=\"RU-22930\">RU-22930</a></li>\n<li><a href=\"/w/index.php?title=RU-56187&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"RU-56187 (page does not exist)\">RU-56187</a></li>\n<li><a href=\"/w/index.php?title=RU-57073&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"RU-57073 (page does not exist)\">RU-57073</a></li>\n<li><a href=\"/wiki/RU-58642\" title=\"RU-58642\">RU-58642</a></li>\n<li><a href=\"/wiki/RU-58841\" title=\"RU-58841\">RU-58841</a></li>\n<li><a href=\"/wiki/Seviteronel\" title=\"Seviteronel\">Seviteronel</a></li>\n<li><a class=\"mw-selflink selflink\">Thalidomide</a></li>\n<li><a href=\"/wiki/Topilutamide\" title=\"Topilutamide\">Topilutamide (fluridil)</a></li>\n<li><a href=\"/wiki/Valproic_acid\" class=\"mw-redirect\" title=\"Valproic acid\">Valproic acid</a></li>\n<li><a href=\"/wiki/Vinclozolin\" title=\"Vinclozolin\">Vinclozolin</a></li>\n<li><a href=\"/w/index.php?title=YM-580&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"YM-580 (page does not exist)\">YM-580</a></li>\n<li><a href=\"/w/index.php?title=YM-92088&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"YM-92088 (page does not exist)\">YM-92088</a></li>\n<li><a href=\"/w/index.php?title=YM-175735&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"YM-175735 (page does not exist)\">YM-175735</a></li></ul>\n</div></td></tr></tbody></table><div></div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%;text-align:center;\"><a href=\"/wiki/G_protein-coupled_receptor_family_C_group_6_member_A\" class=\"mw-redirect\" title=\"G protein-coupled receptor family C group 6 member A\"><abbr title=\"G protein-coupled receptor family C group 6 member A\">GPRC6A</abbr></a></th><td class=\"navbox-list navbox-odd\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\"></div><table class=\"nowraplinks navbox-subgroup\" style=\"border-spacing:0\"><tbody><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:6em;;text-align:center;\">Agonists</th><td class=\"navbox-list navbox-even\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;padding:0px\"><div style=\"padding:0em 0.25em\">\n<ul><li><a href=\"/wiki/Cation\" class=\"mw-redirect\" title=\"Cation\">Cations</a> (incl. <a href=\"/wiki/Aluminum\" class=\"mw-redirect\" title=\"Aluminum\">aluminum</a>, <a href=\"/wiki/Calcium\" title=\"Calcium\">calcium</a>, <a href=\"/wiki/Gadolinium\" title=\"Gadolinium\">gadolinium</a>, <a href=\"/wiki/Magnesium\" title=\"Magnesium\">magnesium</a>, <a href=\"/wiki/Strontium\" title=\"Strontium\">strontium</a>, <a href=\"/wiki/Zinc\" title=\"Zinc\">zinc</a>)</li>\n<li><a href=\"/wiki/Dehydroandrosterone\" title=\"Dehydroandrosterone\">Dehydroandrosterone</a></li>\n<li><a href=\"/wiki/Dihydrotestosterone\" title=\"Dihydrotestosterone\">Dihydrotestosterone</a></li>\n<li><a href=\"/wiki/Estradiol\" title=\"Estradiol\">Estradiol</a></li>\n<li><a href=\"/wiki/Amino_acid\" title=\"Amino acid\"><small>L</small>-\u03b1-Amino acids</a> (incl. <a href=\"/wiki/Arginine\" title=\"Arginine\"><small>L</small>-arginine</a>, <a href=\"/wiki/Lysine\" title=\"Lysine\"><small>L</small>-lysine</a>, <a href=\"/wiki/Ornithine\" title=\"Ornithine\"><small>L</small>-ornithine</a>)</li>\n<li><a href=\"/wiki/Osteocalcin\" title=\"Osteocalcin\">Osteocalcin</a></li>\n<li><a href=\"/wiki/Sex_hormone_binding_globulin\" class=\"mw-redirect\" title=\"Sex hormone binding globulin\"><abbr title=\"Sex hormone binding globulin\">SHBG</abbr></a></li>\n<li><a href=\"/wiki/Testosterone\" title=\"Testosterone\">Testosterone</a></li></ul>\n</div></td></tr></tbody></table><div></div></td></tr><tr><td class=\"navbox-abovebelow\" colspan=\"2\"><div>\n<dl><dt>See also</dt>\n<dd><a href=\"/wiki/Template:Receptor_modulators\" title=\"Template:Receptor modulators\">Receptor/signaling modulators</a></dd>\n<dd><a href=\"/wiki/Template:Androgens_and_antiandrogens\" title=\"Template:Androgens and antiandrogens\">Androgens and antiandrogens</a></dd>\n<dd><a href=\"/wiki/Template:Estrogen_receptor_modulators\" title=\"Template:Estrogen receptor modulators\">Estrogen receptor modulators</a></dd>\n<dd><a href=\"/wiki/Template:Progesterone_receptor_modulators\" title=\"Template:Progesterone receptor modulators\">Progesterone receptor modulators</a></dd>\n<dd><a href=\"/wiki/List_of_androgens/anabolic_steroids\" title=\"List of androgens/anabolic steroids\">List of androgens/anabolic steroids</a></dd></dl>\n</div></td></tr></tbody></table></div>\n<div role=\"navigation\" class=\"navbox\" aria-labelledby=\"Authority_control_frameless_&amp;#124;text-top_&amp;#124;10px_&amp;#124;alt=Edit_this_at_Wikidata_&amp;#124;link=https&amp;#58;//www.wikidata.org/wiki/Q203174&amp;#124;Edit_this_at_Wikidata\" style=\"padding:3px\"><table class=\"nowraplinks hlist navbox-inner\" style=\"border-spacing:0;background:transparent;color:inherit\"><tbody><tr><th id=\"Authority_control_frameless_&amp;#124;text-top_&amp;#124;10px_&amp;#124;alt=Edit_this_at_Wikidata_&amp;#124;link=https&amp;#58;//www.wikidata.org/wiki/Q203174&amp;#124;Edit_this_at_Wikidata\" scope=\"row\" class=\"navbox-group\" style=\"width:1%\"><a href=\"/wiki/Help:Authority_control\" title=\"Help:Authority control\">Authority control</a> <a href=\"https://www.wikidata.org/wiki/Q203174\" title=\"Edit this at Wikidata\"><img alt=\"Edit this at Wikidata\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/7/73/Blue_pencil.svg/10px-Blue_pencil.svg.png\" width=\"10\" height=\"10\" style=\"vertical-align: text-top\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/7/73/Blue_pencil.svg/15px-Blue_pencil.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/7/73/Blue_pencil.svg/20px-Blue_pencil.svg.png 2x\" data-file-width=\"600\" data-file-height=\"600\" /></a></th><td class=\"navbox-list navbox-odd\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\n<ul><li><span class=\"nowrap\"><a href=\"/wiki/Integrated_Authority_File\" title=\"Integrated Authority File\">GND</a>: <span class=\"uid\"><a rel=\"nofollow\" class=\"external text\" href=\"https://d-nb.info/gnd/4184973-5\">4184973-5</a></span></span></li>\n<li><span class=\"nowrap\"><a href=\"/wiki/National_Diet_Library\" title=\"National Diet Library\">NDL</a>: <span class=\"uid\"><a rel=\"nofollow\" class=\"external text\" href=\"https://id.ndl.go.jp/auth/ndlna/00570209\">00570209</a></span></span></li></ul>\n</div></td></tr></tbody></table></div>\n\n<!-- \nNewPP limit report\nParsed by mw2196\nCached time: 20180921135635\nCache expiry: 1900800\nDynamic content: false\nCPU time usage: 2.220 seconds\nReal time usage: 2.427 seconds\nPreprocessor visited node count: 11475/1000000\nPreprocessor generated node count: 0/1500000\nPost\u2010expand include size: 419170/2097152 bytes\nTemplate argument size: 13683/2097152 bytes\nHighest expansion depth: 17/40\nExpensive parser function count: 9/500\nUnstrip recursion depth: 0/20\nUnstrip post\u2010expand size: 150000/5000000 bytes\nNumber of Wikibase entities loaded: 1/400\nLua time usage: 0.977/10.000 seconds\nLua memory usage: 8.3 MB/50 MB\n-->\n<!--\nTransclusion expansion time report (%,ms,calls,template)\n100.00% 1778.335      1 -total\n 52.18%  928.012      1 Template:Reflist\n 26.66%  474.098      1 Template:Drugbox\n 21.10%  375.246     50 Template:Cite_journal\n 20.09%  357.297      1 Template:Infobox\n  9.54%  169.652     28 Template:Cite_web\n  6.52%  116.016     20 Template:Cite_news\n  5.38%   95.715      7 Template:Citation_needed\n  5.35%   95.186     10 Template:Fix\n  4.63%   82.342     10 Template:Navbox\n-->\n\n<!-- Saved in parser cache with key enwiki:pcache:idhash:51078-0!canonical and timestamp 20180921135633 and revision id 860300017\n -->\n</div>"},"langlinks":[{"lang":"ar","url":"https://ar.wikipedia.org/wiki/%D8%AB%D8%A7%D9%84%D9%8A%D8%AF%D9%88%D9%85%D9%8A%D8%AF","langname":"Arabic","autonym":"\u0627\u0644\u0639\u0631\u0628\u064a\u0629","*":"\u062b\u0627\u0644\u064a\u062f\u0648\u0645\u064a\u062f"},{"lang":"ast","url":"https://ast.wikipedia.org/wiki/Talidomida","langname":"Asturian","autonym":"asturianu","*":"Talidomida"},{"lang":"azb","url":"https://azb.wikipedia.org/wiki/%D8%AA%D8%A7%D9%84%DB%8C%D8%AF%D9%88%D9%85%DB%8C%D8%AF","langname":"South Azerbaijani","autonym":"\u062a\u06c6\u0631\u06a9\u062c\u0647","*":"\u062a\u0627\u0644\u06cc\u062f\u0648\u0645\u06cc\u062f"},{"lang":"ca","url":"https://ca.wikipedia.org/wiki/Talidomida","langname":"Catalan","autonym":"catal\u00e0","*":"Talidomida"},{"lang":"cs","url":"https://cs.wikipedia.org/wiki/Thalidomid","langname":"Czech","autonym":"\u010de\u0161tina","*":"Thalidomid"},{"lang":"cy","url":"https://cy.wikipedia.org/wiki/Thalidomid","langname":"Welsh","autonym":"Cymraeg","*":"Thalidomid"},{"lang":"da","url":"https://da.wikipedia.org/wiki/Thalidomid","langname":"Danish","autonym":"dansk","*":"Thalidomid"},{"lang":"de","url":"https://de.wikipedia.org/wiki/Thalidomid","langname":"German","autonym":"Deutsch","*":"Thalidomid"},{"lang":"el","url":"https://el.wikipedia.org/wiki/%CE%98%CE%B1%CE%BB%CE%B9%CE%B4%CE%BF%CE%BC%CE%AF%CE%B4%CE%B7","langname":"Greek","autonym":"\u0395\u03bb\u03bb\u03b7\u03bd\u03b9\u03ba\u03ac","*":"\u0398\u03b1\u03bb\u03b9\u03b4\u03bf\u03bc\u03af\u03b4\u03b7"},{"lang":"es","url":"https://es.wikipedia.org/wiki/Talidomida","langname":"Spanish","autonym":"espa\u00f1ol","*":"Talidomida"},{"lang":"eo","url":"https://eo.wikipedia.org/wiki/Talidomido","langname":"Esperanto","autonym":"Esperanto","*":"Talidomido"},{"lang":"eu","url":"https://eu.wikipedia.org/wiki/Talidomida","langname":"Basque","autonym":"euskara","*":"Talidomida"},{"lang":"fa","url":"https://fa.wikipedia.org/wiki/%D8%AA%D8%A7%D9%84%DB%8C%D8%AF%D9%88%D9%85%DB%8C%D8%AF","langname":"Persian","autonym":"\u0641\u0627\u0631\u0633\u06cc","*":"\u062a\u0627\u0644\u06cc\u062f\u0648\u0645\u06cc\u062f"},{"lang":"fr","url":"https://fr.wikipedia.org/wiki/Thalidomide","langname":"French","autonym":"fran\u00e7ais","*":"Thalidomide"},{"lang":"ga","url":"https://ga.wikipedia.org/wiki/Tail%C3%ADdim%C3%ADd","langname":"Irish","autonym":"Gaeilge","*":"Tail\u00eddim\u00edd"},{"lang":"gl","url":"https://gl.wikipedia.org/wiki/Talidomida","langname":"Galician","autonym":"galego","*":"Talidomida"},{"lang":"ko","url":"https://ko.wikipedia.org/wiki/%ED%83%88%EB%A6%AC%EB%8F%84%EB%A7%88%EC%9D%B4%EB%93%9C","langname":"Korean","autonym":"\ud55c\uad6d\uc5b4","*":"\ud0c8\ub9ac\ub3c4\ub9c8\uc774\ub4dc"},{"lang":"hi","url":"https://hi.wikipedia.org/wiki/%E0%A4%A5%E0%A5%88%E0%A4%B2%E0%A4%BF%E0%A4%AF%E0%A5%8B%E0%A4%A1%E0%A5%8B%E0%A4%AE%E0%A4%BE%E0%A4%87%E0%A4%A1","langname":"Hindi","autonym":"\u0939\u093f\u0928\u094d\u0926\u0940","*":"\u0925\u0948\u0932\u093f\u092f\u094b\u0921\u094b\u092e\u093e\u0907\u0921"},{"lang":"it","url":"https://it.wikipedia.org/wiki/Talidomide","langname":"Italian","autonym":"italiano","*":"Talidomide"},{"lang":"he","url":"https://he.wikipedia.org/wiki/%D7%AA%D7%9C%D7%99%D7%93%D7%95%D7%9E%D7%99%D7%93","langname":"Hebrew","autonym":"\u05e2\u05d1\u05e8\u05d9\u05ea","*":"\u05ea\u05dc\u05d9\u05d3\u05d5\u05de\u05d9\u05d3"},{"lang":"ka","url":"https://ka.wikipedia.org/wiki/%E1%83%97%E1%83%90%E1%83%9A%E1%83%98%E1%83%93%E1%83%9D%E1%83%9B%E1%83%98%E1%83%93%E1%83%98","langname":"Georgian","autonym":"\u10e5\u10d0\u10e0\u10d7\u10e3\u10da\u10d8","*":"\u10d7\u10d0\u10da\u10d8\u10d3\u10dd\u10db\u10d8\u10d3\u10d8"},{"lang":"hu","url":"https://hu.wikipedia.org/wiki/Thalidomid","langname":"Hungarian","autonym":"magyar","*":"Thalidomid"},{"lang":"mk","url":"https://mk.wikipedia.org/wiki/%D0%A2%D0%B0%D0%BB%D0%B8%D0%B4%D0%BE%D0%BC%D0%B8%D0%B4","langname":"Macedonian","autonym":"\u043c\u0430\u043a\u0435\u0434\u043e\u043d\u0441\u043a\u0438","*":"\u0422\u0430\u043b\u0438\u0434\u043e\u043c\u0438\u0434"},{"lang":"xmf","url":"https://xmf.wikipedia.org/wiki/%E1%83%A2%E1%83%94%E1%83%9A%E1%83%90%E1%83%93%E1%83%9D%E1%83%9B%E1%83%98%E1%83%93%E1%83%98","langname":"Mingrelian","autonym":"\u10db\u10d0\u10e0\u10d2\u10d0\u10da\u10e3\u10e0\u10d8","*":"\u10e2\u10d4\u10da\u10d0\u10d3\u10dd\u10db\u10d8\u10d3\u10d8"},{"lang":"nl","url":"https://nl.wikipedia.org/wiki/Thalidomide","langname":"Dutch","autonym":"Nederlands","*":"Thalidomide"},{"lang":"ja","url":"https://ja.wikipedia.org/wiki/%E3%82%B5%E3%83%AA%E3%83%89%E3%83%9E%E3%82%A4%E3%83%89","langname":"Japanese","autonym":"\u65e5\u672c\u8a9e","*":"\u30b5\u30ea\u30c9\u30de\u30a4\u30c9"},{"lang":"no","url":"https://no.wikipedia.org/wiki/Thalidomid","langname":"Norwegian","autonym":"norsk","*":"Thalidomid"},{"lang":"pl","url":"https://pl.wikipedia.org/wiki/Talidomid","langname":"Polish","autonym":"polski","*":"Talidomid"},{"lang":"pt","url":"https://pt.wikipedia.org/wiki/Talidomida","langname":"Portuguese","autonym":"portugu\u00eas","*":"Talidomida"},{"lang":"ru","url":"https://ru.wikipedia.org/wiki/%D0%A2%D0%B0%D0%BB%D0%B8%D0%B4%D0%BE%D0%BC%D0%B8%D0%B4","langname":"Russian","autonym":"\u0440\u0443\u0441\u0441\u043a\u0438\u0439","*":"\u0422\u0430\u043b\u0438\u0434\u043e\u043c\u0438\u0434"},{"lang":"si","url":"https://si.wikipedia.org/wiki/%E0%B6%AD%E0%B7%90%E0%B6%BD%E0%B7%92%E0%B6%B8%E0%B7%9C%E0%B6%BA%E0%B7%92%E0%B6%A9%E0%B7%8A","langname":"Sinhala","autonym":"\u0dc3\u0dd2\u0d82\u0dc4\u0dbd","*":"\u0dad\u0dd0\u0dbd\u0dd2\u0db8\u0ddc\u0dba\u0dd2\u0da9\u0dca"},{"lang":"simple","url":"https://simple.wikipedia.org/wiki/Thalidomide","langname":"Simple English","autonym":"Simple English","*":"Thalidomide"},{"lang":"sk","url":"https://sk.wikipedia.org/wiki/Talidomid","langname":"Slovak","autonym":"sloven\u010dina","*":"Talidomid"},{"lang":"sl","url":"https://sl.wikipedia.org/wiki/Talidomid","langname":"Slovenian","autonym":"sloven\u0161\u010dina","*":"Talidomid"},{"lang":"sr","url":"https://sr.wikipedia.org/wiki/Talidomid","langname":"Serbian","autonym":"\u0441\u0440\u043f\u0441\u043a\u0438 / srpski","*":"Talidomid"},{"lang":"sh","url":"https://sh.wikipedia.org/wiki/Talidomid","langname":"Serbo-Croatian","autonym":"srpskohrvatski / \u0441\u0440\u043f\u0441\u043a\u043e\u0445\u0440\u0432\u0430\u0442\u0441\u043a\u0438","*":"Talidomid"},{"lang":"fi","url":"https://fi.wikipedia.org/wiki/Talidomidi","langname":"Finnish","autonym":"suomi","*":"Talidomidi"},{"lang":"sv","url":"https://sv.wikipedia.org/wiki/Talidomid","langname":"Swedish","autonym":"svenska","*":"Talidomid"},{"lang":"ta","url":"https://ta.wikipedia.org/wiki/%E0%AE%A4%E0%AE%BE%E0%AE%B2%E0%AE%BF%E0%AE%9F%E0%AF%8B%E0%AE%AE%E0%AF%88%E0%AE%9F%E0%AF%81","langname":"Tamil","autonym":"\u0ba4\u0bae\u0bbf\u0bb4\u0bcd","*":"\u0ba4\u0bbe\u0bb2\u0bbf\u0b9f\u0bcb\u0bae\u0bc8\u0b9f\u0bc1"},{"lang":"uk","url":"https://uk.wikipedia.org/wiki/%D0%A2%D0%B0%D0%BB%D1%96%D0%B4%D0%BE%D0%BC%D1%96%D0%B4","langname":"Ukrainian","autonym":"\u0443\u043a\u0440\u0430\u0457\u043d\u0441\u044c\u043a\u0430","*":"\u0422\u0430\u043b\u0456\u0434\u043e\u043c\u0456\u0434"},{"lang":"vi","url":"https://vi.wikipedia.org/wiki/Thalidomide","langname":"Vietnamese","autonym":"Ti\u1ebfng Vi\u1ec7t","*":"Thalidomide"},{"lang":"zh","url":"https://zh.wikipedia.org/wiki/%E6%B2%99%E5%88%A9%E5%BA%A6%E8%83%BA","langname":"Chinese","autonym":"\u4e2d\u6587","*":"\u6c99\u5229\u5ea6\u80fa"}],"categories":[{"sortkey":"","hidden":"","*":"CS1_Portuguese-language_sources_(pt)"},{"sortkey":"","hidden":"","*":"CS1_German-language_sources_(de)"},{"sortkey":"M","hidden":"","*":"Template:drugs.com_link_with_non-standard_subpage"},{"sortkey":"","hidden":"","*":"Articles_with_changed_EBI_identifier"},{"sortkey":"*","hidden":"","*":"ECHA_InfoCard_ID_from_Wikidata"},{"sortkey":"","hidden":"","*":"Drug_has_EMA_link"},{"sortkey":"","hidden":"","*":"Drugboxes_which_contain_changes_to_verified_fields"},{"sortkey":"","hidden":"","*":"Drugboxes_which_contain_changes_to_watched_fields"},{"sortkey":"","hidden":"","*":"All_articles_with_unsourced_statements"},{"sortkey":"","hidden":"","*":"Articles_with_unsourced_statements_from_April_2017"},{"sortkey":"","hidden":"","*":"Articles_with_unsourced_statements_from_March_2017"},{"sortkey":"","hidden":"","*":"All_articles_with_dead_external_links"},{"sortkey":"","hidden":"","*":"Articles_with_dead_external_links_from_October_2015"},{"sortkey":"","hidden":"","*":"Articles_with_dead_external_links_from_June_2014"},{"sortkey":"","hidden":"","*":"Articles_with_unsourced_statements_from_October_2015"},{"sortkey":"","hidden":"","*":"Articles_with_unsourced_statements_from_April_2016"},{"sortkey":"","hidden":"","*":"Wikipedia_articles_with_GND_identifiers"},{"sortkey":"","hidden":"","*":"Wikipedia_articles_with_NDL_identifiers"},{"sortkey":"","*":"Chirality"},{"sortkey":"","*":"Congenital_amputations"},{"sortkey":"","*":"Drugs_with_unknown_mechanisms_of_action"},{"sortkey":"","*":"Drug_safety"},{"sortkey":"","*":"German_inventions"},{"sortkey":"","*":"Glutarimides"},{"sortkey":"","*":"Health_disasters"},{"sortkey":"","*":"Health_disasters_in_the_United_Kingdom"},{"sortkey":"","*":"History_of_mental_health_in_the_United_Kingdom"},{"sortkey":"","*":"Hepatotoxins"},{"sortkey":"","*":"Immunosuppressants"},{"sortkey":"","*":"Leprosy"},{"sortkey":"","*":"Medical_controversies"},{"sortkey":"","*":"Medical_scandals"},{"sortkey":"","*":"Nonsteroidal_antiandrogens"},{"sortkey":"","*":"Phthalimides"},{"sortkey":"","*":"Teratogens"},{"sortkey":"","*":"Withdrawn_drugs"}],"links":[{"ns":0,"*":"Thalidomide (data page)"},{"ns":0,"exists":"","*":"Open access"},{"ns":0,"exists":"","*":"1-Androstenediol"},{"ns":0,"exists":"","*":"1-Androstenedione"},{"ns":0,"exists":"","*":"1-Androsterone"},{"ns":0,"exists":"","*":"1-Testosterone"},{"ns":0,"exists":"","*":"11-Ketodihydrotestosterone"},{"ns":0,"exists":"","*":"11-Ketotestosterone"},{"ns":0,"exists":"","*":"11\u03b1-Hydroxyprogesterone"},{"ns":0,"exists":"","*":"11\u03b2-Hydroxyandrostenedione"},{"ns":0,"exists":"","*":"11\u03b2-Methyl-19-nortestosterone"},{"ns":0,"exists":"","*":"11\u03b2-Methyl-19-nortestosterone dodecylcarbonate"},{"ns":0,"exists":"","*":"15\u03b2-Hydroxycyproterone acetate"},{"ns":0,"exists":"","*":"19-Nor-5-androstenediol"},{"ns":0,"exists":"","*":"19-Nor-5-androstenedione"},{"ns":0,"exists":"","*":"19-Norandrosterone"},{"ns":0,"exists":"","*":"19-Nordehydroepiandrosterone"},{"ns":0,"exists":"","*":"2-Methoxyestradiol"},{"ns":0,"exists":"","*":"3-Keto-5\u03b1-abiraterone"},{"ns":0,"exists":"","*":"3\u03b1-Androstanediol"},{"ns":0,"exists":"","*":"4-Androstenediol"},{"ns":0,"exists":"","*":"4-Androstenedione"},{"ns":0,"exists":"","*":"4-Dehydroepiandrosterone"},{"ns":0,"exists":"","*":"4-Hydroxytestosterone"},{"ns":0,"exists":"","*":"5-Androstenediol"},{"ns":0,"exists":"","*":"5-Androstenedione"},{"ns":0,"exists":"","*":"5N-Bicalutamide"},{"ns":0,"exists":"","*":"5\u03b1-Androst-2-en-17-one"},{"ns":0,"exists":"","*":"5\u03b1-Androstane"},{"ns":0,"exists":"","*":"5\u03b1-Dihydrolevonorgestrel"},{"ns":0,"exists":"","*":"5\u03b1-Dihydronandrolone"},{"ns":0,"exists":"","*":"5\u03b1-Dihydronorethandrolone"},{"ns":0,"exists":"","*":"5\u03b1-Dihydronorethisterone"},{"ns":0,"exists":"","*":"5\u03b1-Dihydronormethandrone"},{"ns":0,"exists":"","*":"7\u03b1-Methyl-19-norandrostenedione"},{"ns":0,"exists":"","*":"7\u03b1-Thiomethylspironolactone"},{"ns":0,"exists":"","*":"7\u03b1-Thioprogesterone"},{"ns":0,"exists":"","*":"7\u03b1-Thiospironolactone"},{"ns":0,"exists":"","*":"7\u03b2-Hydroxyepiandrosterone"},{"ns":0,"exists":"","*":"AA560"},{"ns":0,"exists":"","*":"ANGPT2"},{"ns":0,"exists":"","*":"ATC code L04"},{"ns":0,"exists":"","*":"Abatacept"},{"ns":0,"exists":"","*":"Abetimus"},{"ns":0,"exists":"","*":"Abiraterone"},{"ns":0,"exists":"","*":"Abiraterone acetate"},{"ns":0,"exists":"","*":"Acetothiolutamide"},{"ns":0,"exists":"","*":"Actinic prurigo"},{"ns":0,"exists":"","*":"Action T4"},{"ns":0,"exists":"","*":"Adalimumab"},{"ns":0,"exists":"","*":"Adrenosterone"},{"ns":0,"exists":"","*":"Afelimomab"},{"ns":0,"exists":"","*":"Aflibercept"},{"ns":0,"exists":"","*":"Alefacept"},{"ns":0,"exists":"","*":"Allyltestosterone"},{"ns":0,"exists":"","*":"Alpha-V beta-3"},{"ns":0,"exists":"","*":"Alternariol"},{"ns":0,"exists":"","*":"Aluminum"},{"ns":0,"exists":"","*":"Amenorrhea"},{"ns":0,"exists":"","*":"American Society of Health-System Pharmacists"},{"ns":0,"exists":"","*":"Amino acid"},{"ns":0,"exists":"","*":"Anakinra"},{"ns":0,"exists":"","*":"Analog (chemistry)"},{"ns":0,"exists":"","*":"Anatomical Therapeutic Chemical Classification System"},{"ns":0,"exists":"","*":"Andarine"},{"ns":0,"exists":"","*":"Androgen receptor"},{"ns":0,"exists":"","*":"Androisoxazole"},{"ns":0,"exists":"","*":"Androstanolone"},{"ns":0,"exists":"","*":"Androstenediol 17\u03b2-acetate"},{"ns":0,"exists":"","*":"Androstenediol 3\u03b2-acetate"},{"ns":0,"exists":"","*":"Androstenediol diacetate"},{"ns":0,"exists":"","*":"Androstenediol dipropionate"},{"ns":0,"exists":"","*":"Androsterone"},{"ns":0,"exists":"","*":"Anemia"},{"ns":0,"exists":"","*":"Angiogenesis"},{"ns":0,"exists":"","*":"Angiogenesis inhibitor"},{"ns":0,"exists":"","*":"Angiogenesis inhibitors"},{"ns":0,"exists":"","*":"Angiostatin"},{"ns":0,"exists":"","*":"Anti-lymphocyte globulin"},{"ns":0,"exists":"","*":"Anti-thymocyte globulin"},{"ns":0,"exists":"","*":"Antiangiogenic"},{"ns":0,"exists":"","*":"Antibody"},{"ns":0,"exists":"","*":"Antiemetic"},{"ns":0,"exists":"","*":"Antifolate"},{"ns":0,"exists":"","*":"Antimetabolite"},{"ns":0,"exists":"","*":"Antithrombin III"},{"ns":0,"exists":"","*":"Anxiety"},{"ns":0,"exists":"","*":"Apalutamide"},{"ns":0,"exists":"","*":"Aphthous stomatitis"},{"ns":0,"exists":"","*":"Apremilast"},{"ns":0,"exists":"","*":"Arginine"},{"ns":0,"exists":"","*":"Aselizumab"},{"ns":0,"exists":"","*":"Atamestane"},{"ns":0,"exists":"","*":"Atorolimumab"},{"ns":0,"exists":"","*":"Atraric acid"},{"ns":0,"exists":"","*":"Atrioventricular block"},{"ns":0,"exists":"","*":"Australian Associated Press"},{"ns":0,"exists":"","*":"Australian Broadcasting Corporation"},{"ns":0,"exists":"","*":"Austria"},{"ns":0,"exists":"","*":"Azathioprine"},{"ns":0,"exists":"","*":"BBC"},{"ns":0,"exists":"","*":"BMS-641988"},{"ns":0,"exists":"","*":"BOMT"},{"ns":0,"exists":"","*":"Bakuchiol"},{"ns":0,"exists":"","*":"Basigin"},{"ns":0,"exists":"","*":"Basiliximab"},{"ns":0,"exists":"","*":"Bayreuth"},{"ns":0,"exists":"","*":"Behcet's syndrome"},{"ns":0,"exists":"","*":"Belatacept"},{"ns":0,"exists":"","*":"Belimumab"},{"ns":0,"exists":"","*":"Benorterone"},{"ns":0,"exists":"","*":"Bertilimumab"},{"ns":0,"exists":"","*":"Bevacizumab"},{"ns":0,"exists":"","*":"Bicalutamide"},{"ns":0,"exists":"","*":"Bioavailability"},{"ns":0,"exists":"","*":"Biological half-life"},{"ns":0,"exists":"","*":"Biomarker"},{"ns":0,"exists":"","*":"Bisphenol"},{"ns":0,"exists":"","*":"Bisphenol A"},{"ns":0,"exists":"","*":"Bisphenol A diglycidyl ether"},{"ns":0,"exists":"","*":"Bisphenol F"},{"ns":0,"exists":"","*":"Bisphenol S"},{"ns":0,"exists":"","*":"Blisibimod"},{"ns":0,"exists":"","*":"Blood cancers"},{"ns":0,"exists":"","*":"Bolandiol"},{"ns":0,"exists":"","*":"Bolandiol dipropionate"},{"ns":0,"exists":"","*":"Bolandione"},{"ns":0,"exists":"","*":"Bolasterone"},{"ns":0,"exists":"","*":"Bolazine"},{"ns":0,"exists":"","*":"Bolazine capronate"},{"ns":0,"exists":"","*":"Boldenone"},{"ns":0,"exists":"","*":"Boldenone undecylenate"},{"ns":0,"exists":"","*":"Boldione"},{"ns":0,"exists":"","*":"Bolenol"},{"ns":0,"exists":"","*":"Bolmantalate"},{"ns":0,"exists":"","*":"Bradycardia"},{"ns":0,"exists":"","*":"Breast cancer"},{"ns":0,"exists":"","*":"CAS Registry Number"},{"ns":0,"exists":"","*":"CD11a"},{"ns":0,"exists":"","*":"CD154"},{"ns":0,"exists":"","*":"CD18"},{"ns":0,"exists":"","*":"CD20"},{"ns":0,"exists":"","*":"CD23"},{"ns":0,"exists":"","*":"CD3 (immunology)"},{"ns":0,"exists":"","*":"CD4"},{"ns":0,"exists":"","*":"CD40 (protein)"},{"ns":0,"exists":"","*":"CD80"},{"ns":0,"exists":"","*":"CTLA-4"},{"ns":0,"exists":"","*":"CXCL10"},{"ns":0,"exists":"","*":"CYP2C19"},{"ns":0,"exists":"","*":"Calcineurin"},{"ns":0,"exists":"","*":"Calcium"},{"ns":0,"exists":"","*":"Calreticulin"},{"ns":0,"exists":"","*":"Calusterone"},{"ns":0,"exists":"","*":"Canrenoic acid"},{"ns":0,"exists":"","*":"Canrenone"},{"ns":0,"exists":"","*":"Capsule (pharmacy)"},{"ns":0,"exists":"","*":"Carbonyldiimidazole"},{"ns":0,"exists":"","*":"Carboxyamidotriazole"},{"ns":0,"exists":"","*":"Carl Zimmer"},{"ns":0,"exists":"","*":"Cartilage-Derived Angiogenesis Inhibitory Factor"},{"ns":0,"exists":"","*":"Cartilage-derived angiogenesis inhibitor"},{"ns":0,"exists":"","*":"Cation"},{"ns":0,"exists":"","*":"Cedelizumab"},{"ns":0,"exists":"","*":"Celgene Corporation"},{"ns":0,"exists":"","*":"Cereblon"},{"ns":0,"exists":"","*":"Certolizumab pegol"},{"ns":0,"exists":"","*":"ChEBI"},{"ns":0,"exists":"","*":"ChEMBL"},{"ns":0,"exists":"","*":"ChemSpider"},{"ns":0,"exists":"","*":"Chemical formula"},{"ns":0,"exists":"","*":"Chiral centre"},{"ns":0,"exists":"","*":"Chirality (chemistry)"},{"ns":0,"exists":"","*":"Chloramphenicol acetyltransferase"},{"ns":0,"exists":"","*":"Chlormadinone acetate"},{"ns":0,"exists":"","*":"Chlorodehydromethylandrostenediol"},{"ns":0,"exists":"","*":"Chlorodehydromethyltestosterone"},{"ns":0,"exists":"","*":"Chloromethylandrostenediol"},{"ns":0,"exists":"","*":"Ciclosporin"},{"ns":0,"exists":"","*":"Cimetidine"},{"ns":0,"exists":"","*":"Cioteronel"},{"ns":0,"exists":"","*":"Cl-4AS-1"},{"ns":0,"exists":"","*":"Clascoterone"},{"ns":0,"exists":"","*":"Class action"},{"ns":0,"exists":"","*":"Clenoliximab"},{"ns":0,"exists":"","*":"Clofazimine"},{"ns":0,"exists":"","*":"Clometerone"},{"ns":0,"exists":"","*":"Clostebol"},{"ns":0,"exists":"","*":"Clostebol acetate"},{"ns":0,"exists":"","*":"Clostebol caproate"},{"ns":0,"exists":"","*":"Clostebol propionate"},{"ns":0,"exists":"","*":"Cloxotestosterone"},{"ns":0,"exists":"","*":"Cloxotestosterone acetate"},{"ns":0,"exists":"","*":"Colorectal cancer"},{"ns":0,"exists":"","*":"Complement component 5"},{"ns":0,"exists":"","*":"Congenital disorder"},{"ns":0,"exists":"","*":"Corticosteroid"},{"ns":0,"exists":"","*":"Crohn's disease"},{"ns":0,"exists":"","*":"Crown Street Women's Hospital"},{"ns":0,"exists":"","*":"Cyclophilin"},{"ns":0,"exists":"","*":"Cyproheptadine"},{"ns":0,"exists":"","*":"Cyproterone"},{"ns":0,"exists":"","*":"Cyproterone acetate"},{"ns":0,"exists":"","*":"DDT"},{"ns":0,"exists":"","*":"DIMP (antiandrogen)"},{"ns":0,"exists":"","*":"DU-41165"},{"ns":0,"exists":"","*":"Daclizumab"},{"ns":0,"exists":"","*":"Danazol"},{"ns":0,"exists":"","*":"Darolutamide"},{"ns":0,"exists":"","*":"Deformities"},{"ns":0,"exists":"","*":"Dehydroandrosterone"},{"ns":0,"exists":"","*":"Dehydroepiandrosterone"},{"ns":0,"exists":"","*":"Dehydroepiandrosterone sulfate"},{"ns":0,"exists":"","*":"Delanterone"},{"ns":0,"exists":"","*":"Delmadinone acetate"},{"ns":0,"exists":"","*":"Department of Health and Social Security"},{"ns":0,"exists":"","*":"Derivative (chemistry)"},{"ns":0,"exists":"","*":"Desogestrel"},{"ns":0,"exists":"","*":"Desoxymethyltestosterone"},{"ns":0,"exists":"","*":"Deutsche Mark"},{"ns":0,"exists":"","*":"Development of analogs of thalidomide"},{"ns":0,"exists":"","*":"Dexamethasone"},{"ns":0,"exists":"","*":"Diageo"},{"ns":0,"exists":"","*":"Diageo plc"},{"ns":0,"exists":"","*":"Dichlorodiphenyldichloroethylene"},{"ns":0,"exists":"","*":"Dicirenone"},{"ns":0,"exists":"","*":"Dieldrin"},{"ns":0,"exists":"","*":"Dienedione"},{"ns":0,"exists":"","*":"Dienogest"},{"ns":0,"exists":"","*":"Dienolone"},{"ns":0,"exists":"","*":"Diethylstilbestrol"},{"ns":0,"exists":"","*":"Digital object identifier"},{"ns":0,"exists":"","*":"Dihydroethisterone"},{"ns":0,"exists":"","*":"Dihydrofluoxymesterone"},{"ns":0,"exists":"","*":"Dihydrotestosterone"},{"ns":0,"exists":"","*":"Dimethandrolone"},{"ns":0,"exists":"","*":"Dimethandrolone buciclate"},{"ns":0,"exists":"","*":"Dimethandrolone dodecylcarbonate"},{"ns":0,"exists":"","*":"Dimethandrolone undecanoate"},{"ns":0,"exists":"","*":"Dimethyldienolone"},{"ns":0,"exists":"","*":"Dimethyltrienolone"},{"ns":0,"exists":"","*":"Directive 65/65/EEC1"},{"ns":0,"exists":"","*":"Discovery and development of thalidomide and its analogs"},{"ns":0,"exists":"","*":"Distillers Company"},{"ns":0,"exists":"","*":"Drospirenone"},{"ns":0,"exists":"","*":"Drostanolone"},{"ns":0,"exists":"","*":"Drostanolone propionate"},{"ns":0,"exists":"","*":"DrugBank"},{"ns":0,"exists":"","*":"Drug Efficacy Study Implementation"},{"ns":0,"exists":"","*":"Drug discovery"},{"ns":0,"exists":"","*":"Drug metabolism"},{"ns":0,"exists":"","*":"Drug nomenclature"},{"ns":0,"exists":"","*":"Drug of last resort"},{"ns":0,"exists":"","*":"Drugs.com"},{"ns":0,"exists":"","*":"Drupanol"},{"ns":0,"exists":"","*":"Dysmelia"},{"ns":0,"exists":"","*":"ECHA InfoCard"},{"ns":0,"exists":"","*":"EM-5854"},{"ns":0,"exists":"","*":"EPI-001"},{"ns":0,"exists":"","*":"East Germany"},{"ns":0,"exists":"","*":"Eculizumab"},{"ns":0,"exists":"","*":"Edogestrone"},{"ns":0,"exists":"","*":"Efalizumab"},{"ns":0,"exists":"","*":"Elsilimomab"},{"ns":0,"exists":"","*":"Enantiomer"},{"ns":0,"exists":"","*":"Endogeny"},{"ns":0,"exists":"","*":"Endostatin"},{"ns":0,"exists":"","*":"Endosulfan"},{"ns":0,"exists":"","*":"Enestebol"},{"ns":0,"exists":"","*":"Enobosarm"},{"ns":0,"exists":"","*":"Enzalutamide"},{"ns":0,"exists":"","*":"Epiandrosterone"},{"ns":0,"exists":"","*":"Epidermolysis bullosa"},{"ns":0,"exists":"","*":"Epitestosterone"},{"ns":0,"exists":"","*":"Epitiostanol"},{"ns":0,"exists":"","*":"Erich Mende"},{"ns":0,"exists":"","*":"Erlizumab"},{"ns":0,"exists":"","*":"Erythema nodosum"},{"ns":0,"exists":"","*":"Erythema nodosum leprosum"},{"ns":0,"exists":"","*":"Esterified estrogens/methyltestosterone"},{"ns":0,"exists":"","*":"Estradiol"},{"ns":0,"exists":"","*":"Etanercept"},{"ns":0,"exists":"","*":"Ethisterone"},{"ns":0,"exists":"","*":"Ethyldienolone"},{"ns":0,"exists":"","*":"Ethylestrenol"},{"ns":0,"exists":"","*":"Ethyltestosterone"},{"ns":0,"exists":"","*":"Etonogestrel"},{"ns":0,"exists":"","*":"Etynodiol"},{"ns":0,"exists":"","*":"Etynodiol diacetate"},{"ns":0,"exists":"","*":"European Commission"},{"ns":0,"exists":"","*":"European Medicines Agency"},{"ns":0,"exists":"","*":"Everolimus"},{"ns":0,"exists":"","*":"Excretion"},{"ns":0,"exists":"","*":"Exemestane"},{"ns":0,"exists":"","*":"Exogeny"},{"ns":0,"exists":"","*":"FKBP"},{"ns":0,"exists":"","*":"Faralimomab"},{"ns":0,"exists":"","*":"Federal Ministry of Health (Germany)"},{"ns":0,"exists":"","*":"Fenarimol"},{"ns":0,"exists":"","*":"Fetus"},{"ns":0,"exists":"","*":"Fluoxymesterone"},{"ns":0,"exists":"","*":"Flutamide"},{"ns":0,"exists":"","*":"Fontolizumab"},{"ns":0,"exists":"","*":"Food and Drug Administration"},{"ns":0,"exists":"","*":"Food and Drug Administration (United States)"},{"ns":0,"exists":"","*":"Formebolone"},{"ns":0,"exists":"","*":"Formestane"},{"ns":0,"exists":"","*":"Frances Oldham Kelsey"},{"ns":0,"exists":"","*":"Franz B\u00fcchner (pathologist)"},{"ns":0,"exists":"","*":"Free Democratic Party (Germany)"},{"ns":0,"exists":"","*":"Furazabol"},{"ns":0,"exists":"","*":"Fusion protein"},{"ns":0,"exists":"","*":"G protein-coupled receptor family C group 6 member A"},{"ns":0,"exists":"","*":"Gadolinium"},{"ns":0,"exists":"","*":"Galeterone"},{"ns":0,"exists":"","*":"Galiximab"},{"ns":0,"exists":"","*":"Gastritis"},{"ns":0,"exists":"","*":"Gavilimomab"},{"ns":0,"exists":"","*":"Gesellschaft mit beschr\u00e4nkter Haftung"},{"ns":0,"exists":"","*":"Gestodene"},{"ns":0,"exists":"","*":"Gestrinone"},{"ns":0,"exists":"","*":"GlaxoSmithKline"},{"ns":0,"exists":"","*":"Glioblastoma multiforme"},{"ns":0,"exists":"","*":"Glutamate"},{"ns":0,"exists":"","*":"Glutamic acid"},{"ns":0,"exists":"","*":"Glutamine"},{"ns":0,"exists":"","*":"Glutethimide"},{"ns":0,"exists":"","*":"Golimumab"},{"ns":0,"exists":"","*":"Gomiliximab"},{"ns":0,"exists":"","*":"Government of Canada"},{"ns":0,"exists":"","*":"Graft versus host"},{"ns":0,"exists":"","*":"Gr\u00fcnenthal"},{"ns":0,"exists":"","*":"Gr\u00fcnenthal GmbH"},{"ns":0,"exists":"","*":"Guggulsterone"},{"ns":0,"exists":"","*":"Guide to Pharmacology"},{"ns":0,"exists":"","*":"Gusperimus"},{"ns":0,"exists":"","*":"Gynecomastia"},{"ns":0,"exists":"","*":"Harold Evans"},{"ns":0,"exists":"","*":"Head and neck cancer"},{"ns":0,"exists":"","*":"Health crisis"},{"ns":0,"exists":"","*":"Heart attack"},{"ns":0,"exists":"","*":"Helen B. Taussig"},{"ns":0,"exists":"","*":"Heparin"},{"ns":0,"exists":"","*":"Holt-Oram syndrome"},{"ns":0,"exists":"","*":"Hydroxyflutamide"},{"ns":0,"exists":"","*":"Hydroxystenozole"},{"ns":0,"exists":"","*":"Hypnotic"},{"ns":0,"exists":"","*":"IL-2 receptor"},{"ns":0,"exists":"","*":"IUPAC nomenclature of chemistry"},{"ns":0,"exists":"","*":"Immunoglobulin E"},{"ns":0,"exists":"","*":"Immunomodulator"},{"ns":0,"exists":"","*":"Immunomodulatory drug"},{"ns":0,"exists":"","*":"Immunomodulatory imide drug"},{"ns":0,"exists":"","*":"Immunosuppression"},{"ns":0,"exists":"","*":"Immunosuppressive drug"},{"ns":0,"exists":"","*":"Immunotherapy"},{"ns":0,"exists":"","*":"In vivo"},{"ns":0,"exists":"","*":"Infliximab"},{"ns":0,"exists":"","*":"Inocoterone"},{"ns":0,"exists":"","*":"Inocoterone acetate"},{"ns":0,"exists":"","*":"Inolimomab"},{"ns":0,"exists":"","*":"Insomnia"},{"ns":0,"exists":"","*":"Integrated Authority File"},{"ns":0,"exists":"","*":"Integrin"},{"ns":0,"exists":"","*":"Interferon"},{"ns":0,"exists":"","*":"Interferon alpha"},{"ns":0,"exists":"","*":"Interferon beta"},{"ns":0,"exists":"","*":"Interferon gamma"},{"ns":0,"exists":"","*":"Interleukin-6 receptor"},{"ns":0,"exists":"","*":"Interleukin 12"},{"ns":0,"exists":"","*":"Interleukin 17"},{"ns":0,"exists":"","*":"Interleukin 18"},{"ns":0,"exists":"","*":"Interleukin 1 receptor antagonist"},{"ns":0,"exists":"","*":"Interleukin 2"},{"ns":0,"exists":"","*":"Interleukin 23"},{"ns":0,"exists":"","*":"Interleukin 4"},{"ns":0,"exists":"","*":"Interleukin 5"},{"ns":0,"exists":"","*":"Interleukin 6"},{"ns":0,"exists":"","*":"International Chemical Identifier"},{"ns":0,"exists":"","*":"International Standard Book Number"},{"ns":0,"exists":"","*":"Ipilimumab"},{"ns":0,"exists":"","*":"Itraconazole"},{"ns":0,"exists":"","*":"JSmol"},{"ns":0,"exists":"","*":"Jacob Sheskin"},{"ns":0,"exists":"","*":"John F. Kennedy"},{"ns":0,"exists":"","*":"Judah Folkman"},{"ns":0,"exists":"","*":"KEGG"},{"ns":0,"exists":"","*":"Kaposi's sarcoma"},{"ns":0,"exists":"","*":"Kaposi's sarcoma-associated herpesvirus"},{"ns":0,"exists":"","*":"Kefauver Harris Amendment"},{"ns":0,"exists":"","*":"Keliximab"},{"ns":0,"exists":"","*":"Ketoconazole"},{"ns":0,"exists":"","*":"Kringle domain"},{"ns":0,"exists":"","*":"L-selectin"},{"ns":0,"exists":"","*":"LG-120907"},{"ns":0,"exists":"","*":"LG-121071"},{"ns":0,"exists":"","*":"LGD-2226"},{"ns":0,"exists":"","*":"LGD-3303"},{"ns":0,"exists":"","*":"LGD-4033"},{"ns":0,"exists":"","*":"LS-1727"},{"ns":0,"exists":"","*":"Lavender oil"},{"ns":0,"exists":"","*":"Law for the Prevention of Hereditarily Diseased Offspring"},{"ns":0,"exists":"","*":"Lebrikizumab"},{"ns":0,"exists":"","*":"Leflunomide"},{"ns":0,"exists":"","*":"Lenalidomide"},{"ns":0,"exists":"","*":"Leprosy"},{"ns":0,"exists":"","*":"Lerdelimumab"},{"ns":0,"exists":"","*":"Leukopenia"},{"ns":0,"exists":"","*":"Levonorgestrel"},{"ns":0,"exists":"","*":"Levonorgestrel butanoate"},{"ns":0,"exists":"","*":"Levonorgestrel ester"},{"ns":0,"exists":"","*":"Linuron"},{"ns":0,"exists":"","*":"List of androgen esters"},{"ns":0,"exists":"","*":"List of androgens/anabolic steroids"},{"ns":0,"exists":"","*":"List of thalidomide side effects"},{"ns":0,"exists":"","*":"Liver"},{"ns":0,"exists":"","*":"Liver damage"},{"ns":0,"exists":"","*":"Lorraine Mercer"},{"ns":0,"exists":"","*":"Lumiliximab"},{"ns":0,"exists":"","*":"Lymphocyte function-associated antigen 1"},{"ns":0,"exists":"","*":"Lymphopenia"},{"ns":0,"exists":"","*":"Lynestrenol"},{"ns":0,"exists":"","*":"Lynestrenol phenylpropionate"},{"ns":0,"exists":"","*":"Lysine"},{"ns":0,"exists":"","*":"M.D."},{"ns":0,"exists":"","*":"MK-0773"},{"ns":0,"exists":"","*":"MTOR"},{"ns":0,"exists":"","*":"Macrolide"},{"ns":0,"exists":"","*":"Magnesium"},{"ns":0,"exists":"","*":"Marion Merrell Dow"},{"ns":0,"exists":"","*":"Maslimomab"},{"ns":0,"exists":"","*":"Maspin"},{"ns":0,"exists":"","*":"Matrix metalloproteinase inhibitor"},{"ns":0,"exists":"","*":"Mebolazine"},{"ns":0,"exists":"","*":"Medicines Act 1968"},{"ns":0,"exists":"","*":"MedlinePlus"},{"ns":0,"exists":"","*":"Medrogestone"},{"ns":0,"exists":"","*":"Medroxyprogesterone acetate"},{"ns":0,"exists":"","*":"Megestrol acetate"},{"ns":0,"exists":"","*":"Melanoma"},{"ns":0,"exists":"","*":"Melphalan"},{"ns":0,"exists":"","*":"Mepitiostane"},{"ns":0,"exists":"","*":"Mepolizumab"},{"ns":0,"exists":"","*":"Merc\u00e9des Benegbi"},{"ns":0,"exists":"","*":"Mesabolone"},{"ns":0,"exists":"","*":"Mespirenone"},{"ns":0,"exists":"","*":"Mestanolone"},{"ns":0,"exists":"","*":"Mesterolone"},{"ns":0,"exists":"","*":"Mesterolone cipionate"},{"ns":0,"exists":"","*":"Metandienone"},{"ns":0,"exists":"","*":"Metelimumab"},{"ns":0,"exists":"","*":"Metenolone"},{"ns":0,"exists":"","*":"Metenolone acetate"},{"ns":0,"exists":"","*":"Metenolone enanthate"},{"ns":0,"exists":"","*":"Meth-1"},{"ns":0,"exists":"","*":"Meth-2"},{"ns":0,"exists":"","*":"Methandriol"},{"ns":0,"exists":"","*":"Methandriol bisenanthoyl acetate"},{"ns":0,"exists":"","*":"Methandriol diacetate"},{"ns":0,"exists":"","*":"Methandriol dipropionate"},{"ns":0,"exists":"","*":"Methandriol propionate"},{"ns":0,"exists":"","*":"Methasterone"},{"ns":0,"exists":"","*":"Methiocarb"},{"ns":0,"exists":"","*":"Methotrexate"},{"ns":0,"exists":"","*":"Methoxydienone"},{"ns":0,"exists":"","*":"Methyl-1-testosterone"},{"ns":0,"exists":"","*":"Methylclostebol"},{"ns":0,"exists":"","*":"Methyldiazinol"},{"ns":0,"exists":"","*":"Methyldienolone"},{"ns":0,"exists":"","*":"Methylepitiostanol"},{"ns":0,"exists":"","*":"Methylhydroxynandrolone"},{"ns":0,"exists":"","*":"Methylstenbolone"},{"ns":0,"exists":"","*":"Methyltestosterone"},{"ns":0,"exists":"","*":"Methyltestosterone 3-hexyl ether"},{"ns":0,"exists":"","*":"Metogest"},{"ns":0,"exists":"","*":"Metribolone"},{"ns":0,"exists":"","*":"Mexrenone"},{"ns":0,"exists":"","*":"Mibolerone"},{"ns":0,"exists":"","*":"Midwife"},{"ns":0,"exists":"","*":"Mifepristone"},{"ns":0,"exists":"","*":"Molar mass"},{"ns":0,"exists":"","*":"Monoclonal antibodies"},{"ns":0,"exists":"","*":"Morning sickness"},{"ns":0,"exists":"","*":"Morolimumab"},{"ns":0,"exists":"","*":"Multiple myeloma"},{"ns":0,"exists":"","*":"Muromonab-CD3"},{"ns":0,"exists":"","*":"Mycophenolic acid"},{"ns":0,"exists":"","*":"Myelosuppression"},{"ns":0,"exists":"","*":"N-Desmethylapalutamide"},{"ns":0,"exists":"","*":"N-Desmethylenzalutamide"},{"ns":0,"exists":"","*":"NRP-1"},{"ns":0,"exists":"","*":"Nandrolone"},{"ns":0,"exists":"","*":"Natalizumab"},{"ns":0,"exists":"","*":"National Diet Library"},{"ns":0,"exists":"","*":"National Health Service (England)"},{"ns":0,"exists":"","*":"Nausea"},{"ns":0,"exists":"","*":"Nerelimomab"},{"ns":0,"exists":"","*":"Neues Deutschland"},{"ns":0,"exists":"","*":"Neutropenia"},{"ns":0,"exists":"","*":"New York Times"},{"ns":0,"exists":"","*":"Niko von Glasow"},{"ns":0,"exists":"","*":"Nilutamide"},{"ns":0,"exists":"","*":"Nisterime"},{"ns":0,"exists":"","*":"Nisterime acetate"},{"ns":0,"exists":"","*":"NoBody's Perfect"},{"ns":0,"exists":"","*":"Nomegestrol acetate"},{"ns":0,"exists":"","*":"Nonsteroidal antiandrogen"},{"ns":0,"exists":"","*":"Norboletone"},{"ns":0,"exists":"","*":"Norclostebol"},{"ns":0,"exists":"","*":"Norclostebol acetate"},{"ns":0,"exists":"","*":"Nordinone"},{"ns":0,"exists":"","*":"Norethandrolone"},{"ns":0,"exists":"","*":"Norethisterone"},{"ns":0,"exists":"","*":"Norethisterone acetate"},{"ns":0,"exists":"","*":"Norethisterone enanthate"},{"ns":0,"exists":"","*":"Norethisterone ester"},{"ns":0,"exists":"","*":"Norgestrel"},{"ns":0,"exists":"","*":"Norgestrienone"},{"ns":0,"exists":"","*":"Normethandrone"},{"ns":0,"exists":"","*":"Norvinisterone"},{"ns":0,"exists":"","*":"ORF (broadcaster)"},{"ns":0,"exists":"","*":"ORM-15341"},{"ns":0,"exists":"","*":"Obinutuzumab"},{"ns":0,"exists":"","*":"Ocrelizumab"},{"ns":0,"exists":"","*":"Odulimomab"},{"ns":0,"exists":"","*":"Off-label use"},{"ns":0,"exists":"","*":"Omalizumab"},{"ns":0,"exists":"","*":"Order of the British Empire"},{"ns":0,"exists":"","*":"Ornithine"},{"ns":0,"exists":"","*":"Osaterone"},{"ns":0,"exists":"","*":"Osaterone acetate"},{"ns":0,"exists":"","*":"Osteocalcin"},{"ns":0,"exists":"","*":"Osteonectin"},{"ns":0,"exists":"","*":"Osteopontin"},{"ns":0,"exists":"","*":"Otelixizumab"},{"ns":0,"exists":"","*":"Ovarian cancer"},{"ns":0,"exists":"","*":"Over the counter"},{"ns":0,"exists":"","*":"Oxabolone"},{"ns":0,"exists":"","*":"Oxabolone cipionate"},{"ns":0,"exists":"","*":"Oxandrolone"},{"ns":0,"exists":"","*":"Oxendolone"},{"ns":0,"exists":"","*":"Oxford English Dictionary"},{"ns":0,"exists":"","*":"Oxymesterone"},{"ns":0,"exists":"","*":"Oxymetholone"},{"ns":0,"exists":"","*":"PDE4 inhibitor"},{"ns":0,"exists":"","*":"Paediatrician"},{"ns":0,"exists":"","*":"Pascolizumab"},{"ns":0,"exists":"","*":"Pegsunercept"},{"ns":0,"exists":"","*":"Penmesterol"},{"ns":0,"exists":"","*":"Pentomone"},{"ns":0,"exists":"","*":"Peripheral neuritis"},{"ns":0,"exists":"","*":"Peripheral neuropathy"},{"ns":0,"exists":"","*":"Perseus Books"},{"ns":0,"exists":"","*":"Pexelizumab"},{"ns":0,"exists":"","*":"Pharmacokinetics"},{"ns":0,"exists":"","*":"Pharmacologist"},{"ns":0,"exists":"","*":"Pharmacovigilance"},{"ns":0,"exists":"","*":"Phenothrin"},{"ns":0,"exists":"","*":"Phillip Knightley"},{"ns":0,"exists":"","*":"Phocomelia"},{"ns":0,"exists":"","*":"Pimecrolimus"},{"ns":0,"exists":"","*":"Placental barrier"},{"ns":0,"exists":"","*":"Plasma protein binding"},{"ns":0,"exists":"","*":"Platelet factor-4"},{"ns":0,"exists":"","*":"Plomestane"},{"ns":0,"exists":"","*":"Polyclonal antibodies"},{"ns":0,"exists":"","*":"Polytestosterone phloretin phosphate"},{"ns":0,"exists":"","*":"Pomalidomide"},{"ns":0,"exists":"","*":"Potassium canrenoate"},{"ns":0,"exists":"","*":"Prasterone enanthate"},{"ns":0,"exists":"","*":"Prednisone"},{"ns":0,"exists":"","*":"Pregnancy category"},{"ns":0,"exists":"","*":"Prescription drug"},{"ns":0,"exists":"","*":"Prescription medication"},{"ns":0,"exists":"","*":"President's Award for Distinguished Federal Civilian Service"},{"ns":0,"exists":"","*":"Prochloraz"},{"ns":0,"exists":"","*":"Procymidone"},{"ns":0,"exists":"","*":"Prolactin"},{"ns":0,"exists":"","*":"Promegestone"},{"ns":0,"exists":"","*":"Propetandrol"},{"ns":0,"exists":"","*":"Prorenone"},{"ns":0,"exists":"","*":"Prostanozol"},{"ns":0,"exists":"","*":"Prostate cancer"},{"ns":0,"exists":"","*":"Prothrombin"},{"ns":0,"exists":"","*":"Proxalutamide"},{"ns":0,"exists":"","*":"PubChem"},{"ns":0,"exists":"","*":"PubMed Central"},{"ns":0,"exists":"","*":"PubMed Identifier"},{"ns":0,"exists":"","*":"Pulmonary hypertension"},{"ns":0,"exists":"","*":"Purine synthesis inhibitor"},{"ns":0,"exists":"","*":"Pyrimidine synthesis inhibitor"},{"ns":0,"exists":"","*":"Quinbolone"},{"ns":0,"exists":"","*":"Quingestanol"},{"ns":0,"exists":"","*":"Quingestanol acetate"},{"ns":0,"exists":"","*":"RAD140"},{"ns":0,"exists":"","*":"RD-162"},{"ns":0,"exists":"","*":"RU-22930"},{"ns":0,"exists":"","*":"RU-2309"},{"ns":0,"exists":"","*":"RU-58642"},{"ns":0,"exists":"","*":"RU-58841"},{"ns":0,"exists":"","*":"RU-59063"},{"ns":0,"exists":"","*":"Racemic mixture"},{"ns":0,"exists":"","*":"Racemization"},{"ns":0,"exists":"","*":"Ralaniten"},{"ns":0,"exists":"","*":"Ralaniten acetate"},{"ns":0,"exists":"","*":"Reactive oxygen species"},{"ns":0,"exists":"","*":"Reagents"},{"ns":0,"exists":"","*":"Receptor antagonist"},{"ns":0,"exists":"","*":"Receptor modulator"},{"ns":0,"exists":"","*":"Regulation of therapeutic goods"},{"ns":0,"exists":"","*":"Renal cell carcinoma"},{"ns":0,"exists":"","*":"Reslizumab"},{"ns":0,"exists":"","*":"Rheumatoid arthritis"},{"ns":0,"exists":"","*":"Ridaforolimus"},{"ns":0,"exists":"","*":"Rilonacept"},{"ns":0,"exists":"","*":"Risk evaluation and mitigation strategy"},{"ns":0,"exists":"","*":"Rituximab"},{"ns":0,"exists":"","*":"Roehampton"},{"ns":0,"exists":"","*":"Rosterolone"},{"ns":0,"exists":"","*":"Route of administration"},{"ns":0,"exists":"","*":"Rovelizumab"},{"ns":0,"exists":"","*":"Ruplizumab"},{"ns":0,"exists":"","*":"S-23 (drug)"},{"ns":0,"exists":"","*":"S-40503"},{"ns":0,"exists":"","*":"SALL4"},{"ns":0,"exists":"","*":"SC-5233"},{"ns":0,"exists":"","*":"SU5416"},{"ns":0,"exists":"","*":"Sanofi"},{"ns":0,"exists":"","*":"Secukinumab"},{"ns":0,"exists":"","*":"Sedative"},{"ns":0,"exists":"","*":"Selective androgen receptor modulator"},{"ns":0,"exists":"","*":"Seviteronel"},{"ns":0,"exists":"","*":"Sex hormone binding globulin"},{"ns":0,"exists":"","*":"Sexual dysfunction"},{"ns":0,"exists":"","*":"Sherri Finkbine"},{"ns":0,"exists":"","*":"Silandrone"},{"ns":0,"exists":"","*":"Simplified molecular-input line-entry system"},{"ns":0,"exists":"","*":"Siplizumab"},{"ns":0,"exists":"","*":"Sirolimus"},{"ns":0,"exists":"","*":"Smith, Kline & French"},{"ns":0,"exists":"","*":"Solid tumors"},{"ns":0,"exists":"","*":"Spironolactone"},{"ns":0,"exists":"","*":"Spirorenone"},{"ns":0,"exists":"","*":"Spiroxasone"},{"ns":0,"exists":"","*":"Standard for the Uniform Scheduling of Drugs and Poisons"},{"ns":0,"exists":"","*":"Stanozolol"},{"ns":0,"exists":"","*":"Stenbolone"},{"ns":0,"exists":"","*":"Stenbolone acetate"},{"ns":0,"exists":"","*":"Stevens-Johnson Syndrome"},{"ns":0,"exists":"","*":"Strontium"},{"ns":0,"exists":"","*":"Supreme Court of Victoria"},{"ns":0,"exists":"","*":"Suramin"},{"ns":0,"exists":"","*":"Sweden"},{"ns":0,"exists":"","*":"Syncope (medicine)"},{"ns":0,"exists":"","*":"TFM-4AS-1"},{"ns":0,"exists":"","*":"TNF inhibitor"},{"ns":0,"exists":"","*":"T cell"},{"ns":0,"exists":"","*":"Tacrolimus"},{"ns":0,"exists":"","*":"Talizumab"},{"ns":0,"exists":"","*":"Tasquinimod"},{"ns":0,"exists":"","*":"Telimomab aritox"},{"ns":0,"exists":"","*":"Temsirolimus"},{"ns":0,"exists":"","*":"Teneliximab"},{"ns":0,"exists":"","*":"Teplizumab"},{"ns":0,"exists":"","*":"Teratogen"},{"ns":0,"exists":"","*":"Teratogenic"},{"ns":0,"exists":"","*":"Teratology"},{"ns":0,"exists":"","*":"Teriflunomide"},{"ns":0,"exists":"","*":"Testifenon"},{"ns":0,"exists":"","*":"Testosterone"},{"ns":0,"exists":"","*":"Testosterone/dutasteride"},{"ns":0,"exists":"","*":"Testosterone (medication)"},{"ns":0,"exists":"","*":"Tetrahydrogestrinone"},{"ns":0,"exists":"","*":"Tetrathiomolybdate"},{"ns":0,"exists":"","*":"The Sunday Star-Times"},{"ns":0,"exists":"","*":"The Sunday Times"},{"ns":0,"exists":"","*":"The Sunday Times Magazine"},{"ns":0,"exists":"","*":"The Sydney Morning Herald"},{"ns":0,"exists":"","*":"The Viking Press"},{"ns":0,"exists":"","*":"Thomas Quasthoff"},{"ns":0,"exists":"","*":"Thrombocytopenia"},{"ns":0,"exists":"","*":"Thrombosis"},{"ns":0,"exists":"","*":"Thrombospondin"},{"ns":0,"exists":"","*":"Thrombospondin 1"},{"ns":0,"exists":"","*":"Tibolone"},{"ns":0,"exists":"","*":"Tiomesterone"},{"ns":0,"exists":"","*":"Tissue inhibitor of metalloproteinases"},{"ns":0,"exists":"","*":"Tocilizumab"},{"ns":0,"exists":"","*":"Topilutamide"},{"ns":0,"exists":"","*":"Topterone"},{"ns":0,"exists":"","*":"Toralizumab"},{"ns":0,"exists":"","*":"Tremelimumab"},{"ns":0,"exists":"","*":"Trenbolone"},{"ns":0,"exists":"","*":"Trenbolone acetate"},{"ns":0,"exists":"","*":"Trenbolone enanthate"},{"ns":0,"exists":"","*":"Trenbolone hexahydrobenzylcarbonate"},{"ns":0,"exists":"","*":"Trenbolone undecanoate"},{"ns":0,"exists":"","*":"Trendione"},{"ns":0,"exists":"","*":"Trestolone"},{"ns":0,"exists":"","*":"Trestolone acetate"},{"ns":0,"exists":"","*":"Trestolone enanthate"},{"ns":0,"exists":"","*":"Triclosan"},{"ns":0,"exists":"","*":"Trimegestone"},{"ns":0,"exists":"","*":"Trimethyltrienolone"},{"ns":0,"exists":"","*":"Tuberculosis"},{"ns":0,"exists":"","*":"Tuberculosis management"},{"ns":0,"exists":"","*":"Tuberculous meningitis"},{"ns":0,"exists":"","*":"Tumor lysis syndrome"},{"ns":0,"exists":"","*":"U.S. Food and Drug Administration"},{"ns":0,"exists":"","*":"Ubiquitin ligase"},{"ns":0,"exists":"","*":"Umirolimus"},{"ns":0,"exists":"","*":"Unique Ingredient Identifier"},{"ns":0,"exists":"","*":"Ustekinumab"},{"ns":0,"exists":"","*":"VEGFR"},{"ns":0,"exists":"","*":"VEGFR-1"},{"ns":0,"exists":"","*":"VEGI"},{"ns":0,"exists":"","*":"Valproic acid"},{"ns":0,"exists":"","*":"Vapaliximab"},{"ns":0,"exists":"","*":"Vasostatin"},{"ns":0,"exists":"","*":"Vepalimomab"},{"ns":0,"exists":"","*":"Vinclozolin"},{"ns":0,"exists":"","*":"Vinyltestosterone"},{"ns":0,"exists":"","*":"Visilizumab"},{"ns":0,"exists":"","*":"W5 (TV series)"},{"ns":0,"exists":"","*":"West Germany"},{"ns":0,"exists":"","*":"Whip (politics)"},{"ns":0,"exists":"","*":"Widukind Lenz"},{"ns":0,"exists":"","*":"William McBride (doctor)"},{"ns":0,"exists":"","*":"World Health Organisation"},{"ns":0,"exists":"","*":"YK-11"},{"ns":0,"exists":"","*":"ZM-182345"},{"ns":0,"exists":"","*":"Zanolimumab"},{"ns":0,"exists":"","*":"Zanoterone"},{"ns":0,"exists":"","*":"Zinc"},{"ns":0,"exists":"","*":"Zolimomab aritox"},{"ns":0,"exists":"","*":"Zotarolimus"},{"ns":0,"exists":"","*":"\u03944-Tibolone"},{"ns":0,"*":"The Thalidomide Victims Association of Canada"},{"ns":0,"*":"Canstatin"},{"ns":0,"*":"Proliferin-related protein"},{"ns":0,"*":"Angiostatic steroid"},{"ns":0,"*":"CM101"},{"ns":0,"*":"Linomide"},{"ns":0,"*":"Tecogalan"},{"ns":0,"*":"TNP-470"},{"ns":0,"*":"4,17\u03b1-Dimethyltestosterone"},{"ns":0,"*":"Dihydroethyltestosterone"},{"ns":0,"*":"Dihydromethylandrostenediol"},{"ns":0,"*":"5\u03b1-Dihydrotrestolone"},{"ns":0,"*":"198RL26"},{"ns":0,"*":"ACP-105"},{"ns":0,"*":"AC-262536"},{"ns":0,"*":"BMS-564929"},{"ns":0,"*":"DTIB"},{"ns":0,"*":"FTBU-1"},{"ns":0,"*":"GSK-4336A"},{"ns":0,"*":"GSK-8698"},{"ns":0,"*":"LGD-2941"},{"ns":0,"*":"JNJ-26146900"},{"ns":0,"*":"JNJ-28330835"},{"ns":0,"*":"JNJ-37654032"},{"ns":0,"*":"ORM-11984"},{"ns":0,"*":"R-1 (drug)"},{"ns":0,"*":"S-1 (drug)"},{"ns":0,"*":"S-101479"},{"ns":0,"*":"EM-9017"},{"ns":0,"*":"EM-4350"},{"ns":0,"*":"EM-5855"},{"ns":0,"*":"EM-6537"},{"ns":0,"*":"RU-15328"},{"ns":0,"*":"Antarlide"},{"ns":0,"*":"Arabilin"},{"ns":0,"*":"AZD-3514"},{"ns":0,"*":"BAY-1024767"},{"ns":0,"*":"Bisphenol F diglycidyl ether"},{"ns":0,"*":"BMS-501949"},{"ns":0,"*":"BMS-570511"},{"ns":0,"*":"CH5137291"},{"ns":0,"*":"LG-105"},{"ns":0,"*":"LGD-1331"},{"ns":0,"*":"N-Butylbenzenesulfonamide"},{"ns":0,"*":"ONC1-13B"},{"ns":0,"*":"PF-998425"},{"ns":0,"*":"Ro 2-7239"},{"ns":0,"*":"Ro 5-2537"},{"ns":0,"*":"RU-56187"},{"ns":0,"*":"RU-57073"},{"ns":0,"*":"YM-580"},{"ns":0,"*":"YM-92088"},{"ns":0,"*":"YM-175735"},{"ns":14,"exists":"","*":"Category:Articles with unsourced statements from April 2017"},{"ns":14,"exists":"","*":"Category:Articles with unsourced statements from March 2017"},{"ns":14,"exists":"","*":"Category:Articles with dead external links from October 2015"},{"ns":14,"exists":"","*":"Category:Articles with dead external links from June 2014"},{"ns":14,"exists":"","*":"Category:Articles with unsourced statements from October 2015"},{"ns":14,"exists":"","*":"Category:Articles with unsourced statements from April 2016"},{"ns":14,"exists":"","*":"Category:Wikipedia articles with GND identifiers"},{"ns":14,"exists":"","*":"Category:Wikipedia articles with NDL identifiers"},{"ns":14,"exists":"","*":"Category:Angiogenesis inhibitors"},{"ns":14,"exists":"","*":"Category:People with phocomelia"},{"ns":10,"exists":"","*":"Template:Antiangiogenics"},{"ns":10,"exists":"","*":"Template:Immunosuppressants"},{"ns":10,"exists":"","*":"Template:Androgen receptor modulators"},{"ns":10,"exists":"","*":"Template:Androgens and antiandrogens"},{"ns":10,"exists":"","*":"Template:Estrogen receptor modulators"},{"ns":10,"exists":"","*":"Template:Progesterone receptor modulators"},{"ns":10,"exists":"","*":"Template:Receptor modulators"},{"ns":4,"exists":"","*":"Wikipedia:Citation needed"},{"ns":4,"exists":"","*":"Wikipedia:Link rot"},{"ns":4,"exists":"","*":"Wikipedia:WikiProject Chemicals/Chembox validation"},{"ns":11,"exists":"","*":"Template talk:Androgen receptor modulators"},{"ns":11,"exists":"","*":"Template talk:Antiangiogenics"},{"ns":11,"exists":"","*":"Template talk:Immunosuppressants"},{"ns":12,"exists":"","*":"Help:Authority control"},{"ns":12,"exists":"","*":"Help:IPA/English"}],"templates":[{"ns":10,"exists":"","*":"Template:Drugbox"},{"ns":10,"exists":"","*":"Template:Infobox drug"},{"ns":10,"exists":"","*":"Template:Infobox"},{"ns":10,"exists":"","*":"Template:Infobox drug/title"},{"ns":10,"exists":"","*":"Template:Drugs.com"},{"ns":10,"exists":"","*":"Template:Main other"},{"ns":10,"exists":"","*":"Template:IPAc-en"},{"ns":10,"exists":"","*":"Template:Infobox drug/licence"},{"ns":10,"exists":"","*":"Template:Abbr"},{"ns":10,"exists":"","*":"Template:ParameterUseFirst"},{"ns":10,"exists":"","*":"Template:Engvar"},{"ns":10,"exists":"","*":"Template:Infobox drug/pregnancy category"},{"ns":10,"exists":"","*":"Template:Unbulleted list"},{"ns":10,"exists":"","*":"Template:Infobox drug/formatATC"},{"ns":10,"exists":"","*":"Template:Infobox drug/legal status"},{"ns":10,"exists":"","*":"Template:Nowrap"},{"ns":10,"exists":"","*":"Template:Collapsible list"},{"ns":10,"exists":"","*":"Template:Infobox drug/formatCASnumber"},{"ns":10,"exists":"","*":"Template:Cascite"},{"ns":10,"exists":"","*":"Template:Tick"},{"ns":10,"exists":"","*":"Template:Infobox drug/formatPubChemCID"},{"ns":10,"exists":"","*":"Template:Infobox drug/formatPubChemSID"},{"ns":10,"exists":"","*":"Template:Infobox drug/formatIUPHARBPS"},{"ns":10,"exists":"","*":"Template:Infobox drug/formatDrugBank"},{"ns":10,"exists":"","*":"Template:Drugbankcite"},{"ns":10,"exists":"","*":"Template:Infobox drug/formatChemSpider"},{"ns":10,"exists":"","*":"Template:Chemspidercite"},{"ns":10,"exists":"","*":"Template:Infobox drug/formatUNII"},{"ns":10,"exists":"","*":"Template:Infobox drug/formatKEGG"},{"ns":10,"exists":"","*":"Template:Keggcite"},{"ns":10,"exists":"","*":"Template:Infobox drug/formatChEBI"},{"ns":10,"exists":"","*":"Template:Ebicite"},{"ns":10,"exists":"","*":"Template:Cross"},{"ns":10,"exists":"","*":"Template:Infobox drug/formatChEMBL"},{"ns":10,"exists":"","*":"Template:Infobox drug/formatChemDBNIAID"},{"ns":10,"exists":"","*":"Template:Infobox drug/formatPDBligand"},{"ns":10,"exists":"","*":"Template:EditAtWikidata"},{"ns":10,"exists":"","*":"Template:Infobox drug/chemical formula"},{"ns":10,"exists":"","*":"Template:Chembox Elements/molecular formula"},{"ns":10,"exists":"","*":"Template:Yesno"},{"ns":10,"exists":"","*":"Template:Chem molar mass"},{"ns":10,"exists":"","*":"Template:Chem molar mass/format"},{"ns":10,"exists":"","*":"Template:Infobox drug/formatJmol"},{"ns":10,"exists":"","*":"Template:Stdinchicite"},{"ns":10,"exists":"","*":"Template:Nobold"},{"ns":10,"exists":"","*":"Template:Template other"},{"ns":10,"exists":"","*":"Template:Button"},{"ns":10,"exists":"","*":"Template:Border-radius"},{"ns":10,"exists":"","*":"Template:Linear-gradient"},{"ns":10,"exists":"","*":"Template:Fdacite"},{"ns":10,"exists":"","*":"Template:Infobox drug/maintenance categories"},{"ns":10,"exists":"","*":"Template:TOC limit"},{"ns":10,"exists":"","*":"Template:See also"},{"ns":10,"exists":"","*":"Template:Citation needed"},{"ns":10,"exists":"","*":"Template:Fix"},{"ns":10,"exists":"","*":"Template:Category handler"},{"ns":10,"exists":"","*":"Template:Fix/category"},{"ns":10,"exists":"","*":"Template:Delink"},{"ns":10,"exists":"","*":"Template:Dead link"},{"ns":10,"exists":"","*":"Template:Main"},{"ns":10,"exists":"","*":"Template:Div col"},{"ns":10,"exists":"","*":"Template:Column-width"},{"ns":10,"exists":"","*":"Template:Div col end"},{"ns":10,"exists":"","*":"Template:Reflist"},{"ns":10,"exists":"","*":"Template:OED"},{"ns":10,"exists":"","*":"Template:Cite OED"},{"ns":10,"exists":"","*":"Template:Citation"},{"ns":10,"exists":"","*":"Template:Harvid"},{"ns":10,"exists":"","*":"Template:SfnRef"},{"ns":10,"exists":"","*":"Template:ODNBsub"},{"ns":10,"exists":"","*":"Template:Link note"},{"ns":10,"exists":"","*":"Template:Cite journal"},{"ns":10,"exists":"","*":"Template:Cite web"},{"ns":10,"exists":"","*":"Template:Cite book"},{"ns":10,"exists":"","*":"Template:Open access"},{"ns":10,"exists":"","*":"Template:Cite news"},{"ns":10,"exists":"","*":"Template:Angiogenesis inhibitors"},{"ns":10,"exists":"","*":"Template:Antiangiogenics"},{"ns":10,"exists":"","*":"Template:Navbox"},{"ns":10,"exists":"","*":"Template:Immunosuppressants"},{"ns":10,"exists":"","*":"Template:Androgen receptor modulators"},{"ns":10,"exists":"","*":"Template:Abbrlink"},{"ns":10,"exists":"","*":"Template:Authority control"},{"ns":828,"exists":"","*":"Module:Infobox"},{"ns":828,"exists":"","*":"Module:Navbar"},{"ns":828,"exists":"","*":"Module:InfoboxImage"},{"ns":828,"exists":"","*":"Module:IPAc-en"},{"ns":828,"exists":"","*":"Module:IPAc-en/data"},{"ns":828,"exists":"","*":"Module:IPAc-en/pronunciation"},{"ns":828,"exists":"","*":"Module:IPAc-en/phonemes"},{"ns":828,"exists":"","*":"Module:Category handler"},{"ns":828,"exists":"","*":"Module:Yesno"},{"ns":828,"exists":"","*":"Module:Category handler/data"},{"ns":828,"exists":"","*":"Module:Category handler/config"},{"ns":828,"exists":"","*":"Module:Category handler/shared"},{"ns":828,"exists":"","*":"Module:Category handler/blacklist"},{"ns":828,"exists":"","*":"Module:Namespace detect/data"},{"ns":828,"exists":"","*":"Module:Namespace detect/config"},{"ns":828,"exists":"","*":"Module:Arguments"},{"ns":828,"exists":"","*":"Module:String"},{"ns":828,"exists":"","*":"Module:Engvar"},{"ns":828,"exists":"","*":"Module:List"},{"ns":828,"exists":"","*":"Module:TableTools"},{"ns":828,"exists":"","*":"Module:Collapsible list"},{"ns":828,"exists":"","*":"Module:EditAtWikidata"},{"ns":828,"exists":"","*":"Module:Math"},{"ns":828,"exists":"","*":"Module:TemplatePar"},{"ns":828,"exists":"","*":"Module:ParameterCount"},{"ns":828,"exists":"","*":"Module:Labelled list hatnote"},{"ns":828,"exists":"","*":"Module:Hatnote"},{"ns":828,"exists":"","*":"Module:Hatnote list"},{"ns":828,"exists":"","*":"Module:Unsubst"},{"ns":828,"exists":"","*":"Module:Delink"},{"ns":828,"exists":"","*":"Module:No globals"},{"ns":828,"exists":"","*":"Module:Main"},{"ns":828,"exists":"","*":"Module:Check for unknown parameters"},{"ns":828,"exists":"","*":"Module:Citation/CS1"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Configuration"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Whitelist"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Utilities"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Date validation"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Identifiers"},{"ns":828,"exists":"","*":"Module:Citation/CS1/COinS"},{"ns":828,"exists":"","*":"Module:Navbox"},{"ns":828,"exists":"","*":"Module:Authority control"},{"ns":828,"exists":"","*":"Module:ResolveEntityId"}],"images":["Lock-green.svg","Open_Access_logo_PLoS_transparent.svg","Thalidomide_enantiomers.svg","Yes_check.svg","X_mark.svg","Blue_pencil.svg","Pack_of_Thalidomide_tablets.jpg","Thalidomide-structures.png","Thalidomide_syntehsis.png","NCP14053.jpg","Artificial_limbs_for_a_thalidomide_child,_1961-1965._(9660575567).jpg","Frances_Oldham_Kelsey_and_John_F._Kennedy.jpg","Niko_von_Glasow.jpg"],"externallinks":["http://oed.com/search?searchType=dictionary&q=Thalidomide","http://www.oxforddnb.com/help/subscribe#public","//doi.org/10.2165/00003088-200443050-00004","//www.ncbi.nlm.nih.gov/pubmed/15080764","https://oncozine.com/reversal-of-fortune-how-a-vilified-drug-became-a-life-saving-agent-in-the-war-against-cancer/","http://www.oxfordreference.com/view/10.1093/acref/9780198524038.001.0001/acref-9780198524038","//doi.org/10.1093/acref/9780198524038.001.0001","https://www.medicines.org.uk/emc/medicine/21005","https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/020785s061lbl.pdf","https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020785","https://web.archive.org/web/20160818223324/http://www.europeanreview.org/wp/wp-content/uploads/827.pdf","//www.ncbi.nlm.nih.gov/pubmed/21222370","http://www.europeanreview.org/wp/wp-content/uploads/827.pdf","//doi.org/10.1016/j.spen.2014.01.006","//www.ncbi.nlm.nih.gov/pubmed/24655399","//doi.org/10.1016/j.jaad.2015.01.002","//www.ncbi.nlm.nih.gov/pubmed/25617013","http://www.bbmt.org/article/S1083-8791(10)00275-2/fulltext","//doi.org/10.1016/j.bbmt.2010.06.015","//www.ncbi.nlm.nih.gov/pubmed/20601036","http://www.bbmt.org/article/S1083-8791(10)00223-5/fulltext","//doi.org/10.1016/j.bbmt.2010.05.011","//www.ncbi.nlm.nih.gov/pubmed/20685255","//doi.org/10.1093/toxsci/kfp097","//www.ncbi.nlm.nih.gov/pubmed/19414517","https://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent&id=CP-2010-PI-03581-3","//doi.org/10.1016/S0006-2952(99)00388-3","//www.ncbi.nlm.nih.gov/pubmed/10799645","//www.ncbi.nlm.nih.gov/pmc/articles/PMC4737249","//doi.org/10.1002/bdrc.21096","//www.ncbi.nlm.nih.gov/pubmed/26043938","//doi.org/10.1093/toxsci/kfr088","//www.ncbi.nlm.nih.gov/pubmed/21507989","https://elifesciences.org/articles/38430","//doi.org/10.7554/eLife.38430","//doi.org/10.1002/cmdc.201000259","//www.ncbi.nlm.nih.gov/pubmed/20853390","//www.ncbi.nlm.nih.gov/pmc/articles/PMC4412434","//doi.org/10.1007/s00228-015-1835-x","//www.ncbi.nlm.nih.gov/pubmed/25827472","//doi.org/10.1002/chir.530070109","//www.ncbi.nlm.nih.gov/pubmed/7702998","//doi.org/10.1016/S0960-894X(03)00778-9","//www.ncbi.nlm.nih.gov/pubmed/14505639","//doi.org/10.1038/nrc1323","//www.ncbi.nlm.nih.gov/pubmed/15057291","//doi.org/10.1021/op980201b","//doi.org/10.1016/S0140-6736(04)16308-3","//www.ncbi.nlm.nih.gov/pubmed/15172781","https://www.grunenthal.com/about-us/history","http://www.contergan.grunenthal.info/thalidomid/Home_/351300028.jsp;jsessionid=D8966B9045A2EDE78D5AC41F85C93424.drp1?naviLocale=en_EN","http://www.bhj.org.in/journal/2008_5003_july/download/page-472-476.pdf","//doi.org/10.1016/0270-3092(82)90018-2","//www.ncbi.nlm.nih.gov/pubmed/7149705","//doi.org/10.1177/00220345670460061201","//www.ncbi.nlm.nih.gov/pubmed/5235007","https://www.youtube.com/watch?v=_NLbhOyLLMY","http://www.vfa.de/de/arzneimittel-forschung/artikel-arzneimittel-forschung/teratogenitaet.html","https://web.archive.org/web/20090512235601/http://www.fda.gov/fdac/features/2001/201_kelsey.html","http://www.fda.gov/fdac/features/2001/201_kelsey.html","//www.ncbi.nlm.nih.gov/pmc/articles/PMC1921912","//www.ncbi.nlm.nih.gov/pubmed/14076167","//doi.org/10.1542/peds.110.2.404","//www.ncbi.nlm.nih.gov/pubmed/12165600","//doi.org/10.1002/(SICI)1096-9926(199702)55:2%3C156::AID-TERA6%3E3.0.CO;2-1","//www.ncbi.nlm.nih.gov/pubmed/9098920","//doi.org/10.1016/j.reprotox.2005.11.007","//www.ncbi.nlm.nih.gov/pubmed/16427249","https://web.archive.org/web/20120313095445/http://www.saude.df.gov.br/003/00301009.asp?ttCD_CHAVE=31041","http://www.saude.df.gov.br/003/00301009.asp?ttCD_CHAVE=31041","https://www.bbc.com/news/magazine-23418102","https://www.nytimes.com/1998/07/17/us/thalidomide-approved-to-treat-leprosy-with-other-uses-seen.html","http://www.who.int/lep/research/thalidomide/en/index.html","//www.ncbi.nlm.nih.gov/pmc/articles/PMC2265446","//doi.org/10.1182/blood-2007-10-078022","//www.ncbi.nlm.nih.gov/pubmed/18332230","http://www.nasonline.org/publications/biographical-memoirs/memoir-pdfs/folkman-judah.pdf","//doi.org/10.1089/lrb.2008.1016","//www.ncbi.nlm.nih.gov/pubmed/19093793","//doi.org/10.1016/s0093-7754(01)90021-1","//www.ncbi.nlm.nih.gov/pubmed/11740806","//www.ncbi.nlm.nih.gov/pmc/articles/PMC2268723","//doi.org/10.1007/s10456-008-9092-6","//www.ncbi.nlm.nih.gov/pubmed/18247146","//doi.org/10.1056/NEJM199911183412102","//www.ncbi.nlm.nih.gov/pubmed/10564685","http://www.cancer.gov/cancertopics/druginfo/fda-thalidomide","http://permanent.access.gpo.gov/lps1609/www.fda.gov/fdac/features/2001/201_kelsey.html","https://www.nytimes.com/2010/03/16/science/16limb.html?ref=science&pagewanted=all","https://web.archive.org/web/20110929135332/http://www.history.ca/ontv/titledetails.aspx?titleid=21267","http://www.history.ca/ontv/titledetails.aspx?titleid=21267","http://news.bbc.co.uk/1/hi/health/8458855.stm","http://www.thesundaytimes.co.uk/sto/Magazine/article1551306.ece","http://www.whonamedit.com/doctor.cfm/1002.html","http://news.bbc.co.uk/1/hi/uk/2031459.stm","https://web.archive.org/web/20121028204857/http://embryology.med.unsw.edu.au/Defect/page5i.htm","http://embryology.med.unsw.edu.au/Defect/page5i.htm","//doi.org/10.1016/S0140-6736(62)90822-X","//www.ncbi.nlm.nih.gov/pubmed/14288814","http://www.openbookpublishers.com/htmlreader/978-1-78374-117-5/Ch-18.xhtml#_idTextAnchor074","https://www.neues-deutschland.de/artikel/120351.html","http://www.aerzteblatt.de/archiv/57224/","http://www.contergan-ag50.de/Seiten/presse/20111125-27_artikel/2007_Die_Contergan-Katastrophe_Die_truegerische_Sicherheit_der_harten_Daten-Deutsches_Aerzteblatt.pdf","https://web.archive.org/web/20090814144428/http://orf.at/070930-17124/index.html","http://orf.at/070930-17124/index.html","https://www.huffingtonpost.com/whitny-braun/thalidomide-the-connectio_b_8881702.html","https://web.archive.org/web/20131218004638/http://www.birthdefects.org/research/bendectin_1.php","http://www.birthdefects.org/research/bendectin_1.php","https://www.cliohistory.org/click/body-health/reproduction/","https://web.archive.org/web/20120901184544/http://www.contergan.grunenthal.info/grt-ctg/GRT-CTG/Stellungnahme/Rede_anlaesslich_Einweihung_des_Contergan-Denkmals/224600963.jsp","http://www.contergan.grunenthal.info/grt-ctg/GRT-CTG/Stellungnahme/Rede_anlaesslich_Einweihung_des_Contergan-Denkmals/224600963.jsp","https://web.archive.org/web/20160316085150/http://www.bbc.com/news/health-19448046","https://www.bbc.com/news/health-19448046","http://news.bbc.co.uk/1/hi/health/3589173.stm","https://web.archive.org/web/20040707121708/http://news.bbc.co.uk/1/hi/health/3589173.stm","https://web.archive.org/web/20080513095824/http://www.timesonline.co.uk/tol/life_and_style/health/article3602694.ece","http://www.timesonline.co.uk/tol/life_and_style/health/article3602694.ece","http://news.bbc.co.uk/1/hi/health/4658919.stm","https://web.archive.org/web/20090120103416/http://news.bbc.co.uk/1/hi/health/4658919.stm","http://news.bbc.co.uk/1/hi/8428838.stm","https://archive.is/20130114042718/http://news.bbc.co.uk/2/hi/8428838.stm","http://www.abc.net.au/news/2011-12-19/australian-thalidomide-victims-win-hearing-bid/3738116","http://www.smh.com.au/national/landmark-thalidomide-payout-offers-hope-for-thousands-20120718-22apa.html","http://www.abc.net.au/news/2014-02-07/supreme-court-formally-approves-2489m-class-action-for-thalido/5245034","http://www.stuff.co.nz/national/health/9698482/Thalidomide-survivors-compensation-approved","http://permanent.access.gpo.gov/lps1609/www.fda.gov/fdac/departs/2001/201_word.html","//www.ncbi.nlm.nih.gov/pubmed/11444250","https://web.archive.org/web/20090624192258/http://www.thalidomide.ca/tvac-mission/","//doi.org/10.1016/S0300-483X(03)00192-6","//www.ncbi.nlm.nih.gov/pubmed/12909394","http://www.ctvnews.ca/w5/the-plight-of-the-thalidomide-sample-babies-who-don-t-qualify-for-gov-t-compensation-1.3176590","https://www.nytimes.com/2010/09/14/health/14kelsey.html?_r=1&8dpc","http://www.midsussextimes.co.uk/news/local/mid-sussex-residents-honoured-by-queen-1-6795898","https://web.archive.org/web/20120306201745/https://www.portlandphoenix.com/archive/music/02/04/19/classical_Orpheus.html","http://www.portlandphoenix.com/archive/music/02/04/19/classical_Orpheus.html","https://www.imdb.com/title/tt1266093/releaseinfo","http://www.spiritualityandpractice.com/films/films.php?id=19559","http://www.uwindsor.ca/dailynews/2016-06-07/outstanding-eight-receive-honorary-doctorates-convocation","http://www.fda.gov/Drugs/NewsEvents/ucm320924.htm","https://web.archive.org/web/20131203020225/http://www.crncc.nihr.ac.uk/workforce_development/learning_and_development/gcp/gcp_resource/research_standards/history/thalidomide","http://www.crncc.nihr.ac.uk/workforce_development/learning_and_development/gcp/gcp_resource/research_standards/history/thalidomide","//www.ncbi.nlm.nih.gov/pmc/articles/PMC1720896","//doi.org/10.1136/fn.80.2.F142","//www.ncbi.nlm.nih.gov/pubmed/10325794","https://web.archive.org/web/20111014114005/https://www.rpharms.com/museum-pdfs/e3a-thalidomide-and-its-aftermath-2011.pdf","https://www.rpharms.com/museum-pdfs/e3a-thalidomide-and-its-aftermath-2011.pdf","//doi.org/10.1021/jm990083y","//www.ncbi.nlm.nih.gov/pubmed/10447943","//doi.org/10.1016/S0093-7754(01)90031-4","//www.ncbi.nlm.nih.gov/pubmed/11740816","//doi.org/10.2146/ajhp070029","//www.ncbi.nlm.nih.gov/pubmed/17724360","http://clinicaltrials.gov/ct/search?term=pomalidomide&submit=Search","//doi.org/10.2174/187152909787581354","//www.ncbi.nlm.nih.gov/pubmed/19275572","http://www.myelomabeacon.com/news/2013/02/08/pomalyst-pomalidomide-fda-approval-multiple-myeloma/","http://www.myelomabeacon.com/news/2013/08/09/pomalidomide-imnovid-pomalyst-europe-ema-approval-multiple-myeloma/","//doi.org/10.1002/14651858.CD007350.pub2","//www.ncbi.nlm.nih.gov/pubmed/19370684","//doi.org/10.1002/14651858.CD007351.pub2","//www.ncbi.nlm.nih.gov/pubmed/19370685","http://emedicine.medscape.com/article/279734-treatment#showall","//www.ncbi.nlm.nih.gov/pmc/articles/PMC1774430","//doi.org/10.1136/gut.2004.047563","//www.ncbi.nlm.nih.gov/pubmed/15753541","//doi.org/10.1053/gast.1997.v112.pm9178672","//www.ncbi.nlm.nih.gov/pubmed/9178672","//www.ncbi.nlm.nih.gov/pubmed/23139966","//doi.org/10.7326/0003-4819-128-6-199803150-00004","//www.ncbi.nlm.nih.gov/pubmed/9499327","//doi.org/10.1038/nri3813","//www.ncbi.nlm.nih.gov/pubmed/25765201","http://www.abc.net.au/news/health/2018-06-29/thalidomide-william-mcbride-flawed-character-norman-swan/9920608","https://www.independent.co.uk/news/world/thalidomide-doctor-guilty-of-medical-fraud-william-mcbride-who-exposed-the-danger-of-one-anti-nausea-1474190.html","News:Health","https://www.wikidata.org/wiki/Q203174#P2566","https://www.wikidata.org/wiki/Q203174","https://www.drugs.com/monograph/thalidomide.html","https://medlineplus.gov/druginfo/meds/a699032.html","http://www.ema.europa.eu/ema/index.jsp?curl=/pages/medicines/landing/epar_search.jsp&mid=&searchTab=searchByKey&alreadyLoaded=true&isNewQuery=true&status=Authorised&status=Withdrawn&status=Suspended&status=Refused&keywordSearch=Submit&searchType=inn&taxonomyPath=&treeNumber=&searchGenericType=generics&keyword=Thalidomide","https://www.accessdata.fda.gov/scripts/cder/drugsatfda/index.cfm?fuseaction=Search.SearchAction&SearchTerm=Thalidomide&SearchType=BasicSearch","https://www.whocc.no/atc_ddd_index/?code=L04AX02","http://www.commonchemistry.org/ChemicalDetail.aspx?ref=50-35-1","https://pubchem.ncbi.nlm.nih.gov/compound/5426","http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7327","https://www.drugbank.ca/drugs/DB01041","http://www.chemspider.com/Chemical-Structure.5233.html","https://fdasis.nlm.nih.gov/srs/srsdirect.jsp?regno=4Z8R6ORS6L","http://www.kegg.jp/entry/D00754","https://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI:9513","https://www.ebi.ac.uk/chembldb/index.php/compound/inspect/CHEMBL468","https://echa.europa.eu/substance-information/-/substanceinfo/100.000.029","https://chemapps.stolaf.edu/jmol/jmol.php?model=O%3DC(N1C2CCC(NC2%3DO)%3DO)C3%3DCC%3DCC%3DC3C1%3DO","http://www.who.int/entity/medicines/publications/newsletter/en/news2003_2.pdf","http://www.cbc.ca/archives/topic/thalidomide-bitter-pills-broken-promises","http://theconversation.com/remind-me-again-what-is-thalidomide-and-how-did-it-cause-so-much-harm-46847","https://d-nb.info/gnd/4184973-5","https://id.ndl.go.jp/auth/ndlna/00570209"],"sections":[{"toclevel":1,"level":"2","line":"Medical uses","number":"1","index":"1","fromtitle":"Thalidomide","byteoffset":5345,"anchor":"Medical_uses"},{"toclevel":1,"level":"2","line":"Contraindications","number":"2","index":"2","fromtitle":"Thalidomide","byteoffset":9374,"anchor":"Contraindications"},{"toclevel":1,"level":"2","line":"Adverse effects","number":"3","index":"3","fromtitle":"Thalidomide","byteoffset":9915,"anchor":"Adverse_effects"},{"toclevel":2,"level":"3","line":"Interactions","number":"3.1","index":"4","fromtitle":"Thalidomide","byteoffset":12409,"anchor":"Interactions"},{"toclevel":2,"level":"3","line":"Overdose","number":"3.2","index":"5","fromtitle":"Thalidomide","byteoffset":13694,"anchor":"Overdose"},{"toclevel":1,"level":"2","line":"Pharmacology","number":"4","index":"6","fromtitle":"Thalidomide","byteoffset":13932,"anchor":"Pharmacology"},{"toclevel":1,"level":"2","line":"Chemistry","number":"5","index":"7","fromtitle":"Thalidomide","byteoffset":17265,"anchor":"Chemistry"},{"toclevel":1,"level":"2","line":"History","number":"6","index":"8","fromtitle":"Thalidomide","byteoffset":19947,"anchor":"History"},{"toclevel":2,"level":"3","line":"Leprosy treatment","number":"6.1","index":"9","fromtitle":"Thalidomide","byteoffset":29252,"anchor":"Leprosy_treatment"},{"toclevel":2,"level":"3","line":"Cancer treatment","number":"6.2","index":"10","fromtitle":"Thalidomide","byteoffset":33893,"anchor":"Cancer_treatment"},{"toclevel":1,"level":"2","line":"Society and culture","number":"7","index":"11","fromtitle":"Thalidomide","byteoffset":37830,"anchor":"Society_and_culture"},{"toclevel":2,"level":"3","line":"Birth defects crisis","number":"7.1","index":"12","fromtitle":"Thalidomide","byteoffset":37855,"anchor":"Birth_defects_crisis"},{"toclevel":2,"level":"3","line":"Aftermath of scandal","number":"7.2","index":"13","fromtitle":"Thalidomide","byteoffset":51097,"anchor":"Aftermath_of_scandal"},{"toclevel":3,"level":"4","line":"Germany","number":"7.2.1","index":"14","fromtitle":"Thalidomide","byteoffset":52059,"anchor":"Germany"},{"toclevel":3,"level":"4","line":"United Kingdom","number":"7.2.2","index":"15","fromtitle":"Thalidomide","byteoffset":54482,"anchor":"United_Kingdom"},{"toclevel":3,"level":"4","line":"Australia","number":"7.2.3","index":"16","fromtitle":"Thalidomide","byteoffset":56536,"anchor":"Australia"},{"toclevel":3,"level":"4","line":"Canada","number":"7.2.4","index":"17","fromtitle":"Thalidomide","byteoffset":58421,"anchor":"Canada"},{"toclevel":3,"level":"4","line":"United States","number":"7.2.5","index":"18","fromtitle":"Thalidomide","byteoffset":60963,"anchor":"United_States"},{"toclevel":2,"level":"3","line":"Notable cases","number":"7.3","index":"19","fromtitle":"Thalidomide","byteoffset":62412,"anchor":"Notable_cases"},{"toclevel":2,"level":"3","line":"Change in drug regulations","number":"7.4","index":"20","fromtitle":"Thalidomide","byteoffset":64832,"anchor":"Change_in_drug_regulations"},{"toclevel":1,"level":"2","line":"Research","number":"8","index":"21","fromtitle":"Thalidomide","byteoffset":66882,"anchor":"Research"},{"toclevel":2,"level":"3","line":"Thalidomide analogs","number":"8.1","index":"22","fromtitle":"Thalidomide","byteoffset":67111,"anchor":"Thalidomide_analogs"},{"toclevel":2,"level":"3","line":"Clinical research","number":"8.2","index":"23","fromtitle":"Thalidomide","byteoffset":70832,"anchor":"Clinical_research"},{"toclevel":1,"level":"2","line":"See also","number":"9","index":"24","fromtitle":"Thalidomide","byteoffset":74659,"anchor":"See_also"},{"toclevel":1,"level":"2","line":"References","number":"10","index":"25","fromtitle":"Thalidomide","byteoffset":74967,"anchor":"References"},{"toclevel":1,"level":"2","line":"Further reading","number":"11","index":"26","fromtitle":"Thalidomide","byteoffset":75002,"anchor":"Further_reading"},{"toclevel":1,"level":"2","line":"External links","number":"12","index":"27","fromtitle":"Thalidomide","byteoffset":75583,"anchor":"External_links"}],"parsewarnings":[],"displaytitle":"Thalidomide","iwlinks":[],"properties":[{"name":"wikibase_item","*":"Q203174"}]}}